Model	Treatment	Treatment target	Treatment type	BestResponse	Day_BestResponse	BestAvgResponse	Day_BestAvgResponse	TimeToDouble	Day_Last	ResponseCategory
X-007	BGJ398	FGFR	single	396.5	11	220.5	11	4	11	PD
X-007	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	189.1	14	77.1	11	6.2	14	PD
X-007	BYL719	PIK3CA	single	303.7	11	196.2	11	4	11	PD
X-007	BYL719 + HSP990	"PIK3CA,HSP90"	combo	-12.7	9	8.7	16	28	30	SD-->PD
X-007	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	47.9	20	40.6	13	22.8	30	PD
X-007	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	25	16	26.5	16	36.8	37	SD
X-007	HDM201	MDM2	single	330.8	11	182.8	11	4	11	PD
X-007	figitumumab	IGF1R	single	428.7	10	153.6	10	4.9	10	PD
X-007	HSP990	HSP90	single	-29.9	15	-21.8	15	28.1	29	SD-->PD
X-007	INC280	MET	single	474.6	13	202	13	3	13	PD
X-007	INC280 + trastuzumab	"ERBB2,MET"	combo	176	20	142.4	13	3	30	PD
X-007	LEE011	"CDK4,CDK6,CDK4/6"	single	405.2	11	230.5	11	4	11	PD
X-007	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-1.1	13	32.2	13	13	13	PD
X-007	LJM716	ERBB3	single	727.4	13	284.6	13	3	13	PD
X-007	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	545.6	13	265.5	13	3	13	PD
X-007	LLM871	FGFR2/4	single	458	11	213.3	11	4	11	PD
X-007	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	55.9	27	51.7	13	30	30	PD
X-007	everolimus	MTOR	single	193.1	26	68.1	12	7.4	33	PD
X-007	trastuzumab	ERBB2	single	233.6	20	51.2	13	8.1	31	PD
X-010	BGJ398	FGFR	single	-65.1	60	-5.3	112	138.3	157	SD-->-->PD
X-010	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	49.1	21	18.8	11	38.7	77	PD
X-010	BYL719	PIK3CA	single	98.5	21	12.7	11	21.6	38	PD
X-010	BYL719 + HSP990	"PIK3CA,HSP90"	combo	-10.7	10	-0.1	14	75.1	91	SD-->PD
X-010	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	342.8	21	132.8	14	5.7	21	PD
X-010	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	24	16	29	16	30	30	SD
X-010	HDM201	MDM2	single	105	20	21.5	14	18.5	42	PD
X-010	figitumumab	IGF1R	single	114.9	20	16.3	14	16.2	34	PD
X-010	HSP990	HSP90	single	382.6	14	147.1	14	7	14	PD
X-010	INC280	MET	single	307.9	21	62.1	14	11.5	21	PD
X-010	INC280 + trastuzumab	"ERBB2,MET"	combo	213.7	23	10.9	11	19.7	31	PD
X-010	LEE011	"CDK4,CDK6,CDK4/6"	single	-15.5	88	4.1	14	111	111	SD-->PD
X-010	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-45.9	26	-26.9	66	118	118	SD
X-010	LJM716	ERBB3	single	308.8	21	132.3	14	4.6	21	PD
X-010	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	185.2	26	53.1	14	12.9	48	PD
X-010	LLM871	FGFR2/4	single	-100	30	-50.1	66	144	155	CR-->-->PD
X-010	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	63.8	34	62.1	14	6.6	58	PD
X-010	everolimus	MTOR	single	140	21	33.3	11	16.5	38	PD
X-010	trastuzumab	ERBB2	single	155.2	21	21	11	14.5	46	PD
X-010	untreated	"UNKNOWN,Untreated"	single	244.3	24	19.3	12	16.9	33	PD
X-011	BGJ398	FGFR	single	182.9	20	36.3	13	14.5	24	PD
X-011	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	145.8	21	28.7	12	17.7	60	PD
X-011	BYL719	PIK3CA	single	152	21	40.3	12	11.6	60	PD
X-011	BYL719 + HSP990	"PIK3CA,HSP90"	combo	37.2	20	10.6	15	29.5	69	PD
X-011	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	19	25	7	11	25	25	SD
X-011	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-23	13	-9.9	20	30	30	SD
X-011	HDM201	MDM2	single	116.9	22	40.8	12	18.6	26	PD
X-011	figitumumab	IGF1R	single	133.8	22	19.3	12	18.7	26	PD
X-011	HSP990	HSP90	single	369.4	20	86.1	13	8.3	24	PD
X-011	INC280	MET	single	114.7	20	34.2	13	18.7	30	PD
X-011	INC280 + trastuzumab	"ERBB2,MET"	combo	38.8	20	34.5	13	28.7	30	PD
X-011	LEE011	"CDK4,CDK6,CDK4/6"	single	79.4	20	24.8	13	21.5	24	PD
X-011	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	122.7	23	33.9	13	17.9	42	PD
X-011	LJM716	ERBB3	single	155.8	20	36.7	13	15.8	30	PD
X-011	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	150.7	23	28.8	13	15.6	30	PD
X-011	LLM871	FGFR2/4	single	400.4	20	101.3	13	6.6	24	PD
X-011	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	78.8	34	14.2	13	27.9	68	PD
X-011	everolimus	MTOR	single	63	25	20.3	11	29	29	PD
X-011	trastuzumab	ERBB2	single	395.1	20	85.2	13	7.5	24	PD
X-015	BGJ398	FGFR	single	290.3	21	31.4	11	11.1	48	PD
X-015	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	110.2	21	11.9	11	15.9	52	PD
X-015	BYL719	PIK3CA	single	16.3	12	7.4	12	44.3	67	SD-->PD
X-015	BYL719 + HSP990	"PIK3CA,HSP90"	combo	72.1	25	31.5	14	26.4	61	PD
X-015	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-100	136	-50.8	136	136	136	CR
X-015	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	74	21	11	14	24.2	41	PD
X-015	HDM201	MDM2	single	250.9	12	121.6	12	5.5	12	PD
X-015	figitumumab	IGF1R	single	-22.6	12	-22.7	12	38.4	75	SD-->PD
X-015	HSP990	HSP90	single	124.9	20	39.1	14	18.2	63	PD
X-015	INC280	MET	single	317.4	23	97.8	11	6.1	31	PD
X-015	INC280 + trastuzumab	"ERBB2,MET"	combo	388.8	23	71.8	11	8.9	31	PD
X-015	LEE011	"CDK4,CDK6,CDK4/6"	single	101.5	20	39.7	14	19.7	63	PD
X-015	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	13.7	16	24.2	16	30	30	SD-->PD
X-015	LJM716	ERBB3	single	217.2	23	34.3	14	15.9	27	PD
X-015	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	108.9	23	2	11	17.5	27	PD
X-015	LLM871	FGFR2/4	single	155	20	50.8	14	11.6	42	PD
X-015	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-82.7	30	-55.6	37	90.9	105	PR-->PD
X-015	everolimus	MTOR	single	114.4	21	28.1	11	18.4	52	PD
X-015	trastuzumab	ERBB2	single	83.6	20	9.5	14	21.3	94	PD
X-015	untreated	"UNKNOWN,Untreated"	single	148	24	24.4	12	20.4	71	PD
X-017	BGJ398	FGFR	single	-79.5	135	-22.2	177	177	177	PR-->PD
X-017	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	75.6	20	15.3	12	36.7	111	PD
X-017	BYL719	PIK3CA	single	5.7	16	2.3	12	83.6	125	SD-->PD
X-017	BYL719 + HSP990	"PIK3CA,HSP90"	combo	-21.6	9	-12.3	16	47.2	97	SD-->PD
X-017	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-29.3	16	-5.4	20	78.1	87	SD-->PD
X-017	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	3.3	10	6.4	18	60.6	102	SD-->PD
X-017	HDM201	MDM2	single	40.7	74	27.3	14	85.2	105	PD
X-017	figitumumab	IGF1R	single	58.6	26	36.8	14	34.9	119	PD
X-017	HSP990	HSP90	single	409.1	20	163	14	5.2	34	PD
X-017	INC280	MET	single	50.7	21	8.1	14	34.4	75	PD
X-017	INC280 + trastuzumab	"ERBB2,MET"	combo	110.9	21	74.8	14	10.8	32	PD
X-017	LEE011	"CDK4,CDK6,CDK4/6"	single	51.6	31	17.1	14	43.3	105	PD
X-017	LJM716	ERBB3	single	146.7	36	104.2	14	7.1	42	PD
X-017	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	57.8	20	38.7	13	22.9	27	PD
X-017	LLM871	FGFR2/4	single	-78.5	196	15.8	15	196	196	SD-->PD
X-017	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	5.7	21	16.3	21	38.3	61	SD-->PD
X-017	everolimus	MTOR	single	8.5	12	9.5	12	48.3	141	SD-->PD
X-017	trastuzumab	ERBB2	single	354.9	20	110.8	14	6	20	PD
X-017	untreated	"UNKNOWN,Untreated"	single	25.4	12	12.7	12	90.5	130	SD
X-020	BGJ398	FGFR	single	179.4	21	35.9	12	12.1	33	PD
X-020	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	54.4	25	40.9	12	33.6	64	PD
X-020	BYL719	PIK3CA	single	15	12	16.8	12	43.2	109	SD
X-020	BYL719 + HSP990	"PIK3CA,HSP90"	combo	50.8	26	21.6	11	36.6	63	PD
X-020	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-64.2	39	-43.2	92	99	99	PR-->-->PD
X-020	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-18.6	17	-10.9	28	100.5	105	SD-->-->PD
X-020	HDM201	MDM2	single	99.7	25	15.2	12	20.8	95	PD
X-020	figitumumab	IGF1R	single	218.4	21	38.7	12	11.5	29	PD
X-020	HSP990	HSP90	single	1.3	12	-4.5	12	30.6	60	SD-->PD
X-020	INC280	MET	single	23	17	34.7	17	85.6	86	PD
X-020	INC280 + trastuzumab	"ERBB2,MET"	combo	124.7	22	26.9	11	19.8	49	PD
X-020	LEE011	"CDK4,CDK6,CDK4/6"	single	75	25	37.4	12	34.3	64	PD
X-020	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-33.6	32	-14.7	63	80	80	SD-->-->PD
X-020	LJM716	ERBB3	single	54	24	46	14	37.7	55	PD
X-020	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	15.1	9	14.9	14	14	14	SD
X-020	LLM871	FGFR2/4	single	136.8	25	30.1	12	18.4	44	PD
X-020	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-63.6	155	1.4	155	155	155	SD
X-020	everolimus	MTOR	single	141.9	21	46.4	12	14.4	44	PD
X-020	trastuzumab	ERBB2	single	16.8	21	1.6	12	33.2	55	SD-->PD
X-020	untreated	"UNKNOWN,Untreated"	single	22.1	46	31.1	12	58.3	130	PD
X-023	BYL719	PIK3CA	single	-40.4	24	-8.8	42	49	49	SD
X-023	BYL719 + HSP990	"PIK3CA,HSP90"	combo	-34.6	53	-18.8	88	112.4	115	SD-->-->PD
X-023	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-18.6	7	-1.4	7	7	7	SD
X-023	HSP990	HSP90	single	122.3	21	55.6	14	12.5	64	PD
X-023	LEE011	"CDK4,CDK6,CDK4/6"	single	-20.6	42	18.1	64	91	91	SD-->PD
X-023	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-58.6	9	-32.2	13	30	30	PR
X-023	LJM716	ERBB3	single	38.5	71	35.2	14	15.1	74	PD
X-023	everolimus	MTOR	single	-66.6	21	-41.7	29	91	91	PR-->PD
X-023	untreated	"UNKNOWN,Untreated"	single	39.4	21	17.5	14	23.4	35	PD
X-024	BYL719	PIK3CA	single	4.1	18	15	18	40.2	122	SD-->PD
X-024	BYL719 + HSP990	"PIK3CA,HSP90"	combo	-77.6	41	-45.2	41	41	41	PR
X-024	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	64.9	21	6.6	14	22.4	36	PD
X-024	HSP990	HSP90	single	107.9	21	27	11	19.8	59	PD
X-024	LEE011	"CDK4,CDK6,CDK4/6"	single	92.9	21	13.8	11	23.4	66	PD
X-024	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-28.3	31	-17.1	39	42	42	SD-->PD
X-024	LJM716	ERBB3	single	93.4	24	20	14	15.5	42	PD
X-024	everolimus	MTOR	single	-13.3	27	8.2	27	122	122	SD-->PD
X-024	untreated	"UNKNOWN,Untreated"	single	226.6	20	52.6	13	9.8	31	PD
X-025	BGJ398	FGFR	single	-38.9	49	-18.4	49	111	111	SD
X-025	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-36.3	14	-21.5	20	20	20	SD
X-025	BYL719	PIK3CA	single	2.8	37	0.5	14	195	218	SD-->PD
X-025	BYL719 + HSP990	"PIK3CA,HSP90"	combo	-35.1	19	-5.7	51	139	139	SD-->-->PD
X-025	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	32.6	27	21.4	14	51	51	SD
X-025	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-30.2	27	5.1	51	51	51	SD
X-025	HDM201	MDM2	single	0.3	37	7.7	14	37	37	SD-->PD
X-025	figitumumab	IGF1R	single	26.9	14	14.3	14	39.1	58	SD-->PD
X-025	HSP990	HSP90	single	81.6	33	36.5	14	34.4	41	PD
X-025	INC280	MET	single	61.4	30	32.3	14	34.9	51	PD
X-025	INC280 + trastuzumab	"ERBB2,MET"	combo	13.9	9	11.6	14	64.8	84	SD-->PD
X-025	LEE011	"CDK4,CDK6,CDK4/6"	single	0	16	-2	12	156.7	183	SD-->PD
X-025	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-18	21	-1.8	36	36	36	SD
X-025	LJM716	ERBB3	single	-9.6	9	-13.3	14	53.7	105	SD-->PD
X-025	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	-27	9	-9.1	14	45.6	51	SD-->PD
X-025	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-38.9	27	-25.3	30	127.3	139	SD-->PD
X-025	everolimus	MTOR	single	6	12	12.6	12	119.5	125	SD-->PD
X-025	trastuzumab	ERBB2	single	92.3	20	40.7	12	21.3	80	PD
X-025	untreated	"UNKNOWN,Untreated"	single	46.1	25	19	18	25	165	PD
X-027	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	205.8	20	41.6	13	11.8	27	PD
X-027	BYL719	PIK3CA	single	-78.2	145	-56.3	153	153	153	PR
X-027	BYL719 + HSP990	"PIK3CA,HSP90"	combo	-64.6	20	-36.2	27	27	27	PR
X-027	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-27.2	10	-4.6	17	35	35	SD-->PD
X-027	HDM201	MDM2	single	13.3	28	17.4	14	28	28	SD
X-027	figitumumab	IGF1R	single	14.6	28	31.3	28	28	28	PD
X-027	LEE011	"CDK4,CDK6,CDK4/6"	single	-25.7	28	-5.2	28	28	28	SD
X-027	LJM716	ERBB3	single	-55.4	29	-25.6	50	50	50	PR
X-027	LLM871	FGFR2/4	single	307.3	21	54.5	14	12.9	24	PD
X-027	trastuzumab	ERBB2	single	-100	77	-83	309	309	309	CR
X-028	BGJ398	FGFR	single	119.2	17	75.7	13	10.6	17	PD
X-028	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	10.8	20	1.6	13	34	34	SD-->PD
X-028	BYL719	PIK3CA	single	67.4	29	32.1	11	34.3	84	PD
X-028	BYL719 + HSP990	"PIK3CA,HSP90"	combo	260.8	20	64.5	15	9	34	PD
X-028	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	19.5	22	-5.8	13	35.1	37	SD-->PD
X-028	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	2.1	9	2.6	14	46.4	69	SD-->PD
X-028	HDM201	MDM2	single	71.3	20	-0.2	13	28.5	31	PD
X-028	figitumumab	IGF1R	single	151.4	22	45.5	15	18.5	33	PD
X-028	HSP990	HSP90	single	-18.1	10	-9.6	13	13	13	SD
X-028	INC280	MET	single	226.9	22	54.6	14	12.1	28	PD
X-028	INC280 + trastuzumab	"ERBB2,MET"	combo	160.6	30	54.9	14	12.2	30	PD
X-028	LEE011	"CDK4,CDK6,CDK4/6"	single	82.4	27	19.4	13	29.1	31	PD
X-028	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	74.4	17	31.5	13	17	17	PD
X-028	LJM716	ERBB3	single	146.1	22	60.6	13	18.4	29	PD
X-028	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	-24.9	54	-19.6	13	54	54	SD
X-028	LLM871	FGFR2/4	single	95.3	20	23	13	15.8	34	PD
X-028	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	110.6	20	50.1	14	18	30	PD
X-028	everolimus	MTOR	single	2.6	15	0.1	12	33	33	SD-->PD
X-028	trastuzumab	ERBB2	single	75.1	24	14	13	28.7	31	PD
X-029	BGJ398	FGFR	single	364	11	131.5	11	7	11	PD
X-029	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	266.3	18	57.5	11	8.9	18	PD
X-029	BYL719	PIK3CA	single	130	21	19	11	16.5	29	PD
X-029	BYL719 + HSP990	"PIK3CA,HSP90"	combo	126.2	12	58	12	10.1	12	PD
X-029	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	291.2	15	160.5	12	5	15	PD
X-029	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	204	12	81.2	12	8.4	12	PD
X-029	HDM201	MDM2	single	297.9	18	48.5	11	11.2	18	PD
X-029	figitumumab	IGF1R	single	351.6	11	144.2	11	5	11	PD
X-029	HSP990	HSP90	single	114.4	9	50.6	9	7.8	9	PD
X-029	INC280	MET	single	307.4	12	137.7	12	5.8	12	PD
X-029	INC280 + trastuzumab	"ERBB2,MET"	combo	312.1	12	168.3	12	5	12	PD
X-029	LEE011	"CDK4,CDK6,CDK4/6"	single	121	20	52.6	13	18.1	24	PD
X-029	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	302.5	22	51.2	12	12.4	33	PD
X-029	LLM871	FGFR2/4	single	347.7	12	186.5	12	5	12	PD
X-029	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-6.1	15	-6.5	12	33	33	SD-->PD
X-029	everolimus	MTOR	single	167.1	18	34.3	11	14.5	18	PD
X-029	trastuzumab	ERBB2	single	234.8	20	110.7	13	3.6	24	PD
X-031	BGJ398	FGFR	single	265.3	21	49.9	12	11.2	33	PD
X-031	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	8.6	16	4.4	12	71.3	95	SD-->PD
X-031	BYL719	PIK3CA	single	-20.4	16	-10.8	16	52.6	77	SD-->PD
X-031	BYL719 + HSP990	"PIK3CA,HSP90"	combo	178.6	22	37.8	13	13.8	41	PD
X-031	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-8.3	55	5.9	14	63	63	SD
X-031	HDM201	MDM2	single	97.2	25	15.7	12	20.8	64	PD
X-031	figitumumab	IGF1R	single	464.5	23	60	11	9.2	23	PD
X-031	HSP990	HSP90	single	184.4	23	27.5	11	13.6	39	PD
X-031	INC280	MET	single	68.4	27	10.2	13	38.1	62	PD
X-031	INC280 + trastuzumab	"ERBB2,MET"	combo	266.8	14	109.7	14	6.4	14	PD
X-031	LEE011	"CDK4,CDK6,CDK4/6"	single	31.3	21	17.3	12	43.3	95	SD-->PD
X-031	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	143.7	23	35.8	13	12.9	42	PD
X-031	LJM716	ERBB3	single	-15	26	22.5	26	8.5	34	SD
X-031	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	194.3	23	55	13	11.3	23	PD
X-031	LLM871	FGFR2/4	single	137.7	23	35.1	11	14	39	PD
X-031	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	83.7	22	15.5	13	26.7	68	PD
X-031	everolimus	MTOR	single	24.3	9	18.7	13	47.6	93	SD
X-031	trastuzumab	ERBB2	single	98.9	23	12.1	11	23.1	44	PD
X-031	untreated	"UNKNOWN,Untreated"	single	-1	12	-0.5	12	69.3	130	SD-->PD
X-034	BGJ398	FGFR	single	42.2	21	24.8	11	32	32	PD
X-034	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	12.6	12	5.3	12	48	90	SD-->PD
X-034	BYL719	PIK3CA	single	-4.6	32	2.2	21	32	32	SD
X-034	BYL719 + HSP990	"PIK3CA,HSP90"	combo	-31.1	37	-15.3	37	37	37	SD
X-034	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	20.2	31	15.9	14	24.8	35	SD-->PD
X-034	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	56.3	31	45.4	17	24.4	35	PD
X-034	HDM201	MDM2	single	60.7	25	16.1	11	32	32	PD
X-034	figitumumab	IGF1R	single	15.9	14	7.4	11	32	32	SD-->PD
X-034	HSP990	HSP90	single	22.4	12	7.2	12	53.8	91	SD-->PD
X-034	INC280	MET	single	73.9	21	21	14	25.7	29	PD
X-034	INC280 + trastuzumab	"ERBB2,MET"	combo	13.7	22	14.1	14	35	35	SD-->PD
X-034	LEE011	"CDK4,CDK6,CDK4/6"	single	3	11	-0.9	11	32	32	SD-->PD
X-034	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-39.4	24	-12.9	34	34	34	SD
X-034	LJM716	ERBB3	single	62.8	21	15.4	14	24.7	29	PD
X-034	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	81.3	31	23.4	14	21.9	35	PD
X-034	LLM871	FGFR2/4	single	104	25	-2.2	11	19.8	32	PD
X-034	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	27.6	19	20	11	35.6	37	SD
X-034	everolimus	MTOR	single	-15	28	4.9	32	266	266	SD-->-->PD
X-034	trastuzumab	ERBB2	single	116.3	21	10	11	19.2	32	PD
X-035	BGJ398	FGFR	single	303.1	20	53.3	13	11.2	31	PD
X-035	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-3.9	34	3.5	13	62	62	SD-->PD
X-035	BYL719	PIK3CA	single	-80.3	69	-46.3	105	135.3	156	PR-->-->PD
X-035	BYL719 + HSP990	"PIK3CA,HSP90"	combo	19.6	32	37.6	11	51.4	63	PD
X-035	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-94.4	63	-64.1	66	66	66	PR
X-035	HDM201	MDM2	single	96.7	20	35.1	13	23.2	34	PD
X-035	figitumumab	IGF1R	single	294.8	20	63.2	13	9.3	24	PD
X-035	HSP990	HSP90	single	2.3	10	2.2	14	28	28	SD-->PD
X-035	INC280 + trastuzumab	"ERBB2,MET"	combo	-100	65	-77	97	97	97	CR
X-035	LEE011	"CDK4,CDK6,CDK4/6"	single	-100	97	-72.6	223	320.3	330	CR-->-->PD
X-035	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-100	97	-77.6	97	97	97	CR
X-035	LJM716	ERBB3	single	-15.5	14	13.2	28	42	42	SD
X-035	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	36.8	31	3.1	15	31	31	PD
X-035	LLM871	FGFR2/4	single	114.1	22	31.2	12	16.5	33	PD
X-035	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	10.8	23	32	14	30	30	PD
X-035	everolimus	MTOR	single	-84.4	89	-52.1	97	138.1	148	PR-->-->PD
X-035	trastuzumab	ERBB2	single	-88	94	-15.1	136	10.9	220	SD-->-->PD
X-037	BGJ398	FGFR	single	75.4	20	13.2	13	24.5	58	PD
X-037	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-97.6	201	-23	201	201	201	PR
X-037	BYL719	PIK3CA	single	-8.1	69	14.9	13	122	122	SD-->PD
X-037	BYL719 + HSP990	"PIK3CA,HSP90"	combo	72.2	23	16.6	13	27.1	42	PD
X-037	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	178.5	23	34.9	13	17.4	31	PD
X-037	HDM201	MDM2	single	118.2	25	32.2	12	18.4	43	PD
X-037	figitumumab	IGF1R	single	155.1	20	38.5	13	15.4	43	PD
X-037	HSP990	HSP90	single	132.2	20	33.2	13	17.8	53	PD
X-037	INC280	MET	single	-78.8	73	28.4	73	23.4	73	SD
X-037	INC280 + trastuzumab	"ERBB2,MET"	combo	328.5	23	86.5	13	6.3	23	PD
X-037	LEE011	"CDK4,CDK6,CDK4/6"	single	18	20	7.2	13	68.8	122	SD-->PD
X-037	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-86.6	52	-29.4	60	60	60	PR
X-037	LJM716	ERBB3	single	287	23	73.5	13	7.5	23	PD
X-037	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	192.2	23	46	13	12.1	23	PD
X-037	LLM871	FGFR2/4	single	-100	83	-29.4	151	151	151	PR
X-037	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	34.2	34	47.5	13	56	56	PD
X-037	everolimus	MTOR	single	48.8	25	20.7	12	33.5	85	PD
X-037	trastuzumab	ERBB2	single	214.2	20	57	13	11.9	38	PD
X-037	untreated	"UNKNOWN,Untreated"	single	147.3	36	41	12	18.6	90	PD
X-038	BGJ398	FGFR	single	108	21	19.7	14	19.7	24	PD
X-038	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	20	28	27.7	14	42.6	112	SD
X-038	BYL719	PIK3CA	single	100.2	21	22.4	14	21	24	PD
X-038	BYL719 + HSP990	"PIK3CA,HSP90"	combo	-53.6	35	-27.1	44	97	97	PR-->PD
X-038	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	172.7	21	19.9	12	13.8	32	PD
X-038	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	120	25	52.1	13	12.5	52	PD
X-038	HDM201	MDM2	single	36.8	14	34.6	14	14	14	PD
X-038	figitumumab	IGF1R	single	160.9	35	31	11	14.9	66	PD
X-038	HSP990	HSP90	single	21.9	48	10.4	11	64.7	109	SD-->PD
X-038	INC280	MET	single	102.9	20	20.2	13	19.4	52	PD
X-038	INC280 + trastuzumab	"ERBB2,MET"	combo	180.9	20	44.9	13	12.8	45	PD
X-038	LEE011	"CDK4,CDK6,CDK4/6"	single	250.7	21	97.9	11	4.7	41	PD
X-038	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-47.4	12	-22.3	21	32	32	SD
X-038	LJM716	ERBB3	single	97.4	21	14.4	12	17.3	60	PD
X-038	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	98.9	20	30.1	13	16.4	52	PD
X-038	LLM871	FGFR2/4	single	380.5	21	42.7	11	10.9	25	PD
X-038	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	60	28	18	13	33.7	52	PD
X-038	everolimus	MTOR	single	-56.7	80	-25	129	129	129	PR-->PD
X-038	trastuzumab	ERBB2	single	50.6	23	16.5	13	33.7	36	PD
X-038	untreated	"UNKNOWN,Untreated"	single	145.8	21	41	12	12.9	60	PD
X-039	BYL719	PIK3CA	single	380.2	22	111	12	6	26	PD
X-039	BYL719 + HSP990	"PIK3CA,HSP90"	combo	148.4	22	34.8	12	16.8	33	PD
X-039	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	179	20	28.6	13	14.5	34	PD
X-039	HSP990	HSP90	single	390.7	22	69.4	12	9.2	33	PD
X-039	LEE011	"CDK4,CDK6,CDK4/6"	single	89.7	22	49.8	12	13.3	67	PD
X-039	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	73.6	23	59.9	13	12.2	55	PD
X-039	LJM716	ERBB3	single	188.6	21	31.4	14	14.9	28	PD
X-039	everolimus	MTOR	single	0.7	19	11.7	19	28.9	60	SD-->PD
X-039	untreated	"UNKNOWN,Untreated"	single	341.9	21	118.9	14	5	24	PD
X-050	BYL719	PIK3CA	single	89.7	20	33.9	11	21	38	PD
X-050	BYL719 + HSP990	"PIK3CA,HSP90"	combo	27.2	14	15.3	14	26.4	49	SD-->PD
X-050	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-92.9	25	-66	54	54	54	PR
X-050	HSP990	HSP90	single	164.4	20	36.7	12	13.9	40	PD
X-050	LEE011	"CDK4,CDK6,CDK4/6"	single	-24.9	7	-10.7	7	7	7	SD
X-050	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-31.2	9	-19.5	27	86	86	SD-->PD
X-050	LJM716	ERBB3	single	-41.7	70	-5.2	11	77	77	SD-->PD
X-050	everolimus	MTOR	single	1.6	12	4.8	12	31.9	76	SD-->PD
X-050	untreated	"UNKNOWN,Untreated"	single	237	21	46	11	11.9	46	PD
X-055	untreated	"UNKNOWN,Untreated"	single	212.1	21	46.6	11	10	28	PD
X-056	BGJ398	FGFR	single	198.8	21	25.9	11	13.5	48	PD
X-056	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-0.8	14	-2.9	11	44	44	SD
X-056	BYL719	PIK3CA	single	-12	38	15.6	12	38	38	SD-->PD
X-056	BYL719 + HSP990	"PIK3CA,HSP90"	combo	5.1	28	-1.6	12	28	28	SD
X-056	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	0.7	12	8	12	51.1	78	SD-->PD
X-056	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	77.3	22	16.7	12	25.6	28	PD
X-056	HDM201	MDM2	single	102	22	31.3	12	21.7	26	PD
X-056	figitumumab	IGF1R	single	-100	137	-6.7	209	18.6	209	SD-->PD
X-056	HSP990	HSP90	single	195.5	21	57.3	14	11.6	33	PD
X-056	INC280	MET	single	141.5	24	-0.3	11	18.2	49	PD
X-056	INC280 + trastuzumab	"ERBB2,MET"	combo	60.6	22	16.3	15	41.8	60	PD
X-056	LEE011	"CDK4,CDK6,CDK4/6"	single	-100	58	-75.9	194	194	194	CR
X-056	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-3.9	12	4.9	12	22	22	SD
X-056	LJM716	ERBB3	single	133	21	26.3	14	16.2	34	PD
X-056	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	66.6	37	31.7	14	22.5	48	PD
X-056	LLM871	FGFR2/4	single	154.2	21	37.3	14	15.1	85	PD
X-056	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-88.6	81	-64.4	113	158	158	PR-->-->PD
X-056	everolimus	MTOR	single	69.6	21	13.4	11	23.3	32	PD
X-056	trastuzumab	ERBB2	single	92.9	22	6.5	12	22.9	54	PD
X-056	untreated	"UNKNOWN,Untreated"	single	155.8	24	42.2	12	19.8	66	PD
X-057	BGJ398	FGFR	single	277.7	18	40.1	11	11.1	18	PD
X-057	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-3.8	11	-3.8	11	36	36	SD-->PD
X-057	BYL719	PIK3CA	single	61.4	21	11.9	11	25	25	PD
X-057	BYL719 + HSP990	"PIK3CA,HSP90"	combo	-10.8	29	-19.1	12	33	33	SD-->PD
X-057	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	26.5	33	-4.2	12	33	33	SD-->PD
X-057	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	3.2	15	8.5	15	29	29	SD-->PD
X-057	HDM201	MDM2	single	287.9	18	57	11	8.8	18	PD
X-057	figitumumab	IGF1R	single	324.7	21	51	11	10	25	PD
X-057	HSP990	HSP90	single	170.1	20	30.7	13	16.6	24	PD
X-057	INC280	MET	single	325.2	21	69	14	10.8	42	PD
X-057	INC280 + trastuzumab	"ERBB2,MET"	combo	316.2	21	60.4	14	11.6	24	PD
X-057	LEE011	"CDK4,CDK6,CDK4/6"	single	252.1	21	65.4	11	7.8	25	PD
X-057	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	10.7	30	14.3	13	30	30	SD-->PD
X-057	LJM716	ERBB3	single	10.7	15	-5.9	12	29.6	33	SD-->PD
X-057	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	239.2	22	28.5	12	14.5	29	PD
X-057	LLM871	FGFR2/4	single	-100	27	-92.2	288	288	288	CR
X-057	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	107.9	14	41.1	14	13.3	14	PD
X-057	everolimus	MTOR	single	17.3	18	3.6	11	39	39	SD-->PD
X-057	trastuzumab	ERBB2	single	263	21	20.7	11	12.8	25	PD
X-064	BGJ398	FGFR	single	163.1	22	23.4	12	17.2	26	PD
X-064	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-18	12	-9.2	12	26	26	SD-->PD
X-064	BYL719	PIK3CA	single	-11.8	12	-4.7	12	33	33	SD-->PD
X-064	BYL719 + HSP990	"PIK3CA,HSP90"	combo	8.1	25	11.4	11	28	28	SD
X-064	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	25.8	11	11.5	11	14	14	SD
X-064	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-4.5	13	-0.8	13	54.4	58	SD-->PD
X-064	HDM201	MDM2	single	-28.7	12	-12.8	16	26	26	SD-->PD
X-064	figitumumab	IGF1R	single	387.6	22	69.8	12	9.2	26	PD
X-064	HSP990	HSP90	single	105.1	20	66.6	13	11.1	31	PD
X-064	INC280	MET	single	14.2	12	2.1	12	15	15	SD-->PD
X-064	INC280 + trastuzumab	"ERBB2,MET"	combo	-76	19	-45.4	29	36	36	PR-->PD
X-064	LEE011	"CDK4,CDK6,CDK4/6"	single	-42.3	42	-25.2	42	125	125	SD-->PD
X-064	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	27.6	26	22.6	11	27	33	SD
X-064	LJM716	ERBB3	single	112.2	22	46.8	12	9.8	26	PD
X-064	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	293.9	20	96	13	8.7	20	PD
X-064	LLM871	FGFR2/4	single	124.7	20	23.8	13	18.6	31	PD
X-064	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-43.2	5	-13	5	5	5	SD
X-064	everolimus	MTOR	single	48.3	22	5.7	12	26	26	PD
X-064	trastuzumab	ERBB2	single	449.5	22	56.5	12	10.3	26	PD
X-065	BGJ398	FGFR	single	123	20	22.9	16	18.6	52	PD
X-065	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-31.8	23	-12.2	23	41	41	SD
X-065	BYL719	PIK3CA	single	-30.5	23	-13.9	23	104.4	127	SD-->PD
X-065	BYL719 + HSP990	"PIK3CA,HSP90"	combo	-64.1	89	-20.4	106	106	106	PR-->PD
X-065	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-87.5	82	-62.9	111	141.7	168	PR-->-->PD
X-065	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-91	38	0.8	38	144.5	155	SD-->-->PD
X-065	HDM201	MDM2	single	29.1	14	32	14	14	14	PD
X-065	figitumumab	IGF1R	single	106.3	23	21.5	12	22	59	PD
X-065	HSP990	HSP90	single	62.1	20	12.7	15	41.4	98	PD
X-065	INC280	MET	single	66.1	27	23.1	13	17.4	41	PD
X-065	INC280 + trastuzumab	"ERBB2,MET"	combo	79.4	21	20.2	14	23.5	42	PD
X-065	LEE011	"CDK4,CDK6,CDK4/6"	single	421.9	29	65.7	14	10.6	42	PD
X-065	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	4.6	13	7.8	13	36.8	97	SD-->PD
X-065	LJM716	ERBB3	single	4.1	9	17.4	15	46.4	75	SD-->PD
X-065	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	-100	86	-52.7	86	86	86	CR
X-065	LLM871	FGFR2/4	single	-2.2	12	-6.2	12	65.4	116	SD-->PD
X-065	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	122.8	22	25.3	13	17.1	41	PD
X-065	everolimus	MTOR	single	-39.4	18	-17.1	34	116.6	127	SD-->PD
X-065	trastuzumab	ERBB2	single	-4.5	12	-2.7	12	37.3	89	SD-->PD
X-065	untreated	"UNKNOWN,Untreated"	single	402.7	36	43.3	12	13	68	PD
X-067	BGJ398	FGFR	single	67.4	25	13.1	11	33.1	96	PD
X-067	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-22.9	25	-5.9	25	25	25	SD
X-067	BYL719	PIK3CA	single	55	30	27.3	11	42.5	96	PD
X-067	BYL719 + HSP990	"PIK3CA,HSP90"	combo	73.3	22	26.9	13	29.4	68	PD
X-067	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	60.9	21	43.5	14	26.3	45	PD
X-067	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-24.6	126	13.9	14	155	155	SD-->-->PD
X-067	HDM201	MDM2	single	64	30	12.2	11	45.8	96	PD
X-067	figitumumab	IGF1R	single	108.2	25	6.1	11	24	66	PD
X-067	HSP990	HSP90	single	63.2	25	23.1	11	30	30	PD
X-067	INC280	MET	single	7	13	4.1	13	19	19	SD
X-067	INC280 + trastuzumab	"ERBB2,MET"	combo	216.9	20	44	15	13	34	PD
X-067	LEE011	"CDK4,CDK6,CDK4/6"	single	50	25	22.9	11	49.4	80	PD
X-067	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	10.2	45	28.7	56	56	56	SD
X-067	LJM716	ERBB3	single	290.2	15	122	15	7.1	15	PD
X-067	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	127.4	20	33.6	15	17.9	34	PD
X-067	LLM871	FGFR2/4	single	18.1	12	3.8	12	47.6	116	SD-->PD
X-067	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-9.3	13	-6.6	13	85.9	96	SD-->PD
X-067	everolimus	MTOR	single	16.7	14	21.7	14	76.2	109	SD-->PD
X-067	trastuzumab	ERBB2	single	-34.1	12	-18.7	28	63.7	89	SD-->PD
X-074	BYL719	PIK3CA	single	92.4	22	25.7	12	22.5	54	PD
X-074	BYL719 + HSP990	"PIK3CA,HSP90"	combo	24.6	22	6.6	12	35.1	88	SD-->PD
X-074	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	2.4	9	12	16	45.6	69	SD-->PD
X-074	HSP990	HSP90	single	243.7	22	42.2	12	12.5	57	PD
X-074	LEE011	"CDK4,CDK6,CDK4/6"	single	356.8	22	101.8	12	6.2	33	PD
X-074	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-12.8	10	-8.9	14	77.1	113	SD-->PD
X-074	LJM716	ERBB3	single	280.9	21	40	14	14.1	24	PD
X-074	everolimus	MTOR	single	99.3	22	36.7	12	17.6	57	PD
X-074	untreated	"UNKNOWN,Untreated"	single	101.8	21	24.9	14	14.9	42	PD
X-075	BGJ398	FGFR	single	159.4	21	10.6	14	18.1	28	PD
X-075	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	194.6	20	32.8	12	13.1	45	PD
X-075	BYL719	PIK3CA	single	105	20	14.1	12	19.6	49	PD
X-075	BYL719 + HSP990	"PIK3CA,HSP90"	combo	10.5	9	19.3	13	30	30	SD
X-075	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-33.5	38	-8.3	41	48	48	SD
X-075	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	112.6	20	42.7	14	17.9	30	PD
X-075	HDM201	MDM2	single	238.7	20	43.6	12	10.2	49	PD
X-075	figitumumab	IGF1R	single	11	22	25.1	12	24.5	33	SD-->PD
X-075	HSP990	HSP90	single	206.1	25	22.3	12	17.9	44	PD
X-075	INC280	MET	single	119.9	20	42.6	14	18.2	30	PD
X-075	INC280 + trastuzumab	"ERBB2,MET"	combo	108.1	20	52.9	14	15.1	27	PD
X-075	LEE011	"CDK4,CDK6,CDK4/6"	single	54.8	20	7.3	12	22.6	64	PD
X-075	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	35.7	22	11.1	11	36.8	62	PD
X-075	LJM716	ERBB3	single	198.9	20	46.5	13	11.5	25	PD
X-075	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	2.8	13	1.2	13	29	29	SD-->PD
X-075	LLM871	FGFR2/4	single	119.1	26	21.6	12	20.3	33	PD
X-075	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	71.2	23	5.4	13	33.5	56	PD
X-075	everolimus	MTOR	single	142	20	8.8	12	15	41	PD
X-075	trastuzumab	ERBB2	single	28.2	18	-1.3	11	28	32	SD-->PD
X-077	BGJ398	FGFR	single	77.6	20	5.4	14	26.6	63	PD
X-077	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	9.3	10	8.1	14	73	73	SD-->PD
X-077	BYL719	PIK3CA	single	-22.6	10	-11.5	14	57.9	107	SD-->PD
X-077	BYL719 + HSP990	"PIK3CA,HSP90"	combo	40.9	27	53.7	30	13.6	70	PD
X-077	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	280.4	21	49.2	14	11.1	34	PD
X-077	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	244.6	22	41.6	11	13.3	29	PD
X-077	HDM201	MDM2	single	144.3	22	53.6	12	10.6	32	PD
X-077	figitumumab	IGF1R	single	356.9	22	75.1	12	9.1	32	PD
X-077	HSP990	HSP90	single	181	21	54.1	14	11.7	49	PD
X-077	INC280	MET	single	202.8	22	32.2	11	12.8	29	PD
X-077	INC280 + trastuzumab	"ERBB2,MET"	combo	108.7	34	8	11	21.7	45	PD
X-077	LEE011	"CDK4,CDK6,CDK4/6"	single	164.9	22	60.2	12	10.2	32	PD
X-077	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-47.3	11	-31.8	11	66	66	SD-->PD
X-077	LJM716	ERBB3	single	218.2	23	2.6	11	15.5	31	PD
X-077	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	156.5	21	35.8	14	15.3	21	PD
X-077	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	17.1	48	36.6	14	72.1	77	PD
X-077	everolimus	MTOR	single	-39.6	42	-23.9	51	78	78	SD
X-077	trastuzumab	ERBB2	single	-50.3	26	4.8	32	50.7	119	SD-->PD
X-077	untreated	"UNKNOWN,Untreated"	single	100.1	27	54.4	13	16.5	82	PD
X-078	BYL719	PIK3CA	single	117.3	26	18.7	13	19.9	57	PD
X-078	BYL719 + HSP990	"PIK3CA,HSP90"	combo	-23.4	12	-10.1	12	36.7	67	SD-->PD
X-078	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-38.5	10	-18	14	38.5	63	SD-->PD
X-078	HSP990	HSP90	single	294.5	22	22.1	12	13.7	33	PD
X-078	LEE011	"CDK4,CDK6,CDK4/6"	single	170.1	22	47.2	12	15.3	33	PD
X-078	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	42.6	20	21.5	13	23	23	PD
X-078	LJM716	ERBB3	single	147.9	20	29.7	13	17.6	30	PD
X-078	everolimus	MTOR	single	81.4	22	24.9	12	23.5	43	PD
X-078	untreated	"UNKNOWN,Untreated"	single	314.4	21	61.7	14	11.1	28	PD
X-080	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	122.9	21	56	13	10.8	55	PD
X-080	LJM716	ERBB3	single	214.9	25	25.7	12	16.6	33	PD
X-080	untreated	"UNKNOWN,Untreated"	single	-100	25	-24.8	25	25	25	PR
X-084	BGJ398	FGFR	single	-34.6	13	-18.4	20	34	34	SD-->PD
X-084	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	8.2	16	12	16	24	24	SD-->PD
X-084	BYL719	PIK3CA	single	77.3	21	13.1	11	26	29	PD
X-084	BYL719 + HSP990	"PIK3CA,HSP90"	combo	40.3	24	24.4	14	38	38	PD
X-084	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	45.6	28	16.7	11	28	28	PD
X-084	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-13	19	-2.6	12	36	36	SD
X-084	HDM201	MDM2	single	112.2	22	25.8	11	20.3	32	PD
X-084	figitumumab	IGF1R	single	301.7	21	48.4	11	11.7	25	PD
X-084	HSP990	HSP90	single	228.7	20	67.3	13	8.7	24	PD
X-084	INC280	MET	single	150.4	22	39.6	12	13.8	40	PD
X-084	INC280 + trastuzumab	"ERBB2,MET"	combo	132.5	26	35.9	12	16	33	PD
X-084	LEE011	"CDK4,CDK6,CDK4/6"	single	108.4	20	58.5	13	8.6	24	PD
X-084	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	9.7	16	9.8	16	55.6	78	SD-->PD
X-084	LJM716	ERBB3	single	1.1	12	-2.2	12	24.1	33	SD-->PD
X-084	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	67.9	26	20.3	12	28.7	36	PD
X-084	LLM871	FGFR2/4	single	208.7	20	65.1	13	9.4	24	PD
X-084	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	67	26	31.2	12	30.8	40	PD
X-084	everolimus	MTOR	single	12.1	11	1.1	11	29	29	SD-->PD
X-084	trastuzumab	ERBB2	single	101	20	31.3	13	19.8	24	PD
X-089	BGJ398	FGFR	single	197	21	46.9	12	11.8	39	PD
X-089	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-7.9	38	0.1	12	59.9	89	SD-->PD
X-089	BYL719	PIK3CA	single	67.1	21	16.8	12	28	50	PD
X-089	BYL719 + HSP990	"PIK3CA,HSP90"	combo	-44.3	39	-3.9	49	91.2	106	SD-->-->PD
X-089	HDM201	MDM2	single	24.8	36	6.6	12	21.3	36	SD-->PD
X-089	figitumumab	IGF1R	single	202.5	23	31.6	12	14.3	28	PD
X-089	HSP990	HSP90	single	230.2	23	54.1	12	11.3	38	PD
X-089	LEE011	"CDK4,CDK6,CDK4/6"	single	-74.1	66	-44.3	96	113.9	124	PR-->-->PD
X-089	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-64.1	67	-18.7	80	80	80	SD
X-089	LJM716	ERBB3	single	-33.5	73	-0.7	84	149	149	SD-->-->PD
X-089	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	218	22	63.7	11	7.3	22	PD
X-089	LLM871	FGFR2/4	single	287.3	23	26.5	12	13.1	28	PD
X-089	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-91.6	126	14	155	16.4	155	SD
X-089	everolimus	MTOR	single	41.4	21	14.9	12	31.9	105	PD
X-089	trastuzumab	ERBB2	single	100	23	26.7	12	17.3	41	PD
X-090	BGJ398	FGFR	single	51.2	21	4.4	14	28	28	PD
X-090	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-31.2	21	-20.5	21	28	28	SD
X-090	BYL719	PIK3CA	single	-58	28	-30.5	28	28	28	PR
X-090	BYL719 + HSP990	"PIK3CA,HSP90"	combo	-100	13	-89.9	48	48	48	CR
X-090	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-28.5	22	-14.5	43	43	43	SD
X-090	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	9.5	20	14.1	14	30	30	SD
X-090	HDM201	MDM2	single	17	21	11.6	14	28	28	SD
X-090	figitumumab	IGF1R	single	60.7	22	-4.3	15	25.6	33	PD
X-090	HSP990	HSP90	single	-59.2	28	-28.1	28	28	28	PR
X-090	INC280	MET	single	50.1	29	-5	11	32	32	PD
X-090	INC280 + trastuzumab	"ERBB2,MET"	combo	-100	27	-82.7	114	158.1	177	CR-->-->PD
X-090	LEE011	"CDK4,CDK6,CDK4/6"	single	57.8	21	31	14	22.8	28	PD
X-090	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-10.6	20	-2.6	20	24	24	SD
X-090	LJM716	ERBB3	single	52.5	21	12.5	11	32	32	PD
X-090	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	-75.7	33	-34.1	33	33	33	PR
X-090	LLM871	FGFR2/4	single	109.3	22	42.5	12	15.7	33	PD
X-090	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-100	23	-83	111	111	111	CR
X-090	everolimus	MTOR	single	-5.9	12	-2.7	12	33	33	SD
X-090	trastuzumab	ERBB2	single	-16.7	31	-0.6	31	31	31	SD
X-091	BGJ398	FGFR	single	-36.7	12	-21	16	49.2	74	SD-->PD
X-091	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	8.1	16	3.3	12	88.3	160	SD-->PD
X-091	BYL719	PIK3CA	single	8.3	12	8.2	12	69.5	109	SD-->PD
X-091	BYL719 + HSP990	"PIK3CA,HSP90"	combo	-54.8	51	-24.7	78	96	96	PR-->-->PD
X-091	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	11.2	16	7.3	13	46.2	58	SD-->PD
X-091	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-13.4	65	14.2	79	79	79	SD
X-091	HDM201	MDM2	single	63.1	21	23	12	25.4	48	PD
X-091	figitumumab	IGF1R	single	-4.8	13	-4.2	13	53	69	SD-->PD
X-091	HSP990	HSP90	single	-31.9	20	-19.2	24	84.9	136	SD-->PD
X-091	INC280	MET	single	297.8	22	37.2	13	13.2	27	PD
X-091	INC280 + trastuzumab	"ERBB2,MET"	combo	16.8	20	4.6	15	49.9	69	SD-->PD
X-091	LEE011	"CDK4,CDK6,CDK4/6"	single	36.8	31	3.2	14	52.5	105	PD
X-091	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	89.5	22	58.1	13	11.2	41	PD
X-091	LJM716	ERBB3	single	-12.3	14	-6.8	14	32	32	SD-->PD
X-091	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	2.3	99	3.8	15	106	106	SD-->PD
X-091	LLM871	FGFR2/4	single	22	213	36.4	13	19.5	234	PD
X-091	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	79	22	27.7	13	25.3	62	PD
X-091	everolimus	MTOR	single	-31.3	10	-16.4	14	42.9	87	SD-->PD
X-091	trastuzumab	ERBB2	single	40.5	24	24.6	13	45.7	93	PD
X-091	untreated	"UNKNOWN,Untreated"	single	21.3	12	10.7	12	49	130	SD-->PD
X-0933	5FU	chemotherapy	single	328.4	20	117.8	20	8	29	PD
X-0933	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-27.8	10	-21.2	14	62	62	SD-->PD
X-0933	BKM120 + LJC049	"panPI3K,TNKS"	combo	62	21	11	11	27.3	33	PD
X-0933	BYL719	PIK3CA	single	-55.9	10	-29.6	15	57.2	72	PR-->PD
X-0933	BYL719 + cetuximab	"PIK3CA,EGFR"	combo	75.4	20	40.9	12	24.3	36	PD
X-0933	BYL719 + cetuximab + encorafenib	"PIK3CA,EGFR,BRAF"	combo	-51.5	50	-34.3	92	102	102	PR-->-->PD
X-0933	BYL719 + encorafenib	"PIK3CA,BRAF"	combo	-12.7	21	-11.5	11	57	57	SD-->PD
X-0933	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-52.1	10	-29.4	15	45.9	48	PR-->PD
X-0933	BYL719 + binimetinib	"PIK3CA,MAPK"	combo	-48.4	14	-23.9	17	98	98	SD-->-->PD
X-0933	cetuximab	EGFR	single	10	14	-1.8	14	36	36	SD-->PD
X-0933	cetuximab + encorafenib	"EGFR,BRAF"	combo	-37.6	15	-16.3	26	71	72	SD-->PD
X-0933	CGM097	MDM2	single	94.5	22	52.1	14	22.4	27	PD
X-0933	CKX620	MAPK	single	-45	33	-29	80	98	98	SD
X-0933	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-33.4	15	-15.1	26	91	91	SD-->PD
X-0933	HDM201	MDM2	single	345	22	28.4	14	15.2	27	PD
X-0933	LEE011	"CDK4,CDK6,CDK4/6"	single	-2.7	10	7.7	14	29	29	SD-->PD
X-0933	encorafenib	BRAF	single	22.4	27	7.4	11	27	27	SD
X-0933	LJC049	TNKS	single	549	24	83.7	11	6	24	PD
X-0933	LKA136	"NTRK1,NTRK2,NTRK3"	single	22.4	10	3.4	15	29	29	SD-->PD
X-0933	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	41.6	24	32.7	14	29	29	PD
X-0933	untreated	"UNKNOWN,Untreated"	single	183.2	21	59	14	9.9	36	PD
X-0933	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	-60	12	-35.01666667	17	17	17	PR
X-096	BGJ398	FGFR	single	330.9	21	114.9	13	3.8	21	PD
X-096	BYL719	PIK3CA	single	-61.7	27	-25.5	27	27	27	PR
X-096	BYL719 + HSP990	"PIK3CA,HSP90"	combo	-23.4	21	17.2	21	21	21	SD
X-096	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	82.2	21	31.5	14	24.8	28	PD
X-096	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	69.2	24	33.9	14	28	28	PD
X-096	HDM201	MDM2	single	354.2	17	148.1	13	3.6	17	PD
X-096	figitumumab	IGF1R	single	286.6	24	62.3	14	11.4	24	PD
X-096	HSP990	HSP90	single	340.5	17	106.1	13	5	17	PD
X-096	INC280	MET	single	293.2	17	119.7	14	5.9	17	PD
X-096	INC280 + trastuzumab	"ERBB2,MET"	combo	16.4	28	25.7	17	28	28	SD
X-096	LEE011	"CDK4,CDK6,CDK4/6"	single	-40.3	24	-13.6	24	24	24	SD
X-096	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	7.9	28	17.3	14	28	28	SD
X-096	LJM716	ERBB3	single	-34	21	-8.2	28	28	28	SD
X-096	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	34.4	24	43.3	28	28	28	PD
X-096	LLM871	FGFR2/4	single	-78.9	14	-60.8	24	24	24	PR
X-096	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	107.1	28	71.8	14	10.2	28	PD
X-096	everolimus	MTOR	single	-12	27	15.3	27	27	27	SD
X-096	trastuzumab	ERBB2	single	-70.8	24	-39.4	24	24	24	PR
X-096	untreated	"UNKNOWN,Untreated"	single	251.3	21	77.1	14	8.5	28	PD
X-097	BGJ398	FGFR	single	287.4	21	51.8	14	12.1	28	PD
X-097	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	64.2	23	15.2	11	27.7	49	PD
X-097	BYL719	PIK3CA	single	-47.5	74	-28.1	84	110.6	113	SD-->-->PD
X-097	BYL719 + HSP990	"PIK3CA,HSP90"	combo	-58.2	23	-38.5	27	37	37	PR-->PD
X-097	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	1.6	13	-2.8	13	40	58	SD-->PD
X-097	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	29.7	23	29.3	14	30	30	SD
X-097	HDM201	MDM2	single	288	23	40.1	11	12.9	39	PD
X-097	figitumumab	IGF1R	single	285.7	22	72.8	15	8.4	26	PD
X-097	HSP990	HSP90	single	42.1	15	47.8	15	15	15	PD
X-097	INC280	MET	single	357.2	20	87.8	14	8.2	27	PD
X-097	INC280 + trastuzumab	"ERBB2,MET"	combo	210	20	58.3	12	10	33	PD
X-097	LEE011	"CDK4,CDK6,CDK4/6"	single	42.1	31	21.1	13	31	31	PD
X-097	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	25.4	31	28.7	13	34	34	SD
X-097	LJM716	ERBB3	single	219.6	23	52.3	12	10.6	33	PD
X-097	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	207.1	20	26.7	12	13.4	33	PD
X-097	LLM871	FGFR2/4	single	244.9	22	50.4	12	12.2	22	PD
X-097	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	157.4	27	51.6	14	11.4	30	PD
X-097	everolimus	MTOR	single	60.4	26	22.9	12	33	33	PD
X-097	trastuzumab	ERBB2	single	137.7	22	44.9	12	19	40	PD
X-098	BGJ398	FGFR	single	-91.9	71	-23	81	81	81	PR
X-098	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	197.7	32	10.7	11	23.2	39	PD
X-098	BYL719	PIK3CA	single	-23.4	14	-6.7	14	26.9	54	SD-->PD
X-098	BYL719 + HSP990	"PIK3CA,HSP90"	combo	1.9	9	1	9	9	9	SD
X-098	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	69.6	26	34.1	18	28.5	67	PD
X-098	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	104.4	29	39.4	18	20.3	60	PD
X-098	HDM201	MDM2	single	104.4	32	19.3	11	29.9	81	PD
X-098	figitumumab	IGF1R	single	0.4	39	34.3	11	57.5	75	PD
X-098	HSP990	HSP90	single	117.3	19	14.1	11	17.3	19	PD
X-098	INC280	MET	single	341.3	25	62.1	12	9	36	PD
X-098	INC280 + trastuzumab	"ERBB2,MET"	combo	256.5	23	61.1	13	12.1	37	PD
X-098	LEE011	"CDK4,CDK6,CDK4/6"	single	48.4	20	28.8	17	51	51	PD
X-098	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-69.4	63	-39.7	67	67	67	PR
X-098	LJM716	ERBB3	single	229.9	26	54.6	18	13.8	39	PD
X-098	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	134.3	26	24.6	13	15.9	51	PD
X-098	LLM871	FGFR2/4	single	266.4	32	19.9	11	20.8	61	PD
X-098	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	306.1	25	82.8	12	7.2	33	PD
X-098	everolimus	MTOR	single	95	20	48.2	12	20.6	51	PD
X-098	trastuzumab	ERBB2	single	252.7	20	100.3	12	9	37	PD
X-098	untreated	"UNKNOWN,Untreated"	single	326.9	25	104.1	12	7.1	33	PD
X-0988	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	14.5	28	24.98	14	28	28	SD-->PD
X-099	BGJ398	FGFR	single	-9.8	16	-8.3	16	38.4	68	SD-->PD
X-099	BYL719 + HSP990	"PIK3CA,HSP90"	combo	-60.5	27	-38.2	34	37	37	PR
X-099	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-22.9	9	3.8	16	24.9	27	SD-->PD
X-099	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	152.8	23	60.2	11	14.6	31	PD
X-099	HDM201	MDM2	single	65	34	10.3	14	34	34	PD
X-099	figitumumab	IGF1R	single	-1	10	-2.2	14	39.5	78	SD-->PD
X-099	HSP990	HSP90	single	0.5	10	2.6	14	38.6	89	SD-->PD
X-099	INC280	MET	single	83.7	23	49.5	11	25	38	PD
X-099	INC280 + trastuzumab	"ERBB2,MET"	combo	-77.4	34	-46.5	45	60	60	PR-->PD
X-099	LEE011	"CDK4,CDK6,CDK4/6"	single	-43.4	17	-29	20	76.5	107	SD-->PD
X-099	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-42.4	18	-15.2	27	71	74	SD-->PD
X-099	LJM716	ERBB3	single	115.6	27	35.5	11	19.2	45	PD
X-099	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	-80.1	31	-50.1	45	73.6	74	PR-->PD
X-099	LLM871	FGFR2/4	single	-21	10	-13.9	14	41.2	78	SD-->PD
X-099	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-42.2	13	-15.8	27	51.8	55	SD-->PD
X-099	trastuzumab	ERBB2	single	-44.2	10	-31.3	20	44.8	78	SD-->PD
X-0991	abraxane	Tubulin	single	296.8	12	202.2	12	3.2	12	PD
X-0991	abraxane + gemcitabine	"Tubulin,chemotherapy"	combo	-12.7	28	17.2	11	48	48	SD
X-0991	BKM120 + LDE225	"panPI3K,SMO"	combo	-41.8	42	-13.1	18	75.1	95	SD-->PD
X-0991	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-52.9	95	-34.1	95	95	95	PR
X-0991	BYL719	PIK3CA	single	-14.9	13	-7.9	20	55.5	105	SD-->PD
X-0991	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-14.3	11	-9.3	21	83.3	116	SD-->PD
X-0991	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-24.3	17	-13.7	27	69	69	SD-->PD
X-0991	HDM201	MDM2	single	-4.8	41	14.4	13	41	41	SD
X-0991	figitumumab	IGF1R	single	-22.5	25	-5.5	11	56.4	91	SD-->PD
X-0991	figitumumab + binimetinib	"IGF1R,MAPK"	combo	-7.4	18	15.5	18	34.8	39	SD-->PD
X-0991	gemcitabine-50mpk	chemotherapy	single	0.7	13	-1	13	93.5	104	SD-->PD
X-0991	INC424	JAK	single	47.9	20	18.3	13	37	73	PD
X-0991	INC424 + binimetinib	"JAK,MAPK"	combo	-39.2	93	-12.8	93	93	93	SD
X-0991	LEE011	"CDK4,CDK6,CDK4/6"	single	-26.4	77	29.8	91	91	91	SD
X-0991	LKA136	"NTRK1,NTRK2,NTRK3"	single	81.4	22	24.1	15	25.7	50	PD
X-0991	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-46.7	90	-18	119	119	119	SD
X-0991	binimetinib-3.5mpk	MAPK	single	-24.2	78	-10.9	11	113	113	SD-->-->PD
X-0991	trametinib	MAPK	single	-39.9	77	-16.3	86	86	86	SD
X-0991	untreated	"UNKNOWN,Untreated"	single	174.4	20	19.1	11	16.6	44	PD
X-0992	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	-5	73	5.4125	31	90	90	SD-->PD
X-1004	BGJ398	FGFR	single	-54.3	12	-28.1	26	26	26	PR
X-1004	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	64.6	22	23.7	11	14.9	27	PD
X-1004	BYL719	PIK3CA	single	20	18	9.3	11	32.3	42	SD-->PD
X-1004	BYL719 + LEE011	"PIK3CA,CDK4/6"	combo	119	22	52.6	11	16.2	35	PD
X-1004	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	27.7	25	2.7	11	28.5	34	SD-->PD
X-1004	CGM097	MDM2	single	355.1	18	46.3	11	10.5	18	PD
X-1004	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	27.6	19	5.6	12	26.6	47	SD-->PD
X-1004	HDM201	MDM2	single	57	22	16.5	11	26.5	32	PD
X-1004	INC424	JAK	single	61.1	21	-2.1	11	23.5	35	PD
X-1004	LEE011	"CDK4,CDK6,CDK4/6"	single	-15.6	13	-12.1	13	48.8	77	SD-->PD
X-1004	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-64.3	52	-44.6	64	163	163	PR-->-->PD
X-1004	LFA102	PRLR 	single	378.5	20	18.3	13	13.8	20	PD
X-1004	LJM716	ERBB3	single	28.6	18	4	11	24.8	34	SD-->PD
X-1004	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	5.5	13	7.1	13	26.7	34	SD-->PD
X-1004	LKA136	"NTRK1,NTRK2,NTRK3"	single	58.1	23	-1.4	12	26.2	33	PD
X-1004	LLM871	FGFR2/4	single	98.7	20	11.5	13	20.1	27	PD
X-1004	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	77.8	22	35.2	11	27.9	35	PD
X-1004	paclitaxel	Tubulin	single	-26.4	13	-17.5	13	45.7	62	SD-->PD
X-1004	tamoxifen	ESR1	single	415	22	48.2	11	11.1	27	PD
X-1004	trastuzumab	ERBB2	single	-18.7	13	-11.6	17	31.8	36	SD-->PD
X-1004	untreated	"UNKNOWN,Untreated"	single	241.1	20	43.7	13	13.6	29	PD
X-1004	LFW527 + everolimus	"IGF1R,MTOR"	combo	-45.9	111	-19.365625	114	153	153	SD-->-->PD
X-1008	BGJ398	FGFR	single	57.2	20	20.3	17	34.6	80	PD
X-1008	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	25.3	52	10.5	17	86.8	87	SD-->PD
X-1008	BYL719	PIK3CA	single	-63.1	88	-30.7	88	88	88	PR
X-1008	BYL719 + LEE011	"PIK3CA,CDK4/6"	combo	-35.9	43	-26.7	56	95	95	SD-->-->PD
X-1008	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-26.4	10	-16.8	13	76	97	SD-->PD
X-1008	CGM097	MDM2	single	205.1	21	42.6	11	10	38	PD
X-1008	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-15	14	-7.5	14	61.8	94	SD-->PD
X-1008	HDM201	MDM2	single	200.5	20	79	17	9.5	25	PD
X-1008	INC424	JAK	single	55.5	25	6.1	11	32.4	63	PD
X-1008	LEE011	"CDK4,CDK6,CDK4/6"	single	-4.1	14	-6.1	11	44.1	77	SD-->PD
X-1008	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-29.6	53	-16.4	56	98	98	SD-->-->PD
X-1008	LFA102	PRLR 	single	195.8	20	54.4	14	13	48	PD
X-1008	LJM716	ERBB3	single	-18.3	11	-18	11	59.9	84	SD-->PD
X-1008	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	-78.9	45	-47.4	62	95.8	125	PR-->PD
X-1008	LKA136	"NTRK1,NTRK2,NTRK3"	single	135.7	21	41.9	11	16.2	42	PD
X-1008	LLM871	FGFR2/4	single	192	20	73.7	14	9.9	27	PD
X-1008	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	43.1	21	17.5	14	29	98	PD
X-1008	paclitaxel	Tubulin	single	-77.6	90	-44.8	90	90	90	PR
X-1008	tamoxifen	ESR1	single	144	20	36	17	17.7	45	PD
X-1008	trastuzumab	ERBB2	single	133.8	20	44.2	14	16.7	41	PD
X-1008	untreated	"UNKNOWN,Untreated"	single	102.1	21	20	11	20.7	42	PD
X-1008	LFW527 + everolimus	"IGF1R,MTOR"	combo	-37.8	14	-26.92857143	21	35	35	SD
X-101	BYL719	PIK3CA	single	83.9	22	16.6	13	27.4	74	PD
X-101	BYL719 + HSP990	"PIK3CA,HSP90"	combo	28.1	19	18.4	12	22	67	SD-->PD
X-101	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	179.8	21	72.7	11	8	39	PD
X-101	HSP990	HSP90	single	135.3	22	31.8	13	20	57	PD
X-101	LEE011	"CDK4,CDK6,CDK4/6"	single	222.8	13	105	13	5.6	13	PD
X-101	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-10	21	0.3	21	24	24	SD
X-101	LJM716	ERBB3	single	260.2	21	57.1	11	10.2	25	PD
X-101	everolimus	MTOR	single	365.7	22	73.4	13	7.8	33	PD
X-101	untreated	"UNKNOWN,Untreated"	single	257.7	21	68.4	11	9.2	25	PD
X-102	BGJ398	FGFR	single	-28.8	11	-20.5	15	126.2	142	SD-->PD
X-102	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-78.6	41	-55.6	49	103.8	125	PR-->PD
X-102	BYL719	PIK3CA	single	-41.2	15	-25.3	29	134.8	156	SD-->-->PD
X-102	BYL719 + HSP990	"PIK3CA,HSP90"	combo	-24.1	9	-5.2	15	44.1	48	SD-->PD
X-102	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-69	82	-35.2	99	99	99	PR
X-102	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-14.4	14	-8.3	24	105	155	SD-->PD
X-102	HSP990	HSP90	single	-91.9	117	-45.7	124	124	124	PR
X-102	INC280	MET	single	91.7	22	17.8	13	18.7	41	PD
X-102	INC280 + trastuzumab	"ERBB2,MET"	combo	76.6	21	30.9	14	22.7	32	PD
X-102	LEE011	"CDK4,CDK6,CDK4/6"	single	75.4	20	26.7	15	22.1	55	PD
X-102	LJM716	ERBB3	single	-32	79	1.6	98	155	155	SD-->-->PD
X-102	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	-100	115	-66.4	115	115	115	CR
X-102	LLM871	FGFR2/4	single	9.9	15	9.3	15	32.5	71	SD-->PD
X-1027	5FU	chemotherapy	single	640.3	20	184.2	13	4.9	20	PD
X-1027	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	157.2	21	66	14	11.6	24	PD
X-1027	BKM120 + LJC049	"panPI3K,TNKS"	combo	430.7	17	176.2	13	7	17	PD
X-1027	BYL719	PIK3CA	single	173.2	21	15	11	15.5	21	PD
X-1027	BYL719 + cetuximab	"PIK3CA,EGFR"	combo	120.2	23	19.7	13	20.7	31	PD
X-1027	BYL719 + cetuximab + encorafenib	"PIK3CA,EGFR,BRAF"	combo	342.9	20	68.8	13	10.1	22	PD
X-1027	BYL719 + encorafenib	"PIK3CA,BRAF"	combo	374.5	17	174.4	13	7	17	PD
X-1027	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	65.6	21	-3.1	11	21	21	PD
X-1027	BYL719 + binimetinib	"PIK3CA,MAPK"	combo	168.6	13	104.1	13	7	13	PD
X-1027	cetuximab	EGFR	single	499.1	21	83.1	11	7.4	24	PD
X-1027	cetuximab + encorafenib	"EGFR,BRAF"	combo	491.6	20	79.8	13	8.8	22	PD
X-1027	CGM097	MDM2	single	348.2	14	169.5	14	3.7	14	PD
X-1027	CKX620	MAPK	single	95.8	21	33	14	24	24	PD
X-1027	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	148.5	21	24.2	14	17.6	24	PD
X-1027	HDM201	MDM2	single	505.2	21	156.2	14	4.3	24	PD
X-1027	LEE011	"CDK4,CDK6,CDK4/6"	single	43	10	19.6	10	10	10	PD
X-1027	encorafenib	BRAF	single	793	21	158	14	5.2	21	PD
X-1027	LJC049	TNKS	single	284.5	10	126.8	10	4.6	10	PD
X-1027	LKA136	"NTRK1,NTRK2,NTRK3"	single	405.6	14	189.1	14	3	14	PD
X-1027	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	63.3	10	35.8	10	10	10	PD
X-1027	untreated	"UNKNOWN,Untreated"	single	470.6	17	187.9	14	3.2	17	PD
X-105	BYL719	PIK3CA	single	11.7	15	9.5	12	39	39	SD-->PD
X-105	BYL719 + HSP990	"PIK3CA,HSP90"	combo	-45.4	34	-25.1	34	34	34	SD
X-105	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	59.2	26	34.9	13	26	26	PD
X-105	HSP990	HSP90	single	14.2	15	9.5	12	46	46	SD-->PD
X-105	LEE011	"CDK4,CDK6,CDK4/6"	single	74.3	32	21.3	12	24.9	46	PD
X-105	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	44.9	23	18.4	13	34.7	51	PD
X-105	LJM716	ERBB3	single	-6.1	19	-0.1	13	51	51	SD-->PD
X-105	everolimus	MTOR	single	141.2	22	23.9	12	18.5	40	PD
X-105	untreated	"UNKNOWN,Untreated"	single	225.2	23	79	13	10.9	44	PD
X-1055	5FU	chemotherapy	single	13.7	26	29.1	12	56.4	97	SD
X-1055	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-8.2	23	-3.7	23	65	65	SD-->PD
X-1055	BKM120 + LJC049	"panPI3K,TNKS"	combo	-37.9	56	-11.8	56	56	56	SD
X-1055	BYL719	PIK3CA	single	-46.5	10	-30.7	43	93	93	SD-->PD
X-1055	BYL719 + cetuximab	"PIK3CA,EGFR"	combo	-59.2	29	-33	29	29	29	PR
X-1055	BYL719 + cetuximab + encorafenib	"PIK3CA,EGFR,BRAF"	combo	-83.7	85	-54.7	86	86	86	PR
X-1055	BYL719 + encorafenib	"PIK3CA,BRAF"	combo	-35.7	17	-27.1	20	88	88	SD-->PD
X-1055	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-42.5	31	-22.9	43	49	49	SD
X-1055	BYL719 + binimetinib	"PIK3CA,MAPK"	combo	-75.1	21	-54.4	35	35	35	PR
X-1055	cetuximab	EGFR	single	-67.5	48	-41.2	103	103	103	PR
X-1055	cetuximab + encorafenib	"EGFR,BRAF"	combo	-38	36	-18.4	44	82	82	SD-->PD
X-1055	CGM097	MDM2	single	2.2	9	8.8	16	35	35	SD-->PD
X-1055	CKX620	MAPK	single	-47.3	31	-21.7	31	31	31	SD
X-1055	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-44.9	86	-22.1	38	93	93	SD-->PD
X-1055	HDM201	MDM2	single	82.5	23	18.9	14	26.6	35	PD
X-1055	LEE011	"CDK4,CDK6,CDK4/6"	single	-28.1	70	1.7	17	84	84	SD-->PD
X-1055	encorafenib	BRAF	single	52.9	24	20.9	16	28.1	35	PD
X-1055	LJC049	TNKS	single	6.3	19	6.1	12	47.2	68	SD-->PD
X-1055	LKA136	"NTRK1,NTRK2,NTRK3"	single	-13.1	14	-6	14	25.9	28	SD-->PD
X-1055	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	6.1	18	11.3	18	59.2	95	SD-->PD
X-1055	untreated	"UNKNOWN,Untreated"	single	274.1	22	81.9	12	7.1	33	PD
X-1055	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	-49.1	20	-30.55	20	78.89958848	91	SD-->PD
X-1119	5FU	chemotherapy	single	-56.8	71	-28.8	90	90	90	PR
X-1119	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	110.8	20	10.6	15	19.1	23	PD
X-1119	BKM120 + LJC049	"panPI3K,TNKS"	combo	141.8	15	58.3	13	9.9	15	PD
X-1119	BYL719	PIK3CA	single	180.9	20	48.1	13	13	20	PD
X-1119	BYL719 + cetuximab	"PIK3CA,EGFR"	combo	165.7	21	18.7	11	15.6	28	PD
X-1119	BYL719 + cetuximab + encorafenib	"PIK3CA,EGFR,BRAF"	combo	272.7	20	54.1	13	11.5	28	PD
X-1119	BYL719 + encorafenib	"PIK3CA,BRAF"	combo	245.4	20	62.3	13	8.7	20	PD
X-1119	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	219.8	20	17.2	13	14.6	20	PD
X-1119	BYL719 + binimetinib	"PIK3CA,MAPK"	combo	25.9	23	16.1	13	51	51	SD
X-1119	cetuximab	EGFR	single	241.8	20	60.9	13	10.4	31	PD
X-1119	cetuximab + encorafenib	"EGFR,BRAF"	combo	199.4	21	58.4	15	12.7	28	PD
X-1119	CGM097	MDM2	single	83.2	20	33.2	15	21.6	27	PD
X-1119	CKX620	MAPK	single	35	44	22.7	15	56	56	PD
X-1119	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	80.4	20	9.8	13	21.9	34	PD
X-1119	HDM201	MDM2	single	74.2	20	37.6	15	20.8	23	PD
X-1119	LEE011	"CDK4,CDK6,CDK4/6"	single	255.6	24	26.9	14	13.6	27	PD
X-1119	encorafenib	BRAF	single	416.9	20	96.6	15	7.9	23	PD
X-1119	LJC049	TNKS	single	498	20	133.8	15	7.1	22	PD
X-1119	LKA136	"NTRK1,NTRK2,NTRK3"	single	236.6	20	56.3	13	10.7	20	PD
X-1119	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	154.5	27	41.7	14	17.4	27	PD
X-1119	untreated	"UNKNOWN,Untreated"	single	291.4	21	38.2	11	10.3	29	PD
X-1119	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	47.1	21	40.01666667	17	3.884430177	70	PD
X-114	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-46.7	28	-29.6	32	92.9	93	SD-->PD
X-114	BYL719	PIK3CA	single	-62.4	17	-36.1	35	96.1	112	PR-->PD
X-114	BYL719 + HSP990	"PIK3CA,HSP90"	combo	-9.6	10	7.1	14	75.8	112	SD-->PD
X-114	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-15.9	15	-9.4	15	60.5	63	SD-->PD
X-114	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-20.2	15	-16.8	15	113.3	124	SD-->PD
X-114	HDM201	MDM2	single	-6.3	10	0.5	14	14	14	SD
X-114	HSP990	HSP90	single	-42.1	26	-27.9	26	125	125	SD-->-->PD
X-114	INC280	MET	single	129.6	21	36.6	14	14.7	41	PD
X-114	INC280 + trastuzumab	"ERBB2,MET"	combo	-53.9	89	-1.3	130	138	138	SD-->PD
X-114	LEE011	"CDK4,CDK6,CDK4/6"	single	14.8	14	13.1	14	49.8	104	SD-->PD
X-114	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-21.6	10	-13.5	14	92	92	SD-->PD
X-114	LJM716	ERBB3	single	-19	7	-20.4	7	7	7	SD
X-114	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	-72.6	73	-52.1	94	105	105	PR-->-->PD
X-114	LLM871	FGFR2/4	single	-8.3	10	-7	14	27.4	63	SD-->PD
X-114	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-23	16	-7.7	16	132	132	SD-->PD
X-114	everolimus	MTOR	single	31.7	24	18.7	11	38.2	95	SD-->PD
X-114	untreated	"UNKNOWN,Untreated"	single	144.1	21	49.3	12	13.3	49	PD
X-1156	BGJ398	FGFR	single	427.2	21	81.2	13	6.2	21	PD
X-1156	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	498	20	98.5	13	4.4	20	PD
X-1156	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	179.1	21	57	13	12.4	34	PD
X-1156	BYL719	PIK3CA	single	136.4	21	63.1	13	11.2	31	PD
X-1156	BYL719 + LGH447	"PIK3CA,PIM"	combo	131.5	20	29.7	13	15.4	34	PD
X-1156	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	600.4	20	128.3	13	5.6	20	PD
X-1156	cetuximab	EGFR	single	674.5	21	125.8	14	7	24	PD
X-1156	CGM097	MDM2	single	1014.2	20	138.1	13	6.4	20	PD
X-1156	CKX620	MAPK	single	765.2	20	130.6	13	6.2	20	PD
X-1156	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	173.4	21	74.3	14	10.7	32	PD
X-1156	HDM201	MDM2	single	650.5	20	112.8	13	5.6	20	PD
X-1156	erlotinib	EGFR	single	486.5	20	130.4	13	4.1	20	PD
X-1156	HSP990	HSP90	single	402.2	21	57.1	14	10.9	24	PD
X-1156	INC280	MET	single	396.8	21	86.7	14	7.2	24	PD
X-1156	LCL161 + paclitaxel	"BIRC2,TUBB,Tubulin"	combo	292.5	21	99.2	14	6.8	31	PD
X-1156	LEE011	"CDK4,CDK6,CDK4/6"	single	141.1	27	76.8	13	7.1	41	PD
X-1156	LGH447	PIM	single	701	20	128.6	13	5.1	20	PD
X-1156	LLM871	FGFR2/4	single	513.4	21	114.9	14	7.4	24	PD
X-1156	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	170	21	57.1	14	15.9	46	PD
X-1156	paclitaxel	Tubulin	single	395.4	21	83.9	14	7.6	31	PD
X-1156	untreated	"UNKNOWN,Untreated"	single	832.6	20	135.8	13	4.5	20	PD
X-1156	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	98.8	21	16.15	11	14.00890869	30	PD
X-1167	5FU	chemotherapy	single	12.8	66	23.5	20	105	105	SD-->-->PD
X-1167	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-13.8	17	-8.8	17	33.7	43	SD-->PD
X-1167	BKM120 + LJC049	"panPI3K,TNKS"	combo	418.7	21	116.4	14	8.2	32	PD
X-1167	BYL719	PIK3CA	single	365.3	21	27.7	11	12	29	PD
X-1167	BYL719 + cetuximab	"PIK3CA,EGFR"	combo	335.2	21	45.2	12	12.1	28	PD
X-1167	BYL719 + cetuximab + encorafenib	"PIK3CA,EGFR,BRAF"	combo	-1.3	11	-0.5	11	37	37	SD-->PD
X-1167	BYL719 + encorafenib	"PIK3CA,BRAF"	combo	185	21	81.7	12	6.4	33	PD
X-1167	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	130.2	21	10.5	11	18.6	29	PD
X-1167	BYL719 + binimetinib	"PIK3CA,MAPK"	combo	-48.2	14	-28.8	25	56	56	SD-->PD
X-1167	cetuximab	EGFR	single	393.6	20	96.9	14	6.7	27	PD
X-1167	cetuximab + encorafenib	"EGFR,BRAF"	combo	82.7	21	59.3	13	11.9	27	PD
X-1167	CGM097	MDM2	single	113.8	21	11	11	19.9	29	PD
X-1167	CKX620	MAPK	single	-6	9	-5.2	14	43	43	SD-->PD
X-1167	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	208.8	24	23.3	11	19.1	32	PD
X-1167	HDM201	MDM2	single	93.6	20	-17.2	14	22.3	35	PD
X-1167	LEE011	"CDK4,CDK6,CDK4/6"	single	139	20	30	14	14.7	35	PD
X-1167	encorafenib	BRAF	single	305.6	24	12.8	14	16.9	32	PD
X-1167	LJC049	TNKS	single	430.2	17	132.4	11	4.1	17	PD
X-1167	LKA136	"NTRK1,NTRK2,NTRK3"	single	569.5	24	52.5	11	8.5	24	PD
X-1167	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	136.8	20	39.1	14	15.1	35	PD
X-1167	untreated	"UNKNOWN,Untreated"	single	102.9	20	20.2	12	19.5	36	PD
X-1167	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	21.5	18	39.04	12	14.90718039	29	PD
X-1172	BGJ398	FGFR	single	102.4	21	48.5	11	9.1	27	PD
X-1172	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-71.9	22	-60.6	43	84.7	90	PR-->PD
X-1172	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-48.1	15	-38.3	15	65.6	90	SD-->PD
X-1172	BYL719	PIK3CA	single	93.4	26	-16.9	12	26.3	29	PD
X-1172	BYL719 + LGH447	"PIK3CA,PIM"	combo	28.6	22	-12.1	12	29.5	42	SD-->PD
X-1172	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	149.4	22	18.7	12	14.4	28	PD
X-1172	cetuximab	EGFR	single	293.3	20	79.4	11	5.6	20	PD
X-1172	CGM097	MDM2	single	259.3	14	56	12	7.4	14	PD
X-1172	CKX620	MAPK	single	-30.2	32	11.1	32	40.7	75	SD-->PD
X-1172	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	281.5	21	14.5	12	15.8	21	PD
X-1172	HDM201	MDM2	single	-8.2	10	-18.8	13	26.1	33	SD-->PD
X-1172	erlotinib	EGFR	single	186.4	14	46.1	12	8.6	14	PD
X-1172	HSP990	HSP90	single	-5.5	11	-4	11	28	28	SD-->PD
X-1172	INC280	MET	single	234.4	14	50.9	12	8.5	14	PD
X-1172	LCL161 + paclitaxel	"BIRC2,TUBB,Tubulin"	combo	-97.7	95	-53.4	95	95	95	CR
X-1172	LEE011	"CDK4,CDK6,CDK4/6"	single	-11.7	33	-22	12	70.9	117	SD-->PD
X-1172	LGH447	PIM	single	278.1	20	34.8	11	10.5	20	PD
X-1172	LLM871	FGFR2/4	single	209.9	13	53	11	8.2	13	PD
X-1172	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-53.4	15	-29.5	29	76	76	PR-->PD
X-1172	paclitaxel	Tubulin	single	321.8	20	-14.5	11	14.8	20	PD
X-1172	untreated	"UNKNOWN,Untreated"	single	357.7	14	142.5	12	2	14	PD
X-1172	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	-44.8	10	-32.24	13	122.006263	173	SD-->PD
X-1173	5FU	chemotherapy	single	-36.9	71	-4.9	90	90	90	SD
X-1173	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-51.6	13	-25.7	15	62	62	PR-->PD
X-1173	BKM120 + LJC049	"panPI3K,TNKS"	combo	24	17	16.5	14	20.6	22	SD-->PD
X-1173	BYL719	PIK3CA	single	158.9	22	37.6	13	14.1	22	PD
X-1173	BYL719 + cetuximab	"PIK3CA,EGFR"	combo	157.2	21	31.9	15	16.5	28	PD
X-1173	BYL719 + cetuximab + encorafenib	"PIK3CA,EGFR,BRAF"	combo	72	21	19.4	15	24.7	49	PD
X-1173	BYL719 + encorafenib	"PIK3CA,BRAF"	combo	-27.4	14	-9.6	14	42.5	43	SD-->PD
X-1173	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-34.1	18	-25	35	53	53	SD-->PD
X-1173	BYL719 + binimetinib	"PIK3CA,MAPK"	combo	-61.8	14	-44.8	43	98	98	PR-->-->PD
X-1173	cetuximab	EGFR	single	655.7	19	94.3	11	6.2	19	PD
X-1173	cetuximab + encorafenib	"EGFR,BRAF"	combo	239.8	21	72.5	15	9.1	28	PD
X-1173	CGM097	MDM2	single	315.2	24	40	11	11.1	24	PD
X-1173	CKX620	MAPK	single	65	22	51.3	14	11.8	22	PD
X-1173	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-39.4	17	-29.6	22	90	90	SD-->PD
X-1173	HDM201	MDM2	single	80.9	24	8.3	11	20.8	24	PD
X-1173	LEE011	"CDK4,CDK6,CDK4/6"	single	178.4	24	67.3	11	8.1	24	PD
X-1173	encorafenib	BRAF	single	730.5	24	82.2	11	6.2	24	PD
X-1173	LJC049	TNKS	single	854.7	17	35.7	11	10.2	17	PD
X-1173	LKA136	"NTRK1,NTRK2,NTRK3"	single	957.1	15	231.3	11	3	15	PD
X-1173	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	81	29	12.2	11	20.7	29	PD
X-1173	untreated	"UNKNOWN,Untreated"	single	300	21	66.1	13	11.1	30	PD
X-118	BGJ398	FGFR	single	565.5	18	135.6	11	5.1	18	PD
X-118	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	145.3	21	33.6	11	13.6	52	PD
X-118	BYL719	PIK3CA	single	121	21	45.8	14	18.4	41	PD
X-118	BYL719 + HSP990	"PIK3CA,HSP90"	combo	94.5	22	27.3	12	22.4	53	PD
X-118	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	82	22	15.3	12	23	60	PD
X-118	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	186.3	22	38.3	12	12.9	33	PD
X-118	HDM201	MDM2	single	284.4	14	177.4	14	7	14	PD
X-118	figitumumab	IGF1R	single	382.7	14	180.1	14	7	14	PD
X-118	HSP990	HSP90	single	442.8	21	131.4	14	7.4	21	PD
X-118	INC280	MET	single	535.9	22	66.6	11	9.2	22	PD
X-118	INC280 + trastuzumab	"ERBB2,MET"	combo	305.1	22	69.2	15	9.6	26	PD
X-118	LEE011	"CDK4,CDK6,CDK4/6"	single	387.9	18	116.6	11	5.1	18	PD
X-118	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	56.9	53	53.5	12	28.4	60	PD
X-118	LJM716	ERBB3	single	553.6	22	153.4	11	3.1	22	PD
X-118	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	-86.8	92	-31.1	154	20.2	154	PR-->PD
X-118	LLM871	FGFR2/4	single	456.1	21	112.9	14	7.1	21	PD
X-118	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	74.1	26	42.6	15	31.1	70	PD
X-118	everolimus	MTOR	single	102.2	21	23.4	11	20.5	52	PD
X-118	trastuzumab	ERBB2	single	254.7	14	151.5	14	7	14	PD
X-1189	BGJ398	FGFR	single	136	16	37.7	11	10.4	16	PD
X-1189	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-100	48	-69.7	122	122	122	CR
X-1189	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-28.6	119	37.7	18	10.3	121	PD
X-1189	BYL719	PIK3CA	single	242	21	37.7	11	9.9	25	PD
X-1189	BYL719 + LGH447	"PIK3CA,PIM"	combo	-100	31	-80.5	119	119	119	CR
X-1189	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-100	31	-76.3	119	7.2	119	CR
X-1189	cetuximab	EGFR	single	306.4	21	38.9	11	10.2	22	PD
X-1189	CGM097	MDM2	single	-100	59	-50.1	122	122	122	CR-->PD
X-1189	CKX620	MAPK	single	7.4	18	25.9	11	33.9	34	SD-->PD
X-1189	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-91.9	118	-20	124	18.6	124	SD-->PD
X-1189	HDM201	MDM2	single	-34.4	59	21.7	11	20.7	61	SD
X-1189	erlotinib	EGFR	single	-100	40	-74.1	99	99	99	CR
X-1189	HSP990	HSP90	single	-45.4	40	-14.4	16	43	43	SD-->PD
X-1189	INC280	MET	single	290.4	11	81.7	11	7.2	11	PD
X-1189	LCL161 + paclitaxel	"BIRC2,TUBB,Tubulin"	combo	-100	17	-89.7	97	97	97	CR
X-1189	LEE011	"CDK4,CDK6,CDK4/6"	single	-100	52	-13.1	122	3	122	SD
X-1189	LGH447	PIM	single	365.9	19	30.3	11	9.5	19	PD
X-1189	LLM871	FGFR2/4	single	197.2	20	64.4	14	7.5	29	PD
X-1189	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	306.1	21	6.1	11	11.7	25	PD
X-1189	paclitaxel	Tubulin	single	-100	31	-80.7	82	82	82	CR
X-1189	untreated	"UNKNOWN,Untreated"	single	-45.2	34	-10.9	39	39	39	SD
X-119	BGJ398	FGFR	single	-100	35	-86.5	78	78	78	CR
X-119	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	42.5	25	25.2	11	32	32	PD
X-119	BYL719	PIK3CA	single	0.8	14	1.2	14	32	32	SD-->PD
X-119	BYL719 + HSP990	"PIK3CA,HSP90"	combo	19.8	9	20.8	13	30	30	SD
X-119	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	207	20	57.9	13	12.1	20	PD
X-119	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	65.7	23	46.7	13	10.7	37	PD
X-119	HDM201	MDM2	single	-31.1	11	-13.7	14	27.1	32	SD-->PD
X-119	figitumumab	IGF1R	single	378.3	18	131.5	11	4	18	PD
X-119	HSP990	HSP90	single	-44.9	14	-26.3	14	32	32	SD
X-119	INC280	MET	single	104.4	20	29.9	13	16.7	25	PD
X-119	INC280 + trastuzumab	"ERBB2,MET"	combo	265.5	20	102.4	13	6.3	31	PD
X-119	LEE011	"CDK4,CDK6,CDK4/6"	single	280.3	18	82	11	6.8	18	PD
X-119	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-19.9	24	-10.4	24	24	24	SD
X-119	LJM716	ERBB3	single	-26.4	9	-21.3	13	24.1	42	SD-->PD
X-119	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	644.4	17	160.7	13	3.6	17	PD
X-119	LLM871	FGFR2/4	single	-100	28	-93.1	320	320	320	CR
X-119	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	6.3	9	8.1	15	29.5	48	SD-->PD
X-119	everolimus	MTOR	single	11.2	12	8.7	12	33	33	SD
X-119	trastuzumab	ERBB2	single	357.1	18	57.4	11	12	18	PD
X-1199	abraxane	Tubulin	single	199.5	29	58.9	12	7.2	29	PD
X-1199	abraxane + gemcitabine	"Tubulin,chemotherapy"	combo	12.7	97	39.4	13	97	97	PD
X-1199	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-0.4	11	0.7	11	34	34	SD
X-1199	BKM120 + LDE225	"panPI3K,SMO"	combo	-34	32	10.3	35	35	35	SD
X-1199	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-66.4	39	-34.8	63	63	63	PR
X-1199	BYL719	PIK3CA	single	45.6	22	16.1	12	46	46	PD
X-1199	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-4.4	33	2.2	12	46	46	SD
X-1199	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	74.9	24	33.7	13	34	34	PD
X-1199	figitumumab	IGF1R	single	258.6	23	186.9	12	3.2	27	PD
X-1199	figitumumab + binimetinib	"IGF1R,MAPK"	combo	-30.7	18	14.2	18	39	39	SD-->PD
X-1199	gemcitabine-50mpk	chemotherapy	single	15.1	74	20.6	11	90.3	101	SD
X-1199	INC424	JAK	single	-19.2	14	-16.3	19	29	60	SD-->PD
X-1199	INC424 + binimetinib	"JAK,MAPK"	combo	-29.7	34	-5.7	34	34	34	SD
X-1199	LEE011	"CDK4,CDK6,CDK4/6"	single	-35.8	74	1	81	81	81	SD
X-1199	WNT974	PORCN	single	9.3	89	-2.9	12	106	106	SD-->PD
X-1199	LKA136	"NTRK1,NTRK2,NTRK3"	single	12.7	32	23.5	14	42.8	60	SD
X-1199	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-88.4	48	-60.4	51	51	51	PR
X-1199	binimetinib-3.5mpk	MAPK	single	-43.7	44	-11.1	96	96	96	SD
X-1199	trametinib	MAPK	single	-73.3	84	-44.5	98	98	98	PR
X-1199	untreated	"UNKNOWN,Untreated"	single	23.5	27	15.8	14	47.9	70	SD-->PD
X-1210	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	379	17	146.9	13	5.310107949	17	PD
X-1228	BGJ398	FGFR	single	-33.4	19	-31.6	19	41	41	SD-->PD
X-1228	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-82.8	87	-69.4	131	131	131	PR
X-1228	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-100	121	-86.2	140	140	140	CR
X-1228	BYL719	PIK3CA	single	-62.7	12	-43.3	51	146.8	147	PR-->-->PD
X-1228	BYL719 + LGH447	"PIK3CA,PIM"	combo	-100	15	-96.2	140	140	140	CR
X-1228	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-63.5	12	-42.4	19	70.4	83	PR-->PD
X-1228	cetuximab	EGFR	single	-63	15	-48.8	32	113.8	128	PR-->PD
X-1228	CGM097	MDM2	single	146.6	23	-10.7	12	18.9	28	PD
X-1228	CKX620	MAPK	single	-100	28	-85.6	73	73	73	CR
X-1228	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-48	12	-40.9	15	50.2	55	SD-->PD
X-1228	HDM201	MDM2	single	20	15	3.5	15	32.9	45	SD-->PD
X-1228	erlotinib	EGFR	single	-46.6	13	-39.2	13	94	94	SD-->PD
X-1228	HSP990	HSP90	single	-42.5	19	-24.4	47	91	91	SD-->-->PD
X-1228	INC280	MET	single	91.9	20	-12.3	12	20.3	28	PD
X-1228	LCL161 + paclitaxel	"BIRC2,TUBB,Tubulin"	combo	-48.7	19	-21.7	43	100.9	119	SD-->PD
X-1228	LEE011	"CDK4,CDK6,CDK4/6"	single	1.9	13	-7.8	11	27.8	46	SD-->PD
X-1228	LGH447	PIM	single	-25.7	13	-25.1	13	39.6	61	SD-->PD
X-1228	LLM871	FGFR2/4	single	-69.9	11	-53.2	15	68.2	75	PR-->PD
X-1228	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	75.9	22	-2.2	12	18.4	28	PD
X-1228	paclitaxel	Tubulin	single	-41.6	19	-28.3	19	61.1	126	SD-->PD
X-1228	untreated	"UNKNOWN,Untreated"	single	99.1	20	52.2	11	20.1	39	PD
X-1228	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	-26.9	9	-19.96	13	31.56814159	90	SD-->PD
X-1234	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	170.9	23	17.92	12	19.09366391	41	PD
X-1256	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	146.4	20	37.92	12	13.62763466	26	PD
X-127	BGJ398	FGFR	single	-100	13	-96.8	248	248	248	CR
X-127	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-100	76	-87.3	334	334	334	CR
X-127	BYL719	PIK3CA	single	-16	17	-7	17	31	31	SD-->PD
X-127	BYL719 + HSP990	"PIK3CA,HSP90"	combo	-8.6	23	7.7	23	30	30	SD-->PD
X-127	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	10.3	29	25.9	12	33	33	SD
X-127	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-39.6	20	-19.8	33	33	33	SD
X-127	HDM201	MDM2	single	-100	34	-61.1	38	38	38	CR
X-127	figitumumab	IGF1R	single	-7.9	22	14.1	12	29.1	33	SD-->PD
X-127	HSP990	HSP90	single	-64.3	10	-36.9	27	38	38	PR-->PD
X-127	INC280	MET	single	152	20	28.5	12	16.3	33	PD
X-127	INC280 + trastuzumab	"ERBB2,MET"	combo	164.1	20	54.3	12	12.3	33	PD
X-127	LEE011	"CDK4,CDK6,CDK4/6"	single	-15.8	10	-2.5	17	31	31	SD
X-127	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	93	26	81.3	11	8.2	49	PD
X-127	LJM716	ERBB3	single	79.8	23	45.7	12	24.7	33	PD
X-127	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	120.7	20	31.2	12	17.3	33	PD
X-127	LLM871	FGFR2/4	single	-100	19	-95.5	329	329	329	CR
X-127	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-100	20	-87.3	119	119	119	CR
X-127	everolimus	MTOR	single	-32.2	40	-15.1	47	54	54	SD-->PD
X-127	trastuzumab	ERBB2	single	4	12	4.1	12	33	33	SD-->PD
X-1270	5FU	chemotherapy	single	150.8	23	64.9	12	11	23	PD
X-1270	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	381.3	21	118.5	14	6.5	21	PD
X-1270	BKM120 + LJC049	"panPI3K,TNKS"	combo	-9.7	10	1.8	13	43	43	SD-->PD
X-1270	BYL719	PIK3CA	single	-9.1	22	-3.2	22	66	66	SD-->PD
X-1270	BYL719 + cetuximab	"PIK3CA,EGFR"	combo	61.7	23	19.8	13	37	37	PD
X-1270	BYL719 + cetuximab + encorafenib	"PIK3CA,EGFR,BRAF"	combo	101.8	21	26.5	11	17	41	PD
X-1270	BYL719 + encorafenib	"PIK3CA,BRAF"	combo	184.2	24	72.3	13	10.5	27	PD
X-1270	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	65.6	27	10.2	12	28.3	43	PD
X-1270	BYL719 + binimetinib	"PIK3CA,MAPK"	combo	-23.5	21	-8.9	31	87	87	SD-->PD
X-1270	cetuximab	EGFR	single	114.4	20	36.7	14	18.3	38	PD
X-1270	cetuximab + encorafenib	"EGFR,BRAF"	combo	174.3	21	66.6	11	11	35	PD
X-1270	CGM097	MDM2	single	573	21	120	14	6.7	21	PD
X-1270	CKX620	MAPK	single	28.2	35	-6.7	14	39	39	SD-->PD
X-1270	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	19.1	18	14.8	12	62.2	66	SD-->PD
X-1270	HDM201	MDM2	single	489.2	21	136.5	14	5.5	21	PD
X-1270	LEE011	"CDK4,CDK6,CDK4/6"	single	45.3	20	11.8	12	30.7	33	PD
X-1270	encorafenib	BRAF	single	130.3	21	33.1	14	16.7	27	PD
X-1270	LJC049	TNKS	single	-22.4	39	18.1	53	53	53	SD-->PD
X-1270	LKA136	"NTRK1,NTRK2,NTRK3"	single	379	24	50.9	11	9.5	24	PD
X-1270	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	94.2	9	61.6	9	9	9	PD
X-1270	untreated	"UNKNOWN,Untreated"	single	25.6	18	16.5	14	26	56	SD-->PD
X-128	BGJ398	FGFR	single	145.1	22	28.2	12	16.1	26	PD
X-128	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-100	32	-87.1	98	140.5	156	CR-->-->PD
X-128	BYL719	PIK3CA	single	-59.3	51	-49.6	61	112.8	138	PR-->-->PD
X-128	BYL719 + HSP990	"PIK3CA,HSP90"	combo	-57.7	43	-19.9	58	92.7	104	SD-->PD
X-128	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-82.7	37	-64.8	52	143.7	154	PR-->-->PD
X-128	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	90.8	23	34	13	24.8	42	PD
X-128	HDM201	MDM2	single	25	22	24	11	30.6	32	SD
X-128	figitumumab	IGF1R	single	204.4	20	32	13	14.8	24	PD
X-128	HSP990	HSP90	single	-62.4	50	-32.1	50	50	50	PR
X-128	INC280	MET	single	184.5	22	50.8	12	12	33	PD
X-128	INC280 + trastuzumab	"ERBB2,MET"	combo	46.2	22	32.1	15	29.6	33	PD
X-128	LEE011	"CDK4,CDK6,CDK4/6"	single	51.8	24	33.8	13	31	31	PD
X-128	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-60.3	41	-41.6	52	131.4	161	PR-->-->PD
X-128	LJM716	ERBB3	single	168.2	33	68.3	12	7	33	PD
X-128	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	-46.4	26	-12.9	36	47	47	SD-->PD
X-128	LLM871	FGFR2/4	single	132.2	24	21.1	13	16.9	31	PD
X-128	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-68.3	26	-41.5	50	96.4	104	PR-->PD
X-128	everolimus	MTOR	single	1.2	18	5.2	18	32	32	SD-->PD
X-128	trastuzumab	ERBB2	single	255.2	22	47.1	12	13.6	26	PD
X-1286	BGJ398	FGFR	single	210	21	45.3	14	14.2	41	PD
X-1286	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-49.5	144	-19.3	144	144	144	SD
X-1286	BYL719	PIK3CA	single	45.1	21	11.9	11	34.6	60	PD
X-1286	BYL719 + LEE011	"PIK3CA,CDK4/6"	combo	-37	52	-21.5	52	52	52	SD
X-1286	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	13.4	11	3.4	11	26.8	81	SD-->PD
X-1286	CGM097	MDM2	single	229.7	21	42.1	14	13.3	35	PD
X-1286	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-33.2	102	-19.5	105	123	123	SD
X-1286	HDM201	MDM2	single	103	21	41.8	14	20.4	41	PD
X-1286	INC424	JAK	single	61.6	21	8.8	11	26.4	60	PD
X-1286	LEE011	"CDK4,CDK6,CDK4/6"	single	88	21	14	11	21.7	38	PD
X-1286	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	0.7	12	0.2	12	57	57	SD-->PD
X-1286	LFA102	PRLR 	single	153.3	20	38.1	13	13	56	PD
X-1286	LJM716	ERBB3	single	53.2	21	4.5	11	26.8	45	PD
X-1286	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	97	20	23.3	13	20.2	49	PD
X-1286	LKA136	"NTRK1,NTRK2,NTRK3"	single	93.7	21	9	11	21.2	38	PD
X-1286	LLM871	FGFR2/4	single	76.4	20	11.1	13	28.1	69	PD
X-1286	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	34.7	21	2.8	11	43.2	81	SD-->PD
X-1286	paclitaxel	Tubulin	single	113.9	27	41.2	13	12	70	PD
X-1286	tamoxifen	ESR1	single	263	21	50	14	11.8	28	PD
X-1286	trastuzumab	ERBB2	single	156.9	20	20.2	13	15.5	49	PD
X-1286	untreated	"UNKNOWN,Untreated"	single	340.5	21	107	14	9.5	28	PD
X-1286	LFW527 + everolimus	"IGF1R,MTOR"	combo	11.4	10	5.8	14	45.76010782	80	SD-->PD
X-1289	abraxane	Tubulin	single	331.6	21	91.5	13	5.8	21	PD
X-1289	abraxane + gemcitabine	"Tubulin,chemotherapy"	combo	42	24	6.5	14	33.6	56	PD
X-1289	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	184.8	21	82.5	12	6	32	PD
X-1289	BYL719	PIK3CA	single	90.6	20	36.3	13	21.4	48	PD
X-1289	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-100	35	-80.3	95	95	95	CR
X-1289	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	88.9	20	24.9	13	27	45	PD
X-1289	HDM201	MDM2	single	-15.7	39	16.7	39	39	39	SD
X-1289	figitumumab	IGF1R	single	337.8	22	73.9	12	8.2	22	PD
X-1289	figitumumab + binimetinib	"IGF1R,MAPK"	combo	91.8	29	37.7	12	18.7	39	PD
X-1289	gemcitabine-50mpk	chemotherapy	single	-100	48	-77.1	111	111	111	CR
X-1289	INC424	JAK	single	194.8	20	53.6	13	9.9	27	PD
X-1289	LEE011	"CDK4,CDK6,CDK4/6"	single	285.8	16	94.7	13	6.9	16	PD
X-1289	WNT974	PORCN	single	239.3	23	42.4	12	10.3	30	PD
X-1289	LKA136	"NTRK1,NTRK2,NTRK3"	single	-100	51	-56.3	83	6.5	83	CR
X-1289	binimetinib-3.5mpk	MAPK	single	-23.1	12	16.1	19	33.6	39	SD
X-1289	trametinib	MAPK	single	-95.6	87	-44.2	87	87	87	CR
X-1289	untreated	"UNKNOWN,Untreated"	single	221.5	23	41	12	11	33	PD
X-129	BGJ398	FGFR	single	51.5	20	5.3	13	31	31	PD
X-129	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-60	9	-27	9	9	9	PR
X-129	BYL719	PIK3CA	single	-100	125	-79.9	251	251	251	CR-->PD
X-129	BYL719 + HSP990	"PIK3CA,HSP90"	combo	-59.9	9	-29.2	9	9	9	PR
X-129	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-96.8	88	-79.3	97	285	285	CR-->-->PD
X-129	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-75.5	17	-52.4	31	46	70	PR-->PD
X-129	HDM201	MDM2	single	8.1	10	5.3	13	24	24	SD-->PD
X-129	figitumumab	IGF1R	single	189.6	20	57.8	13	9.6	24	PD
X-129	HSP990	HSP90	single	282.3	20	80.2	13	7.7	24	PD
X-129	INC280	MET	single	120.8	21	14.1	11	19.1	32	PD
X-129	INC280 + trastuzumab	"ERBB2,MET"	combo	86	20	18.6	13	20.5	30	PD
X-129	LEE011	"CDK4,CDK6,CDK4/6"	single	-10.1	27	14.7	34	41	41	SD-->PD
X-129	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-63	31	-40.8	42	95.8	108	PR-->PD
X-129	LJM716	ERBB3	single	82.6	20	37.9	13	20.9	30	PD
X-129	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	92.6	20	29.7	13	20.8	31	PD
X-129	LLM871	FGFR2/4	single	198.7	20	70	13	9.7	24	PD
X-129	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-13	13	-1	13	30	30	SD-->PD
X-129	everolimus	MTOR	single	40.9	20	9.4	13	24	24	PD
X-129	trastuzumab	ERBB2	single	262.7	20	83	13	6.6	24	PD
X-129	untreated	"UNKNOWN,Untreated"	single	132.2	20	32.6	13	17.3	31	PD
X-1290	5FU	chemotherapy	single	-35.2	13	-31.8	13	57	62	SD-->PD
X-1290	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	272.7	12	108.9	12	7.3	12	PD
X-1290	BKM120 + LJC049	"panPI3K,TNKS"	combo	27.5	16	7.4	14	16	16	SD-->PD
X-1290	BYL719	PIK3CA	single	352	21	31.7	11	12.2	24	PD
X-1290	BYL719 + cetuximab	"PIK3CA,EGFR"	combo	145.7	21	44.5	14	16.3	21	PD
X-1290	BYL719 + cetuximab + encorafenib	"PIK3CA,EGFR,BRAF"	combo	270.3	22	52.8	11	10	29	PD
X-1290	BYL719 + encorafenib	"PIK3CA,BRAF"	combo	84.5	22	26.3	14	23.4	27	PD
X-1290	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-44.7	11	-26.7	24	92	92	SD
X-1290	BYL719 + binimetinib	"PIK3CA,MAPK"	combo	78.7	22	74.2	17	5.1	24	PD
X-1290	cetuximab	EGFR	single	-32.3	17	-19.1	17	76	76	SD
X-1290	cetuximab + encorafenib	"EGFR,BRAF"	combo	428.6	21	73.1	11	8.5	29	PD
X-1290	CGM097	MDM2	single	818.1	15	251.2	12	4	15	PD
X-1290	CKX620	MAPK	single	519.5	21	66.8	12	8	25	PD
X-1290	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	356.9	21	37	11	11.5	24	PD
X-1290	HDM201	MDM2	single	294.4	25	78.9	12	8.3	28	PD
X-1290	LEE011	"CDK4,CDK6,CDK4/6"	single	205.1	21	30	12	16.8	28	PD
X-1290	encorafenib	BRAF	single	738	17	88.4	11	8.4	17	PD
X-1290	LJC049	TNKS	single	452.5	21	155.4	11	4.5	21	PD
X-1290	LKA136	"NTRK1,NTRK2,NTRK3"	single	111.6	24	84.8	11	5.9	24	PD
X-1290	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	184.9	12	80.9	12	6.6	12	PD
X-1290	untreated	"UNKNOWN,Untreated"	single	425.9	21	77.8	13	9.3	30	PD
X-1290	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	111.5	17	35.06	13	15.27715356	17	PD
X-1298	BGJ398	FGFR	single	167.4	27	13.8	12	14.9	37	PD
X-1298	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-66.4	65	-46.2	114	114	114	PR
X-1298	BYL719	PIK3CA	single	274	21	72.5	12	8.2	21	PD
X-1298	BYL719 + LEE011	"PIK3CA,CDK4/6"	combo	196.1	22	49.2	11	10	32	PD
X-1298	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	318	21	54.7	13	10.6	31	PD
X-1298	CGM097	MDM2	single	380.3	21	65	12	9.4	21	PD
X-1298	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	146.2	27	26.1	12	18.1	27	PD
X-1298	HDM201	MDM2	single	356.2	21	76.1	12	8.5	21	PD
X-1298	INC424	JAK	single	-20.5	12	-10.8	12	24.9	37	SD-->PD
X-1298	LEE011	"CDK4,CDK6,CDK4/6"	single	77.8	27	15	12	31.5	37	PD
X-1298	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-86.8	54	-65	114	114	114	PR
X-1298	LFA102	PRLR 	single	66	14	7	11	14	14	PD
X-1298	LJM716	ERBB3	single	124.9	22	13	11	15.2	32	PD
X-1298	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	128.4	22	0.5	11	18.1	29	PD
X-1298	LKA136	"NTRK1,NTRK2,NTRK3"	single	298.2	21	96.7	12	7.2	21	PD
X-1298	LLM871	FGFR2/4	single	27.6	20	18.1	12	33	33	SD-->PD
X-1298	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	92.2	22	68.5	12	8.8	22	PD
X-1298	paclitaxel	Tubulin	single	69.6	22	17.3	15	26.8	28	PD
X-1298	tamoxifen	ESR1	single	24.2	14	-0.5	11	24.9	32	SD-->PD
X-1298	trastuzumab	ERBB2	single	195.8	22	32.8	11	12	32	PD
X-1298	untreated	"UNKNOWN,Untreated"	single	322.5	27	59.6	12	11.6	37	PD
X-1298	LFW527 + everolimus	"IGF1R,MTOR"	combo	-58.2	9	-32.36	13	13	13	PR
X-1303	5FU	chemotherapy	single	-19.4	11	-17.5	16	61.9	92	SD-->PD
X-1303	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	183.6	23	34.5	11	16.6	23	PD
X-1303	BYL719	PIK3CA	single	-29.1	9	-17.9	18	28	28	SD-->PD
X-1303	BYL719 + cetuximab	"PIK3CA,EGFR"	combo	64	40	29	11	27.8	76	PD
X-1303	BYL719 + cetuximab + encorafenib	"PIK3CA,EGFR,BRAF"	combo	42.4	31	14.2	16	59	59	PD
X-1303	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-42.2	9	-18.9	14	32	32	SD
X-1303	BYL719 + binimetinib	"PIK3CA,MAPK"	combo	-18.4	24	0.1	27	92	92	SD-->-->PD
X-1303	cetuximab	EGFR	single	-90.2	84	-50.9	92	92	92	PR
X-1303	cetuximab + encorafenib	"EGFR,BRAF"	combo	28.9	19	3.7	13	51.7	75	SD-->PD
X-1303	CGM097	MDM2	single	102.8	21	40.2	11	19.9	24	PD
X-1303	CKX620	MAPK	single	-73	43	-16.6	55	55	55	SD
X-1303	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	127.9	22	35.3	14	18	22	PD
X-1303	HDM201	MDM2	single	150.9	21	67.6	11	8.9	24	PD
X-1303	LEE011	"CDK4,CDK6,CDK4/6"	single	-16.5	9	0.3	18	53.8	78	SD-->PD
X-1303	encorafenib	BRAF	single	189.7	23	59.2	11	7.8	23	PD
X-1303	LJC049	TNKS	single	251	24	43	11	9.6	24	PD
X-1303	LKA136	"NTRK1,NTRK2,NTRK3"	single	523.1	21	110.8	11	4.5	21	PD
X-1303	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-17.6	39	5.8	39	92	92	SD-->-->PD
X-1303	untreated	"UNKNOWN,Untreated"	single	441	23	143.6	11	5.2	23	PD
X-1303	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	-37.6	32	-7.155555556	32	69.12468828	94	SD-->PD
X-131	BGJ398	FGFR	single	68.8	10	51.7	10	10	10	PD
X-131	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	107.9	20	33.4	13	19.3	31	PD
X-131	BYL719	PIK3CA	single	115.3	20	46	13	18.9	31	PD
X-131	BYL719 + HSP990	"PIK3CA,HSP90"	combo	3.5	13	5.1	13	30	30	SD-->PD
X-131	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	185	20	70.5	13	7.1	20	PD
X-131	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	42.3	27	27.3	13	30	30	PD
X-131	HDM201	MDM2	single	211.7	22	52.8	12	11.4	26	PD
X-131	figitumumab	IGF1R	single	172.2	10	58	10	8.3	10	PD
X-131	HSP990	HSP90	single	90.6	22	17.8	12	22.7	29	PD
X-131	INC280	MET	single	293.7	13	139.7	13	4.9	13	PD
X-131	INC280 + trastuzumab	"ERBB2,MET"	combo	119.7	20	16	13	18.5	30	PD
X-131	LEE011	"CDK4,CDK6,CDK4/6"	single	113.8	10	64.1	10	7.6	10	PD
X-131	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-37.4	24	-25	13	24	24	SD
X-131	LJM716	ERBB3	single	428.5	20	103.2	13	5.9	20	PD
X-131	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	381.7	20	92.1	13	6.6	20	PD
X-131	LLM871	FGFR2/4	single	47.8	10	34	10	10	10	PD
X-131	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	23.2	20	41.3	13	22.6	30	PD
X-131	everolimus	MTOR	single	74.6	26	39.8	12	33	33	PD
X-131	trastuzumab	ERBB2	single	245.5	13	98.6	13	7.1	13	PD
X-1310	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	135.4	21	38.06	13	14.18952618	31	PD
X-1317	BKM120 + LDE225	"panPI3K,SMO"	combo	-54.3	51	-20.5	79	79	79	PR
X-1317	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-81.1	55	-53.9	81	81	81	PR
X-1317	figitumumab	IGF1R	single	112.1	20	40.2	13	15.8	33	PD
X-1317	gemcitabine-50mpk	chemotherapy	single	127	20	9	14	18.2	20	PD
X-1317	INC424 + binimetinib	"JAK,MAPK"	combo	-20.3	43	-2.2	47	53	53	SD
X-1317	LEE011	"CDK4,CDK6,CDK4/6"	single	107.9	20	44.2	13	18.3	29	PD
X-1317	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-46.5	55	-22.2	55	55	55	SD
X-1317	binimetinib-3.5mpk	MAPK	single	-86.5	44	-40.5	44	44	44	PR
X-1317	untreated	"UNKNOWN,Untreated"	single	256.7	18	46.8	11	11.1	18	PD
X-1323	BGJ398	FGFR	single	196.1	21	-13.4	11	17.3	26	PD
X-1323	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-29.7	11	-22.3	11	75	75	SD-->PD
X-1323	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-35.5	31	-24.6	31	90.2	120	SD-->PD
X-1323	BYL719	PIK3CA	single	-32.4	11	-20.9	11	50.5	55	SD-->PD
X-1323	BYL719 + LGH447	"PIK3CA,PIM"	combo	-54.7	14	-40	24	65.8	85	PR-->PD
X-1323	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	152.8	21	18.9	14	17.3	37	PD
X-1323	cetuximab	EGFR	single	234.8	22	11.3	14	15.6	22	PD
X-1323	CGM097	MDM2	single	236.2	21	20.9	11	12.3	26	PD
X-1323	CKX620	MAPK	single	-25	28	-11.7	11	34.5	89	SD-->PD
X-1323	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-18.3	9	-9.6	13	35.4	57	SD-->PD
X-1323	HDM201	MDM2	single	221.9	20	60.4	13	9.6	22	PD
X-1323	erlotinib	EGFR	single	127.7	21	-4.3	11	19.8	41	PD
X-1323	HSP990	HSP90	single	-15	3	-8.2	3	3	3	SD
X-1323	INC280	MET	single	445	20	62	13	9.9	22	PD
X-1323	LCL161 + paclitaxel	"BIRC2,TUBB,Tubulin"	combo	-29.1	13	-25.1	13	44.9	56	SD-->PD
X-1323	LEE011	"CDK4,CDK6,CDK4/6"	single	56.3	33	8.6	11	46.2	55	PD
X-1323	LGH447	PIM	single	138.6	28	53.3	11	9.9	41	PD
X-1323	LLM871	FGFR2/4	single	296.9	21	13.2	14	15.9	22	PD
X-1323	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-50.7	13	-30.3	13	42.6	70	PR-->PD
X-1323	paclitaxel	Tubulin	single	269.2	15	75.7	13	8.3	15	PD
X-1323	untreated	"UNKNOWN,Untreated"	single	387.8	20	94.9	13	5.8	22	PD
X-1323	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	-22.3	11	-12.6	11	33.8852459	65	SD-->PD
X-1329	5FU	chemotherapy	single	95.7	23	15.6	15	23.8	54	PD
X-1329	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	223.8	23	44.4	15	15.6	29	PD
X-1329	BKM120 + LJC049	"panPI3K,TNKS"	combo	521	21	122.4	14	6.5	21	PD
X-1329	BYL719	PIK3CA	single	105.3	13	46	13	12.3	13	PD
X-1329	BYL719 + cetuximab	"PIK3CA,EGFR"	combo	185.3	20	63.2	14	9.2	28	PD
X-1329	BYL719 + cetuximab + encorafenib	"PIK3CA,EGFR,BRAF"	combo	70.8	22	51.4	13	12.2	54	PD
X-1329	BYL719 + encorafenib	"PIK3CA,BRAF"	combo	-13.5	36	-0.3	14	57.3	81	SD-->PD
X-1329	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	85.1	21	17.3	13	21.5	45	PD
X-1329	BYL719 + binimetinib	"PIK3CA,MAPK"	combo	-57.9	42	-38	67	92	92	PR-->-->PD
X-1329	cetuximab	EGFR	single	426.9	21	89	11	6.6	25	PD
X-1329	cetuximab + encorafenib	"EGFR,BRAF"	combo	200.8	35	65.3	11	8.4	49	PD
X-1329	CGM097	MDM2	single	269.5	23	67.1	15	10.1	29	PD
X-1329	CKX620	MAPK	single	-2.9	19	-4.7	15	56.4	92	SD-->PD
X-1329	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	338.1	21	67	13	8.8	24	PD
X-1329	HDM201	MDM2	single	286.1	26	74.5	15	10	29	PD
X-1329	LEE011	"CDK4,CDK6,CDK4/6"	single	206.3	23	42.5	15	18.3	29	PD
X-1329	encorafenib	BRAF	single	4	33	9.3	15	45	61	SD-->PD
X-1329	LJC049	TNKS	single	648.8	19	154.3	15	6.8	19	PD
X-1329	LKA136	"NTRK1,NTRK2,NTRK3"	single	486.1	23	82.9	15	9.5	26	PD
X-1329	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	107.8	23	23.2	15	22.1	75	PD
X-1329	untreated	"UNKNOWN,Untreated"	single	353.7	23	75.6	15	8.1	29	PD
X-1329	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	14.7	17	10	13	37.18446602	45	SD-->PD
X-1333	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	262.6	22	12.975	11	17.99704579	22	PD
X-1349	LFW527 + everolimus	"IGF1R,MTOR"	combo	302.4	5	151.2	5	5	5	PD
X-135	BYL719	PIK3CA	single	18.6	20	27	20	33.9	45	SD
X-135	BYL719 + HSP990	"PIK3CA,HSP90"	combo	-60.5	105	-18.7	115	115	115	SD
X-135	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	121.3	14	59.4	11	12.5	14	PD
X-135	HSP990	HSP90	single	29.6	17	21.5	11	31.9	73	SD-->PD
X-135	LEE011	"CDK4,CDK6,CDK4/6"	single	141.6	20	32.7	11	16.5	45	PD
X-135	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	8.1	16	5.7	13	38.9	97	SD-->PD
X-135	LJM716	ERBB3	single	10.2	9	10.2	13	24.1	55	SD-->PD
X-135	everolimus	MTOR	single	-17.3	10	-9.3	13	98	98	SD-->-->PD
X-135	untreated	"UNKNOWN,Untreated"	single	96.3	20	24.4	13	21.1	55	PD
X-136	BYL719	PIK3CA	single	-52	10	-34.2	21	75.2	91	PR-->PD
X-136	BYL719 + HSP990	"PIK3CA,HSP90"	combo	-52.1	10	-33.3	13	38	38	PR
X-136	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-83.7	18	-56.3	26	88	88	PR-->PD
X-136	HSP990	HSP90	single	8.7	14	3.5	14	36.3	78	SD-->PD
X-136	LEE011	"CDK4,CDK6,CDK4/6"	single	50.2	21	30	14	33.8	64	PD
X-136	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-44.5	28	-34.3	54	95	95	SD-->-->PD
X-136	LJM716	ERBB3	single	-25.4	21	-23	11	74	74	SD-->PD
X-136	everolimus	MTOR	single	-38.5	35	-17.9	74	84	84	SD
X-136	untreated	"UNKNOWN,Untreated"	single	62.8	21	18.5	14	24.7	42	PD
X-1362	abraxane	Tubulin	single	96.5	25	28.9	11	19.7	49	PD
X-1362	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	90.5	25	27.3	11	17.3	28	PD
X-1362	BKM120 + LDE225	"panPI3K,SMO"	combo	-39.1	36	-23.7	40	40	40	SD
X-1362	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-28.6	26	-6.8	26	60.3	116	SD-->PD
X-1362	BYL719	PIK3CA	single	92.3	20	15.9	13	21.9	29	PD
X-1362	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	215.5	20	73.3	13	8.8	34	PD
X-1362	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	129.3	20	34.7	13	15.8	34	PD
X-1362	HDM201	MDM2	single	186.8	21	26.7	11	15.5	22	PD
X-1362	figitumumab	IGF1R	single	60	35	10.3	11	45	88	PD
X-1362	figitumumab + binimetinib	"IGF1R,MAPK"	combo	-17.6	20	3.8	20	50	63	SD-->PD
X-1362	gemcitabine-50mpk	chemotherapy	single	47.9	20	38.5	14	30	37	PD
X-1362	INC424	JAK	single	97.9	21	12.3	11	22.4	45	PD
X-1362	INC424 + binimetinib	"JAK,MAPK"	combo	-18.6	13	0.6	13	59.1	114	SD-->PD
X-1362	LEE011	"CDK4,CDK6,CDK4/6"	single	0.5	10	4	14	30.7	98	SD-->PD
X-1362	WNT974	PORCN	single	207	23	32.2	13	13.7	26	PD
X-1362	LKA136	"NTRK1,NTRK2,NTRK3"	single	169.6	21	52.6	14	11.7	26	PD
X-1362	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	5.8	16	13.2	16	31	31	SD
X-1362	binimetinib-3.5mpk	MAPK	single	-9.3	11	-1.3	11	46	54	SD-->PD
X-1362	trametinib	MAPK	single	-65.6	10	-42.8	23	23	23	PR
X-1362	untreated	"UNKNOWN,Untreated"	single	116.8	22	32.4	15	19.1	22	PD
X-137	BYL719	PIK3CA	single	131	31	29.8	14	15.2	48	PD
X-137	BYL719 + HSP990	"PIK3CA,HSP90"	combo	-100	11	-75.2	45	45	45	CR
X-137	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-100	14	-83.3	45	53.2	71	CR-->PD
X-137	HSP990	HSP90	single	300.7	20	96.2	11	4.6	31	PD
X-137	LEE011	"CDK4,CDK6,CDK4/6"	single	117.3	25	27.9	11	19.2	53	PD
X-137	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-8.3	20	7.7	23	34.3	55	SD-->PD
X-137	LJM716	ERBB3	single	-48.8	10	-38.3	14	19.8	31	SD-->PD
X-137	everolimus	MTOR	single	206.1	13	102.7	13	6.1	13	PD
X-137	untreated	"UNKNOWN,Untreated"	single	342.7	21	80	14	9.1	21	PD
X-1371	BGJ398	FGFR	single	243.8	21	49.5	11	14.2	23	PD
X-1371	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	63.9	23	8.9	12	26.3	35	PD
X-1371	BYL719	PIK3CA	single	221.1	20	76.1	13	9.3	22	PD
X-1371	BYL719 + LEE011	"PIK3CA,CDK4/6"	combo	-27.5	11	-13	11	28.3	32	SD-->PD
X-1371	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-23	12	2.5	19	44.1	48	SD-->PD
X-1371	CGM097	MDM2	single	227.3	23	3.1	12	16.7	27	PD
X-1371	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	220.5	20	68.9	13	8.6	22	PD
X-1371	HDM201	MDM2	single	265.5	20	59.7	13	9.2	28	PD
X-1371	INC424	JAK	single	197.1	20	72.2	13	8.2	29	PD
X-1371	LEE011	"CDK4,CDK6,CDK4/6"	single	295.4	20	79.5	13	7.8	27	PD
X-1371	LFA102	PRLR 	single	299.2	20	32.9	13	12.6	21	PD
X-1371	LJM716	ERBB3	single	101.7	25	13.8	11	24.3	34	PD
X-1371	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	197.8	20	25.8	13	14.2	34	PD
X-1371	LKA136	"NTRK1,NTRK2,NTRK3"	single	601.8	20	99.7	13	6.2	22	PD
X-1371	LLM871	FGFR2/4	single	492.9	20	73.2	13	8.8	21	PD
X-1371	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	3.8	13	5.3	13	28.9	36	SD-->PD
X-1371	paclitaxel	Tubulin	single	76.8	20	11.4	13	26	34	PD
X-1371	tamoxifen	ESR1	single	160.4	20	40.6	13	13.5	29	PD
X-1371	trastuzumab	ERBB2	single	273	20	58.1	13	11.2	21	PD
X-1371	untreated	"UNKNOWN,Untreated"	single	384.6	20	77.9	13	9.8	21	PD
X-1371	LFW527 + everolimus	"IGF1R,MTOR"	combo	-6.1	10	-6.5	14	30.76519916	101	SD-->PD
X-138	BGJ398	FGFR	single	282.3	22	53.3	12	11.3	26	PD
X-138	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	63.7	22	11.9	12	26	26	PD
X-138	BYL719	PIK3CA	single	-25.8	44	-10.1	52	101.3	113	SD-->-->PD
X-138	BYL719 + HSP990	"PIK3CA,HSP90"	combo	-59	41	-24	52	82.5	93	PR-->PD
X-138	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	34.2	14	19.9	14	14	14	SD
X-138	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-35.4	23	-15	23	23	23	SD
X-138	HDM201	MDM2	single	127.8	22	34.3	12	15.2	26	PD
X-138	figitumumab	IGF1R	single	312	22	53.2	12	10.8	26	PD
X-138	HSP990	HSP90	single	66.3	20	40.7	13	23.6	31	PD
X-138	INC280	MET	single	226	21	44.7	11	12.6	32	PD
X-138	INC280 + trastuzumab	"ERBB2,MET"	combo	46.6	20	2.5	13	27.1	30	PD
X-138	LEE011	"CDK4,CDK6,CDK4/6"	single	93.6	20	43.2	13	21.6	31	PD
X-138	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-77.2	62	-52	80	117.3	135	PR-->-->PD
X-138	LJM716	ERBB3	single	107.4	20	40.8	13	12.2	30	PD
X-138	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	60.2	20	22.1	13	30	30	PD
X-138	LLM871	FGFR2/4	single	65	20	14.7	13	28.3	31	PD
X-138	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	25	60	15.1	13	34.9	97	SD-->PD
X-138	everolimus	MTOR	single	148.9	20	15.9	12	17.2	37	PD
X-138	trastuzumab	ERBB2	single	187.1	22	29.6	12	13.9	26	PD
X-1383	BGJ398	FGFR	single	141.7	21	10.3	11	15.9	28	PD
X-1383	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-39.7	32	-23.1	60	119.7	151	SD-->PD
X-1383	BYL719	PIK3CA	single	-14.8	11	-9.7	18	67.4	88	SD-->PD
X-1383	BYL719 + LEE011	"PIK3CA,CDK4/6"	combo	21	14	15.4	11	26.9	35	SD-->PD
X-1383	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-34.7	42	-19.1	46	91	91	SD-->PD
X-1383	CGM097	MDM2	single	59.1	25	19	11	27.7	60	PD
X-1383	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	33.4	21	18.1	14	41.7	73	SD
X-1383	HDM201	MDM2	single	-47	87	-23.1	91	91	91	SD
X-1383	INC424	JAK	single	126.6	21	35.7	11	16	42	PD
X-1383	LEE011	"CDK4,CDK6,CDK4/6"	single	54.4	21	20.9	11	29.2	56	PD
X-1383	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	2.3	10	9.3	14	62.7	101	SD-->PD
X-1383	LFA102	PRLR 	single	92.5	20	26.3	14	20.4	55	PD
X-1383	LJM716	ERBB3	single	25.1	18	20.2	11	28.4	53	SD-->PD
X-1383	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	113.8	20	45.3	13	13	41	PD
X-1383	LKA136	"NTRK1,NTRK2,NTRK3"	single	91.4	21	18.1	14	23.1	52	PD
X-1383	LLM871	FGFR2/4	single	122.2	20	40.3	14	16.1	41	PD
X-1383	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	110.9	21	31.7	11	20	56	PD
X-1383	paclitaxel	Tubulin	single	23.7	17	18.1	13	52.5	83	SD
X-1383	tamoxifen	ESR1	single	139.8	21	43.9	14	13.9	38	PD
X-1383	trastuzumab	ERBB2	single	95	20	45.1	14	20.9	48	PD
X-1383	untreated	"UNKNOWN,Untreated"	single	90.7	20	28.6	14	24.9	76	PD
X-1383	LFW527 + everolimus	"IGF1R,MTOR"	combo	97.5	20	52.72	13	12.41132075	41	PD
X-1402	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	97.1	22	14.6	11	22.75652174	50	PD
X-1407	BGJ398	FGFR	single	98.1	24	30.9	14	19.5	52	PD
X-1407	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	14.4	15	12.3	11	41	81	SD-->PD
X-1407	BYL719	PIK3CA	single	119	22	32.8	12	19.8	53	PD
X-1407	BYL719 + LEE011	"PIK3CA,CDK4/6"	combo	-65.5	56	1.4	56	56	56	SD-->PD
X-1407	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-45.4	95	-1.2	11	95	95	SD-->PD
X-1407	CGM097	MDM2	single	280.7	17	105.7	14	7.1	17	PD
X-1407	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-31.5	35	-14.5	42	71.6	80	SD-->PD
X-1407	HDM201	MDM2	single	264.2	29	67.8	12	7.7	32	PD
X-1407	INC424	JAK	single	120.8	25	14.7	11	19.6	42	PD
X-1407	LEE011	"CDK4,CDK6,CDK4/6"	single	87.9	21	21.1	11	23.2	49	PD
X-1407	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	17.7	18	14.7	11	55.8	91	SD-->PD
X-1407	LFA102	PRLR 	single	264.6	20	68.2	14	10.4	20	PD
X-1407	LJM716	ERBB3	single	197.3	22	63.7	11	9.7	32	PD
X-1407	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	25.9	17	0.3	13	33.1	55	SD-->PD
X-1407	LKA136	"NTRK1,NTRK2,NTRK3"	single	214.2	24	60.7	14	11.5	31	PD
X-1407	LLM871	FGFR2/4	single	86.4	65	58.6	14	15.1	111	PD
X-1407	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-74.6	74	-16.3	102	102	102	SD
X-1407	paclitaxel	Tubulin	single	151.8	20	68.3	14	10.4	48	PD
X-1407	tamoxifen	ESR1	single	240.9	21	54.1	11	10.6	28	PD
X-1407	trastuzumab	ERBB2	single	229.1	20	66.2	14	8.9	27	PD
X-1407	untreated	"UNKNOWN,Untreated"	single	189.1	20	43.2	14	14.9	34	PD
X-1407	LFW527 + everolimus	"IGF1R,MTOR"	combo	-45.5	18	-15.27142857	20	20	20	SD
X-141	BYL719	PIK3CA	single	-48.3	35	-18.9	44	110.6	139	SD-->PD
X-141	BYL719 + HSP990	"PIK3CA,HSP90"	combo	-100	105	-66.8	139	139	139	CR
X-141	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	139.9	21	7.7	12	16.2	28	PD
X-141	HSP990	HSP90	single	43.6	41	35.1	11	15.7	109	PD
X-141	LEE011	"CDK4,CDK6,CDK4/6"	single	53.6	21	18.8	14	31.5	44	PD
X-141	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-49.9	42	-27.1	66	136	136	SD-->-->PD
X-141	LJM716	ERBB3	single	-17.5	31	2.8	38	48.7	52	SD-->PD
X-141	everolimus	MTOR	single	-42.9	23	-24.1	94	118	118	SD-->-->PD
X-141	untreated	"UNKNOWN,Untreated"	single	-22.8	11	-10.9	18	49.5	112	SD-->PD
X-142	BYL719	PIK3CA	single	196.7	20	62.9	12	9.3	55	PD
X-142	BYL719 + HSP990	"PIK3CA,HSP90"	combo	2.2	33	15.4	33	55.5	82	SD-->PD
X-142	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	180.8	21	27.9	13	15.3	55	PD
X-142	HSP990	HSP90	single	71.8	20	24.7	12	30.6	55	PD
X-142	LEE011	"CDK4,CDK6,CDK4/6"	single	10.8	12	9.3	12	35.5	82	SD-->PD
X-142	LJM716	ERBB3	single	78.1	21	13.3	13	37.1	76	PD
X-142	everolimus	MTOR	single	-15.6	15	-11.4	20	61.5	82	SD-->PD
X-142	untreated	"UNKNOWN,Untreated"	single	316.4	21	70.6	13	9.7	42	PD
X-144	BYL719 + HSP990	"PIK3CA,HSP90"	combo	133.9	29	110.5	13	4	36	PD
X-144	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	99.4	21	23.9	14	21	31	PD
X-144	HSP990	HSP90	single	586.1	15	197.5	13	4.6	15	PD
X-144	LEE011	"CDK4,CDK6,CDK4/6"	single	284.1	19	140.9	12	5	19	PD
X-144	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	97	23	38.7	13	23.2	55	PD
X-144	LJM716	ERBB3	single	525	20	98.2	13	6.7	20	PD
X-144	everolimus	MTOR	single	435.6	19	122.6	13	5.2	19	PD
X-144	untreated	"UNKNOWN,Untreated"	single	766	13	264.3	13	4.6	13	PD
X-1441	5FU	chemotherapy	single	8.2	13	8.8	13	55.8	86	SD-->PD
X-1441	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-51.7	17	-39.8	31	81	81	PR
X-1441	BKM120 + LJC049	"panPI3K,TNKS"	combo	-11.2	14	-8.2	14	14	14	SD
X-1441	BYL719	PIK3CA	single	-0.1	29	3.8	16	90	90	SD-->PD
X-1441	BYL719 + cetuximab	"PIK3CA,EGFR"	combo	-7.4	11	-4.7	11	62.1	78	SD-->PD
X-1441	BYL719 + cetuximab + encorafenib	"PIK3CA,EGFR,BRAF"	combo	15.5	11	8.2	11	88	88	SD-->PD
X-1441	BYL719 + encorafenib	"PIK3CA,BRAF"	combo	-5.7	14	-1.8	19	42	42	SD
X-1441	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-17.3	17	-6.6	35	88	88	SD-->PD
X-1441	BYL719 + binimetinib	"PIK3CA,MAPK"	combo	-56.4	22	-34.3	56	88	88	PR
X-1441	cetuximab	EGFR	single	-32.7	13	-14.1	16	48.7	86	SD-->PD
X-1441	cetuximab + encorafenib	"EGFR,BRAF"	combo	-9.1	31	5.1	42	81	81	SD-->-->PD
X-1441	CGM097	MDM2	single	72.4	21	23.9	14	29.3	84	PD
X-1441	CKX620	MAPK	single	-56.2	24	-21.2	39	88	88	PR-->PD
X-1441	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-31	34	-17	45	90	90	SD-->PD
X-1441	HDM201	MDM2	single	34.5	28	7	14	52	52	SD-->PD
X-1441	LEE011	"CDK4,CDK6,CDK4/6"	single	6.8	17	5	14	70.5	91	SD-->PD
X-1441	encorafenib	BRAF	single	81.5	24	42.4	14	26.8	45	PD
X-1441	LJC049	TNKS	single	104.6	21	41.8	14	13.7	42	PD
X-1441	LKA136	"NTRK1,NTRK2,NTRK3"	single	39.8	24	4.2	13	43.1	90	PD
X-1441	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-57.6	28	-32.6	49	91	91	PR-->-->PD
X-1441	untreated	"UNKNOWN,Untreated"	single	148.5	21	49	14	15.1	49	PD
X-1442	BGJ398	FGFR	single	266.1	21	102.1	13	7.5	21	PD
X-1442	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	44.8	21	24.2	13	29.5	55	PD
X-1442	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-100	80	-48.6	125	23.8	125	CR
X-1442	BYL719	PIK3CA	single	127.9	21	36.3	13	19.4	21	PD
X-1442	BYL719 + LGH447	"PIK3CA,PIM"	combo	265.8	21	97.5	13	7.5	21	PD
X-1442	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	85.9	21	25.2	13	21.6	34	PD
X-1442	cetuximab	EGFR	single	705.9	21	145.1	13	7	21	PD
X-1442	CGM097	MDM2	single	261.9	13	138.2	13	7	13	PD
X-1442	CKX620	MAPK	single	-13.8	13	0.6	13	39.2	71	SD-->PD
X-1442	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	129	20	66.1	14	8.1	27	PD
X-1442	HDM201	MDM2	single	158.2	13	86.2	13	8.8	13	PD
X-1442	erlotinib	EGFR	single	13.6	11	0	11	11	11	SD
X-1442	HSP990	HSP90	single	273	18	125.2	14	4.5	18	PD
X-1442	INC280	MET	single	72.1	23	35.2	14	9.7	97	PD
X-1442	LCL161 + paclitaxel	"BIRC2,TUBB,Tubulin"	combo	228.8	24	47.3	11	12.9	24	PD
X-1442	LEE011	"CDK4,CDK6,CDK4/6"	single	267.7	13	154.8	13	7	13	PD
X-1442	LGH447	PIM	single	197.9	21	44.8	13	13.6	21	PD
X-1442	LLM871	FGFR2/4	single	396.5	18	76.9	14	10.2	18	PD
X-1442	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-29.6	14	-20	14	97	97	SD-->PD
X-1442	paclitaxel	Tubulin	single	246.3	10	136.1	10	4	10	PD
X-1442	untreated	"UNKNOWN,Untreated"	single	111.8	13	62.3	13	12.2	13	PD
X-1443	5FU	chemotherapy	single	6.5	20	9.8	20	29	29	SD-->PD
X-1443	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	210.7	20	139.8	15	7	29	PD
X-1443	BKM120 + LJC049	"panPI3K,TNKS"	combo	212.6	33	9.1	14	15.2	46	PD
X-1443	BYL719	PIK3CA	single	179.9	24	93.5	15	8.7	48	PD
X-1443	BYL719 + cetuximab	"PIK3CA,EGFR"	combo	-74.7	77	-51.8	91	91	91	PR
X-1443	BYL719 + cetuximab + encorafenib	"PIK3CA,EGFR,BRAF"	combo	-100	52	-84.5	96	96	96	CR
X-1443	BYL719 + encorafenib	"PIK3CA,BRAF"	combo	-1.2	9	5.2	13	37.7	69	SD-->PD
X-1443	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-33.7	32	-19.6	32	32	32	SD
X-1443	BYL719 + binimetinib	"PIK3CA,MAPK"	combo	-59.6	49	-44.6	65	83	83	PR
X-1443	cetuximab	EGFR	single	-100	39	-81.4	83	83	83	CR
X-1443	cetuximab + encorafenib	"EGFR,BRAF"	combo	-95.3	66	-60.6	105	105	105	CR
X-1443	CGM097	MDM2	single	118.8	20	28.3	15	18.6	29	PD
X-1443	CKX620	MAPK	single	-15.1	15	-6.1	20	29	29	SD-->PD
X-1443	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-18.2	14	-9.4	14	55	55	SD-->PD
X-1443	HDM201	MDM2	single	173.9	20	77.5	15	7	29	PD
X-1443	LEE011	"CDK4,CDK6,CDK4/6"	single	-3.4	20	-2.9	20	29	29	SD-->PD
X-1443	encorafenib	BRAF	single	125.1	20	50.6	15	13	29	PD
X-1443	LJC049	TNKS	single	122.4	16	42.5	15	14.2	16	PD
X-1443	LKA136	"NTRK1,NTRK2,NTRK3"	single	-14.4	9	-8.4	14	50	55	SD-->PD
X-1443	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-39.8	15	-31.6	15	29	29	SD
X-1443	untreated	"UNKNOWN,Untreated"	single	-7.9	20	-2.1	20	40.8	61	SD-->PD
X-1443	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	4.9	28	3.575	11	32	32	SD-->PD
X-146	BYL719	PIK3CA	single	-22.9	10	-20.9	14	65.1	91	SD-->PD
X-146	BYL719 + HSP990	"PIK3CA,HSP90"	combo	-94.6	33	-64.1	40	40	40	PR
X-146	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-81.9	64	-56.3	64	64	64	PR
X-146	HSP990	HSP90	single	-28.3	20	-15.3	40	40	40	SD
X-146	LEE011	"CDK4,CDK6,CDK4/6"	single	-55.8	12	-35	15	34.8	55	PR-->PD
X-146	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-32.9	25	-13.1	60	60	60	SD
X-146	LJM716	ERBB3	single	-55.5	60	-34.5	60	60	60	PR
X-146	untreated	"UNKNOWN,Untreated"	single	13.7	53	34.6	11	16.3	88	PD
X-1468	BGJ398	FGFR	single	100	21	25.6	14	21	56	PD
X-1468	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-27.2	17	-13.9	38	91	91	SD-->-->PD
X-1468	BYL719	PIK3CA	single	-2.5	17	1.5	21	89.3	91	SD-->-->PD
X-1468	BYL719 + LEE011	"PIK3CA,CDK4/6"	combo	-46.8	63	-30.7	97	97	97	SD
X-1468	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-11.9	10	-11.9	14	39.6	91	SD-->PD
X-1468	CGM097	MDM2	single	185.9	21	15.9	14	16.7	35	PD
X-1468	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	7.7	10	6	14	91	91	SD-->PD
X-1468	HDM201	MDM2	single	10	10	5.9	14	43.6	77	SD-->PD
X-1468	INC424	JAK	single	255	21	54	14	11	49	PD
X-1468	LEE011	"CDK4,CDK6,CDK4/6"	single	-14.7	14	-3.1	21	67.9	91	SD-->PD
X-1468	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	14.7	10	10.3	14	45.3	84	SD-->PD
X-1468	LFA102	PRLR 	single	153.6	21	43.2	14	13.9	42	PD
X-1468	LJM716	ERBB3	single	2.9	15	10.3	15	48.4	81	SD-->PD
X-1468	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	5.2	14	7.1	14	29.8	56	SD-->PD
X-1468	LKA136	"NTRK1,NTRK2,NTRK3"	single	122.7	21	25.6	14	18.9	56	PD
X-1468	LLM871	FGFR2/4	single	4.9	10	4.7	14	67.3	97	SD-->PD
X-1468	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	1.2	10	1.2	14	71	91	SD-->PD
X-1468	paclitaxel	Tubulin	single	48.3	45	17.9	14	78.8	91	PD
X-1468	tamoxifen	ESR1	single	338.5	21	74.2	14	9.6	28	PD
X-1468	trastuzumab	ERBB2	single	68.6	21	14.9	14	23.6	42	PD
X-1468	untreated	"UNKNOWN,Untreated"	single	121	21	20.8	14	19.5	35	PD
X-1468	LFW527 + everolimus	"IGF1R,MTOR"	combo	-4.8	10	6.483333333	17	48	48	SD
X-1479	5FU	chemotherapy	single	-0.1	40	-3.1	12	67.6	82	SD-->PD
X-1479	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	2.4	10	5.1	14	45.9	84	SD-->PD
X-1479	BKM120 + LJC049	"panPI3K,TNKS"	combo	-3	12	-2	12	33	33	SD-->PD
X-1479	BYL719	PIK3CA	single	1.2	12	-2.1	12	46.3	78	SD-->PD
X-1479	BYL719 + cetuximab	"PIK3CA,EGFR"	combo	27.1	24	11.1	11	28	28	SD-->PD
X-1479	BYL719 + cetuximab + encorafenib	"PIK3CA,EGFR,BRAF"	combo	77.7	21	27.2	11	24.4	67	PD
X-1479	BYL719 + encorafenib	"PIK3CA,BRAF"	combo	-7.6	12	-3	12	46.1	90	SD-->PD
X-1479	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-15	17	-12.1	17	64.2	83	SD-->PD
X-1479	BYL719 + binimetinib	"PIK3CA,MAPK"	combo	-61.1	47	-34.2	72	90	90	PR-->-->PD
X-1479	cetuximab	EGFR	single	32.3	21	18.2	11	43.2	46	SD
X-1479	cetuximab + encorafenib	"EGFR,BRAF"	combo	130.2	21	45.6	11	18.4	39	PD
X-1479	CGM097	MDM2	single	221.9	22	27.1	12	15.4	22	PD
X-1479	CKX620	MAPK	single	-28.7	49	-8.2	56	56	56	SD
X-1479	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	11.1	10	9.5	14	46.3	80	SD-->PD
X-1479	HDM201	MDM2	single	120.7	21	24.3	14	18	24	PD
X-1479	LEE011	"CDK4,CDK6,CDK4/6"	single	0.2	10	0.7	13	27	27	SD-->PD
X-1479	encorafenib	BRAF	single	100.1	20	7.4	13	20	31	PD
X-1479	LJC049	TNKS	single	171.7	20	35.1	13	12.9	20	PD
X-1479	LKA136	"NTRK1,NTRK2,NTRK3"	single	119.6	20	19	13	18.9	20	PD
X-1479	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-1.1	10	1.1	13	70.5	87	SD-->PD
X-1479	untreated	"UNKNOWN,Untreated"	single	-4.1	11	-4.4	11	88	88	SD-->PD
X-1499	BGJ398	FGFR	single	158.3	15	56.3	11	9.2	15	PD
X-1499	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	216.7	15	52.7	11	7.4	15	PD
X-1499	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	151.9	20	30.9	13	13.1	25	PD
X-1499	BYL719	PIK3CA	single	268.6	9	153.8	9	4	9	PD
X-1499	BYL719 + LGH447	"PIK3CA,PIM"	combo	517.1	15	124.2	11	5.7	15	PD
X-1499	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	136.8	15	54.4	11	9.3	15	PD
X-1499	cetuximab	EGFR	single	653.1	15	209.7	14	5	15	PD
X-1499	CGM097	MDM2	single	-100	21	-82.5	100	100	100	CR
X-1499	CKX620	MAPK	single	182.2	22	50.6	11	13.1	26	PD
X-1499	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	295.2	15	84.8	14	9.5	15	PD
X-1499	HDM201	MDM2	single	500.5	15	180.3	14	5.6	15	PD
X-1499	erlotinib	EGFR	single	307.7	15	98.8	14	9.4	15	PD
X-1499	HSP990	HSP90	single	132.6	11	72.3	11	6.9	11	PD
X-1499	INC280	MET	single	229.6	8	108.5	8	4.1	8	PD
X-1499	LCL161 + paclitaxel	"BIRC2,TUBB,Tubulin"	combo	212.3	13	69.3	13	9.9	13	PD
X-1499	LEE011	"CDK4,CDK6,CDK4/6"	single	-76.1	56	-29.9	94	112.8	139	PR-->-->PD
X-1499	LGH447	PIM	single	247	9	122.7	9	5.5	9	PD
X-1499	LLM871	FGFR2/4	single	228.8	5	127.2	5	4	5	PD
X-1499	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	236.3	16	102.6	11	3.8	16	PD
X-1499	paclitaxel	Tubulin	single	267.3	11	120.5	11	4.8	11	PD
X-1499	untreated	"UNKNOWN,Untreated"	single	412.9	12	185.4	12	5	12	PD
X-1499	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	-19.7	10	-4.55	14	20.61048689	24	SD-->PD
X-1500	5FU	chemotherapy	single	-20.5	28	-8.3	57	76	76	SD-->-->PD
X-1500	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-94.4	154	-55	154	154	154	PR
X-1500	BKM120 + LJC049	"panPI3K,TNKS"	combo	-55	31	-22.1	31	31	31	PR
X-1500	BYL719	PIK3CA	single	-57.2	25	-34.9	49	49	49	PR-->PD
X-1500	BYL719 + cetuximab	"PIK3CA,EGFR"	combo	-100	101	-80.5	118	118	118	CR
X-1500	BYL719 + cetuximab + encorafenib	"PIK3CA,EGFR,BRAF"	combo	-100	57	-72.2	69	69	69	CR
X-1500	BYL719 + encorafenib	"PIK3CA,BRAF"	combo	36	28	62.5	18	32.3	36	PD
X-1500	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-34.1	18	-21.5	18	49	49	SD-->PD
X-1500	BYL719 + binimetinib	"PIK3CA,MAPK"	combo	-85.9	25	-66.7	68	122	122	PR-->-->PD
X-1500	cetuximab	EGFR	single	-93	106	-54.2	123	123	123	PR
X-1500	cetuximab + encorafenib	"EGFR,BRAF"	combo	-100	87	-79.6	123	123	123	CR
X-1500	CGM097	MDM2	single	216.4	22	98.2	22	6.6	29	PD
X-1500	CKX620	MAPK	single	-6	32	2.8	32	53	53	SD-->PD
X-1500	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-72.4	41	-51.8	75	75	75	PR
X-1500	HDM201	MDM2	single	491.3	22	173.5	22	6.4	32	PD
X-1500	LEE011	"CDK4,CDK6,CDK4/6"	single	-6.4	38	4	25	56	56	SD-->PD
X-1500	encorafenib	BRAF	single	264.9	22	119.3	22	5	29	PD
X-1500	LJC049	TNKS	single	124.6	25	14.9	18	19.6	25	PD
X-1500	LKA136	"NTRK1,NTRK2,NTRK3"	single	59.3	21	18.8	17	21	21	PD
X-1500	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-29.1	28	-6.7	53	86.5	129	SD-->PD
X-1500	untreated	"UNKNOWN,Untreated"	single	289	25	59.5	11	8.8	32	PD
X-1500	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	40.6	24	12.91666667	15	35.95930233	143	PD
X-152	BYL719	PIK3CA	single	-8.7	14	-2.4	17	37.3	91	SD-->PD
X-152	HSP990	HSP90	single	41.9	23	28.3	13	32.4	97	PD
X-152	LEE011	"CDK4,CDK6,CDK4/6"	single	-12.5	23	1.5	23	27	27	SD
X-1536	5FU	chemotherapy	single	34.9	24	21.3	14	46	46	SD-->PD
X-1536	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	42.3	20	16.2	13	40.6	44	PD
X-1536	BKM120 + LJC049	"panPI3K,TNKS"	combo	-8.6	24	-0.9	27	69	69	SD-->PD
X-1536	BYL719	PIK3CA	single	114.5	21	19.6	13	19.9	44	PD
X-1536	BYL719 + cetuximab	"PIK3CA,EGFR"	combo	8.8	11	7.3	11	91	91	SD
X-1536	BYL719 + cetuximab + encorafenib	"PIK3CA,EGFR,BRAF"	combo	7.1	13	3.5	13	45.2	49	SD-->PD
X-1536	BYL719 + encorafenib	"PIK3CA,BRAF"	combo	103.3	23	8.9	13	22.7	43	PD
X-1536	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	7.4	14	9.2	14	39.5	43	SD-->PD
X-1536	BYL719 + binimetinib	"PIK3CA,MAPK"	combo	-24.2	10	-14.9	20	20	20	SD
X-1536	cetuximab	EGFR	single	118.9	22	24.4	12	19.8	42	PD
X-1536	cetuximab + encorafenib	"EGFR,BRAF"	combo	52	21	20.2	14	28.4	43	PD
X-1536	CKX620	MAPK	single	8.1	10	7.3	13	95	95	SD-->PD
X-1536	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-11.2	24	-2.2	37	76.9	91	SD-->PD
X-1536	HDM201	MDM2	single	4.6	13	3.9	13	46	46	SD-->PD
X-1536	LEE011	"CDK4,CDK6,CDK4/6"	single	-54.9	71	-28.5	89	89	89	PR
X-1536	encorafenib	BRAF	single	146.9	20	35.7	11	13.4	41	PD
X-1536	LJC049	TNKS	single	159.3	21	45.3	15	13.5	30	PD
X-1536	LKA136	"NTRK1,NTRK2,NTRK3"	single	59.9	21	23.3	15	24.5	45	PD
X-1536	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-52.2	82	-17.6	89	89	89	SD
X-1536	untreated	"UNKNOWN,Untreated"	single	107.6	23	15.2	13	22.1	43	PD
X-1538	BYL719	PIK3CA	single	-6.9	28	-1.7	11	56	56	SD
X-1538	BYL719 + binimetinib	"PIK3CA,MAPK"	combo	-3.9	14	-1.8	18	53	53	SD
X-1538	cetuximab	EGFR	single	71.1	17	20.6	13	17	17	PD
X-1538	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	5.5	21	8.9	11	49	49	SD
X-1538	LEE011	"CDK4,CDK6,CDK4/6"	single	-21.2	35	-15.1	49	66	66	SD
X-1538	encorafenib	BRAF	single	0.8	11	0.6	11	32	32	SD-->PD
X-1538	untreated	"UNKNOWN,Untreated"	single	3.4	10	2.3	15	76	76	SD-->PD
X-154	BGJ398	FGFR	single	358.9	20	55.6	11	9.2	24	PD
X-154	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-8.4	11	8.1	17	31.6	73	SD-->PD
X-154	BYL719	PIK3CA	single	294.9	21	53.9	14	9.7	42	PD
X-154	BYL719 + HSP990	"PIK3CA,HSP90"	combo	-2.8	20	18.8	24	36.1	66	SD-->PD
X-154	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	98.4	21	21.7	11	21.2	46	PD
X-154	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	25.1	26	15.4	18	37.3	67	SD-->PD
X-154	HDM201	MDM2	single	152.4	21	56.1	14	13.1	49	PD
X-154	figitumumab	IGF1R	single	83.1	20	24.8	14	21.4	41	PD
X-154	HSP990	HSP90	single	96.1	29	48.1	14	16.8	60	PD
X-154	INC280	MET	single	-95.5	18	-73.1	26	88	88	CR-->PD
X-154	INC280 + trastuzumab	"ERBB2,MET"	combo	-100	19	-78.9	23	23	23	CR
X-154	LEE011	"CDK4,CDK6,CDK4/6"	single	57	23	22.5	13	29.2	54	PD
X-154	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-56.9	14	-30.8	25	77	77	PR-->PD
X-154	LJM716	ERBB3	single	348	21	33.4	11	11.8	25	PD
X-154	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	355.3	20	99.5	13	7.3	23	PD
X-154	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	246.8	21	39.3	13	13	42	PD
X-154	everolimus	MTOR	single	9.5	14	6.3	14	43.4	64	SD-->PD
X-154	trastuzumab	ERBB2	single	337.9	20	63	14	11.3	23	PD
X-154	untreated	"UNKNOWN,Untreated"	single	277.1	21	108.6	14	6.2	21	PD
X-158	BGJ398	FGFR	single	-17.1	10	-6.7	14	44.3	73	SD-->PD
X-158	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-34.3	14	-25.3	14	50	78	SD-->PD
X-158	BYL719	PIK3CA	single	-10.9	10	-4.4	14	87.6	107	SD-->PD
X-158	BYL719 + HSP990	"PIK3CA,HSP90"	combo	64.3	48	20.7	15	28.2	48	PD
X-158	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-37.8	107	-0.7	114	114	114	SD-->PD
X-158	HDM201	MDM2	single	112.9	20	32.9	14	16.3	42	PD
X-158	figitumumab	IGF1R	single	250.4	20	62	14	11.3	30	PD
X-158	HSP990	HSP90	single	128.5	26	34.7	14	18.4	43	PD
X-158	INC280	MET	single	163	25	35.5	14	18.6	32	PD
X-158	INC280 + trastuzumab	"ERBB2,MET"	combo	-75.7	53	-31.4	133	133	133	PR-->-->PD
X-158	LEE011	"CDK4,CDK6,CDK4/6"	single	75	20	12	14	24	63	PD
X-158	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-81.2	97	-49	114	114	114	PR
X-158	LJM716	ERBB3	single	19.7	9	9.3	15	34.1	52	SD-->PD
X-158	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	95.1	23	-2.4	13	23	23	PD
X-158	LLM871	FGFR2/4	single	42.1	30	48.2	13	48.1	73	PD
X-158	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-12.1	25	4.3	25	36	36	SD-->PD
X-158	everolimus	MTOR	single	10.5	10	14.7	14	56.5	94	SD-->PD
X-158	trastuzumab	ERBB2	single	82.4	22	25	14	23.8	35	PD
X-158	untreated	"UNKNOWN,Untreated"	single	53.7	22	47.5	13	9	60	PD
X-1586	BGJ398	FGFR	single	6.3	11	-8.8	11	35	35	SD-->PD
X-1586	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-45.4	28	-26.7	18	68	117	SD-->PD
X-1586	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-74.1	52	-53.1	67	106	106	PR-->-->PD
X-1586	BYL719	PIK3CA	single	-47.7	18	-28.7	21	83.9	110	SD-->PD
X-1586	BYL719 + LGH447	"PIK3CA,PIM"	combo	-59.5	14	-36.4	21	54.5	63	PR-->PD
X-1586	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-51.1	17	-37.3	24	60	106	PR-->PD
X-1586	cetuximab	EGFR	single	48.8	21	19.3	14	16.1	31	PD
X-1586	CGM097	MDM2	single	-11.5	11	-8.9	11	54.9	60	SD-->PD
X-1586	CKX620	MAPK	single	-59.1	63	-39.2	63	117	117	PR-->-->PD
X-1586	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	13.3	18	-3.6	11	41.6	74	SD-->PD
X-1586	HDM201	MDM2	single	-41.1	39	-22.8	14	42	42	SD
X-1586	erlotinib	EGFR	single	-46.5	12	-23.4	12	19	19	SD
X-1586	HSP990	HSP90	single	-44.5	40	-33.7	43	56	56	SD
X-1586	INC280	MET	single	42.8	21	-24.7	14	30.7	51	PD
X-1586	LCL161 + paclitaxel	"BIRC2,TUBB,Tubulin"	combo	-54.9	55	-16.2	18	55	55	SD-->PD
X-1586	LEE011	"CDK4,CDK6,CDK4/6"	single	-26.4	28	-24	21	57	60	SD-->PD
X-1586	LGH447	PIM	single	193.3	23	-6	12	17	26	PD
X-1586	LLM871	FGFR2/4	single	27	18	-6.5	11	33.7	48	SD-->PD
X-1586	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-33.9	10	-28.9	14	68	100	SD-->PD
X-1586	paclitaxel	Tubulin	single	99.1	21	22.2	11	18	34	PD
X-1586	untreated	"UNKNOWN,Untreated"	single	3.4	36	-0.7	15	58.3	70	SD-->PD
X-1586	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	-13.7	10	-10.34	14	87	87	SD-->PD
X-160	BGJ398	FGFR	single	-20.4	11	-6.4	14	117	138	SD-->PD
X-160	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-45.2	103	-17	152	221	221	SD-->-->PD
X-160	BYL719	PIK3CA	single	-3.3	10	-0.2	15	84.8	98	SD-->PD
X-160	BYL719 + HSP990	"PIK3CA,HSP90"	combo	-10.5	21	14.5	28	63.7	69	SD-->PD
X-160	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	17.7	21	21.6	14	34.1	69	SD
X-160	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-10.5	28	-2.8	28	68.2	86	SD-->PD
X-160	HDM201	MDM2	single	-12.4	11	-6.7	11	64.3	109	SD-->PD
X-160	figitumumab	IGF1R	single	225.3	23	28	12	13.9	49	PD
X-160	HSP990	HSP90	single	2.9	11	4.1	11	29	95	SD-->PD
X-160	INC280	MET	single	95.1	24	5.6	14	24.4	49	PD
X-160	INC280 + trastuzumab	"ERBB2,MET"	combo	-23.5	11	-10.4	18	77	80	SD-->PD
X-160	LEE011	"CDK4,CDK6,CDK4/6"	single	-15.4	11	-6.7	11	63.4	96	SD-->PD
X-160	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	33.9	57	19.2	15	64.5	80	SD
X-160	LJM716	ERBB3	single	-17.2	38	-1.2	38	86	86	SD-->PD
X-160	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	-2.3	14	1.9	14	29.8	55	SD-->PD
X-160	LLM871	FGFR2/4	single	59.9	23	5.8	12	28.5	73	PD
X-160	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	19.7	24	8	14	28	28	SD-->PD
X-160	everolimus	MTOR	single	-38.1	70	-23.1	35	130.8	152	SD-->PD
X-1600	BGJ398	FGFR	single	659.8	14	135.5	11	5	14	PD
X-1600	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-32.2	11	-19.9	14	42.2	51	SD-->PD
X-1600	BYL719	PIK3CA	single	275.8	24	49.4	14	11.9	26	PD
X-1600	BYL719 + LEE011	"PIK3CA,CDK4/6"	combo	-15.4	9	-8.6	13	43.2	49	SD-->PD
X-1600	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	520.9	20	86.2	11	7	20	PD
X-1600	CGM097	MDM2	single	279.8	14	76.9	11	8.4	14	PD
X-1600	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-15.7	11	-10.3	11	39.7	48	SD-->PD
X-1600	HDM201	MDM2	single	463	24	117.7	14	6.3	26	PD
X-1600	INC424	JAK	single	1022.3	18	86.2	11	7.5	18	PD
X-1600	LEE011	"CDK4,CDK6,CDK4/6"	single	78.3	20	16.2	13	21.5	34	PD
X-1600	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-36.3	9	-26.4	13	128.9	148	SD-->PD
X-1600	LFA102	PRLR 	single	746.6	14	157.6	13	5.8	14	PD
X-1600	LJM716	ERBB3	single	794.9	14	156.3	11	5.3	14	PD
X-1600	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	318.2	20	53.4	13	11.2	21	PD
X-1600	LKA136	"NTRK1,NTRK2,NTRK3"	single	782.4	13	173.5	11	5.2	13	PD
X-1600	LLM871	FGFR2/4	single	502.5	20	43.8	13	11.7	20	PD
X-1600	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	948.6	18	116.8	11	6.5	18	PD
X-1600	paclitaxel	Tubulin	single	269.4	20	53.2	13	10.9	21	PD
X-1600	tamoxifen	ESR1	single	231.1	22	21.9	11	12.9	26	PD
X-1600	trastuzumab	ERBB2	single	1333.7	13	425.7	13	4.2	13	PD
X-1600	untreated	"UNKNOWN,Untreated"	single	637.9	10	270.2	10	3	10	PD
X-1600	LFW527 + everolimus	"IGF1R,MTOR"	combo	33.6	27	-5.15	13	37.09893455	63	SD-->PD
X-161	BGJ398	FGFR	single	-62.7	29	-42.6	40	116	116	PR-->PD
X-161	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	79.2	22	31.7	12	28.3	88	PD
X-161	BYL719	PIK3CA	single	69.5	22	15.7	12	24.7	67	PD
X-161	BYL719 + HSP990	"PIK3CA,HSP90"	combo	-25.2	17	-14.7	24	53	97	SD-->PD
X-161	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	191.4	20	56.1	13	10.9	34	PD
X-161	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	163	30	62.9	12	9.5	54	PD
X-161	HDM201	MDM2	single	369.3	22	60.6	12	7.5	33	PD
X-161	figitumumab	IGF1R	single	137.1	22	1.7	12	17	50	PD
X-161	HSP990	HSP90	single	154.2	22	25.9	12	14.1	43	PD
X-161	INC280	MET	single	8.7	27	-13.8	12	38.2	54	SD-->PD
X-161	INC280 + trastuzumab	"ERBB2,MET"	combo	246.6	21	59.9	14	11.2	28	PD
X-161	LEE011	"CDK4,CDK6,CDK4/6"	single	27.9	22	36.8	12	37	88	PD
X-161	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-44.4	21	-23.5	63	63	63	SD
X-161	LJM716	ERBB3	single	213.6	24	29.8	14	17	36	PD
X-161	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	116.9	24	18.3	14	19.1	52	PD
X-161	LLM871	FGFR2/4	single	-100	19	-89.8	134	158	158	CR-->-->PD
X-161	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	29.4	30	23.8	12	39.4	131	SD
X-161	everolimus	MTOR	single	65.6	21	14.7	14	37.1	104	PD
X-161	trastuzumab	ERBB2	single	277.6	22	42.3	12	12.2	33	PD
X-161	untreated	"UNKNOWN,Untreated"	single	435.3	21	96.5	14	7.4	31	PD
X-162	BYL719	PIK3CA	single	-28.5	108	-4.2	13	108	108	SD-->PD
X-162	BYL719 + HSP990	"PIK3CA,HSP90"	combo	139.9	20	-2.6	13	18.8	59	PD
X-162	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	39.8	21	25.5	14	25.3	71	PD
X-162	HSP990	HSP90	single	-17.8	17	46	17	17	17	PD
X-162	LEE011	"CDK4,CDK6,CDK4/6"	single	28	20	5.8	13	61.8	108	SD-->PD
X-162	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	50.6	57	50.4	11	12.7	63	PD
X-162	everolimus	MTOR	single	1.7	13	5.3	13	38.6	81	SD-->PD
X-162	untreated	"UNKNOWN,Untreated"	single	320.5	21	65.2	14	9.3	31	PD
X-1631	BGJ398	FGFR	single	363	11	172.6	11	4	11	PD
X-1631	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	19.2	18	11	12	44.2	67	SD-->PD
X-1631	BYL719	PIK3CA	single	47.4	20	22.8	13	29.3	34	PD
X-1631	BYL719 + LEE011	"PIK3CA,CDK4/6"	combo	-22.6	38	-11	38	63.9	94	SD-->PD
X-1631	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	119	22	16.4	12	18.9	25	PD
X-1631	CGM097	MDM2	single	265	20	53.3	13	11.5	27	PD
X-1631	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-15.7	63	-7	11	98	98	SD-->-->PD
X-1631	HDM201	MDM2	single	113.3	25	24.2	11	23.5	33	PD
X-1631	LEE011	"CDK4,CDK6,CDK4/6"	single	218.8	21	99	13	5.6	24	PD
X-1631	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	14.5	17	16.8	17	17	17	SD
X-1631	LFA102	PRLR 	single	312.1	20	67.9	14	8.9	20	PD
X-1631	LJM716	ERBB3	single	354.2	18	76.6	12	7.1	18	PD
X-1631	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	397.2	20	77.6	14	7.6	20	PD
X-1631	LKA136	"NTRK1,NTRK2,NTRK3"	single	325	21	60.2	13	8.7	21	PD
X-1631	LLM871	FGFR2/4	single	-98.7	41	-80	87	137.6	181	CR-->-->PD
X-1631	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	99.5	20	37.3	17	20.1	45	PD
X-1631	paclitaxel	Tubulin	single	-62.3	31	-32.2	38	50.9	55	PR-->PD
X-1631	tamoxifen	ESR1	single	152.7	13	71.3	13	8.9	13	PD
X-1631	trastuzumab	ERBB2	single	365.7	20	88.1	14	6.1	20	PD
X-1631	untreated	"UNKNOWN,Untreated"	single	402.6	21	59.8	11	10.7	21	PD
X-165	BGJ398	FGFR	single	136.5	23	43	11	13	49	PD
X-165	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-61.8	84	-37.1	147	147	147	PR
X-165	BYL719	PIK3CA	single	-21.1	113	14.5	135	178.6	225	SD-->-->PD
X-165	BYL719 + HSP990	"PIK3CA,HSP90"	combo	-66.5	89	-36	89	89	89	PR
X-165	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	26.6	20	11.2	15	34	34	SD-->PD
X-165	HDM201	MDM2	single	-22.5	11	-10.9	18	156	156	SD-->PD
X-165	HSP990	HSP90	single	115.9	21	34.2	11	19	66	PD
X-165	INC280	MET	single	-15.9	9	-11.4	15	58.2	69	SD-->PD
X-165	INC280 + trastuzumab	"ERBB2,MET"	combo	-18	5	-6.1	5	5	5	SD
X-165	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-37.5	52	-8.9	65	65	65	SD
X-165	LJM716	ERBB3	single	19.5	18	19.9	11	28.7	43	SD-->PD
X-165	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	-6.3	57	11.3	15	25.9	80	SD-->PD
X-165	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	1.7	9	3.5	15	35.5	48	SD-->PD
X-165	everolimus	MTOR	single	-58.9	82	-29.5	95	133	138	PR-->-->PD
X-1655	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	92	23	46.9	11	7.6	32	PD
X-1655	BKM120 + encorafenib	"panPI3K,BRAF,BRAF,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	384.4	28	46.7	11	11.2	30	PD
X-1655	CGM097	MDM2	single	357.6	22	164.6	14	2.8	30	PD
X-1655	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	2	10	-1	14	29.9	34	SD-->PD
X-1655	dacarbazine	chemotherapy	single	214.6	23	37.3	14	15.4	27	PD
X-1655	LDE225	SMO	single	279.7	20	72.7	13	9.6	29	PD
X-1655	LDK378	ALK	single	260.4	22	68.2	11	8.8	30	PD
X-1655	LEE011	"CDK4,CDK6,CDK4/6"	single	38.1	23	8.1	11	32	32	PD
X-1655	LEE011 + encorafenib	"CDK4/6,BRAF,BRAF,CDK4,CDK6"	combo	209.9	30	79.2	11	6.5	30	PD
X-1655	LEE011 + binimetinib	"CDK4,CDK6,MAP2K1,MAP2K2,CDK4/6,MAPK"	combo	-47.5	65	-18.9	84	115	115	SD-->-->PD
X-1655	WNT974	PORCN	single	674.5	18	128.7	11	4.2	18	PD
X-1655	LGW813	IAP	single	291.7	20	32.5	13	14.3	29	PD
X-1655	encorafenib	BRAF	single	362.8	22	69.8	14	9.4	32	PD
X-1655	encorafenib + binimetinib	"BRAF,MAP2K1,MAP2K2,MAPK"	combo	275.6	25	75.6	12	9.2	32	PD
X-1655	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	270.2	23	-5.5	11	17.7	32	PD
X-1655	TAS266	DR5	single	465.7	22	70.8	14	9.5	30	PD
X-1655	untreated	"UNKNOWN,Untreated"	single	144	20	56.1	12	11.2	33	PD
X-1658	BGJ398	FGFR	single	244.4	13	109.4	13	7.1	13	PD
X-1658	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-34.6	13	-12.7	13	21.5	42	SD-->PD
X-1658	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-22.3	10	-16.1	13	48.3	55	SD-->PD
X-1658	BYL719	PIK3CA	single	18.7	31	22.5	13	48.2	50	SD
X-1658	BYL719 + LGH447	"PIK3CA,PIM"	combo	-7.4	11	-12.5	11	67.3	102	SD-->PD
X-1658	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-94.3	42	-41.2	42	42	42	PR
X-1658	cetuximab	EGFR	single	328.6	21	47.5	13	11.2	21	PD
X-1658	CGM097	MDM2	single	351.9	20	45.4	13	9.4	20	PD
X-1658	CKX620	MAPK	single	425	13	251.7	13	3	13	PD
X-1658	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-21.8	10	-10	14	56.2	60	SD-->PD
X-1658	HDM201	MDM2	single	-23.9	39	0.1	42	75.6	82	SD-->PD
X-1658	erlotinib	EGFR	single	-80.3	14	-65.1	42	88	88	PR
X-1658	HSP990	HSP90	single	-33.7	10	-1.7	14	20.5	47	SD-->PD
X-1658	INC280	MET	single	216.8	21	38.2	13	13.7	28	PD
X-1658	LCL161 + paclitaxel	"BIRC2,TUBB,Tubulin"	combo	-100	39	-86	98	98	98	CR
X-1658	LEE011	"CDK4,CDK6,CDK4/6"	single	488.7	17	142.6	11	5.3	17	PD
X-1658	LGH447	PIM	single	600.4	20	87.9	13	6.4	20	PD
X-1658	LLM871	FGFR2/4	single	442.3	18	70.7	14	11.3	18	PD
X-1658	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	92.9	24	59.2	13	6.3	42	PD
X-1658	paclitaxel	Tubulin	single	-38.6	31	0.1	73	92.1	105	SD-->-->PD
X-1658	untreated	"UNKNOWN,Untreated"	single	156.6	21	12.3	11	14.4	25	PD
X-1658	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	449.2	14	123	11	4	14	PD
X-166	BGJ398	FGFR	single	188.1	20	55.5	14	12.6	34	PD
X-166	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-20.3	46	-3.2	51	103.4	107	SD-->-->PD
X-166	BYL719	PIK3CA	single	-100	89	-34.9	175	175	175	PR-->PD
X-166	BYL719 + HSP990	"PIK3CA,HSP90"	combo	11.5	19	29.9	19	19	19	SD
X-166	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-90.8	111	-65.9	111	111	111	PR
X-166	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-18.3	11	-2.4	11	23	23	SD
X-166	HDM201	MDM2	single	160.1	20	49.3	14	16.4	34	PD
X-166	figitumumab	IGF1R	single	145.1	20	34.7	14	18	34	PD
X-166	HSP990	HSP90	single	143.6	20	59.8	14	12.1	42	PD
X-166	INC280	MET	single	166.6	23	71.4	11	6.7	31	PD
X-166	INC280 + trastuzumab	"ERBB2,MET"	combo	93	27	8.9	11	19.9	31	PD
X-166	LEE011	"CDK4,CDK6,CDK4/6"	single	31.8	20	11.9	14	46.5	78	SD-->PD
X-166	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	17.6	19	26.6	23	38.2	51	SD
X-166	LJM716	ERBB3	single	114.8	23	6.1	11	20.7	45	PD
X-166	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	116.8	34	17.1	11	20.4	38	PD
X-166	LLM871	FGFR2/4	single	161.2	20	36.8	14	15.3	34	PD
X-166	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-32.1	27	10.1	92	16	105	SD-->PD
X-166	everolimus	MTOR	single	19.7	17	21.3	17	46	46	SD
X-166	trastuzumab	ERBB2	single	128	20	33.7	14	16.7	42	PD
X-166	untreated	"UNKNOWN,Untreated"	single	157.1	21	87.5	12	4.5	47	PD
X-1683	BGJ398	FGFR	single	-100	10	-92	55	55	55	CR
X-1683	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-68.4	10	-48.2	14	93.1	110	PR-->PD
X-1683	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-84.8	66	-69.3	131	131	131	PR
X-1683	BYL719	PIK3CA	single	-90.1	83	-74.8	134	134	134	PR
X-1683	BYL719 + LGH447	"PIK3CA,PIM"	combo	-79.7	35	-68.6	141	141	141	PR
X-1683	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-91.2	35	-72.5	36	36	36	PR
X-1683	cetuximab	EGFR	single	-38.2	10	-32.1	15	110.4	128	SD-->PD
X-1683	CGM097	MDM2	single	-76.2	23	-53.5	27	134	134	PR-->PD
X-1683	CKX620	MAPK	single	-94.8	27	-79.8	31	34	34	PR
X-1683	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-19.7	12	-18.5	12	53.3	111	SD-->PD
X-1683	HDM201	MDM2	single	-49.3	11	-41.7	11	53	53	SD-->PD
X-1683	erlotinib	EGFR	single	-69.6	24	-56.2	25	25	25	PR
X-1683	HSP990	HSP90	single	-52.3	15	-35.8	15	28	28	PR
X-1683	INC280	MET	single	-51.3	12	-43.5	15	63.3	111	PR-->PD
X-1683	LCL161 + paclitaxel	"BIRC2,TUBB,Tubulin"	combo	-100	15	-88.2	48	48	48	CR
X-1683	LEE011	"CDK4,CDK6,CDK4/6"	single	-57.2	13	-41.4	13	44.2	81	PR-->PD
X-1683	LGH447	PIM	single	-61.5	11	-51.1	11	38	38	PR-->PD
X-1683	LLM871	FGFR2/4	single	-61.1	10	-41.3	21	45.9	50	PR-->PD
X-1683	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-59.8	15	-45.8	26	77	97	PR-->PD
X-1683	paclitaxel	Tubulin	single	-55	23	-41.7	26	100	119	PR-->PD
X-1683	untreated	"UNKNOWN,Untreated"	single	122.9	20	-13.2	11	17.5	39	PD
X-169	BYL719	PIK3CA	single	17.9	12	16	12	12	12	SD
X-169	BYL719 + HSP990	"PIK3CA,HSP90"	combo	-7.7	10	-3.3	20	34	34	SD
X-169	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-76.1	25	-54.2	28	28	28	PR
X-169	HSP990	HSP90	single	-3.1	13	2.8	13	27	27	SD
X-169	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-73.9	14	-44.4	14	14	14	PR
X-169	LJM716	ERBB3	single	-100	38	-35.9	38	38	38	PR
X-169	everolimus	MTOR	single	-58.5	13	-35.6	27	27	27	PR
X-169	untreated	"UNKNOWN,Untreated"	single	25.2	49	14.1	12	74	74	SD-->PD
X-171	BGJ398	FGFR	single	409.3	15	93	11	6.3	15	PD
X-171	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	370	19	68.5	13	9.2	19	PD
X-171	BYL719	PIK3CA	single	120.5	15	40.1	13	13.6	15	PD
X-171	BYL719 + HSP990	"PIK3CA,HSP90"	combo	167.5	13	77.3	13	6.9	13	PD
X-171	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	446.8	17	88.6	14	8.7	17	PD
X-171	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	315.1	13	126.8	13	5.8	13	PD
X-171	HDM201	MDM2	single	269.7	22	26.3	13	14.6	26	PD
X-171	figitumumab	IGF1R	single	439.4	13	169.7	13	5	13	PD
X-171	HSP990	HSP90	single	208.6	13	127.1	13	4	13	PD
X-171	INC280	MET	single	-100	37	-75	126	126	126	CR
X-171	LEE011	"CDK4,CDK6,CDK4/6"	single	310.8	22	70.4	11	8.4	36	PD
X-171	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	96.1	20	81.3	13	7	52	PD
X-171	LJM716	ERBB3	single	228.1	16	66.4	13	9.6	16	PD
X-171	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	311.7	21	44.8	14	12.9	24	PD
X-171	LLM871	FGFR2/4	single	498.8	13	178.2	13	5.2	13	PD
X-171	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	512	13	209.6	13	3.9	13	PD
X-171	everolimus	MTOR	single	264.5	22	29.1	11	13.2	22	PD
X-171	trastuzumab	ERBB2	single	513.4	19	121.6	13	5.7	19	PD
X-171	untreated	"UNKNOWN,Untreated"	single	821.7	20	183.9	13	4.3	20	PD
X-1725	BGJ398	FGFR	single	56	22	-12.9	12	30.9	34	PD
X-1725	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-81.5	133	10.8	14	134	134	SD-->PD
X-1725	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-28	10	-21.2	13	69.2	116	SD-->PD
X-1725	BYL719	PIK3CA	single	10	119	33.7	14	37	127	PD
X-1725	BYL719 + LGH447	"PIK3CA,PIM"	combo	127.2	21	45.1	14	18	29	PD
X-1725	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-26.3	28	-7.3	14	41.9	57	SD-->PD
X-1725	cetuximab	EGFR	single	111.3	21	20.9	14	20.1	36	PD
X-1725	CGM097	MDM2	single	11.4	26	21.9	12	28.5	63	SD-->PD
X-1725	CKX620	MAPK	single	-25.4	33	-16.8	15	85.1	113	SD-->PD
X-1725	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	108.2	21	28.6	14	20	43	PD
X-1725	HDM201	MDM2	single	-80.6	66	-43.4	66	66	66	PR
X-1725	erlotinib	EGFR	single	-33.1	14	-16.2	17	17	17	SD
X-1725	HSP990	HSP90	single	-56.2	50	-29.7	12	50	50	PR
X-1725	INC280	MET	single	95.8	21	44.1	14	21.4	36	PD
X-1725	LCL161 + paclitaxel	"BIRC2,TUBB,Tubulin"	combo	3.4	25	3.8	11	47.5	74	SD-->PD
X-1725	LEE011	"CDK4,CDK6,CDK4/6"	single	-12.8	18	-0.2	18	34.4	48	SD-->PD
X-1725	LGH447	PIM	single	-6.7	11	-2.3	11	22.9	40	SD-->PD
X-1725	LLM871	FGFR2/4	single	-20.5	21	-23.8	11	47.8	54	SD-->PD
X-1725	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-37.9	42	-12.2	21	72.7	98	SD-->PD
X-1725	paclitaxel	Tubulin	single	-3.1	21	0	11	47.9	74	SD-->PD
X-1725	untreated	"UNKNOWN,Untreated"	single	292.6	21	105.8	14	7.6	29	PD
X-1725	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	-14.2	32	12.48571429	32	7.896226415	184	SD-->PD
X-177	BYL719 + HSP990	"PIK3CA,HSP90"	combo	37.1	26	16.4	12	43.8	77	PD
X-177	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	159.9	20	67.9	13	9.7	30	PD
X-177	HSP990	HSP90	single	235.2	29	58.4	12	10.2	57	PD
X-177	LEE011	"CDK4,CDK6,CDK4/6"	single	221.3	22	55.5	12	12.7	40	PD
X-177	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	138.6	27	71.5	13	7	55	PD
X-177	LJM716	ERBB3	single	478.3	20	125.9	13	4.8	20	PD
X-177	everolimus	MTOR	single	129.6	25	50.7	11	9.9	53	PD
X-177	untreated	"UNKNOWN,Untreated"	single	324.2	20	95.6	13	6.2	23	PD
X-1787	BGJ398	FGFR	single	91.4	21	59.7	14	11.4	31	PD
X-1787	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-27.2	24	1.3	14	44.8	58	SD-->PD
X-1787	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	12.7	19	19.3	19	49	90	SD-->PD
X-1787	BYL719	PIK3CA	single	173.6	21	61.1	17	8.3	23	PD
X-1787	BYL719 + LGH447	"PIK3CA,PIM"	combo	52	22	59.2	12	10.3	47	PD
X-1787	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	13.9	22	-0.8	12	25.2	41	SD-->PD
X-1787	cetuximab	EGFR	single	529	12	200.3	12	5.2	12	PD
X-1787	CGM097	MDM2	single	471.9	17	128.3	14	6.3	17	PD
X-1787	CKX620	MAPK	single	22.2	17	28.3	20	38.1	53	SD
X-1787	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	323.5	20	107.5	13	6.1	20	PD
X-1787	HDM201	MDM2	single	234.3	21	148.8	14	3	21	PD
X-1787	erlotinib	EGFR	single	225.3	24	95	14	4.2	30	PD
X-1787	HSP990	HSP90	single	212.2	21	88	14	5.5	23	PD
X-1787	INC280	MET	single	14.8	20	-15.9	13	26.1	39	SD-->PD
X-1787	LCL161 + paclitaxel	"BIRC2,TUBB,Tubulin"	combo	570.7	20	95.4	13	8	22	PD
X-1787	LEE011	"CDK4,CDK6,CDK4/6"	single	135.5	21	11.4	14	15.7	23	PD
X-1787	LGH447	PIM	single	391.3	21	82.5	14	8.3	23	PD
X-1787	LLM871	FGFR2/4	single	-9.8	12	-6.3	12	33.4	48	SD-->PD
X-1787	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	5.3	24	-4.6	13	26.4	52	SD-->PD
X-1787	paclitaxel	Tubulin	single	34.1	31	51.2	14	6.8	92	PD
X-1787	untreated	"UNKNOWN,Untreated"	single	622.4	20	127.6	13	6.5	20	PD
X-1787	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	26.6	20	34.1	13	34.95642202	39	PD
X-1795	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	137.3	21	32.7	11	13.14893617	26	PD
X-1823	BGJ398	FGFR	single	216.4	21	56.8	12	8.2	26	PD
X-1823	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	386.2	12	120.2	12	5.7	12	PD
X-1823	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	104.3	26	21.6	12	18.9	53	PD
X-1823	BYL719	PIK3CA	single	-70.1	40	51.2	40	6.6	40	PD
X-1823	BYL719 + LGH447	"PIK3CA,PIM"	combo	76.6	12	31.7	12	12	12	PD
X-1823	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	226	21	31.3	12	13.9	40	PD
X-1823	cetuximab	EGFR	single	266.3	24	39.7	15	12.8	29	PD
X-1823	CGM097	MDM2	single	341.3	15	125.6	15	5.2	15	PD
X-1823	CKX620	MAPK	single	92.8	27	62.9	11	7.4	46	PD
X-1823	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	250.4	24	34.9	15	13.3	37	PD
X-1823	HDM201	MDM2	single	324.4	20	149.5	13	6	20	PD
X-1823	erlotinib	EGFR	single	522	20	36.2	11	11.3	25	PD
X-1823	HSP990	HSP90	single	195.3	18	65	11	8.1	18	PD
X-1823	INC280	MET	single	417.1	15	134.5	15	5.1	15	PD
X-1823	LCL161 + paclitaxel	"BIRC2,TUBB,Tubulin"	combo	303.6	11	129.4	11	5.7	11	PD
X-1823	LEE011	"CDK4,CDK6,CDK4/6"	single	88.3	20	47.8	13	12.4	55	PD
X-1823	LGH447	PIM	single	512.1	18	95.8	11	6.8	18	PD
X-1823	LLM871	FGFR2/4	single	408.3	18	86.4	11	7	18	PD
X-1823	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	212.4	13	78.7	13	8.6	13	PD
X-1823	paclitaxel	Tubulin	single	260.2	18	58.8	11	11.2	18	PD
X-1823	untreated	"UNKNOWN,Untreated"	single	-100	42	-30.3	100	7.3	100	PR
X-1823	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	105.1	31	26.26	13	19.17318436	45	PD
X-1828	BGJ398	FGFR	single	3.7	22	9.7	31	44.6	65	SD-->PD
X-1828	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-2.5	10	-0.6	14	52	52	SD-->PD
X-1828	BYL719	PIK3CA	single	81.7	20	87.4	20	4.4	32	PD
X-1828	BYL719 + LEE011	"PIK3CA,CDK4/6"	combo	-21.3	42	9	11	46	46	SD
X-1828	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-16.3	10	-8	14	40.3	101	SD-->PD
X-1828	CGM097	MDM2	single	107.8	20	32.3	14	16.9	49	PD
X-1828	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-100	81	-44.3	56	81	81	CR-->-->PD
X-1828	HDM201	MDM2	single	73.3	22	19.5	11	25.3	43	PD
X-1828	INC424	JAK	single	248.7	25	64.1	13	9.1	32	PD
X-1828	LEE011	"CDK4,CDK6,CDK4/6"	single	42.9	21	7.4	11	38.3	60	PD
X-1828	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	36.9	42	12.5	11	42	42	PD
X-1828	LFA102	PRLR 	single	97	21	25.4	14	21.4	28	PD
X-1828	LJM716	ERBB3	single	5.9	10	2.3	10	10	10	SD
X-1828	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	13.8	15	6.5	15	51.9	70	SD-->PD
X-1828	LKA136	"NTRK1,NTRK2,NTRK3"	single	101.6	21	41.3	13	20.6	53	PD
X-1828	LLM871	FGFR2/4	single	34.3	41	16.5	12	55	55	SD-->PD
X-1828	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-61	28	-36.3	42	88	88	PR-->PD
X-1828	paclitaxel	Tubulin	single	-15.1	28	1.6	38	49	49	SD-->PD
X-1828	tamoxifen	ESR1	single	58.1	21	17.2	11	44.7	74	PD
X-1828	trastuzumab	ERBB2	single	-1.9	31	4.9	15	67.4	76	SD-->PD
X-1828	untreated	"UNKNOWN,Untreated"	single	168.1	20	50.7	13	13.7	53	PD
X-1832	BGJ398	FGFR	single	520.2	21	87.9	14	8.7	21	PD
X-1832	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	215.1	21	36.2	14	14.1	35	PD
X-1832	BYL719	PIK3CA	single	379.2	17	89.3	14	7	17	PD
X-1832	BYL719 + LEE011	"PIK3CA,CDK4/6"	combo	387.2	21	83.5	19	11.8	25	PD
X-1832	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	132	21	17.9	14	17.3	70	PD
X-1832	CGM097	MDM2	single	605.8	17	84.8	11	7.2	17	PD
X-1832	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	519.3	26	65.8	11	7.9	32	PD
X-1832	HDM201	MDM2	single	457.7	17	190.1	14	3.1	17	PD
X-1832	INC424	JAK	single	607.6	17	95.9	11	6.7	17	PD
X-1832	LEE011	"CDK4,CDK6,CDK4/6"	single	354.7	26	33.8	11	14	32	PD
X-1832	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	169.3	21	48.9	19	15.3	46	PD
X-1832	LFA102	PRLR 	single	265.6	22	60.8	13	10.7	28	PD
X-1832	LJM716	ERBB3	single	224.8	23	22.1	11	14.5	29	PD
X-1832	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	893.3	22	172.9	13	4.8	22	PD
X-1832	LKA136	"NTRK1,NTRK2,NTRK3"	single	423.7	26	15	11	13.8	32	PD
X-1832	LLM871	FGFR2/4	single	162.7	14	81.5	14	9.6	14	PD
X-1832	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	327.1	17	72.2	11	7.9	17	PD
X-1832	paclitaxel	Tubulin	single	3.4	17	-0.5	15	33.5	49	SD-->PD
X-1832	tamoxifen	ESR1	single	772.5	19	240.5	19	5.5	19	PD
X-1832	trastuzumab	ERBB2	single	487	13	207.4	13	4.3	13	PD
X-1832	untreated	"UNKNOWN,Untreated"	single	215.1	22	82	12	8.2	33	PD
X-1832	LFW527 + everolimus	"IGF1R,MTOR"	combo	77.6	17	41.1	14	17	17	PD
X-1834	BGJ398	FGFR	single	77.6	20	26.6	13	20	20	PD
X-1834	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-18	13	-2	13	27.9	47	SD-->PD
X-1834	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	9.7	13	9.4	13	22.7	47	SD-->PD
X-1834	BYL719	PIK3CA	single	-4.6	13	-11.5	13	33.8	68	SD-->PD
X-1834	BYL719 + LGH447	"PIK3CA,PIM"	combo	106	13	41	13	12.4	13	PD
X-1834	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	149.2	20	52.1	13	10.6	21	PD
X-1834	cetuximab	EGFR	single	57.8	21	47	14	24.7	69	PD
X-1834	CGM097	MDM2	single	227.1	20	88	13	3	21	PD
X-1834	CKX620	MAPK	single	-23.9	54	6.3	86	86	86	SD
X-1834	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-39.1	49	-21.2	15	56	56	SD
X-1834	HDM201	MDM2	single	314	20	105.1	13	2	21	PD
X-1834	erlotinib	EGFR	single	-2.9	13	10.1	13	24.8	68	SD-->PD
X-1834	HSP990	HSP90	single	-39.9	31	22	31	31	31	SD
X-1834	INC280	MET	single	23.8	13	20.6	13	27.3	68	SD-->PD
X-1834	LCL161 + paclitaxel	"BIRC2,TUBB,Tubulin"	combo	-89.5	17	-54.4	17	17	17	PR
X-1834	LEE011	"CDK4,CDK6,CDK4/6"	single	29.1	40	49.5	54	5.7	117	PD
X-1834	LGH447	PIM	single	311.8	13	105.9	13	5.9	13	PD
X-1834	LLM871	FGFR2/4	single	205.1	11	92.4	11	5.5	11	PD
X-1834	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-38.2	41	-20.6	44	118	118	SD-->PD
X-1834	paclitaxel	Tubulin	single	71.1	21	18.5	11	33.2	45	PD
X-1834	untreated	"UNKNOWN,Untreated"	single	54.5	21	19.7	14	31.3	55	PD
X-1834	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	87.5	27	14.58	13	18.4954955	35	PD
X-1835	BGJ398	FGFR	single	175.4	15	75.4	11	6.7	15	PD
X-1835	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	149.3	21	24.6	14	18.3	35	PD
X-1835	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-4.4	31	35.1	17	39.6	50	PD
X-1835	BYL719	PIK3CA	single	78.1	35	59.7	11	10.2	43	PD
X-1835	BYL719 + LGH447	"PIK3CA,PIM"	combo	136.3	24	38.4	11	11.5	43	PD
X-1835	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	17.9	10	2.2	14	29.2	50	SD-->PD
X-1835	cetuximab	EGFR	single	72.2	24	20	14	26.1	42	PD
X-1835	CGM097	MDM2	single	164.5	28	-2.4	14	17.8	43	PD
X-1835	CKX620	MAPK	single	-82.2	14	-64.9	85	85	85	PR
X-1835	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-17.5	9	-11.1	14	22.4	50	SD-->PD
X-1835	HDM201	MDM2	single	62.5	21	22.8	17	27.1	36	PD
X-1835	erlotinib	EGFR	single	-12	21	-5.5	21	42	76	SD-->PD
X-1835	HSP990	HSP90	single	-48.8	31	-17.3	31	42	42	SD
X-1835	INC280	MET	single	153.9	24	59.9	17	9.1	36	PD
X-1835	LCL161 + paclitaxel	"BIRC2,TUBB,Tubulin"	combo	-51	14	-22.9	14	14	14	PR
X-1835	LEE011	"CDK4,CDK6,CDK4/6"	single	-95.7	154	-58.5	181	181	181	CR
X-1835	LGH447	PIM	single	5.8	18	5.7	14	53	73	SD-->PD
X-1835	LLM871	FGFR2/4	single	2.2	17	-4.1	17	33	39	SD-->PD
X-1835	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-100	10	-86.3	65	65	65	CR
X-1835	paclitaxel	Tubulin	single	-9	31	37	11	38.7	53	PD
X-1835	untreated	"UNKNOWN,Untreated"	single	396.2	25	44.6	15	12.5	29	PD
X-1835	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	-66.5	28	-22.3	31	120	120	PR-->-->PD
X-1855	5FU	chemotherapy	single	9.1	10	5	17	87	87	SD-->PD
X-1855	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	0.2	14	-0.2	14	84	84	SD-->PD
X-1855	BKM120 + LJC049	"panPI3K,TNKS"	combo	64	21	3.9	12	24.8	45	PD
X-1855	BYL719	PIK3CA	single	4.7	11	3.2	11	64.1	91	SD-->PD
X-1855	BYL719 + cetuximab	"PIK3CA,EGFR"	combo	68.7	21	13	12	30.9	45	PD
X-1855	BYL719 + cetuximab + encorafenib	"PIK3CA,EGFR,BRAF"	combo	-0.7	10	0.8	14	64.1	87	SD-->PD
X-1855	BYL719 + encorafenib	"PIK3CA,BRAF"	combo	-63	91	-22.8	91	91	91	PR
X-1855	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	5.9	11	2.5	11	41.6	63	SD-->PD
X-1855	BYL719 + binimetinib	"PIK3CA,MAPK"	combo	-44	45	-29.1	59	84	84	SD-->-->PD
X-1855	cetuximab	EGFR	single	0	10	1.8	14	33.2	57	SD-->PD
X-1855	cetuximab + encorafenib	"EGFR,BRAF"	combo	38.9	22	4.5	14	77.2	87	PD
X-1855	CGM097	MDM2	single	45.7	21	2.3	11	30.8	77	PD
X-1855	CKX620	MAPK	single	-1.3	14	0.3	14	77.5	84	SD-->PD
X-1855	HDM201	MDM2	single	91.4	21	17.4	11	25.2	56	PD
X-1855	LEE011	"CDK4,CDK6,CDK4/6"	single	0	17	0.1	17	82.1	87	SD-->PD
X-1855	encorafenib	BRAF	single	91.1	70	10.2	11	21.7	84	PD
X-1855	LJC049	TNKS	single	97.7	21	7.2	11	21.5	43	PD
X-1855	LKA136	"NTRK1,NTRK2,NTRK3"	single	78.8	21	8.8	11	24.1	35	PD
X-1855	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-8	80	-1.8	87	87	87	SD
X-1855	untreated	"UNKNOWN,Untreated"	single	124.4	21	31.9	14	16.3	38	PD
X-1855	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	-3.5	48	2.19	65	182.8046875	195	SD-->-->PD
X-1869	BGJ398	FGFR	single	161	14	44.3	14	12	14	PD
X-1869	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-100	10	-83	37	37	37	CR
X-1869	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-100	9	-57.1	23	23	23	CR
X-1869	BYL719	PIK3CA	single	105.2	16	29.8	13	11.6	16	PD
X-1869	BYL719 + LGH447	"PIK3CA,PIM"	combo	-100	9	-70.2	20	22.1	23	CR-->PD
X-1869	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	362	6	139.5	6	2.6	6	PD
X-1869	cetuximab	EGFR	single	655.1	11	305.8	11	4	11	PD
X-1869	CGM097	MDM2	single	492.2	7	199.9	7	3	7	PD
X-1869	CKX620	MAPK	single	-100	14	-4.4	14	14	14	SD
X-1869	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	842.3	11	293.6	11	4	11	PD
X-1869	HDM201	MDM2	single	514.5	21	-45.3	14	17.5	21	PD
X-1869	erlotinib	EGFR	single	527.5	7	230.8	7	3	7	PD
X-1869	HSP990	HSP90	single	-100	14	-43.9	14	14	14	CR
X-1869	INC280	MET	single	120.8	14	152.3	14	4	14	PD
X-1869	LCL161 + paclitaxel	"BIRC2,TUBB,Tubulin"	combo	-58.5	11	-34.3	11	32	32	PR-->PD
X-1869	LEE011	"CDK4,CDK6,CDK4/6"	single	-100	10	-89.2	63	63	63	CR
X-1869	LGH447	PIM	single	139.6	20	-7.9	13	18.7	20	PD
X-1869	LLM871	FGFR2/4	single	557.3	13	151.9	13	7.4	13	PD
X-1869	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	312.9	11	130.6	11	4.6	11	PD
X-1869	paclitaxel	Tubulin	single	450.1	11	166.4	11	5.3	11	PD
X-1869	untreated	"UNKNOWN,Untreated"	single	565.5	11	213.6	11	4.4	11	PD
X-1869	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	127.6	21	28.675	11	16.35416667	33	PD
X-1870	BGJ398	FGFR	single	-7.2	11	-2.8	14	26.8	77	SD-->PD
X-1870	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-32.7	21	-12.9	21	86.5	106	SD-->PD
X-1870	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-51.5	109	-19.7	133	133	133	SD-->-->PD
X-1870	BYL719	PIK3CA	single	74.6	21	36.8	14	29.2	64	PD
X-1870	BYL719 + LGH447	"PIK3CA,PIM"	combo	-10.5	11	-14.1	11	35.7	98	SD-->PD
X-1870	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-28	18	-11.2	35	73.3	92	SD-->PD
X-1870	cetuximab	EGFR	single	60.8	21	17.3	17	34.5	95	PD
X-1870	CGM097	MDM2	single	45.2	25	11.1	14	30.4	71	PD
X-1870	CKX620	MAPK	single	-39.2	21	-20.6	21	84.2	106	SD-->PD
X-1870	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	13.7	36	3.3	11	42.2	84	SD-->PD
X-1870	HDM201	MDM2	single	17.7	79	15.6	14	79	79	SD
X-1870	erlotinib	EGFR	single	-23	11	-14.6	11	34.8	40	SD-->PD
X-1870	HSP990	HSP90	single	-8.7	11	-2.4	11	11	11	SD
X-1870	LCL161 + paclitaxel	"BIRC2,TUBB,Tubulin"	combo	-88.1	129	-68.6	129	129	129	PR
X-1870	LEE011	"CDK4,CDK6,CDK4/6"	single	71.6	22	16.5	11	38.9	74	PD
X-1870	LGH447	PIM	single	31.9	25	22.3	15	40.7	78	SD
X-1870	LLM871	FGFR2/4	single	-14.5	10	-8.1	14	86.6	108	SD-->PD
X-1870	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-21.8	63	-16.4	14	97.4	121	SD-->PD
X-1870	paclitaxel	Tubulin	single	-7.2	14	-4.1	14	73	73	SD-->PD
X-1870	untreated	"UNKNOWN,Untreated"	single	-18.1	11	-11.2	11	48.8	110	SD-->PD
X-1870	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	5.8	20	10.66666667	20	63.82423813	90	SD-->PD
X-1906	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	18.2	16	6.6	11	44.5	47	SD-->PD
X-1906	BKM120 + encorafenib	"panPI3K,BRAF,BRAF,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-100	28	-95.4	264	401	401	CR-->-->PD
X-1906	CGM097	MDM2	single	362.7	21	76.7	14	10.1	21	PD
X-1906	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-6.2	30	17.2	30	57.9	63	SD-->PD
X-1906	dacarbazine	chemotherapy	single	52.7	26	19.5	11	40.7	45	PD
X-1906	LDE225	SMO	single	497.6	21	101.9	13	8.2	21	PD
X-1906	LDK378	ALK	single	184.9	21	37	14	13.4	21	PD
X-1906	LEE011	"CDK4,CDK6,CDK4/6"	single	-88.2	142	-55.6	189	313.9	315	PR-->-->PD
X-1906	LEE011 + encorafenib	"CDK4/6,BRAF,BRAF,CDK4,CDK6"	combo	-100	31	-91.2	218	395	395	CR-->-->PD
X-1906	LEE011 + binimetinib	"CDK4,CDK6,MAP2K1,MAP2K2,CDK4/6,MAPK"	combo	-100	19	-97.2	399	399	399	CR
X-1906	WNT974	PORCN	single	550	17	174.2	14	5.2	17	PD
X-1906	LGW813	IAP	single	206.7	21	33.3	11	11.9	21	PD
X-1906	encorafenib	BRAF	single	-100	38	-89.5	129	217.5	315	CR-->-->PD
X-1906	encorafenib + binimetinib	"BRAF,MAP2K1,MAP2K2,MAPK"	combo	-100	11	-96.4	321	339	339	CR-->-->PD
X-1906	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-100	11	-69.1	85	162	162	CR-->-->PD
X-1906	TAS266	DR5	single	-47.9	10	-37.8	14	27	27	SD-->PD
X-1906	untreated	"UNKNOWN,Untreated"	single	317.4	21	88.6	14	8.3	21	PD
X-1916	BGJ398	FGFR	single	307.9	21	86.2	13	8.3	27	PD
X-1916	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	41.5	21	27.7	14	26.9	42	PD
X-1916	BYL719	PIK3CA	single	462.6	17	115.6	14	7.8	17	PD
X-1916	BYL719 + LEE011	"PIK3CA,CDK4/6"	combo	274.2	20	64.6	14	9.8	28	PD
X-1916	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-59.8	14	-18.6	14	14	14	SD
X-1916	CGM097	MDM2	single	279.6	21	42.7	14	12.7	21	PD
X-1916	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	21.6	14	16.3	14	35.7	50	SD-->PD
X-1916	HDM201	MDM2	single	441.2	14	142.5	14	7.3	14	PD
X-1916	INC424	JAK	single	499.3	12	218.5	12	5	12	PD
X-1916	LEE011	"CDK4,CDK6,CDK4/6"	single	243.7	21	47.4	14	14.2	21	PD
X-1916	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	143.4	20	26.7	14	18.3	28	PD
X-1916	LFA102	PRLR 	single	100.6	20	26	14	20	28	PD
X-1916	LJM716	ERBB3	single	-0.3	14	1	14	26.4	50	SD-->PD
X-1916	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	-50.7	19	-39	30	56.6	83	PR-->PD
X-1916	LKA136	"NTRK1,NTRK2,NTRK3"	single	124.7	21	22	14	18.7	21	PD
X-1916	LLM871	FGFR2/4	single	348.7	20	76.9	14	9.7	24	PD
X-1916	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	329.1	19	48.9	12	10.4	19	PD
X-1916	paclitaxel	Tubulin	single	164	21	40.3	11	17	28	PD
X-1916	tamoxifen	ESR1	single	292.3	19	43.7	12	11.2	19	PD
X-1916	trastuzumab	ERBB2	single	153.5	20	48.2	14	12	28	PD
X-1916	untreated	"UNKNOWN,Untreated"	single	293.7	21	44.9	11	11.2	28	PD
X-1916	LFW527 + everolimus	"IGF1R,MTOR"	combo	9.7	17	16.16	17	36.7008547	59	SD-->PD
X-1921	BGJ398	FGFR	single	80.9	22	36.9	11	24.4	81	PD
X-1921	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	33.2	22	-3.5	12	42.2	88	SD-->PD
X-1921	BYL719	PIK3CA	single	14.7	11	7.8	11	62.5	94	SD-->PD
X-1921	BYL719 + LEE011	"PIK3CA,CDK4/6"	combo	-35.7	18	-25.3	21	140	140	SD-->-->PD
X-1921	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	49.6	25	3.8	11	36.4	67	PD
X-1921	CGM097	MDM2	single	235.6	21	46.1	11	11.7	38	PD
X-1921	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-36.4	11	-25.5	14	141.7	175	SD-->PD
X-1921	HDM201	MDM2	single	102.8	22	34.8	12	14.4	46	PD
X-1921	INC424	JAK	single	118.1	22	61.3	11	9.2	53	PD
X-1921	LEE011	"CDK4,CDK6,CDK4/6"	single	-35.2	22	-19.9	81	120.4	151	SD-->-->PD
X-1921	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-41	81	-15.1	84	84	84	SD
X-1921	LFA102	PRLR 	single	132.4	20	45.6	13	13	41	PD
X-1921	LJM716	ERBB3	single	150.5	20	34.6	13	14.5	34	PD
X-1921	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	138.9	20	51.4	13	14.3	48	PD
X-1921	LKA136	"NTRK1,NTRK2,NTRK3"	single	259.3	22	50.6	11	10.6	25	PD
X-1921	LLM871	FGFR2/4	single	81.4	20	38.1	13	22.3	55	PD
X-1921	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-2.5	25	3.6	11	52.7	59	SD-->PD
X-1921	paclitaxel	Tubulin	single	118.3	20	31.2	13	18.6	34	PD
X-1921	tamoxifen	ESR1	single	76.3	21	10.6	11	23.5	66	PD
X-1921	trastuzumab	ERBB2	single	172.3	20	36.6	14	15.9	55	PD
X-1921	untreated	"UNKNOWN,Untreated"	single	193.9	21	38.5	11	12.3	52	PD
X-1921	LFW527 + everolimus	"IGF1R,MTOR"	combo	-100	56	-33.765625	109	109	109	PR-->PD
X-1934	BGJ398	FGFR	single	322.2	21	-16.4	12	16.2	26	PD
X-1934	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	307.1	12	98.4	12	5.8	12	PD
X-1934	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	165.6	21	65.6	12	8.9	40	PD
X-1934	BYL719	PIK3CA	single	203.6	11	82	11	6.2	11	PD
X-1934	BYL719 + LGH447	"PIK3CA,PIM"	combo	139.9	7	46.6	7	5.5	7	PD
X-1934	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	208.2	19	-8.3	12	13.8	19	PD
X-1934	cetuximab	EGFR	single	479.9	11	180.1	11	3.6	11	PD
X-1934	CGM097	MDM2	single	359.6	12	111.6	12	5.8	12	PD
X-1934	CKX620	MAPK	single	140.1	7	43.7	7	5.7	7	PD
X-1934	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	301.1	10	109.7	10	5.4	10	PD
X-1934	HDM201	MDM2	single	390.3	7	195.7	7	1	7	PD
X-1934	erlotinib	EGFR	single	218.4	7	96.4	7	3.3	7	PD
X-1934	HSP990	HSP90	single	618.5	6	271	6	3	6	PD
X-1934	INC280	MET	single	307.1	7	98.6	7	4.3	7	PD
X-1934	LCL161 + paclitaxel	"BIRC2,TUBB,Tubulin"	combo	443.4	40	149.3	40	9.5	40	PD
X-1934	LEE011	"CDK4,CDK6,CDK4/6"	single	569.4	11	226.2	11	3	11	PD
X-1934	LGH447	PIM	single	397.6	12	115.5	12	6	12	PD
X-1934	LLM871	FGFR2/4	single	282.5	12	151.2	12	5	12	PD
X-1934	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	407.2	15	162.3	15	6.4	15	PD
X-1934	paclitaxel	Tubulin	single	360.4	19	89.4	12	5.1	19	PD
X-1934	untreated	"UNKNOWN,Untreated"	single	391.9	12	117.1	12	6.2	12	PD
X-1934	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	282.4	14	108.52	13	6.887019231	14	PD
X-1948	abraxane	Tubulin	single	3	13	-7.6	11	33.5	48	SD-->PD
X-1948	abraxane + gemcitabine	"Tubulin,chemotherapy"	combo	-17.4	83	16	86	110	110	SD-->PD
X-1948	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-23.6	10	-10.4	24	39	39	SD-->PD
X-1948	BKM120 + LDE225	"panPI3K,SMO"	combo	-1.4	31	9.2	31	58.6	84	SD-->PD
X-1948	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	30.7	39	28.6	11	59.8	84	SD
X-1948	BYL719	PIK3CA	single	-9.5	21	-3.7	25	53	53	SD
X-1948	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	26.3	42	33	11	31.1	64	PD
X-1948	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	124.5	21	18.5	12	14.6	53	PD
X-1948	HDM201	MDM2	single	83	21	24.5	11	27.1	63	PD
X-1948	figitumumab	IGF1R	single	2	14	5.3	14	14	14	SD
X-1948	figitumumab + binimetinib	"IGF1R,MAPK"	combo	193.1	21	62.4	11	11.1	28	PD
X-1948	gemcitabine-50mpk	chemotherapy	single	18.1	33	10.6	13	63.8	104	SD-->PD
X-1948	INC424	JAK	single	6.1	9	7.9	13	43.6	111	SD-->PD
X-1948	INC424 + binimetinib	"JAK,MAPK"	combo	12.2	16	25.1	16	25.9	100	SD
X-1948	LEE011	"CDK4,CDK6,CDK4/6"	single	61.7	48	44.1	12	14.4	55	PD
X-1948	WNT974	PORCN	single	128.6	22	42.2	12	15.8	30	PD
X-1948	LKA136	"NTRK1,NTRK2,NTRK3"	single	27.9	22	21.7	15	27.1	28	SD-->PD
X-1948	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-8.3	11	-2.4	11	18	18	SD
X-1948	binimetinib-3.5mpk	MAPK	single	6.9	21	-4.3	11	31	41	SD-->PD
X-1948	trametinib	MAPK	single	-44.1	98	-18.5	98	98	98	SD-->-->PD
X-1948	untreated	"UNKNOWN,Untreated"	single	27.6	19	6	13	29.7	71	SD-->PD
X-1959	abraxane + gemcitabine	"Tubulin,chemotherapy"	combo	-60.9	37	-23.5	37	37	37	PR
X-1959	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-57.6	37	-27.3	47	47	47	PR
X-1959	gemcitabine-50mpk	chemotherapy	single	31.5	28	9.6	11	17.1	35	SD-->PD
X-1959	INC424 + binimetinib	"JAK,MAPK"	combo	-6.2	34	-4.6	12	48.8	61	SD-->PD
X-1959	LEE011	"CDK4,CDK6,CDK4/6"	single	56.4	21	30.1	11	29.6	35	PD
X-1959	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-47.5	35	-27.3	35	35	35	SD
X-1979	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	-25.6	24	-5.6	24	65.12359551	85	SD-->PD
X-1980	BGJ398	FGFR	single	581.5	18	138.4	13	4.8	18	PD
X-1980	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-18.8	22	-14	12	96.3	98	SD-->PD
X-1980	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-24.1	27	-9.9	30	90.7	92	SD-->PD
X-1980	BYL719	PIK3CA	single	94.6	20	29.7	13	24	33	PD
X-1980	BYL719 + LGH447	"PIK3CA,PIM"	combo	118.5	20	1.5	13	17.5	29	PD
X-1980	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	218.2	20	99.5	13	5.5	25	PD
X-1980	cetuximab	EGFR	single	-12.7	20	20.8	20	42.4	50	SD
X-1980	CGM097	MDM2	single	51.5	22	64.4	12	9.3	27	PD
X-1980	CKX620	MAPK	single	51.2	21	9	11	31.1	34	PD
X-1980	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-24.2	9	-17.6	13	60.1	85	SD-->PD
X-1980	HDM201	MDM2	single	111.5	23	-3.6	13	18.8	30	PD
X-1980	erlotinib	EGFR	single	1	20	4.4	13	21.7	35	SD-->PD
X-1980	HSP990	HSP90	single	-33.6	12	-24.1	12	61.6	63	SD-->PD
X-1980	INC280	MET	single	283.5	23	93.1	13	7	28	PD
X-1980	LCL161 + paclitaxel	"BIRC2,TUBB,Tubulin"	combo	69.5	33	28.8	12	21.5	42	PD
X-1980	LEE011	"CDK4,CDK6,CDK4/6"	single	46.3	74	17.5	11	19.3	83	PD
X-1980	LGH447	PIM	single	1.6	36	-11.8	12	46	56	SD-->PD
X-1980	LLM871	FGFR2/4	single	313.9	21	77.8	13	8.3	21	PD
X-1980	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-22.2	13	-12.7	20	44	44	SD-->PD
X-1980	paclitaxel	Tubulin	single	122.6	20	47.1	13	10.9	29	PD
X-1980	untreated	"UNKNOWN,Untreated"	single	133.3	20	34.5	13	13.1	34	PD
X-1980	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	-43.8	17	-23.66	17	39.26829268	58	SD-->PD
X-1993	BGJ398	FGFR	single	213.5	19	60.1	13	9.7	19	PD
X-1993	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	115.1	23	22.9	11	12.9	23	PD
X-1993	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	86.1	21	1.3	11	22.1	46	PD
X-1993	BYL719	PIK3CA	single	-43.7	13	-21.6	16	36	48	SD-->PD
X-1993	BYL719 + LGH447	"PIK3CA,PIM"	combo	0.1	9	-0.9	13	30	30	SD
X-1993	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	37.2	57	1.7	13	43.8	97	PD
X-1993	cetuximab	EGFR	single	47.2	27	15.6	11	38.7	53	PD
X-1993	CGM097	MDM2	single	386.5	15	111	11	5.2	15	PD
X-1993	CKX620	MAPK	single	-95.8	67	-67.7	85	85	85	CR
X-1993	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-58.7	62	-41.5	62	80.1	95	PR-->-->PD
X-1993	HDM201	MDM2	single	194.6	15	74.4	11	5.5	15	PD
X-1993	erlotinib	EGFR	single	185	25	-2.3	11	17.7	28	PD
X-1993	HSP990	HSP90	single	66.9	35	38.6	11	39.5	47	PD
X-1993	INC280	MET	single	111.2	12	69.5	11	9.4	12	PD
X-1993	LCL161 + paclitaxel	"BIRC2,TUBB,Tubulin"	combo	-78.6	42	-36.4	55	66	95	PR-->PD
X-1993	LEE011	"CDK4,CDK6,CDK4/6"	single	180	22	50.7	11	6.7	28	PD
X-1993	LGH447	PIM	single	237	14	88.6	13	7.9	14	PD
X-1993	LLM871	FGFR2/4	single	411.5	19	80.3	11	8.1	19	PD
X-1993	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-49.2	84	-0.6	88	88	88	SD
X-1993	paclitaxel	Tubulin	single	296.4	12	96.4	11	5.7	12	PD
X-1993	untreated	"UNKNOWN,Untreated"	single	238.3	21	24.9	11	11	31	PD
X-1993	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	-71.4	73	-42.06923077	94	124	124	PR
X-2017	BGJ398	FGFR	single	163.7	21	56.7	14	13.8	29	PD
X-2017	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	101.4	21	39	14	20.3	50	PD
X-2017	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-46.1	24	-25.6	38	105	105	SD-->PD
X-2017	BYL719	PIK3CA	single	22.6	10	17.9	14	40.1	50	SD-->PD
X-2017	BYL719 + LGH447	"PIK3CA,PIM"	combo	-1.8	28	-0.9	18	45.4	49	SD-->PD
X-2017	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	141	21	68.5	14	9.3	50	PD
X-2017	cetuximab	EGFR	single	249.7	21	74.3	11	7.3	26	PD
X-2017	CGM097	MDM2	single	130.1	24	50.3	14	12.7	35	PD
X-2017	CKX620	MAPK	single	-50.3	24	-25.8	92	92	92	PR-->-->PD
X-2017	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	131.9	21	26	14	15.4	29	PD
X-2017	HDM201	MDM2	single	157.3	21	100.5	14	5.9	35	PD
X-2017	erlotinib	EGFR	single	103.6	24	45.3	14	19.6	50	PD
X-2017	HSP990	HSP90	single	159.2	21	29	11	15.7	32	PD
X-2017	INC280	MET	single	235.6	21	43	14	14.9	29	PD
X-2017	LCL161 + paclitaxel	"BIRC2,TUBB,Tubulin"	combo	9.8	33	8.6	11	47	52	SD-->PD
X-2017	LEE011	"CDK4,CDK6,CDK4/6"	single	68.3	21	30.6	14	25.5	50	PD
X-2017	LGH447	PIM	single	112.9	21	43.9	14	20	50	PD
X-2017	LLM871	FGFR2/4	single	81.1	21	4.2	11	22.4	40	PD
X-2017	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-100	81	-79.1	89	89	89	CR
X-2017	paclitaxel	Tubulin	single	35.7	21	17.2	14	35.5	47	PD
X-2017	untreated	"UNKNOWN,Untreated"	single	361	21	104.1	14	8.4	29	PD
X-2017	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	-100	55	-79.9225	143	162	162	CR-->-->PD
X-2026	abraxane + gemcitabine	"Tubulin,chemotherapy"	combo	-94.4	77	-64.3	101	101	101	PR
X-2026	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	83.2	21	25.9	12	25.5	32	PD
X-2026	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-36.6	25	-0.8	34	77.5	84	SD-->PD
X-2026	BYL719	PIK3CA	single	-4.9	10	-1.1	13	41.9	52	SD-->PD
X-2026	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	121.8	21	38.3	13	14.8	48	PD
X-2026	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	65.4	21	14.3	13	31	52	PD
X-2026	HDM201	MDM2	single	211.4	21	64.4	13	9.7	31	PD
X-2026	figitumumab + binimetinib	"IGF1R,MAPK"	combo	46.5	20	34	12	31.3	33	PD
X-2026	gemcitabine-50mpk	chemotherapy	single	-100	71	-71.5	88	88	88	CR
X-2026	INC424	JAK	single	120.5	21	17.2	11	19.1	53	PD
X-2026	INC424 + binimetinib	"JAK,MAPK"	combo	27.9	52	20.2	11	20.8	84	SD
X-2026	WNT974	PORCN	single	175.1	22	22.6	12	16.5	30	PD
X-2026	LKA136	"NTRK1,NTRK2,NTRK3"	single	464.4	22	98.5	13	6.4	22	PD
X-2026	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-4.9	35	10.7	11	102	102	SD-->PD
X-2026	trametinib	MAPK	single	-3.2	12	9.1	18	51.1	52	SD-->PD
X-2026	untreated	"UNKNOWN,Untreated"	single	333.1	21	50.3	13	15.6	28	PD
X-2042	BGJ398	FGFR	single	214.7	26	29.7	12	18.3	26	PD
X-2042	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-34.8	10	-11.1	16	105	105	SD-->PD
X-2042	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-54.4	35	-35.6	35	49	49	PR
X-2042	BYL719	PIK3CA	single	-23.6	12	-17.8	15	91.2	110	SD-->PD
X-2042	BYL719 + LGH447	"PIK3CA,PIM"	combo	-25.5	15	-14.5	15	40.9	71	SD-->PD
X-2042	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	3.4	10	-1.8	15	46.2	78	SD-->PD
X-2042	cetuximab	EGFR	single	192.7	21	65.9	16	12.3	42	PD
X-2042	CGM097	MDM2	single	126.5	26	19.8	13	21.8	88	PD
X-2042	CKX620	MAPK	single	-59.9	45	-38.9	60	60	60	PR
X-2042	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-28.3	19	-18.8	19	98	124	SD-->PD
X-2042	HDM201	MDM2	single	178.5	21	68	16	11.6	42	PD
X-2042	erlotinib	EGFR	single	-37.4	15	-23.6	15	15	15	SD
X-2042	HSP990	HSP90	single	-82.5	108	-42.4	110	110	110	PR
X-2042	INC280	MET	single	30.7	29	14.8	13	69.7	111	SD-->PD
X-2042	LCL161 + paclitaxel	"BIRC2,TUBB,Tubulin"	combo	-86	85	-59.8	101	101	101	PR
X-2042	LEE011	"CDK4,CDK6,CDK4/6"	single	208	21	66.1	16	12.6	56	PD
X-2042	LGH447	PIM	single	16.7	19	15.5	13	41.3	68	SD-->PD
X-2042	LLM871	FGFR2/4	single	147.5	21	1.2	11	19	46	PD
X-2042	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	17.5	29	24.4	29	35	35	SD
X-2042	paclitaxel	Tubulin	single	119.3	21	34.2	12	18.3	25	PD
X-2042	untreated	"UNKNOWN,Untreated"	single	53.7	22	24.7	15	24.5	49	PD
X-2042	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	-100	73	-77.1826087	182	182	182	CR
X-2043	abraxane	Tubulin	single	323.8	22	105.3	12	5.7	22	PD
X-2043	abraxane + gemcitabine	"Tubulin,chemotherapy"	combo	-49	105	-9	111	132	132	SD-->-->PD
X-2043	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	207.7	20	59	13	10.7	27	PD
X-2043	BKM120 + LDE225	"panPI3K,SMO"	combo	176.9	22	40.3	12	10.6	29	PD
X-2043	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-17.7	22	5	13	50.3	132	SD-->PD
X-2043	BYL719	PIK3CA	single	76.2	20	31	13	27.4	34	PD
X-2043	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	43.6	32	11.3	11	54	70	PD
X-2043	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	44.1	20	20.5	13	62.3	79	PD
X-2043	HDM201	MDM2	single	65.9	21	30.9	14	31.8	45	PD
X-2043	figitumumab	IGF1R	single	241.4	22	36.1	12	11.8	29	PD
X-2043	figitumumab + binimetinib	"IGF1R,MAPK"	combo	378.3	20	172.3	13	2	27	PD
X-2043	gemcitabine-50mpk	chemotherapy	single	9.9	10	25.8	14	14	14	SD
X-2043	INC424	JAK	single	72.8	23	34.9	13	30	65	PD
X-2043	INC424 + binimetinib	"JAK,MAPK"	combo	5.7	29	-8	12	76.1	99	SD-->PD
X-2043	LEE011	"CDK4,CDK6,CDK4/6"	single	147.4	21	57.5	11	10.3	23	PD
X-2043	LKA136	"NTRK1,NTRK2,NTRK3"	single	155.7	24	50.7	13	13.4	24	PD
X-2043	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-35	10	-15.8	19	27	27	SD
X-2043	binimetinib-3.5mpk	MAPK	single	129.7	20	32.5	13	18	27	PD
X-2043	untreated	"UNKNOWN,Untreated"	single	310.5	22	77.3	11	6.4	24	PD
X-20508	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	-33.1	49	-20.92222222	28	70	70	SD-->PD
X-20689	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	-33.2	9	-21.9	12	71.37423313	115	SD-->PD
X-2081	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	156.5	21	27.1	14	19.1	28	PD
X-2081	BKM120 + LDE225	"panPI3K,SMO"	combo	-35.6	36	-9.8	40	62.6	82	SD-->PD
X-2081	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-61.2	11	-35	29	52.1	53	PR-->PD
X-2081	BYL719	PIK3CA	single	0	15	2.4	15	27	42	SD-->PD
X-2081	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	167.3	20	59.9	13	10.3	34	PD
X-2081	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	359.7	22	52	11	11.1	32	PD
X-2081	HDM201	MDM2	single	526	22	84.8	11	6.2	28	PD
X-2081	figitumumab	IGF1R	single	554	13	224.5	13	4.5	13	PD
X-2081	figitumumab + binimetinib	"IGF1R,MAPK"	combo	290.6	20	78.5	13	8.4	27	PD
X-2081	gemcitabine-50mpk	chemotherapy	single	95.4	24	40.8	14	24.7	37	PD
X-2081	INC424 + binimetinib	"JAK,MAPK"	combo	-3.4	25	15.4	31	84	84	SD-->PD
X-2081	LEE011	"CDK4,CDK6,CDK4/6"	single	245.6	20	68.7	14	8.5	27	PD
X-2081	WNT974	PORCN	single	357.3	20	86.3	11	6.2	20	PD
X-2081	LKA136	"NTRK1,NTRK2,NTRK3"	single	645.7	18	134.5	11	5	18	PD
X-2081	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-50.8	17	-24.3	21	51	51	PR-->PD
X-2081	binimetinib-3.5mpk	MAPK	single	152.4	24	67.3	11	5.5	24	PD
X-2081	trametinib	MAPK	single	192.4	27	92.8	13	4.7	30	PD
X-2081	untreated	"UNKNOWN,Untreated"	single	697.6	22	116.3	11	5.6	22	PD
X-20810	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	-59.6	9	-41.96666667	16	70	70	PR-->PD
X-2082	BGJ398	FGFR	single	113.8	19	10.9	11	17.4	19	PD
X-2082	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	170.3	22	26.8	11	14.3	37	PD
X-2082	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-29.6	32	-9.3	37	62.9	100	SD-->PD
X-2082	BYL719	PIK3CA	single	-3.1	21	3.9	21	35.1	42	SD-->PD
X-2082	BYL719 + LGH447	"PIK3CA,PIM"	combo	212.5	26	20	12	17.7	26	PD
X-2082	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	22.1	21	2.4	14	35.6	61	SD-->PD
X-2082	cetuximab	EGFR	single	69.1	21	28.2	11	25.5	47	PD
X-2082	CGM097	MDM2	single	99.5	26	9.3	11	20.5	47	PD
X-2082	CKX620	MAPK	single	-67.5	21	-52	35	102	102	PR-->PD
X-2082	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	142.6	22	29.9	11	19.8	37	PD
X-2082	HDM201	MDM2	single	196.3	22	67.6	11	6.1	43	PD
X-2082	erlotinib	EGFR	single	-27.6	12	1.2	14	41.6	47	SD-->PD
X-2082	HSP990	HSP90	single	16.7	32	4.2	11	32	32	SD-->PD
X-2082	INC280	MET	single	113.3	22	48	11	13.4	37	PD
X-2082	LCL161 + paclitaxel	"BIRC2,TUBB,Tubulin"	combo	-61	21	-30.4	26	50	89	PR-->PD
X-2082	LEE011	"CDK4,CDK6,CDK4/6"	single	-100	72	-63.9	100	100	100	CR
X-2082	LGH447	PIM	single	98.3	21	10.2	11	21	32	PD
X-2082	LLM871	FGFR2/4	single	424.7	21	104.9	11	5.4	25	PD
X-2082	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-77.1	39	-61.3	60	100	100	PR-->-->PD
X-2082	paclitaxel	Tubulin	single	301.5	21	71.6	11	7.7	26	PD
X-2082	untreated	"UNKNOWN,Untreated"	single	66.2	21	29.2	11	24.1	45	PD
X-2082	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	-63.1	38	-44.96666667	97	145	145	PR-->-->PD
X-2088	BGJ398	FGFR	single	431.2	18	109.1	14	11.2	18	PD
X-2088	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	414.7	23	88.5	11	6.1	23	PD
X-2088	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	316.8	11	139.5	11	7	11	PD
X-2088	BYL719	PIK3CA	single	341.3	20	146.6	15	4.4	22	PD
X-2088	BYL719 + LGH447	"PIK3CA,PIM"	combo	-48.1	91	-17.9	21	127	127	SD-->PD
X-2088	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	177.8	12	64.1	12	9.2	12	PD
X-2088	cetuximab	EGFR	single	1075.6	11	473.5	11	7	11	PD
X-2088	CGM097	MDM2	single	749.6	15	148.7	11	4.9	15	PD
X-2088	CKX620	MAPK	single	-69	49	-18.9	55	55	55	SD-->PD
X-2088	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	332.4	11	154.6	11	7	11	PD
X-2088	HDM201	MDM2	single	257.9	24	69.6	15	5.8	28	PD
X-2088	erlotinib	EGFR	single	160.5	8	93.6	8	4	8	PD
X-2088	HSP990	HSP90	single	5.6	11	8.6	11	19.5	26	SD-->PD
X-2088	INC280	MET	single	195.6	11	109.6	11	7	11	PD
X-2088	LCL161 + paclitaxel	"BIRC2,TUBB,Tubulin"	combo	-95	14	-62.4	14	54.7	60	PR-->PD
X-2088	LEE011	"CDK4,CDK6,CDK4/6"	single	225.6	8	102.2	8	4.5	8	PD
X-2088	LGH447	PIM	single	-100	71	-55.7	128	7.1	128	CR
X-2088	LLM871	FGFR2/4	single	-100	21	-90.3	117	117	117	CR
X-2088	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	266.7	11	160.9	11	7	11	PD
X-2088	untreated	"UNKNOWN,Untreated"	single	477.6	11	243.8	11	7	11	PD
X-2088	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	765.8	5	392.0666667	5	4	5	PD
X-2094	BGJ398	FGFR	single	364.1	21	105.4	14	4	24	PD
X-2094	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	315.1	21	62.2	14	10.7	24	PD
X-2094	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	35.7	24	21.7	14	33.5	82	PD
X-2094	BYL719	PIK3CA	single	147.4	21	60.2	14	11.3	31	PD
X-2094	BYL719 + LGH447	"PIK3CA,PIM"	combo	124.6	21	12.6	14	17.7	31	PD
X-2094	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	115.1	28	75.9	14	9.5	46	PD
X-2094	cetuximab	EGFR	single	231.6	24	88.1	14	7	31	PD
X-2094	CGM097	MDM2	single	367.1	21	128.6	14	4.7	24	PD
X-2094	CKX620	MAPK	single	-29.6	35	24	40	7.5	82	SD-->PD
X-2094	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	73.9	28	27.8	14	20.6	61	PD
X-2094	HDM201	MDM2	single	360.9	21	135	14	5.1	24	PD
X-2094	erlotinib	EGFR	single	494.3	20	102.9	13	6.3	20	PD
X-2094	HSP990	HSP90	single	141.6	28	109.3	14	4.2	61	PD
X-2094	INC280	MET	single	711.9	17	187.1	14	4	17	PD
X-2094	LCL161 + paclitaxel	"BIRC2,TUBB,Tubulin"	combo	292.1	21	80.8	14	6.8	46	PD
X-2094	LEE011	"CDK4,CDK6,CDK4/6"	single	215.7	21	64.9	14	11.5	38	PD
X-2094	LGH447	PIM	single	125.3	21	91.4	14	4	31	PD
X-2094	LLM871	FGFR2/4	single	373.2	17	143	14	4	17	PD
X-2094	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-100	35	-71.1	49	49	49	CR
X-2094	paclitaxel	Tubulin	single	-15.1	10	-7	14	40.9	61	SD-->PD
X-2094	untreated	"UNKNOWN,Untreated"	single	592.8	17	151.4	14	5.4	17	PD
X-2094	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	-51.8	25	-17.14545455	32	45.069869	57	SD-->PD
X-2127	LFW527 + everolimus	"IGF1R,MTOR"	combo	27.6	23	24.42	14	16.8526149	27	SD-->PD
X-2145	5FU	chemotherapy	single	89.4	41	41.5	13	18	41	PD
X-2145	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-12.5	10	-5.1	19	60.9	75	SD-->PD
X-2145	BKM120 + LJC049	"panPI3K,TNKS"	combo	0.5	15	6.2	15	45.9	54	SD-->PD
X-2145	BYL719	PIK3CA	single	115.3	24	44	13	18.9	40	PD
X-2145	BYL719 + cetuximab	"PIK3CA,EGFR"	combo	158.7	24	6.8	13	17.4	40	PD
X-2145	BYL719 + cetuximab + encorafenib	"PIK3CA,EGFR,BRAF"	combo	-57	46	-32.4	61	100	100	PR-->-->PD
X-2145	BYL719 + encorafenib	"PIK3CA,BRAF"	combo	-82.2	37	-61.4	48	48	48	PR
X-2145	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	157.1	24	1.1	13	19.9	40	PD
X-2145	BYL719 + binimetinib	"PIK3CA,MAPK"	combo	-68.3	46	-49.8	77	95	95	PR
X-2145	cetuximab	EGFR	single	292.9	20	79.4	15	7.9	36	PD
X-2145	cetuximab + encorafenib	"EGFR,BRAF"	combo	-15.1	19	-4.4	35	55.7	60	SD-->PD
X-2145	CGM097	MDM2	single	-42.3	19	-16.5	28	63	63	SD-->PD
X-2145	CKX620	MAPK	single	-43.7	77	-20.4	98	98	98	SD-->PD
X-2145	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	13.1	24	24.5	28	46	52	SD
X-2145	HDM201	MDM2	single	-23.4	9	-18	30	75.2	79	SD-->PD
X-2145	LEE011	"CDK4,CDK6,CDK4/6"	single	56.6	28	51	12	45	45	PD
X-2145	encorafenib	BRAF	single	-10.3	14	0.3	19	56.8	63	SD-->PD
X-2145	LJC049	TNKS	single	105.7	14	42.9	11	10.6	14	PD
X-2145	LKA136	"NTRK1,NTRK2,NTRK3"	single	359.4	24	98.8	13	5	40	PD
X-2145	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-44.6	39	-27.4	45	91	91	SD-->PD
X-2145	untreated	"UNKNOWN,Untreated"	single	192.6	24	83	13	6.5	40	PD
X-2145	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	-12.5	17	-4.016666667	17	46	46	SD-->PD
X-21617	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	436.3	8	214.55	8	2.582561482	8	PD
X-2163	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-7.8	13	5.4	13	45.9	55	SD-->PD
X-2163	BKM120 + encorafenib	"panPI3K,BRAF,BRAF,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	62.1	22	7	14	30	30	PD
X-2163	CGM097	MDM2	single	120.9	26	61.8	12	5.9	30	PD
X-2163	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	52.7	20	10	12	27.7	37	PD
X-2163	dacarbazine	chemotherapy	single	-26.6	14	-11.6	14	14	14	SD
X-2163	LDE225	SMO	single	3.4	10	3.5	13	32	32	SD-->PD
X-2163	LDK378	ALK	single	-24.5	35	-12.7	13	62	62	SD-->PD
X-2163	LEE011	"CDK4,CDK6,CDK4/6"	single	2.6	9	3.1	9	9	9	SD
X-2163	LEE011 + encorafenib	"CDK4/6,BRAF,BRAF,CDK4,CDK6"	combo	-33.4	14	-11.1	17	56	56	SD-->PD
X-2163	LEE011 + binimetinib	"CDK4,CDK6,MAP2K1,MAP2K2,CDK4/6,MAPK"	combo	-60.3	118	-30.7	201	218.4	242	PR-->-->PD
X-2163	WNT974	PORCN	single	33.4	21	32.9	11	21	21	PD
X-2163	LGW813	IAP	single	138.5	23	70.4	13	7.6	35	PD
X-2163	encorafenib	BRAF	single	89.6	26	22.1	12	27	30	PD
X-2163	encorafenib + binimetinib	"BRAF,MAP2K1,MAP2K2,MAPK"	combo	100.3	22	20.7	14	22	30	PD
X-2163	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-17.6	9	-13.8	12	54	58	SD-->PD
X-2163	TAS266	DR5	single	29.1	19	19.3	12	30	30	SD
X-2163	untreated	"UNKNOWN,Untreated"	single	183.8	23	70.8	12	10.9	30	PD
X-2182	5FU	chemotherapy	single	120.8	15	60.3	15	12.9	15	PD
X-2182	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	627.3	16	161.6	13	6.5	16	PD
X-2182	BKM120 + LJC049	"panPI3K,TNKS"	combo	516.5	15	240.6	15	3	15	PD
X-2182	BYL719	PIK3CA	single	630.9	15	239.2	15	5.1	15	PD
X-2182	BYL719 + cetuximab	"PIK3CA,EGFR"	combo	188.4	21	44.4	11	13.4	28	PD
X-2182	BYL719 + cetuximab + encorafenib	"PIK3CA,EGFR,BRAF"	combo	458.1	20	123.2	14	7.2	21	PD
X-2182	BYL719 + encorafenib	"PIK3CA,BRAF"	combo	487.6	22	112.3	15	8.6	24	PD
X-2182	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	651.1	18	120.3	15	8	18	PD
X-2182	BYL719 + binimetinib	"PIK3CA,MAPK"	combo	570.4	18	166.6	15	4.3	18	PD
X-2182	cetuximab	EGFR	single	291.2	20	81.7	13	8	27	PD
X-2182	cetuximab + encorafenib	"EGFR,BRAF"	combo	358.2	20	98.4	14	7.6	21	PD
X-2182	CGM097	MDM2	single	655	13	257.2	13	4	13	PD
X-2182	CKX620	MAPK	single	170.7	21	29.4	13	18.5	27	PD
X-2182	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	192.5	22	68.6	15	9.3	24	PD
X-2182	HDM201	MDM2	single	361	18	162.3	13	3.5	18	PD
X-2182	LEE011	"CDK4,CDK6,CDK4/6"	single	553.9	18	181.5	13	4.4	18	PD
X-2182	encorafenib	BRAF	single	755.5	10	304	10	3	10	PD
X-2182	LJC049	TNKS	single	842.2	7	386.9	7	3	7	PD
X-2182	LKA136	"NTRK1,NTRK2,NTRK3"	single	823.9	18	183.1	15	4.9	18	PD
X-2182	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	490.6	16	172.4	13	5.4	16	PD
X-2182	untreated	"UNKNOWN,Untreated"	single	336.3	21	55.2	12	10.6	21	PD
X-2182	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	423.3	18	112.86	13	5.524495677	18	PD
X-2195	BGJ398	FGFR	single	133.6	34	20.9	12	24	37	PD
X-2195	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	108.2	27	37.6	12	25.3	37	PD
X-2195	BYL719	PIK3CA	single	145.4	27	49.7	12	13.6	37	PD
X-2195	BYL719 + LEE011	"PIK3CA,CDK4/6"	combo	-60.7	21	-31	21	21	21	PR
X-2195	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-0.6	10	-13	14	22.7	35	SD-->PD
X-2195	CGM097	MDM2	single	-16.5	16	8.8	37	37	37	SD
X-2195	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	131.3	27	33.6	12	22.1	27	PD
X-2195	HDM201	MDM2	single	-8	28	7.2	13	38	38	SD
X-2195	INC424	JAK	single	-13.3	9	-4.1	12	27.4	30	SD-->PD
X-2195	LEE011	"CDK4,CDK6,CDK4/6"	single	25	18	20.6	11	24	24	SD
X-2195	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-100	35	-58.8	80	80	80	CR
X-2195	LFA102	PRLR 	single	34.8	21	4.4	15	21	21	SD-->PD
X-2195	LJM716	ERBB3	single	223.1	21	51.2	11	10	24	PD
X-2195	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	244	20	62.3	14	11.7	28	PD
X-2195	LKA136	"NTRK1,NTRK2,NTRK3"	single	7.3	15	1.9	15	36	50	SD-->PD
X-2195	LLM871	FGFR2/4	single	-54.3	25	-9.6	31	47	64	SD-->PD
X-2195	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	61.9	25	13	11	31.7	32	PD
X-2195	paclitaxel	Tubulin	single	172.5	20	58.9	14	11.4	28	PD
X-2195	tamoxifen	ESR1	single	-25.8	11	-13.6	11	31	31	SD-->PD
X-2195	trastuzumab	ERBB2	single	187.5	21	44.2	15	14.9	21	PD
X-2195	untreated	"UNKNOWN,Untreated"	single	289.5	27	77.3	12	7.7	37	PD
X-2220	figitumumab	IGF1R	single	100	5	50	5	5	5	PD
X-2220	WNT974	PORCN	single	430.2	15	215.9	13	6	15	PD
X-2220	LKA136	"NTRK1,NTRK2,NTRK3"	single	498.8	13	189.3	13	4.3	13	PD
X-2220	trametinib	MAPK	single	153.3	22	73.3	12	7.7	29	PD
X-2220	untreated	"UNKNOWN,Untreated"	single	609.2	16	269.6	13	6	16	PD
X-2239	5FU	chemotherapy	single	26.2	21	13	13	21	21	SD-->PD
X-2239	BKM120 + LJC049	"panPI3K,TNKS"	combo	109.5	21	25.7	13	19.5	48	PD
X-2239	BYL719	PIK3CA	single	109.8	21	36.8	13	20.2	55	PD
X-2239	BYL719 + cetuximab	"PIK3CA,EGFR"	combo	108.1	23	15.5	12	21	40	PD
X-2239	BYL719 + cetuximab + encorafenib	"PIK3CA,EGFR,BRAF"	combo	-21.7	10	-9	18	41	41	SD
X-2239	BYL719 + encorafenib	"PIK3CA,BRAF"	combo	-50.7	37	-31.7	56	56	56	PR
X-2239	BYL719 + binimetinib	"PIK3CA,MAPK"	combo	-14.5	18	-4.5	24	43	43	SD
X-2239	cetuximab	EGFR	single	194.2	24	27.6	13	17.3	28	PD
X-2239	cetuximab + encorafenib	"EGFR,BRAF"	combo	-38.8	34	-23.3	41	43	43	SD
X-2239	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	52.5	21	20.5	13	31.9	55	PD
X-2239	LEE011	"CDK4,CDK6,CDK4/6"	single	-32.2	51	-18.4	51	70	70	SD-->PD
X-2239	encorafenib	BRAF	single	81	26	26.4	13	30.4	47	PD
X-2239	LJC049	TNKS	single	237.4	24	40.9	13	14.3	36	PD
X-2239	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-20.5	9	-10.6	14	64.2	78	SD-->PD
X-2239	untreated	"UNKNOWN,Untreated"	single	115.5	21	29.7	13	19.1	43	PD
X-2239	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	83.4	26	18.425	12	27.06183369	36	PD
X-2283	abraxane	Tubulin	single	376.3	16	115.7	13	7.8	16	PD
X-2283	abraxane + gemcitabine	"Tubulin,chemotherapy"	combo	169.5	23	47.9	14	13.8	27	PD
X-2283	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	273.5	17	71.3	13	10.1	17	PD
X-2283	BYL719	PIK3CA	single	222.8	20	94.1	14	6.8	32	PD
X-2283	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	177.6	20	95	14	7	32	PD
X-2283	HDM201	MDM2	single	93.9	20	97.2	20	10.2	32	PD
X-2283	gemcitabine-50mpk	chemotherapy	single	194.6	20	48.9	11	11.3	31	PD
X-2283	INC424	JAK	single	194.9	24	41.3	11	10.9	39	PD
X-2283	INC424 + binimetinib	"JAK,MAPK"	combo	276.7	24	58.5	14	12.6	28	PD
X-2283	LEE011	"CDK4,CDK6,CDK4/6"	single	277.8	20	42.6	13	11.3	23	PD
X-2283	WNT974	PORCN	single	275.1	16	87.8	13	7.9	16	PD
X-2283	LKA136	"NTRK1,NTRK2,NTRK3"	single	202	20	61.7	13	10.6	29	PD
X-2283	binimetinib-3.5mpk	MAPK	single	465.3	20	134.8	13	2	22	PD
X-2283	trametinib	MAPK	single	311.4	25	25	13	12.7	39	PD
X-2306	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	8.1	12	0.7	12	32	32	SD-->PD
X-2306	BKM120 + encorafenib	"panPI3K,BRAF,BRAF,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	91.7	20	16.2	13	23.2	27	PD
X-2306	CGM097	MDM2	single	-47	17	-26.8	22	22	22	SD
X-2306	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	0.1	13	-0.5	13	31	31	SD-->PD
X-2306	dacarbazine	chemotherapy	single	-9.7	13	-8.6	13	41	41	SD-->PD
X-2306	LDE225	SMO	single	47.3	25	11.3	12	32	32	PD
X-2306	LDK378	ALK	single	76.8	22	23	12	27.9	29	PD
X-2306	LEE011	"CDK4,CDK6,CDK4/6"	single	3.5	23	0.3	11	99	99	SD-->PD
X-2306	LEE011 + encorafenib	"CDK4/6,BRAF,BRAF,CDK4,CDK6"	combo	5	55	-3.9	13	68	68	SD-->PD
X-2306	LEE011 + binimetinib	"CDK4,CDK6,MAP2K1,MAP2K2,CDK4/6,MAPK"	combo	-55.1	50	-36.1	165	201	201	PR
X-2306	WNT974	PORCN	single	134.2	20	59.1	14	11.4	27	PD
X-2306	LGW813	IAP	single	41.8	21	9.8	12	26.7	32	PD
X-2306	encorafenib	BRAF	single	145.4	20	26.7	12	15.9	28	PD
X-2306	encorafenib + binimetinib	"BRAF,MAP2K1,MAP2K2,MAPK"	combo	-21.9	24	-9.7	24	68	68	SD-->PD
X-2306	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-6.7	19	-5.5	11	32	32	SD-->PD
X-2306	TAS266	DR5	single	153.5	22	18.5	14	19	30	PD
X-2306	untreated	"UNKNOWN,Untreated"	single	241.6	20	62	12	8.5	27	PD
X-2339	abraxane	Tubulin	single	148	21	48.6	11	14.5	32	PD
X-2339	abraxane + gemcitabine	"Tubulin,chemotherapy"	combo	48.6	23	17.9	13	33.8	69	PD
X-2339	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	19.4	80	20	14	24.5	80	SD-->PD
X-2339	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-70.5	89	-45.4	99	99	99	PR
X-2339	BYL719	PIK3CA	single	-8.6	13	-4	17	69	69	SD-->PD
X-2339	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	8.4	11	2.1	11	62.7	63	SD-->PD
X-2339	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-43.9	13	-27	20	51	51	SD-->PD
X-2339	HDM201	MDM2	single	55.9	20	9.9	13	26.3	55	PD
X-2339	figitumumab	IGF1R	single	39.4	26	29.1	12	42.4	92	PD
X-2339	figitumumab + binimetinib	"IGF1R,MAPK"	combo	-36.9	70	-13.5	70	86	86	SD-->PD
X-2339	gemcitabine-50mpk	chemotherapy	single	48.4	32	21.8	12	33.9	78	PD
X-2339	INC424	JAK	single	41.9	21	4.6	11	63	63	PD
X-2339	INC424 + binimetinib	"JAK,MAPK"	combo	-39	62	-15.4	72	72	72	SD
X-2339	LEE011	"CDK4,CDK6,CDK4/6"	single	3.3	64	7.2	12	89	89	SD-->PD
X-2339	WNT974	PORCN	single	-37.2	10	-17.2	21	21	21	SD
X-2339	LKA136	"NTRK1,NTRK2,NTRK3"	single	154.4	23	24	12	16.2	58	PD
X-2339	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-44.7	82	-11.2	99	99	99	SD
X-2339	binimetinib-3.5mpk	MAPK	single	-70.4	84	-30	101	101	101	PR
X-2339	trametinib	MAPK	single	-45.8	84	-8.4	33	91	91	SD-->PD
X-2339	untreated	"UNKNOWN,Untreated"	single	35	21	12.1	13	36.5	91	PD
X-2344	BGJ398	FGFR	single	153	24	53.8	18	13.7	31	PD
X-2344	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-41.3	29	-15.7	43	43	43	SD
X-2344	BYL719	PIK3CA	single	245.8	22	48.8	11	10.5	25	PD
X-2344	BYL719 + LEE011	"PIK3CA,CDK4/6"	combo	-46.8	15	-35.3	25	88	88	SD-->PD
X-2344	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-28.5	15	-13.9	15	28.9	46	SD-->PD
X-2344	CGM097	MDM2	single	492.6	18	132.3	11	4.9	18	PD
X-2344	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	143.6	22	23.2	11	17.5	33	PD
X-2344	HDM201	MDM2	single	350	22	87.5	11	5.8	25	PD
X-2344	INC424	JAK	single	488.4	22	96.1	11	6.4	25	PD
X-2344	LEE011	"CDK4,CDK6,CDK4/6"	single	147.4	20	52.7	13	14.9	20	PD
X-2344	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-38.3	13	-21.2	24	24	24	SD
X-2344	LFA102	PRLR 	single	217.1	21	48.9	14	12.2	24	PD
X-2344	LJM716	ERBB3	single	-22.5	10	-13.9	13	27	27	SD
X-2344	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	-92.1	28	-27.4	28	28	28	PR
X-2344	LKA136	"NTRK1,NTRK2,NTRK3"	single	706.9	18	216.5	11	4	18	PD
X-2344	LLM871	FGFR2/4	single	270	21	78.1	13	8.1	34	PD
X-2344	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	298.2	18	111.6	11	4	18	PD
X-2344	paclitaxel	Tubulin	single	345.5	21	69.5	14	11	24	PD
X-2344	tamoxifen	ESR1	single	432.9	18	62.9	11	8.7	18	PD
X-2344	trastuzumab	ERBB2	single	110.3	24	14	14	19.8	24	PD
X-2344	untreated	"UNKNOWN,Untreated"	single	276.1	13	113.1	13	7	13	PD
X-2344	LFW527 + everolimus	"IGF1R,MTOR"	combo	-18.5	20	-8.8	24	67.70588235	76	SD-->PD
X-2353	BGJ398	FGFR	single	99	21	34	14	21.1	91	PD
X-2353	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	92.6	21	21.8	14	24.2	84	PD
X-2353	BYL719	PIK3CA	single	-6.9	10	-5.1	14	51	91	SD-->PD
X-2353	BYL719 + LEE011	"PIK3CA,CDK4/6"	combo	2.7	84	3.3	11	95	95	SD
X-2353	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	45.8	14	52.6	14	9	14	PD
X-2353	CGM097	MDM2	single	94.3	21	23.7	14	21.6	70	PD
X-2353	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	48.8	26	8.3	11	36	74	PD
X-2353	HDM201	MDM2	single	140.7	21	27.8	14	15.7	56	PD
X-2353	INC424	JAK	single	78.5	26	18.8	11	30.8	88	PD
X-2353	LEE011	"CDK4,CDK6,CDK4/6"	single	-7.2	11	-9.2	11	116	116	SD-->PD
X-2353	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-18.8	11	-11.4	17	95	95	SD
X-2353	LFA102	PRLR 	single	79.6	22	20.3	13	24.1	35	PD
X-2353	LJM716	ERBB3	single	-19.2	14	-12.6	14	70.8	92	SD-->PD
X-2353	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	20.1	13	13.7	13	38.3	91	SD-->PD
X-2353	LKA136	"NTRK1,NTRK2,NTRK3"	single	59.7	26	8.5	11	30.5	74	PD
X-2353	LLM871	FGFR2/4	single	66.5	21	21.3	14	26.9	77	PD
X-2353	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	1.4	56	10	11	76.8	88	SD-->-->PD
X-2353	paclitaxel	Tubulin	single	16.6	10	13.6	13	71	91	SD-->PD
X-2353	tamoxifen	ESR1	single	153.5	21	47.4	14	13.8	56	PD
X-2353	trastuzumab	ERBB2	single	201.2	22	42.7	13	14.3	49	PD
X-2353	untreated	"UNKNOWN,Untreated"	single	131.1	21	32.4	14	16.3	56	PD
X-2353	LFW527 + everolimus	"IGF1R,MTOR"	combo	-45.9	28	-15.92307692	41	136.6245955	157	SD-->PD
X-2374	5FU	chemotherapy	single	18	10	15.1	16	47.8	92	SD-->PD
X-2374	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-79.1	43	5.6	16	37.1	43	SD-->PD
X-2374	BKM120 + LJC049	"panPI3K,TNKS"	combo	107.3	24	31.3	14	21.4	28	PD
X-2374	BYL719	PIK3CA	single	136.9	21	25.2	14	18.4	42	PD
X-2374	BYL719 + cetuximab	"PIK3CA,EGFR"	combo	54.7	23	27.4	12	51	89	PD
X-2374	BYL719 + cetuximab + encorafenib	"PIK3CA,EGFR,BRAF"	combo	91.1	23	28.8	12	23.8	33	PD
X-2374	BYL719 + encorafenib	"PIK3CA,BRAF"	combo	85.8	31	20.3	14	27.3	63	PD
X-2374	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	58.5	21	11.3	14	22.2	45	PD
X-2374	BYL719 + binimetinib	"PIK3CA,MAPK"	combo	-5.8	48	9	76	89	89	SD-->-->PD
X-2374	cetuximab	EGFR	single	11.1	10	14.1	14	65.5	91	SD-->PD
X-2374	cetuximab + encorafenib	"EGFR,BRAF"	combo	48.3	24	22.2	14	26	44	PD
X-2374	CKX620	MAPK	single	-13.4	21	-3.1	21	44	44	SD
X-2374	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	34.6	21	5.7	13	23.8	25	SD-->PD
X-2374	HDM201	MDM2	single	51.8	23	6.9	16	28	28	PD
X-2374	LEE011	"CDK4,CDK6,CDK4/6"	single	6.5	23	24	23	91	91	SD
X-2374	encorafenib	BRAF	single	375.9	21	78.6	16	10.4	21	PD
X-2374	LJC049	TNKS	single	94.9	21	27.8	16	21.4	28	PD
X-2374	LKA136	"NTRK1,NTRK2,NTRK3"	single	168.1	21	61.6	16	12.8	28	PD
X-2374	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-3.4	63	7.1	23	91	91	SD-->PD
X-2374	untreated	"UNKNOWN,Untreated"	single	132.2	23	26	14	16	35	PD
X-2374	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	-22.5	44	6.729411765	55	155	155	SD-->-->PD
X-2403	5FU	chemotherapy	single	15	17	19.1	17	42	42	SD-->PD
X-2403	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	61.1	21	15.4	11	27	27	PD
X-2403	BKM120 + LJC049	"panPI3K,TNKS"	combo	239.4	21	48.1	14	11.5	28	PD
X-2403	BYL719	PIK3CA	single	76.4	34	25.7	14	22.1	37	PD
X-2403	BYL719 + cetuximab	"PIK3CA,EGFR"	combo	-14.9	15	-13.1	15	38.1	67	SD-->PD
X-2403	BYL719 + cetuximab + encorafenib	"PIK3CA,EGFR,BRAF"	combo	-93.9	15	-21.2	15	15	15	PR
X-2403	BYL719 + encorafenib	"PIK3CA,BRAF"	combo	163.4	24	33.2	14	15.2	28	PD
X-2403	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	139.5	20	41	11	12	27	PD
X-2403	BYL719 + binimetinib	"PIK3CA,MAPK"	combo	134.6	21	13.1	14	16.5	28	PD
X-2403	cetuximab	EGFR	single	72.7	21	18.2	12	24.7	54	PD
X-2403	cetuximab + encorafenib	"EGFR,BRAF"	combo	32.9	12	24.6	12	12	12	SD
X-2403	CGM097	MDM2	single	49.2	20	10.4	13	28	28	PD
X-2403	CKX620	MAPK	single	-17.2	10	-12.1	14	41	41	SD-->PD
X-2403	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	26.9	21	4.9	11	41	41	SD
X-2403	HDM201	MDM2	single	-1.2	16	2.8	16	35	35	SD-->PD
X-2403	LEE011	"CDK4,CDK6,CDK4/6"	single	92	24	20.6	14	19.9	28	PD
X-2403	encorafenib	BRAF	single	473	21	114.7	14	4.3	24	PD
X-2403	LJC049	TNKS	single	361.8	21	137.9	14	6.8	28	PD
X-2403	LKA136	"NTRK1,NTRK2,NTRK3"	single	300.4	25	49	11	11.4	28	PD
X-2403	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	273	21	82.1	14	6.4	28	PD
X-2403	untreated	"UNKNOWN,Untreated"	single	217.1	21	62.6	14	12.2	28	PD
X-2428	abraxane	Tubulin	single	102.9	21	52.6	11	12.6	42	PD
X-2428	abraxane + gemcitabine	"Tubulin,chemotherapy"	combo	-47.9	79	-3.2	79	79	79	SD-->PD
X-2428	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-37.9	58	-13.1	12	77.1	78	SD-->PD
X-2428	BKM120 + LDE225	"panPI3K,SMO"	combo	-63.1	49	-39.7	63	81	81	PR
X-2428	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-57.9	73	-40.8	77	81	81	PR
X-2428	BYL719	PIK3CA	single	-1.8	10	2.4	13	32	55	SD-->PD
X-2428	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	15	20	17.9	20	97	97	SD-->PD
X-2428	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-5.1	14	-2.2	14	87.5	122	SD-->PD
X-2428	HDM201	MDM2	single	220.6	20	55.4	13	13.1	24	PD
X-2428	figitumumab	IGF1R	single	19.9	20	32.8	13	32.4	57	PD
X-2428	figitumumab + binimetinib	"IGF1R,MAPK"	combo	-79.1	35	-57.6	68	90	90	PR-->-->PD
X-2428	gemcitabine-50mpk	chemotherapy	single	78.8	24	40.7	14	31.9	91	PD
X-2428	INC424	JAK	single	78.2	20	9.4	13	22.5	55	PD
X-2428	LEE011	"CDK4,CDK6,CDK4/6"	single	14.2	85	12.3	12	89	89	SD-->PD
X-2428	WNT974	PORCN	single	55.2	13	35.1	13	13	13	PD
X-2428	LKA136	"NTRK1,NTRK2,NTRK3"	single	87	23	49.2	13	24.2	37	PD
X-2428	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-57.2	74	-15.5	77	77	77	SD
X-2428	binimetinib-3.5mpk	MAPK	single	-89.2	68	-54.1	82	82	82	PR
X-2428	trametinib	MAPK	single	-5	33	-4.5	11	59.3	61	SD-->PD
X-2428	untreated	"UNKNOWN,Untreated"	single	-58.3	78	-34.4	99	99	99	PR
X-2470	abraxane	Tubulin	single	98.4	28	-0.5	11	19.5	49	PD
X-2470	abraxane + gemcitabine	"Tubulin,chemotherapy"	combo	25.3	69	31.9	14	79	79	PD
X-2470	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-3.5	33	10.3	15	56.7	57	SD-->PD
X-2470	BYL719	PIK3CA	single	-2.3	10	2.8	14	40.9	70	SD-->PD
X-2470	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-8.4	31	1.3	14	67.1	83	SD-->PD
X-2470	figitumumab	IGF1R	single	164.7	21	52.4	11	9.3	35	PD
X-2470	figitumumab + binimetinib	"IGF1R,MAPK"	combo	98.2	30	43.5	12	15.6	33	PD
X-2470	INC424	JAK	single	8.1	17	6.6	14	47.9	76	SD-->PD
X-2470	LEE011	"CDK4,CDK6,CDK4/6"	single	37.1	40	1.1	11	34.2	54	PD
X-2470	WNT974	PORCN	single	130.6	20	10.2	12	16.8	29	PD
X-2470	LKA136	"NTRK1,NTRK2,NTRK3"	single	430.1	22	104.1	13	6.2	22	PD
X-2470	binimetinib-3.5mpk	MAPK	single	-42.8	57	10.3	97	104	104	SD-->-->PD
X-2470	trametinib	MAPK	single	-55.7	59	-26.8	68	81	81	PR-->-->PD
X-2470	untreated	"UNKNOWN,Untreated"	single	133.9	20	37.6	12	16.3	33	PD
X-2483	5FU	chemotherapy	single	54.4	23	13.5	13	50.4	70	PD
X-2483	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	8.1	11	1.6	11	40	70	SD-->PD
X-2483	BKM120 + LJC049	"panPI3K,TNKS"	combo	61.9	21	9.6	11	29.5	36	PD
X-2483	BYL719	PIK3CA	single	43.3	23	13.8	13	40.7	70	PD
X-2483	BYL719 + cetuximab	"PIK3CA,EGFR"	combo	70.5	21	16.1	11	24.7	47	PD
X-2483	BYL719 + cetuximab + encorafenib	"PIK3CA,EGFR,BRAF"	combo	10.5	14	11.7	14	94	94	SD
X-2483	BYL719 + encorafenib	"PIK3CA,BRAF"	combo	2	92	6	11	99	99	SD
X-2483	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	32.6	21	16.1	11	56.9	69	SD-->PD
X-2483	BYL719 + binimetinib	"PIK3CA,MAPK"	combo	2.9	41	10.6	49	90	90	SD
X-2483	cetuximab	EGFR	single	112.2	21	30.8	11	19.3	45	PD
X-2483	cetuximab + encorafenib	"EGFR,BRAF"	combo	41.3	21	14.7	13	50.4	68	PD
X-2483	CGM097	MDM2	single	101.9	21	12.7	11	20.8	70	PD
X-2483	CKX620	MAPK	single	6.5	11	3.7	11	70	70	SD-->PD
X-2483	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	14.6	28	8.1	11	69	69	SD-->PD
X-2483	HDM201	MDM2	single	122.9	21	27.5	11	18.8	39	PD
X-2483	LEE011	"CDK4,CDK6,CDK4/6"	single	18.4	11	7.8	11	57.1	69	SD-->PD
X-2483	encorafenib	BRAF	single	19.9	56	9.5	11	89	89	SD-->-->PD
X-2483	LJC049	TNKS	single	124.9	21	26.8	11	18.8	52	PD
X-2483	LKA136	"NTRK1,NTRK2,NTRK3"	single	42.4	28	12.6	11	35.9	69	PD
X-2483	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	9.3	11	3.1	11	89	89	SD-->PD
X-2483	untreated	"UNKNOWN,Untreated"	single	80.5	21	19.9	11	35.2	70	PD
X-2483	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	-33.7	112	-6.575	11	140.0647482	158	SD-->PD
X-2484	5FU	chemotherapy	single	-9.4	9	1.2	13	33.9	55	SD-->PD
X-2484	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-14.6	17	1.1	17	26.9	42	SD-->PD
X-2484	BKM120 + LJC049	"panPI3K,TNKS"	combo	131.5	21	25.1	13	19	30	PD
X-2484	BYL719	PIK3CA	single	-50.9	20	-30.3	31	87	87	PR-->PD
X-2484	BYL719 + cetuximab	"PIK3CA,EGFR"	combo	-15.3	14	-10	14	43.4	47	SD-->PD
X-2484	BYL719 + cetuximab + encorafenib	"PIK3CA,EGFR,BRAF"	combo	-21.2	11	-6.2	11	31.9	32	SD-->PD
X-2484	BYL719 + encorafenib	"PIK3CA,BRAF"	combo	66.1	23	18.6	12	26.9	36	PD
X-2484	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-56.2	66	-9	16	66	66	SD-->PD
X-2484	BYL719 + binimetinib	"PIK3CA,MAPK"	combo	-0.7	56	-2.4	12	89	89	SD-->PD
X-2484	cetuximab	EGFR	single	83.6	22	12	13	25.2	29	PD
X-2484	cetuximab + encorafenib	"EGFR,BRAF"	combo	190.9	21	35.7	11	14.5	32	PD
X-2484	CGM097	MDM2	single	56	24	1.5	14	40.2	45	PD
X-2484	CKX620	MAPK	single	53.7	24	9.3	14	33	39	PD
X-2484	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-8.1	10	-1	15	80	80	SD-->PD
X-2484	HDM201	MDM2	single	81.1	22	23.5	13	22	22	PD
X-2484	LEE011	"CDK4,CDK6,CDK4/6"	single	-48.8	13	-33.1	22	62.8	63	SD-->PD
X-2484	encorafenib	BRAF	single	180.9	24	29.5	14	15.9	27	PD
X-2484	LJC049	TNKS	single	116.9	24	7.5	14	17.9	27	PD
X-2484	LKA136	"NTRK1,NTRK2,NTRK3"	single	125.8	24	25	14	20.3	27	PD
X-2484	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	50.2	22	5.2	13	28.6	30	PD
X-2484	untreated	"UNKNOWN,Untreated"	single	86.8	21	31	11	22.7	63	PD
X-2487	BGJ398	FGFR	single	82.3	21	25.4	13	22.6	48	PD
X-2487	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	148.7	32	28.4	11	17.6	53	PD
X-2487	BYL719	PIK3CA	single	81.9	26	10.4	11	29.8	60	PD
X-2487	BYL719 + LEE011	"PIK3CA,CDK4/6"	combo	-47.8	10	-25.4	20	55	55	SD-->PD
X-2487	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-9.8	15	-6.2	15	42.3	67	SD-->PD
X-2487	CGM097	MDM2	single	184.9	21	66.9	13	10.3	34	PD
X-2487	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	73.3	26	13.4	11	28.3	67	PD
X-2487	HDM201	MDM2	single	182.7	21	49.8	11	17.6	25	PD
X-2487	INC424	JAK	single	369.3	21	84	13	8	27	PD
X-2487	LEE011	"CDK4,CDK6,CDK4/6"	single	161.1	20	55.8	13	11.5	20	PD
X-2487	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-12.5	13	-6.9	20	83	83	SD-->PD
X-2487	LFA102	PRLR 	single	175.1	20	35.5	13	14.6	34	PD
X-2487	LJM716	ERBB3	single	18.5	25	3.7	12	33.7	46	SD-->PD
X-2487	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	96.2	20	26.1	13	20.3	41	PD
X-2487	LKA136	"NTRK1,NTRK2,NTRK3"	single	383.9	18	71.2	11	7.5	18	PD
X-2487	LLM871	FGFR2/4	single	249.8	21	78.1	13	8.5	27	PD
X-2487	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	148.3	21	36.3	13	16.1	34	PD
X-2487	paclitaxel	Tubulin	single	61.6	28	28.8	13	33.9	55	PD
X-2487	tamoxifen	ESR1	single	78.8	26	4	11	29.8	60	PD
X-2487	trastuzumab	ERBB2	single	282.7	21	56.9	13	9.7	27	PD
X-2487	untreated	"UNKNOWN,Untreated"	single	407.1	18	96.9	11	6	18	PD
X-2487	LFW527 + everolimus	"IGF1R,MTOR"	combo	4.2	14	2.82	14	45	45	SD-->PD
X-2514	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	225.8	24	30.12	17	16.29155313	27	PD
X-2524	BGJ398	FGFR	single	515.5	14	170.8	14	7.1	14	PD
X-2524	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	232.2	21	64.7	14	10.7	27	PD
X-2524	BYL719	PIK3CA	single	120.9	21	30.4	14	18.7	36	PD
X-2524	BYL719 + LEE011	"PIK3CA,CDK4/6"	combo	161.6	26	12.7	11	21.6	32	PD
X-2524	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	42.5	21	10.5	14	39.2	70	PD
X-2524	CGM097	MDM2	single	244.4	21	68.5	14	9.3	27	PD
X-2524	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	157	21	30.5	14	16.6	42	PD
X-2524	HDM201	MDM2	single	243.2	21	50.4	14	12.4	27	PD
X-2524	INC424	JAK	single	335.7	17	112.9	14	6.4	17	PD
X-2524	LEE011	"CDK4,CDK6,CDK4/6"	single	180.8	26	36.7	11	13.1	46	PD
X-2524	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	175.6	26	5.9	11	19.8	39	PD
X-2524	LFA102	PRLR 	single	128.9	21	32.5	14	15.9	42	PD
X-2524	LJM716	ERBB3	single	664.5	23	94.1	11	8	23	PD
X-2524	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	462.9	22	60.2	13	9.5	28	PD
X-2524	LKA136	"NTRK1,NTRK2,NTRK3"	single	874.9	17	232	14	4.8	17	PD
X-2524	LLM871	FGFR2/4	single	87.2	21	11.1	14	22	70	PD
X-2524	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	367.1	17	104	14	7.3	17	PD
X-2524	paclitaxel	Tubulin	single	156.5	21	27.6	15	16.5	49	PD
X-2524	tamoxifen	ESR1	single	689.5	21	128.8	14	6	21	PD
X-2524	trastuzumab	ERBB2	single	662.4	22	109.8	13	6.2	22	PD
X-2524	untreated	"UNKNOWN,Untreated"	single	645.2	10	251	10	3.3	10	PD
X-2524	LFW527 + everolimus	"IGF1R,MTOR"	combo	0	16	0	16	26	26	SD
X-2538	5FU	chemotherapy	single	133.5	22	15.3	11	17.8	32	PD
X-2538	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	13.6	9	9.5	13	76.2	79	SD-->PD
X-2538	BKM120 + LJC049	"panPI3K,TNKS"	combo	-13.8	10	-9.3	13	28	28	SD
X-2538	BYL719	PIK3CA	single	-33.2	15	-18.3	15	89.5	94	SD-->PD
X-2538	BYL719 + cetuximab	"PIK3CA,EGFR"	combo	131.2	25	15.3	11	13.4	35	PD
X-2538	BYL719 + cetuximab + encorafenib	"PIK3CA,EGFR,BRAF"	combo	111.2	22	8.2	11	14.6	39	PD
X-2538	BYL719 + encorafenib	"PIK3CA,BRAF"	combo	54.6	20	22.9	14	27.2	37	PD
X-2538	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	33.2	20	15.8	15	43.4	48	SD-->PD
X-2538	BYL719 + binimetinib	"PIK3CA,MAPK"	combo	-10.1	12	-6.1	18	65.8	66	SD-->PD
X-2538	cetuximab	EGFR	single	110.9	21	29.6	11	19	39	PD
X-2538	cetuximab + encorafenib	"EGFR,BRAF"	combo	91.3	21	19.7	11	21.4	28	PD
X-2538	CGM097	MDM2	single	42.1	23	13	11	33.9	44	PD
X-2538	CKX620	MAPK	single	-17	9	-2	13	90	90	SD-->PD
X-2538	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-46.9	48	-27.3	80	94	94	SD
X-2538	HDM201	MDM2	single	69.9	22	25.5	13	32.9	33	PD
X-2538	LEE011	"CDK4,CDK6,CDK4/6"	single	50.4	20	17.9	13	44.3	48	PD
X-2538	encorafenib	BRAF	single	172.7	23	28.2	11	16.1	28	PD
X-2538	LJC049	TNKS	single	108.6	21	12.3	15	20.3	34	PD
X-2538	LKA136	"NTRK1,NTRK2,NTRK3"	single	154.8	21	50.2	15	14.7	34	PD
X-2538	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	56.9	22	13.4	11	42	42	PD
X-2538	untreated	"UNKNOWN,Untreated"	single	171	21	34.8	11	12.3	33	PD
X-2564	abraxane	Tubulin	single	301	21	69	11	6.9	25	PD
X-2564	abraxane + gemcitabine	"Tubulin,chemotherapy"	combo	65.5	24	30.2	11	20.5	90	PD
X-2564	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	19.5	19	16.1	12	43.1	47	SD-->PD
X-2564	BKM120 + LDE225	"panPI3K,SMO"	combo	4.4	17	6.4	17	57	91	SD-->PD
X-2564	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-19.2	56	1.5	63	102	102	SD-->-->PD
X-2564	BYL719	PIK3CA	single	72.9	20	28.4	12	27.6	37	PD
X-2564	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	18.3	66	8	11	57.8	88	SD-->PD
X-2564	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-4.9	18	-0.1	22	70.6	131	SD-->PD
X-2564	HDM201	MDM2	single	10.5	10	6.9	13	23.3	24	SD-->PD
X-2564	figitumumab	IGF1R	single	160	22	22.3	12	15.1	29	PD
X-2564	figitumumab + binimetinib	"IGF1R,MAPK"	combo	-5.2	11	6.6	11	58.5	74	SD-->PD
X-2564	gemcitabine-50mpk	chemotherapy	single	27.6	17	13.2	11	30.5	49	SD-->PD
X-2564	INC424	JAK	single	55.1	20	11.8	13	42	97	PD
X-2564	INC424 + binimetinib	"JAK,MAPK"	combo	52	25	46.5	17	56.9	126	PD
X-2564	LEE011	"CDK4,CDK6,CDK4/6"	single	-0.8	11	8.1	11	101.6	112	SD-->-->PD
X-2564	WNT974	PORCN	single	53	12	19.6	12	12	12	PD
X-2564	LKA136	"NTRK1,NTRK2,NTRK3"	single	14.4	10	17.9	14	14	14	SD
X-2564	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-45.5	60	-10.9	63	63	63	SD-->PD
X-2564	binimetinib-3.5mpk	MAPK	single	33.8	32	54.8	32	44	86	PD
X-2564	trametinib	MAPK	single	-17.4	32	15.9	11	65.6	74	SD-->PD
X-2564	untreated	"UNKNOWN,Untreated"	single	168.3	21	15.9	13	17.1	37	PD
X-2573	5FU	chemotherapy	single	42.3	33	5.5	11	33	33	PD
X-2573	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	487.5	23	33.4	14	14.6	23	PD
X-2573	BKM120 + LJC049	"panPI3K,TNKS"	combo	-62.8	16	-43.3	21	30	30	PR
X-2573	BYL719	PIK3CA	single	-35.7	30	-19.8	39	91	91	SD-->-->PD
X-2573	BYL719 + cetuximab	"PIK3CA,EGFR"	combo	-38.5	9	-24.4	25	77	77	SD-->PD
X-2573	BYL719 + cetuximab + encorafenib	"PIK3CA,EGFR,BRAF"	combo	-23.6	25	-11.6	25	56	73	SD-->PD
X-2573	BYL719 + encorafenib	"PIK3CA,BRAF"	combo	32.7	39	42.8	16	58	58	PD
X-2573	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-68.6	30	-57	30	58	58	PR
X-2573	BYL719 + binimetinib	"PIK3CA,MAPK"	combo	-28.9	21	-11.2	25	91	91	SD-->PD
X-2573	cetuximab	EGFR	single	29.3	18	25.9	14	28	28	SD
X-2573	cetuximab + encorafenib	"EGFR,BRAF"	combo	33.7	23	7.2	14	36.3	53	SD-->PD
X-2573	CGM097	MDM2	single	235.5	23	37.1	14	16.6	28	PD
X-2573	CKX620	MAPK	single	41.1	23	25.5	14	28	28	PD
X-2573	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-28.7	16	-18.9	16	30	30	SD-->PD
X-2573	HDM201	MDM2	single	165.4	21	26.3	11	16.3	24	PD
X-2573	LEE011	"CDK4,CDK6,CDK4/6"	single	145.7	24	28.1	11	12.4	24	PD
X-2573	encorafenib	BRAF	single	89.5	23	40.9	14	23	23	PD
X-2573	LJC049	TNKS	single	207	23	85.3	14	5.8	23	PD
X-2573	LKA136	"NTRK1,NTRK2,NTRK3"	single	365.3	23	81.7	14	7	23	PD
X-2573	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-31.1	14	-11.5	28	74.6	92	SD-->PD
X-2573	untreated	"UNKNOWN,Untreated"	single	348.9	23	106.8	14	7.6	23	PD
X-2573	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	-5.7	24	0.12	15	60.77923497	147	SD-->PD
X-2602	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	46.4	27	19	12	37	37	PD
X-2602	BKM120 + encorafenib	"panPI3K,BRAF,BRAF,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-27.4	9	-17.9	28	180	180	SD-->PD
X-2602	CGM097	MDM2	single	113.1	23	48.9	13	16.3	35	PD
X-2602	dacarbazine	chemotherapy	single	69.8	13	48.4	13	13	13	PD
X-2602	LDE225	SMO	single	88.8	22	30.5	14	23.1	33	PD
X-2602	LDK378	ALK	single	152.3	22	39.6	14	15.7	33	PD
X-2602	LEE011	"CDK4,CDK6,CDK4/6"	single	-10.2	9	0.1	45	180	180	SD-->-->PD
X-2602	LEE011 + encorafenib	"CDK4/6,BRAF,BRAF,CDK4,CDK6"	combo	-23.5	28	-9.9	39	165	165	SD-->PD
X-2602	WNT974	PORCN	single	82.6	20	24.6	12	27	27	PD
X-2602	LGW813	IAP	single	64	24	21	12	30.7	37	PD
X-2602	encorafenib	BRAF	single	-13.5	46	9.6	50	61.4	98	SD-->PD
X-2602	encorafenib + binimetinib	"BRAF,MAP2K1,MAP2K2,MAPK"	combo	-45.7	24	-33.3	44	180	180	SD-->-->PD
X-2602	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	46.1	27	5	12	38	38	PD
X-2602	TAS266	DR5	single	17.6	22	26.7	12	51	51	SD-->PD
X-2602	untreated	"UNKNOWN,Untreated"	single	239.3	21	32.8	11	13	37	PD
X-2613	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	262.8	20	54.8	13	10.2	20	PD
X-2613	BKM120 + encorafenib	"panPI3K,BRAF,BRAF,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-73.9	28	-60.2	48	304.3	333	PR-->-->PD
X-2613	CGM097	MDM2	single	-79.8	50	-39.1	84	109.9	111	PR-->-->PD
X-2613	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	112.9	22	117.5	22	5	22	PD
X-2613	dacarbazine	chemotherapy	single	292.4	22	66.4	12	10.3	22	PD
X-2613	LDE225	SMO	single	918.4	22	90.3	11	7.4	22	PD
X-2613	LDK378	ALK	single	271.8	22	70	11	8.3	22	PD
X-2613	LEE011	"CDK4,CDK6,CDK4/6"	single	-12.6	13	-12.3	13	26.2	30	SD-->PD
X-2613	LEE011 + encorafenib	"CDK4/6,BRAF,BRAF,CDK4,CDK6"	combo	-100	89	-90.5	404	404	404	CR
X-2613	LEE011 + binimetinib	"CDK4,CDK6,MAP2K1,MAP2K2,CDK4/6,MAPK"	combo	-86.6	23	-71.2	53	253	271	PR-->-->PD
X-2613	WNT974	PORCN	single	987.6	22	165.4	11	6	22	PD
X-2613	LGW813	IAP	single	683.6	20	158.4	13	4.7	20	PD
X-2613	encorafenib	BRAF	single	-36.6	30	-39.4	13	92.6	93	SD-->PD
X-2613	encorafenib + binimetinib	"BRAF,MAP2K1,MAP2K2,MAPK"	combo	-100	27	-95	190	391	394	CR-->-->PD
X-2613	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-11.8	16	11.2	16	34.6	56	SD
X-2613	TAS266	DR5	single	-100	13	-82.5	39	64.8	69	CR-->PD
X-2613	untreated	"UNKNOWN,Untreated"	single	549.6	16	179.1	13	3.4	16	PD
X-2633	abraxane	Tubulin	single	188.4	22	61.6	11	8.7	28	PD
X-2633	abraxane + gemcitabine	"Tubulin,chemotherapy"	combo	-97.5	66	-79	104	104	104	CR
X-2633	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-32.2	13	-13	13	63	63	SD-->PD
X-2633	BKM120 + LDE225	"panPI3K,SMO"	combo	-57.6	98	-5	115	132	132	SD-->PD
X-2633	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-69.8	127	-47.9	127	127	127	PR
X-2633	BYL719	PIK3CA	single	-43.5	15	-35.1	51	120	120	SD-->PD
X-2633	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-13.1	17	-5.4	28	99.6	108	SD-->PD
X-2633	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	88.6	22	15.8	11	25.9	56	PD
X-2633	HDM201	MDM2	single	69.6	20	12.8	13	42	42	PD
X-2633	figitumumab	IGF1R	single	58.8	22	10	12	26.9	36	PD
X-2633	figitumumab + binimetinib	"IGF1R,MAPK"	combo	-9.9	10	4.6	14	61.1	75	SD-->PD
X-2633	gemcitabine-50mpk	chemotherapy	single	-77.2	77	-37.8	95	101	101	PR-->-->PD
X-2633	INC424 + binimetinib	"JAK,MAPK"	combo	31.8	21	13.7	11	42.3	127	SD-->PD
X-2633	LEE011	"CDK4,CDK6,CDK4/6"	single	73.5	47	40.3	12	13.6	99	PD
X-2633	WNT974	PORCN	single	-11.8	64	14.4	86	96	96	SD-->PD
X-2633	LKA136	"NTRK1,NTRK2,NTRK3"	single	158.4	22	34.5	13	11.3	33	PD
X-2633	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-10.3	21	4	11	21	21	SD
X-2633	binimetinib-3.5mpk	MAPK	single	-37	13	-19.4	28	65.6	73	SD-->PD
X-2633	trametinib	MAPK	single	-85.4	90	-32.4	90	90	90	PR-->PD
X-2633	untreated	"UNKNOWN,Untreated"	single	133.6	20	37.3	11	11.8	59	PD
X-2640	BGJ398	FGFR	single	-27.6	73	-11.2	97	97	97	SD
X-2640	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-49.4	56	-30.5	91	91	91	SD
X-2640	BYL719	PIK3CA	single	-4	10	-3	17	63.6	87	SD-->PD
X-2640	BYL719 + LEE011	"PIK3CA,CDK4/6"	combo	-43.6	35	-29.7	38	38	38	SD
X-2640	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-27.2	14	-17.8	24	31	31	SD
X-2640	CGM097	MDM2	single	-3.3	10	0.9	14	34.5	70	SD-->PD
X-2640	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-1.9	10	-0.8	13	76.8	87	SD-->PD
X-2640	HDM201	MDM2	single	181.1	20	65.9	17	11.4	25	PD
X-2640	INC424	JAK	single	36.7	23	8.8	13	52.5	90	PD
X-2640	LEE011	"CDK4,CDK6,CDK4/6"	single	54.6	21	8.7	11	30.4	56	PD
X-2640	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	54.4	21	18.8	11	49.1	56	PD
X-2640	LFA102	PRLR 	single	59	20	37.7	13	28.9	76	PD
X-2640	LJM716	ERBB3	single	-11.8	11	-14.1	11	105	105	SD-->PD
X-2640	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	40.3	20	19.2	13	63	97	PD
X-2640	LKA136	"NTRK1,NTRK2,NTRK3"	single	3.3	9	0.9	13	48.4	90	SD-->PD
X-2640	LLM871	FGFR2/4	single	-100	80	-59.9	139	139	139	CR
X-2640	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-0.5	14	-3.9	14	80	80	SD-->PD
X-2640	paclitaxel	Tubulin	single	-4.4	9	-2.5	14	39.9	76	SD-->PD
X-2640	tamoxifen	ESR1	single	115.4	20	43.2	17	16.1	31	PD
X-2640	trastuzumab	ERBB2	single	96	20	33.4	13	20.7	56	PD
X-2640	untreated	"UNKNOWN,Untreated"	single	21.1	10	24.7	20	36.1	125	SD-->PD
X-2640	LFW527 + everolimus	"IGF1R,MTOR"	combo	-53.6	9	-29.64444444	27	111	111	PR-->PD
X-2659	5FU	chemotherapy	single	314.7	20	60	12	9	20	PD
X-2659	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	45.1	21	14.9	11	31	31	PD
X-2659	BKM120 + LJC049	"panPI3K,TNKS"	combo	47.8	22	17.9	13	33	33	PD
X-2659	BYL719	PIK3CA	single	117.2	20	32.1	14	18.5	23	PD
X-2659	BYL719 + cetuximab	"PIK3CA,EGFR"	combo	43.9	22	16.3	13	33	33	PD
X-2659	BYL719 + cetuximab + encorafenib	"PIK3CA,EGFR,BRAF"	combo	61.8	20	34.3	11	23	23	PD
X-2659	BYL719 + encorafenib	"PIK3CA,BRAF"	combo	97.5	23	29	13	23	23	PD
X-2659	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	61.6	20	15.6	14	20	20	PD
X-2659	BYL719 + binimetinib	"PIK3CA,MAPK"	combo	-6.4	17	5.2	34	75.5	90	SD-->PD
X-2659	cetuximab	EGFR	single	459.2	22	101.7	12	6.8	22	PD
X-2659	cetuximab + encorafenib	"EGFR,BRAF"	combo	224.7	20	46.7	11	10.1	23	PD
X-2659	CGM097	MDM2	single	267	20	59.7	14	10.7	23	PD
X-2659	CKX620	MAPK	single	89.8	21	19	11	23.2	24	PD
X-2659	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	97.5	20	25	14	20.6	23	PD
X-2659	HDM201	MDM2	single	279.2	21	58.2	11	9.7	21	PD
X-2659	LEE011	"CDK4,CDK6,CDK4/6"	single	133.6	22	36.6	12	16.6	22	PD
X-2659	encorafenib	BRAF	single	150.6	20	50.8	14	10.5	23	PD
X-2659	LJC049	TNKS	single	250.8	20	56.1	14	9.9	23	PD
X-2659	LKA136	"NTRK1,NTRK2,NTRK3"	single	3.6	90	20.5	50	90	90	SD
X-2659	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	135.2	22	43	12	15.8	22	PD
X-2659	untreated	"UNKNOWN,Untreated"	single	259.8	23	48.3	13	11.4	23	PD
X-2659	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	-100	121	-59.15121951	149	149	149	CR
X-2684	abraxane	Tubulin	single	168.4	21	30.4	14	16.9	24	PD
X-2684	abraxane + gemcitabine	"Tubulin,chemotherapy"	combo	-100	72	-59.3	93	93	93	CR
X-2684	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-13.9	21	8.3	21	85.3	91	SD-->PD
X-2684	BKM120 + LDE225	"panPI3K,SMO"	combo	39	43	14.8	14	49	49	PD
X-2684	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-44	11	-10.1	11	11	11	SD
X-2684	BYL719	PIK3CA	single	62.5	20	5.8	17	22.6	41	PD
X-2684	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	39.1	25	15.5	11	52	95	PD
X-2684	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	152.3	20	30.9	13	15.7	31	PD
X-2684	HDM201	MDM2	single	390.8	21	107.2	14	6.2	28	PD
X-2684	figitumumab	IGF1R	single	-75.2	53	-28.7	87	104	104	PR-->PD
X-2684	figitumumab + binimetinib	"IGF1R,MAPK"	combo	-75	45	-16.3	101	7.9	101	SD
X-2684	INC424	JAK	single	48.2	20	22.3	17	28.8	41	PD
X-2684	INC424 + binimetinib	"JAK,MAPK"	combo	131.1	21	65.4	14	11	31	PD
X-2684	LEE011	"CDK4,CDK6,CDK4/6"	single	47.1	22	-7.3	12	25.7	42	PD
X-2684	WNT974	PORCN	single	249.1	15	125.6	14	7.6	15	PD
X-2684	LKA136	"NTRK1,NTRK2,NTRK3"	single	330.5	20	85.4	13	6.2	24	PD
X-2684	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-17	29	-5.3	11	29	29	SD-->PD
X-2684	binimetinib-3.5mpk	MAPK	single	137.6	21	83.7	14	10.3	28	PD
X-2684	trametinib	MAPK	single	105	26	10	12	21.7	33	PD
X-2684	untreated	"UNKNOWN,Untreated"	single	222.7	23	69.7	13	7.7	34	PD
X-2700	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	106.1	23	18.2	12	22.2	27	PD
X-2700	BKM120 + encorafenib	"panPI3K,BRAF,BRAF,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	74.2	23	20.4	12	25.6	33	PD
X-2700	CGM097	MDM2	single	117.8	20	49.4	14	15.9	27	PD
X-2700	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	241.5	26	66.9	12	9.3	26	PD
X-2700	dacarbazine	chemotherapy	single	191.1	22	35.8	12	11.9	27	PD
X-2700	LDE225	SMO	single	110.9	23	27	11	20.6	28	PD
X-2700	LDK378	ALK	single	99.1	23	43.7	11	13.5	28	PD
X-2700	LEE011	"CDK4,CDK6,CDK4/6"	single	60.3	21	28.7	11	27	27	PD
X-2700	LEE011 + encorafenib	"CDK4/6,BRAF,BRAF,CDK4,CDK6"	combo	-36.4	118	-5.6	14	245.4	254	SD-->-->PD
X-2700	LEE011 + binimetinib	"CDK4,CDK6,MAP2K1,MAP2K2,CDK4/6,MAPK"	combo	-69.7	187	-38.9	235	235	235	PR
X-2700	WNT974	PORCN	single	15.2	25	10.4	11	32.1	43	SD-->PD
X-2700	LGW813	IAP	single	203.7	23	47.3	11	12.8	27	PD
X-2700	encorafenib	BRAF	single	215.6	23	63.4	13	10.4	27	PD
X-2700	encorafenib + binimetinib	"BRAF,MAP2K1,MAP2K2,MAPK"	combo	73.4	22	21.1	14	24.8	28	PD
X-2700	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-30	42	-9.4	52	85	85	SD-->-->PD
X-2700	TAS266	DR5	single	310.1	20	78.7	13	7.9	27	PD
X-2700	untreated	"UNKNOWN,Untreated"	single	342.6	21	71.2	14	9.4	27	PD
X-2723	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	180.7	23	36.8	11	12.3	23	PD
X-2723	BKM120 + encorafenib	"panPI3K,BRAF,BRAF,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-84.9	14	-60.7	23	137.2	140	PR-->PD
X-2723	CGM097	MDM2	single	119.4	23	29.6	11	20	23	PD
X-2723	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	40.3	23	2.7	12	32.9	38	PD
X-2723	dacarbazine	chemotherapy	single	302.1	20	93.8	13	5	23	PD
X-2723	LDE225	SMO	single	235.4	22	77.5	11	6.6	25	PD
X-2723	LDK378	ALK	single	112.5	22	12.1	11	21.1	25	PD
X-2723	LEE011	"CDK4,CDK6,CDK4/6"	single	257.6	22	71.5	11	7.8	23	PD
X-2723	LEE011 + encorafenib	"CDK4/6,BRAF,BRAF,CDK4,CDK6"	combo	-100	84	-79.4	245	245	245	CR
X-2723	LEE011 + binimetinib	"CDK4,CDK6,MAP2K1,MAP2K2,CDK4/6,MAPK"	combo	-100	87	-81.9	235	235	235	CR
X-2723	WNT974	PORCN	single	200.7	21	40.9	14	13.5	21	PD
X-2723	LGW813	IAP	single	-77.1	14	-54.9	22	46	46	PR-->PD
X-2723	encorafenib	BRAF	single	172.6	22	65.2	11	8.8	23	PD
X-2723	encorafenib + binimetinib	"BRAF,MAP2K1,MAP2K2,MAPK"	combo	-69	11	-55.5	11	171.1	229	PR-->PD
X-2723	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-8.5	29	7.4	29	35.3	44	SD-->PD
X-2723	TAS266	DR5	single	196.3	23	56.5	11	10.7	23	PD
X-2723	untreated	"UNKNOWN,Untreated"	single	357.5	22	22.2	11	14.6	23	PD
X-2753	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	203.5	22	3.7	11	18.9	25	PD
X-2753	BKM120 + encorafenib	"panPI3K,BRAF,BRAF,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	421.6	22	95.4	13	6.9	22	PD
X-2753	CGM097	MDM2	single	-33	14	2.7	15	15	15	SD
X-2753	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	20.3	13	15.3	13	24	24	SD-->PD
X-2753	dacarbazine	chemotherapy	single	531	22	42.9	13	11.6	22	PD
X-2753	LDE225	SMO	single	217	22	63	11	8.7	22	PD
X-2753	LDK378	ALK	single	343.1	22	41	11	10.7	25	PD
X-2753	LEE011	"CDK4,CDK6,CDK4/6"	single	255	22	73.3	11	7.7	22	PD
X-2753	LEE011 + encorafenib	"CDK4/6,BRAF,BRAF,CDK4,CDK6"	combo	-11.1	13	-4.7	16	26	26	SD
X-2753	LEE011 + binimetinib	"CDK4,CDK6,MAP2K1,MAP2K2,CDK4/6,MAPK"	combo	97.3	20	7.9	13	20.2	24	PD
X-2753	WNT974	PORCN	single	691.2	19	73.3	11	7.9	19	PD
X-2753	LGW813	IAP	single	-56	56	-23.3	63	109	109	PR-->-->PD
X-2753	encorafenib	BRAF	single	347.9	22	50.7	11	9.5	25	PD
X-2753	encorafenib + binimetinib	"BRAF,MAP2K1,MAP2K2,MAPK"	combo	253.8	22	71.5	13	9.6	22	PD
X-2753	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	454.7	22	57.7	11	8.9	25	PD
X-2753	TAS266	DR5	single	210.9	22	28.9	11	15.4	25	PD
X-2753	untreated	"UNKNOWN,Untreated"	single	349.2	24	93.4	12	6.5	24	PD
X-2761	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	-3.7	10	-4.28	13	36.57777778	83	SD-->PD
X-2780	BGJ398	FGFR	single	171.7	20	19.2	14	15.3	34	PD
X-2780	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-27.5	50	-8.6	22	54	54	SD-->PD
X-2780	BYL719	PIK3CA	single	-24.1	15	-7.6	18	38.3	43	SD-->PD
X-2780	BYL719 + LEE011	"PIK3CA,CDK4/6"	combo	-35.9	5	-5.1	5	5	5	SD
X-2780	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	94.5	29	13	11	22.7	32	PD
X-2780	CGM097	MDM2	single	57.3	20	24.6	13	24	27	PD
X-2780	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	20	15	21	15	28.9	46	SD-->PD
X-2780	HDM201	MDM2	single	31.8	22	10.8	15	28	32	SD-->PD
X-2780	INC424	JAK	single	422.6	20	108.4	13	5.5	28	PD
X-2780	LEE011	"CDK4,CDK6,CDK4/6"	single	121	24	61	13	10	27	PD
X-2780	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-59.3	22	-29.7	68	88	88	PR
X-2780	LFA102	PRLR 	single	429.3	20	83.2	13	8.5	28	PD
X-2780	LJM716	ERBB3	single	304.3	20	36.2	13	11.9	20	PD
X-2780	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	162.8	20	29.9	13	14.7	34	PD
X-2780	LKA136	"NTRK1,NTRK2,NTRK3"	single	199	38	76	13	7.2	41	PD
X-2780	LLM871	FGFR2/4	single	-100	45	-52.1	63	63	63	CR
X-2780	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	10	21	14.7	13	31	42	SD-->PD
X-2780	paclitaxel	Tubulin	single	155.6	20	18.7	13	15.5	35	PD
X-2780	tamoxifen	ESR1	single	0.4	11	-9.3	11	35.2	41	SD-->PD
X-2780	trastuzumab	ERBB2	single	-16.5	10	3.4	24	67.1	69	SD-->PD
X-2780	untreated	"UNKNOWN,Untreated"	single	511.1	21	85.7	13	7.9	21	PD
X-2780	LFW527 + everolimus	"IGF1R,MTOR"	combo	-22.9	42	-3.3	17	64.87064677	108	SD-->PD
X-2822	5FU	chemotherapy	single	3.1	11	0.7	11	40.6	91	SD-->PD
X-2822	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	9.4	9	5.2	13	21	21	SD-->PD
X-2822	BKM120 + LJC049	"panPI3K,TNKS"	combo	53.9	21	3.6	13	28.6	52	PD
X-2822	BYL719	PIK3CA	single	50.2	21	8.4	12	30.2	36	PD
X-2822	BYL719 + cetuximab	"PIK3CA,EGFR"	combo	3.2	10	2.6	13	87	87	SD-->PD
X-2822	BYL719 + cetuximab + encorafenib	"PIK3CA,EGFR,BRAF"	combo	65.2	21	6.8	11	23.3	42	PD
X-2822	BYL719 + encorafenib	"PIK3CA,BRAF"	combo	49.5	24	14.3	13	28.7	52	PD
X-2822	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-1.7	12	-0.9	15	64.2	84	SD-->PD
X-2822	BYL719 + binimetinib	"PIK3CA,MAPK"	combo	-9.1	27	-1.1	27	87	87	SD-->PD
X-2822	cetuximab	EGFR	single	77	23	32.2	11	30.5	63	PD
X-2822	cetuximab + encorafenib	"EGFR,BRAF"	combo	59.5	21	9.2	11	28.1	63	PD
X-2822	CGM097	MDM2	single	108.1	22	16.8	11	21.2	49	PD
X-2822	CKX620	MAPK	single	9.4	9	5.3	13	38.4	62	SD-->PD
X-2822	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	0.4	15	0.5	15	69.3	84	SD-->PD
X-2822	HDM201	MDM2	single	70.3	21	5.1	13	24	24	PD
X-2822	LEE011	"CDK4,CDK6,CDK4/6"	single	5.8	12	2.4	12	71.7	84	SD-->PD
X-2822	encorafenib	BRAF	single	157.1	22	30.4	11	16.4	40	PD
X-2822	LJC049	TNKS	single	0	12	-0.5	12	66.3	84	SD-->PD
X-2822	LKA136	"NTRK1,NTRK2,NTRK3"	single	2	12	0.9	12	57.8	84	SD-->PD
X-2822	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	8.7	11	4.3	11	69.6	91	SD-->PD
X-2822	untreated	"UNKNOWN,Untreated"	single	155.8	23	36.5	11	14.6	47	PD
X-2838	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-5.9	10	14.2	14	20.7	37	SD-->PD
X-2838	BKM120 + encorafenib	"panPI3K,BRAF,BRAF,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-37.6	14	-16.6	21	82.2	83	SD-->PD
X-2838	CGM097	MDM2	single	7.6	10	1.4	14	28	28	SD-->PD
X-2838	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-6.8	11	-7.3	11	131	165	SD-->PD
X-2838	dacarbazine	chemotherapy	single	-40.9	14	-21.5	22	35.1	39	SD-->PD
X-2838	LDE225	SMO	single	40.8	24	12.5	14	30	30	PD
X-2838	LDK378	ALK	single	-26.3	21	-13.7	29	59.2	60	SD-->PD
X-2838	LEE011	"CDK4,CDK6,CDK4/6"	single	50.7	24	20.5	14	31	31	PD
X-2838	LEE011 + encorafenib	"CDK4/6,BRAF,BRAF,CDK4,CDK6"	combo	-63.7	145	-37.8	159	236	236	PR-->-->PD
X-2838	LEE011 + binimetinib	"CDK4,CDK6,MAP2K1,MAP2K2,CDK4/6,MAPK"	combo	-51.1	19	-29.8	54	139	139	PR-->-->PD
X-2838	WNT974	PORCN	single	59.7	21	1.1	11	24	27	PD
X-2838	LGW813	IAP	single	5.4	14	8.4	14	24	24	SD-->PD
X-2838	encorafenib	BRAF	single	-14.5	24	6.5	24	47.7	57	SD-->PD
X-2838	encorafenib + binimetinib	"BRAF,MAP2K1,MAP2K2,MAPK"	combo	56.7	22	33.9	11	27	27	PD
X-2838	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	179.2	24	31.2	14	17.1	24	PD
X-2838	TAS266	DR5	single	18.7	10	11	14	25.8	28	SD
X-2838	untreated	"UNKNOWN,Untreated"	single	305.3	21	38.7	11	14.1	25	PD
X-2846	5FU	chemotherapy	single	53.1	23	37.7	13	24.7	62	PD
X-2846	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-10.5	14	-6	14	68	68	SD-->PD
X-2846	BKM120 + LJC049	"panPI3K,TNKS"	combo	64.2	21	17.4	13	25	25	PD
X-2846	BYL719	PIK3CA	single	50	23	14.1	12	33	33	PD
X-2846	BYL719 + cetuximab	"PIK3CA,EGFR"	combo	-100	48	-79.6	73	73	73	CR
X-2846	BYL719 + cetuximab + encorafenib	"PIK3CA,EGFR,BRAF"	combo	-87.8	84	-70	97	97	97	PR
X-2846	BYL719 + encorafenib	"PIK3CA,BRAF"	combo	-26.8	18	-5.4	23	50	50	SD-->PD
X-2846	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-61.2	33	-40.5	40	53.3	55	PR-->PD
X-2846	BYL719 + binimetinib	"PIK3CA,MAPK"	combo	-70.1	51	-42.4	92	92	92	PR
X-2846	cetuximab	EGFR	single	-45	79	-26.8	101	105	105	SD
X-2846	cetuximab + encorafenib	"EGFR,BRAF"	combo	-74.6	84	-47.7	88	88	88	PR
X-2846	CGM097	MDM2	single	268.5	32	99.9	11	5.7	46	PD
X-2846	CKX620	MAPK	single	-100	71	-71	105	105	105	CR
X-2846	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-63.1	105	-40.4	14	105	105	PR-->PD
X-2846	HDM201	MDM2	single	359.6	25	106.3	11	4	25	PD
X-2846	LEE011	"CDK4,CDK6,CDK4/6"	single	4.2	11	1.2	11	46	46	SD-->PD
X-2846	encorafenib	BRAF	single	55	46	-12.4	11	34.5	46	PD
X-2846	LJC049	TNKS	single	175.6	29	29.1	11	11.5	46	PD
X-2846	LKA136	"NTRK1,NTRK2,NTRK3"	single	55	25	18	11	39.4	46	PD
X-2846	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	9.2	11	-5.5	11	46	46	SD-->PD
X-2846	untreated	"UNKNOWN,Untreated"	single	310.4	25	127.9	11	4	25	PD
X-2861	5FU	chemotherapy	single	67	21	33.7	11	33	33	PD
X-2861	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	121.1	20	30.1	11	18.6	27	PD
X-2861	BKM120 + LJC049	"panPI3K,TNKS"	combo	121.2	14	44	11	12.2	14	PD
X-2861	BYL719	PIK3CA	single	143.4	20	21.3	11	15.8	20	PD
X-2861	BYL719 + cetuximab	"PIK3CA,EGFR"	combo	409.5	27	50.6	11	10.3	27	PD
X-2861	BYL719 + cetuximab + encorafenib	"PIK3CA,EGFR,BRAF"	combo	267.9	20	30.5	11	11.8	27	PD
X-2861	BYL719 + encorafenib	"PIK3CA,BRAF"	combo	291.8	21	71.3	11	9	33	PD
X-2861	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	174.1	20	4	11	16.9	27	PD
X-2861	BYL719 + binimetinib	"PIK3CA,MAPK"	combo	-36.1	27	-29.7	27	32	32	SD
X-2861	cetuximab	EGFR	single	522.5	20	122.5	11	6.5	20	PD
X-2861	cetuximab + encorafenib	"EGFR,BRAF"	combo	541.3	14	186.5	11	6	14	PD
X-2861	CGM097	MDM2	single	231	21	64.9	11	7.9	33	PD
X-2861	CKX620	MAPK	single	-17.8	11	-19	11	53	53	SD-->PD
X-2861	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	118.6	27	15.4	11	18.3	33	PD
X-2861	HDM201	MDM2	single	162.4	14	60.1	11	8.9	14	PD
X-2861	LEE011	"CDK4,CDK6,CDK4/6"	single	110	20	23.1	14	16.9	30	PD
X-2861	encorafenib	BRAF	single	240.6	22	76.2	13	6.7	39	PD
X-2861	LJC049	TNKS	single	586.9	20	147.4	11	6	20	PD
X-2861	LKA136	"NTRK1,NTRK2,NTRK3"	single	111.2	21	16	11	18.5	33	PD
X-2861	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	280.5	20	75.7	14	8.8	23	PD
X-2861	untreated	"UNKNOWN,Untreated"	single	127.3	21	40.6	11	16.2	47	PD
X-2861	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	20.1	21	23.26	13	38.62790698	106	SD-->PD
X-2921	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	386.7	23	50.1	11	8.8	23	PD
X-2921	BKM120 + encorafenib	"panPI3K,BRAF,BRAF,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-100	22	-93	272	272	272	CR
X-2921	CGM097	MDM2	single	655.8	14	269.7	14	5	14	PD
X-2921	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	113.5	20	44.1	12	10.9	22	PD
X-2921	dacarbazine	chemotherapy	single	-81.1	19	-61.7	29	53.9	55	PR-->PD
X-2921	LDE225	SMO	single	193.3	23	49.6	11	8.7	23	PD
X-2921	LDK378	ALK	single	712.2	21	167.7	14	4	21	PD
X-2921	LEE011	"CDK4,CDK6,CDK4/6"	single	379.6	22	110.9	14	8.2	22	PD
X-2921	LEE011 + encorafenib	"CDK4/6,BRAF,BRAF,CDK4,CDK6"	combo	-11.8	37	3.1	40	62.2	66	SD-->PD
X-2921	LEE011 + binimetinib	"CDK4,CDK6,MAP2K1,MAP2K2,CDK4/6,MAPK"	combo	129.1	22	57.5	12	17.2	22	PD
X-2921	WNT974	PORCN	single	154.7	23	30.1	12	19.6	23	PD
X-2921	LGW813	IAP	single	304.8	23	66.3	11	7.4	23	PD
X-2921	encorafenib	BRAF	single	738.1	22	252.8	14	5	22	PD
X-2921	encorafenib + binimetinib	"BRAF,MAP2K1,MAP2K2,MAPK"	combo	410.1	19	110.6	15	7.1	19	PD
X-2921	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	565.9	19	129.4	11	3.3	19	PD
X-2921	TAS266	DR5	single	492.9	22	166.2	14	5	22	PD
X-2921	untreated	"UNKNOWN,Untreated"	single	950.1	9	469.3	9	5	9	PD
X-2992	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	233.2	20	49.1	11	10.5	22	PD
X-2992	BKM120 + encorafenib	"panPI3K,BRAF,BRAF,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-83.2	71	-47	94	132.7	141	PR-->-->PD
X-2992	CGM097	MDM2	single	233	21	38.5	12	11.4	21	PD
X-2992	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	118.4	22	15	11	16.3	28	PD
X-2992	dacarbazine	chemotherapy	single	42.2	13	23.9	11	13	13	PD
X-2992	LDE225	SMO	single	277.4	17	121.8	14	5.5	17	PD
X-2992	LDK378	ALK	single	574	17	179.9	14	4	17	PD
X-2992	LEE011	"CDK4,CDK6,CDK4/6"	single	205.3	21	81.5	12	6.1	21	PD
X-2992	LEE011 + encorafenib	"CDK4/6,BRAF,BRAF,CDK4,CDK6"	combo	-71.1	71	-44.3	160	206.3	218	PR-->PD
X-2992	LEE011 + binimetinib	"CDK4,CDK6,MAP2K1,MAP2K2,CDK4/6,MAPK"	combo	-41.6	18	-27	18	107	107	SD-->PD
X-2992	WNT974	PORCN	single	248.6	21	84.4	14	9.1	21	PD
X-2992	LGW813	IAP	single	411.7	20	63.4	11	8.6	22	PD
X-2992	encorafenib	BRAF	single	90.7	21	-13.9	12	21	21	PD
X-2992	encorafenib + binimetinib	"BRAF,MAP2K1,MAP2K2,MAPK"	combo	-55.7	40	-36.9	55	85.6	91	PR-->-->PD
X-2992	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-13.6	16	-0.6	16	27.6	33	SD-->PD
X-2992	TAS266	DR5	single	560	21	166.6	14	5.4	21	PD
X-2992	untreated	"UNKNOWN,Untreated"	single	660.7	14	314.5	14	3	14	PD
X-2997	abraxane	Tubulin	single	414.9	22	77.1	12	7.9	26	PD
X-2997	abraxane + gemcitabine	"Tubulin,chemotherapy"	combo	-80.2	61	-42.9	64	87	87	PR-->-->PD
X-2997	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	36.6	23	14.8	13	41	58	PD
X-2997	BKM120 + LDE225	"panPI3K,SMO"	combo	27.4	20	17.1	13	69	69	SD-->PD
X-2997	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-14.4	25	5.1	25	61.6	91	SD-->PD
X-2997	BYL719	PIK3CA	single	119.4	20	28.3	13	18.1	37	PD
X-2997	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	47.1	20	35.6	13	30	30	PD
X-2997	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	166.7	20	51.5	13	13.5	31	PD
X-2997	HDM201	MDM2	single	509.3	21	99.3	11	5.1	21	PD
X-2997	figitumumab	IGF1R	single	275	20	87.6	13	7	27	PD
X-2997	figitumumab + binimetinib	"IGF1R,MAPK"	combo	243.3	21	58.1	11	8.9	32	PD
X-2997	INC424	JAK	single	323.8	20	90.7	13	6.3	27	PD
X-2997	INC424 + binimetinib	"JAK,MAPK"	combo	71	34	13.3	13	23	99	PD
X-2997	LEE011	"CDK4,CDK6,CDK4/6"	single	184.3	25	67	11	7.9	27	PD
X-2997	LKA136	"NTRK1,NTRK2,NTRK3"	single	384.4	24	95.5	13	6.8	24	PD
X-2997	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	119.2	25	27.9	12	19.1	63	PD
X-2997	binimetinib-3.5mpk	MAPK	single	420.3	21	102.5	11	5.6	25	PD
X-2997	trametinib	MAPK	single	133.5	26	33.7	12	19.1	33	PD
X-2997	untreated	"UNKNOWN,Untreated"	single	313.6	22	39.9	12	12.2	28	PD
X-3028	abraxane	Tubulin	single	128.9	20	23.9	14	18.3	24	PD
X-3028	abraxane + gemcitabine	"Tubulin,chemotherapy"	combo	-80.3	74	-44.3	100	100	100	PR
X-3028	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-2.7	79	2.1	13	93.2	97	SD-->PD
X-3028	BKM120 + LDE225	"panPI3K,SMO"	combo	-38.2	25	-20.3	25	25	25	SD
X-3028	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-23.1	14	0.5	14	135	135	SD-->-->PD
X-3028	BYL719	PIK3CA	single	10.2	84	33.2	14	91	91	PD
X-3028	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	89.9	20	34.1	17	21.1	38	PD
X-3028	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	3.7	10	2.5	17	65.5	90	SD-->PD
X-3028	HDM201	MDM2	single	6.9	10	3	12	31	31	SD-->PD
X-3028	figitumumab	IGF1R	single	134.6	26	23.4	12	19.3	42	PD
X-3028	figitumumab + binimetinib	"IGF1R,MAPK"	combo	42.5	24	62.9	24	9.7	57	PD
X-3028	INC424	JAK	single	9.5	17	8.2	13	60.6	90	SD-->PD
X-3028	INC424 + binimetinib	"JAK,MAPK"	combo	51.7	26	21.4	11	47.2	57	PD
X-3028	LEE011	"CDK4,CDK6,CDK4/6"	single	-37.6	19	-27.9	22	99	99	SD-->PD
X-3028	WNT974	PORCN	single	18.1	18	14.3	11	18	18	SD
X-3028	LKA136	"NTRK1,NTRK2,NTRK3"	single	6.7	49	11.4	12	96	96	SD-->PD
X-3028	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	35.1	21	29.4	11	40.5	127	PD
X-3028	binimetinib-3.5mpk	MAPK	single	138.2	20	89.8	13	7.5	27	PD
X-3028	trametinib	MAPK	single	33.8	22	13.2	12	31.8	33	SD-->PD
X-3028	untreated	"UNKNOWN,Untreated"	single	252.3	24	61.1	13	9.2	29	PD
X-3029	BGJ398	FGFR	single	2.5	14	-0.7	14	43.7	49	SD-->PD
X-3029	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-76.7	91	-57.8	91	91	91	PR
X-3029	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-72.9	84	-46.2	88	88	88	PR
X-3029	BYL719	PIK3CA	single	-78.1	59	-50.3	84	84	84	PR-->PD
X-3029	BYL719 + LGH447	"PIK3CA,PIM"	combo	-80.8	38	-51.6	38	38	38	PR
X-3029	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-80.7	25	-58.2	39	39	39	PR
X-3029	cetuximab	EGFR	single	-93.1	61	-57	67	67	67	PR
X-3029	CGM097	MDM2	single	-81.4	42	-57.2	90	90	90	PR
X-3029	CKX620	MAPK	single	-72.7	16	-46	42	42	42	PR
X-3029	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-63.3	15	-48.4	19	96	96	PR-->PD
X-3029	HDM201	MDM2	single	-32.6	10	-25.8	17	42	42	SD-->PD
X-3029	erlotinib	EGFR	single	-72.8	96	-51.7	96	96	96	PR
X-3029	HSP990	HSP90	single	-56.3	11	-33.1	18	18	18	PR
X-3029	INC280	MET	single	-55.6	15	-38.3	15	85.3	96	PR-->PD
X-3029	LCL161 + paclitaxel	"BIRC2,TUBB,Tubulin"	combo	-71.4	74	-46.5	74	74	74	PR
X-3029	LEE011	"CDK4,CDK6,CDK4/6"	single	-70.4	30	-46.3	42	91	91	PR-->PD
X-3029	LGH447	PIM	single	-73.8	17	-55.3	56	91	91	PR-->-->PD
X-3029	LLM871	FGFR2/4	single	-69.3	45	-33.8	91	114	114	PR-->-->PD
X-3029	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-100	40	-79.3	64	64	64	CR
X-3029	paclitaxel	Tubulin	single	-55	18	-32.2	35	82.8	88	PR-->PD
X-3029	untreated	"UNKNOWN,Untreated"	single	-2.9	21	5.9	21	45.5	84	SD-->PD
X-3038	abraxane	Tubulin	single	71.4	23	47.7	13	18.5	51	PD
X-3038	abraxane + gemcitabine	"Tubulin,chemotherapy"	combo	-33.8	71	-4.3	100	100	100	SD
X-3038	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	9.8	31	-0.1	13	60.4	62	SD-->PD
X-3038	BKM120 + LDE225	"panPI3K,SMO"	combo	10.1	39	22.7	11	65.4	95	SD
X-3038	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-35.6	54	-8.8	54	54	54	SD
X-3038	BYL719	PIK3CA	single	-3.5	20	0.3	20	83.2	100	SD-->PD
X-3038	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-20.1	97	-10.1	101	101	101	SD
X-3038	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	50	20	14.1	13	36.8	55	PD
X-3038	HDM201	MDM2	single	26.2	45	13.9	14	45	45	SD-->PD
X-3038	figitumumab	IGF1R	single	-48.3	97	21	14	25	97	SD-->PD
X-3038	figitumumab + binimetinib	"IGF1R,MAPK"	combo	37.1	20	20.2	13	24.2	38	PD
X-3038	INC424	JAK	single	51.5	20	21.3	13	69	69	PD
X-3038	INC424 + binimetinib	"JAK,MAPK"	combo	-43.3	11	-21.9	39	88	88	SD-->PD
X-3038	LEE011	"CDK4,CDK6,CDK4/6"	single	-8.5	105	-1.5	11	109	109	SD-->PD
X-3038	WNT974	PORCN	single	137.4	22	16.1	12	20.5	30	PD
X-3038	LKA136	"NTRK1,NTRK2,NTRK3"	single	158.5	20	63	13	11.4	24	PD
X-3038	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	1.6	43	17.8	12	43	43	SD-->PD
X-3038	binimetinib-3.5mpk	MAPK	single	105.8	34	27.2	13	15	39	PD
X-3038	trametinib	MAPK	single	-49.8	26	-16.6	29	29	29	SD
X-3038	untreated	"UNKNOWN,Untreated"	single	165.5	20	74.5	13	11.4	31	PD
X-3052	abraxane	Tubulin	single	135.6	21	26.8	11	17	36	PD
X-3052	abraxane + gemcitabine	"Tubulin,chemotherapy"	combo	-77.4	77	-40.7	101	101	101	PR
X-3052	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	5.1	12	0.1	12	30.9	36	SD-->PD
X-3052	BKM120 + LDE225	"panPI3K,SMO"	combo	12.1	14	-5.1	14	29.2	107	SD-->PD
X-3052	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-26.4	27	-6.4	27	67.9	91	SD-->PD
X-3052	BYL719	PIK3CA	single	15.1	9	11	13	29.1	37	SD-->PD
X-3052	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-35.5	17	-21.8	34	58.6	75	SD-->PD
X-3052	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	72.5	21	12.8	11	25.9	49	PD
X-3052	HDM201	MDM2	single	56.2	20	18.9	13	20	20	PD
X-3052	figitumumab	IGF1R	single	295.6	21	60.3	11	9	21	PD
X-3052	figitumumab + binimetinib	"IGF1R,MAPK"	combo	-6.4	49	-4.7	14	63	63	SD-->PD
X-3052	gemcitabine-50mpk	chemotherapy	single	238.5	21	66.2	14	7.6	35	PD
X-3052	INC424	JAK	single	89.1	20	40.7	13	20.8	45	PD
X-3052	INC424 + binimetinib	"JAK,MAPK"	combo	12.7	27	6.5	14	31	91	SD-->PD
X-3052	LEE011	"CDK4,CDK6,CDK4/6"	single	-95.7	98	-5.7	98	12.8	98	SD
X-3052	WNT974	PORCN	single	375.9	23	71.9	13	7.5	29	PD
X-3052	LKA136	"NTRK1,NTRK2,NTRK3"	single	196.8	20	38.6	12	12.8	33	PD
X-3052	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	12.5	28	-0.8	14	77.9	94	SD-->PD
X-3052	binimetinib-3.5mpk	MAPK	single	206.1	22	25.9	14	16	22	PD
X-3052	trametinib	MAPK	single	185.9	20	51.7	13	13.2	27	PD
X-3052	untreated	"UNKNOWN,Untreated"	single	185.3	20	31.2	12	13.8	33	PD
X-3077	BGJ398	FGFR	single	-47.6	29	-17.9	29	29	29	SD
X-3077	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-59.8	11	-42.8	29	32	32	PR
X-3077	BYL719	PIK3CA	single	-65.9	32	-43.7	43	43	43	PR
X-3077	BYL719 + LEE011	"PIK3CA,CDK4/6"	combo	-83.1	32	-61.6	74	74	74	PR
X-3077	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-100	22	-75.4	36	36	36	CR
X-3077	CGM097	MDM2	single	63	22	1.3	11	24.9	32	PD
X-3077	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-82.5	43	-55.4	53	89	89	PR-->PD
X-3077	HDM201	MDM2	single	92.6	29	6.3	11	21.1	32	PD
X-3077	INC424	JAK	single	42.2	22	16.1	12	29.7	46	PD
X-3077	LEE011	"CDK4,CDK6,CDK4/6"	single	9	13	17.1	13	29.4	34	SD-->PD
X-3077	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-59	32	-36.2	50	96	96	PR-->-->PD
X-3077	LFA102	PRLR 	single	159.5	21	26.5	13	14.1	35	PD
X-3077	LJM716	ERBB3	single	-17	11	-2.9	18	43.2	48	SD-->PD
X-3077	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	-71.1	24	-45.1	28	55.3	63	PR-->PD
X-3077	LKA136	"NTRK1,NTRK2,NTRK3"	single	175.9	22	14.6	11	15.5	25	PD
X-3077	LLM871	FGFR2/4	single	25.6	24	12.8	13	36.3	41	SD
X-3077	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-3.6	20	30.8	20	20	20	PD
X-3077	paclitaxel	Tubulin	single	6.8	13	6.5	13	23.3	41	SD-->PD
X-3077	tamoxifen	ESR1	single	10	18	-4.7	11	36.9	46	SD-->PD
X-3077	trastuzumab	ERBB2	single	138.6	21	47	13	15.3	41	PD
X-3077	untreated	"UNKNOWN,Untreated"	single	173.4	32	16.2	11	14.6	46	PD
X-3077	LFW527 + everolimus	"IGF1R,MTOR"	combo	-11.7	13	-5.66	13	27	27	SD
X-3078	BGJ398	FGFR	single	147.4	22	44.2	11	16.6	32	PD
X-3078	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	40.3	25	7.9	11	25	25	PD
X-3078	BYL719	PIK3CA	single	-6.3	10	-5.2	14	32	32	SD
X-3078	BYL719 + LEE011	"PIK3CA,CDK4/6"	combo	-47.5	25	-35.4	25	39	39	SD-->PD
X-3078	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-30	17	-16.1	17	56.8	72	SD-->PD
X-3078	CGM097	MDM2	single	64.6	39	36.8	13	15.9	39	PD
X-3078	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	17	22	8.2	11	31	31	SD-->PD
X-3078	HDM201	MDM2	single	-21.8	13	-27.6	13	34	34	SD
X-3078	INC424	JAK	single	141.8	20	45.2	13	15.2	41	PD
X-3078	LEE011	"CDK4,CDK6,CDK4/6"	single	85.5	21	26.2	13	22.6	45	PD
X-3078	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-28.3	38	-9.9	41	41	41	SD
X-3078	LFA102	PRLR 	single	90	21	4.2	14	22.4	32	PD
X-3078	LJM716	ERBB3	single	184.1	20	36.8	13	13.5	28	PD
X-3078	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	78.8	20	14.8	13	26	34	PD
X-3078	LKA136	"NTRK1,NTRK2,NTRK3"	single	144.3	22	45.1	11	10.5	39	PD
X-3078	LLM871	FGFR2/4	single	81.5	21	29.5	13	22.5	27	PD
X-3078	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	260.8	22	66.9	11	8.3	33	PD
X-3078	paclitaxel	Tubulin	single	-75.7	38	-54.4	45	94	94	PR-->PD
X-3078	tamoxifen	ESR1	single	120.2	26	19.4	11	23.2	46	PD
X-3078	trastuzumab	ERBB2	single	137.5	21	36.7	14	17.2	38	PD
X-3078	untreated	"UNKNOWN,Untreated"	single	140.2	21	45.7	15	17.2	35	PD
X-3078	LFW527 + everolimus	"IGF1R,MTOR"	combo	-23.2	13	-3.114285714	21	21	21	SD
X-3093	5FU	chemotherapy	single	181.5	20	101.8	13	5.1	27	PD
X-3093	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	33.9	21	8.1	11	27.3	35	SD-->PD
X-3093	BKM120 + LJC049	"panPI3K,TNKS"	combo	75.9	20	9.7	13	22.1	30	PD
X-3093	BYL719	PIK3CA	single	65.3	20	9.7	13	27.7	30	PD
X-3093	BYL719 + cetuximab	"PIK3CA,EGFR"	combo	4.6	12	2.8	12	46.2	64	SD-->PD
X-3093	BYL719 + cetuximab + encorafenib	"PIK3CA,EGFR,BRAF"	combo	301.9	21	70.1	11	9.2	32	PD
X-3093	BYL719 + encorafenib	"PIK3CA,BRAF"	combo	503.2	13	208.9	13	4.2	13	PD
X-3093	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	5.6	9	7.9	13	13	13	SD
X-3093	BYL719 + binimetinib	"PIK3CA,MAPK"	combo	16.4	6	8.9	6	6	6	SD
X-3093	cetuximab	EGFR	single	308.2	21	39.2	11	13.8	32	PD
X-3093	cetuximab + encorafenib	"EGFR,BRAF"	combo	791.7	21	135.8	11	5	21	PD
X-3093	CGM097	MDM2	single	180.3	20	39.4	13	14.3	27	PD
X-3093	CKX620	MAPK	single	13.1	11	11	11	14	14	SD
X-3093	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	86.5	20	33.4	13	21.5	30	PD
X-3093	HDM201	MDM2	single	82.1	20	17.2	13	21.6	30	PD
X-3093	LEE011	"CDK4,CDK6,CDK4/6"	single	67.1	25	21.2	11	33.3	35	PD
X-3093	encorafenib	BRAF	single	528.9	20	70	13	9.4	20	PD
X-3093	LJC049	TNKS	single	137.1	13	57.6	13	10.5	13	PD
X-3093	LKA136	"NTRK1,NTRK2,NTRK3"	single	199.6	20	60.6	13	10.8	30	PD
X-3093	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-9.9	7	-6.1	7	7	7	SD
X-3093	untreated	"UNKNOWN,Untreated"	single	116.7	21	32.9	11	13.6	29	PD
X-3127	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	46.9	20	10.8	13	31	43	PD
X-3127	BKM120 + encorafenib	"panPI3K,BRAF,BRAF,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	2.2	26	16	33	61	61	SD-->PD
X-3127	CGM097	MDM2	single	-10.4	91	20.6	14	126.4	131	SD-->PD
X-3127	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	47.6	23	8.3	14	37.9	43	PD
X-3127	dacarbazine	chemotherapy	single	-100	136	-79.8	136	136	136	CR
X-3127	LDE225	SMO	single	82.1	22	23	11	23.9	37	PD
X-3127	LDK378	ALK	single	91.1	22	21	11	23.5	43	PD
X-3127	LEE011	"CDK4,CDK6,CDK4/6"	single	17.9	10	15.5	14	43	43	SD-->PD
X-3127	LEE011 + encorafenib	"CDK4/6,BRAF,BRAF,CDK4,CDK6"	combo	-50.1	165	-28.7	179	204	204	PR-->-->PD
X-3127	LEE011 + binimetinib	"CDK4,CDK6,MAP2K1,MAP2K2,CDK4/6,MAPK"	combo	-91.4	144	-62.7	215	227	227	PR-->-->PD
X-3127	WNT974	PORCN	single	0.8	15	6.4	15	43	43	SD-->PD
X-3127	LGW813	IAP	single	-56.3	14	-32.1	40	94.2	106	PR-->PD
X-3127	encorafenib	BRAF	single	11.1	10	11.4	14	43	43	SD-->PD
X-3127	encorafenib + binimetinib	"BRAF,MAP2K1,MAP2K2,MAPK"	combo	60.2	30	10.7	11	65.9	121	PD
X-3127	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	26.1	20	9.2	13	43	43	SD-->PD
X-3127	TAS266	DR5	single	-80.6	58	-59.3	87	256	256	PR-->-->PD
X-3127	untreated	"UNKNOWN,Untreated"	single	105.3	24	31.6	14	18.1	43	PD
X-3201	BGJ398	FGFR	single	146.6	20	46	13	13	27	PD
X-3201	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	201.8	20	64.6	13	9.7	27	PD
X-3201	BYL719	PIK3CA	single	75.5	23	19.9	11	26.2	53	PD
X-3201	BYL719 + LEE011	"PIK3CA,CDK4/6"	combo	-2.9	10	-1.3	14	63	63	SD-->PD
X-3201	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	54.8	21	-3.9	12	29.6	45	PD
X-3201	CGM097	MDM2	single	191.4	24	47.1	13	11.6	38	PD
X-3201	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	71.4	22	28.8	11	25.2	39	PD
X-3201	HDM201	MDM2	single	123.6	21	51.7	16	14.3	49	PD
X-3201	INC424	JAK	single	151	13	67.7	13	9	13	PD
X-3201	LEE011	"CDK4,CDK6,CDK4/6"	single	132.9	21	47.8	11	12.4	35	PD
X-3201	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	9.6	25	14.2	14	59	59	SD-->PD
X-3201	LFA102	PRLR 	single	-2.5	10	7.3	16	32.3	69	SD-->PD
X-3201	LJM716	ERBB3	single	223.1	21	28.1	14	14.9	24	PD
X-3201	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	140.6	20	49	13	12	34	PD
X-3201	LKA136	"NTRK1,NTRK2,NTRK3"	single	284.6	13	134.9	13	5.4	13	PD
X-3201	LLM871	FGFR2/4	single	96.6	22	30.6	16	22.5	55	PD
X-3201	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	55.2	28	33.2	11	42.2	95	PD
X-3201	paclitaxel	Tubulin	single	-31.5	34	-14.2	49	88.5	105	SD-->PD
X-3201	tamoxifen	ESR1	single	268.7	21	65.9	16	11.3	21	PD
X-3201	trastuzumab	ERBB2	single	179.3	22	35.7	16	14.9	41	PD
X-3201	untreated	"UNKNOWN,Untreated"	single	286.8	18	80.9	11	7.5	18	PD
X-3201	LFW527 + everolimus	"IGF1R,MTOR"	combo	6.2	68	31.74	14	68	68	PD
X-3205	5FU	chemotherapy	single	102.9	22	41.3	14	20.9	22	PD
X-3205	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-1.8	13	-0.8	13	36	36	SD-->PD
X-3205	BKM120 + LJC049	"panPI3K,TNKS"	combo	15.1	10	3.9	13	34.7	42	SD-->PD
X-3205	BYL719	PIK3CA	single	35.7	22	17.6	13	22	22	PD
X-3205	BYL719 + cetuximab	"PIK3CA,EGFR"	combo	390.9	22	122.8	13	6.2	22	PD
X-3205	BYL719 + cetuximab + encorafenib	"PIK3CA,EGFR,BRAF"	combo	186.3	25	78.3	13	7.2	28	PD
X-3205	BYL719 + encorafenib	"PIK3CA,BRAF"	combo	76.6	25	29.7	13	28	28	PD
X-3205	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	188.1	19	114	13	5	19	PD
X-3205	BYL719 + binimetinib	"PIK3CA,MAPK"	combo	-9.9	77	9.5	48	77	77	SD-->PD
X-3205	cetuximab	EGFR	single	453.4	22	121.8	14	3	22	PD
X-3205	cetuximab + encorafenib	"EGFR,BRAF"	combo	121.7	22	87.7	13	5	27	PD
X-3205	CGM097	MDM2	single	74.7	22	29.3	13	26.7	28	PD
X-3205	CKX620	MAPK	single	-46	92	-2.7	106	106	106	SD
X-3205	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	2.8	13	1.3	13	35	47	SD-->PD
X-3205	HDM201	MDM2	single	109.1	22	24.7	13	17.6	27	PD
X-3205	LEE011	"CDK4,CDK6,CDK4/6"	single	27.5	17	0.5	14	22	22	SD-->PD
X-3205	encorafenib	BRAF	single	602.4	22	173.1	13	3.3	22	PD
X-3205	LJC049	TNKS	single	217.5	22	58.2	13	10.9	27	PD
X-3205	LKA136	"NTRK1,NTRK2,NTRK3"	single	172.2	22	74.1	13	9.5	27	PD
X-3205	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	129.2	22	16.7	14	16.6	22	PD
X-3205	untreated	"UNKNOWN,Untreated"	single	497.3	22	136.6	14	4.1	22	PD
X-3205	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	160.2	22	38.75	12	17.68686869	41	PD
X-3209	abraxane	Tubulin	single	96.3	20	21.2	13	20.6	44	PD
X-3209	abraxane + gemcitabine	"Tubulin,chemotherapy"	combo	54.5	20	17.6	14	26.8	37	PD
X-3209	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-25.4	13	-6.5	13	13	13	SD
X-3209	BKM120 + LDE225	"panPI3K,SMO"	combo	-45.7	32	-17.3	49	81	81	SD-->PD
X-3209	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-76	77	-31.5	81	81	81	PR
X-3209	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-29.6	18	-18.9	45	45	45	SD
X-3209	figitumumab + binimetinib	"IGF1R,MAPK"	combo	-16.6	25	7.8	25	25	25	SD
X-3209	gemcitabine-50mpk	chemotherapy	single	-9.6	20	-1.1	14	69	70	SD-->PD
X-3209	INC424	JAK	single	13.9	14	7.8	11	45	45	SD-->PD
X-3209	INC424 + binimetinib	"JAK,MAPK"	combo	-28.5	49	0.7	49	81	81	SD
X-3209	LEE011	"CDK4,CDK6,CDK4/6"	single	87.4	44	83.8	13	6.9	44	PD
X-3209	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	9.3	42	19.1	11	42	42	SD
X-3211	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-20	15	-12.3	15	58.7	64	SD-->PD
X-3211	BKM120 + encorafenib	"panPI3K,BRAF,BRAF,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-96.9	53	-81	228	228	228	CR
X-3211	CGM097	MDM2	single	11.4	17	2.1	11	18	18	SD
X-3211	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-45.1	47	-23.4	50	77	77	SD-->PD
X-3211	dacarbazine	chemotherapy	single	-3.6	22	5.5	22	34	34	SD
X-3211	LDE225	SMO	single	-8.1	12	-4.4	12	12	12	SD
X-3211	LDK378	ALK	single	42	32	13.1	11	37.8	42	PD
X-3211	LEE011	"CDK4,CDK6,CDK4/6"	single	24	17	11	11	18	18	SD
X-3211	LEE011 + encorafenib	"CDK4/6,BRAF,BRAF,CDK4,CDK6"	combo	-79.1	32	-58.1	168	213.2	214	PR-->-->PD
X-3211	LEE011 + binimetinib	"CDK4,CDK6,MAP2K1,MAP2K2,CDK4/6,MAPK"	combo	-89	119	-66.2	176	176	176	PR
X-3211	WNT974	PORCN	single	-20.4	16	-12.7	16	40	40	SD-->PD
X-3211	LGW813	IAP	single	-50.3	61	-26.1	77	77	77	PR
X-3211	encorafenib	BRAF	single	-52.1	23	-33.6	26	142	142	PR-->-->PD
X-3211	encorafenib + binimetinib	"BRAF,MAP2K1,MAP2K2,MAPK"	combo	-97.2	33	-81	200	211	211	CR-->-->PD
X-3211	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-71.5	80	-56.5	110	208	208	PR-->-->PD
X-3211	TAS266	DR5	single	144	24	5	13	18	38	PD
X-3211	untreated	"UNKNOWN,Untreated"	single	37.4	22	7.9	16	32.7	67	PD
X-3224	5FU	chemotherapy	single	30.7	20	9.7	12	24	24	SD-->PD
X-3224	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-28.1	10	-14	18	49	49	SD-->PD
X-3224	BKM120 + LJC049	"panPI3K,TNKS"	combo	333.6	21	232.9	14	7	21	PD
X-3224	BYL719	PIK3CA	single	-15.1	12	-11.4	12	110	110	SD-->PD
X-3224	BYL719 + cetuximab	"PIK3CA,EGFR"	combo	-16.1	34	5.7	34	34	34	SD
X-3224	BYL719 + cetuximab + encorafenib	"PIK3CA,EGFR,BRAF"	combo	97.8	21	47.5	14	21.6	38	PD
X-3224	BYL719 + encorafenib	"PIK3CA,BRAF"	combo	93.7	25	26.3	12	27.3	34	PD
X-3224	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-59.5	85	-32.5	90	90	90	PR
X-3224	BYL719 + binimetinib	"PIK3CA,MAPK"	combo	7.6	26	31.3	38	38	38	PD
X-3224	cetuximab	EGFR	single	83.4	20	23.2	12	21.5	24	PD
X-3224	cetuximab + encorafenib	"EGFR,BRAF"	combo	28.8	18	14.6	14	26	26	SD
X-3224	CGM097	MDM2	single	89.2	24	48.5	12	9.8	24	PD
X-3224	CKX620	MAPK	single	170.9	10	127.9	10	3	10	PD
X-3224	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	15.8	14	11.1	14	28.8	67	SD-->PD
X-3224	HDM201	MDM2	single	207	21	159.2	14	3	38	PD
X-3224	LEE011	"CDK4,CDK6,CDK4/6"	single	169.7	21	105.5	14	3	21	PD
X-3224	encorafenib	BRAF	single	59.9	20	20	12	23.3	24	PD
X-3224	LJC049	TNKS	single	-13.1	12	-7.4	12	23.8	30	SD-->PD
X-3224	LKA136	"NTRK1,NTRK2,NTRK3"	single	321.9	21	110.7	14	7	21	PD
X-3224	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	381.3	21	145.4	14	4.9	21	PD
X-3224	untreated	"UNKNOWN,Untreated"	single	-27.2	18	-14.9	18	96.8	110	SD-->PD
X-3237	BGJ398	FGFR	single	165.6	20	30.9	13	13.5	27	PD
X-3237	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	101.8	21	4.8	14	20.8	24	PD
X-3237	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-19.4	24	-22.4	14	53.7	78	SD-->PD
X-3237	BYL719	PIK3CA	single	-23.2	17	-17.9	17	45.9	52	SD-->PD
X-3237	BYL719 + LGH447	"PIK3CA,PIM"	combo	-20.9	15	-14.9	15	43.8	47	SD-->PD
X-3237	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	176.3	21	36.3	14	14.6	24	PD
X-3237	cetuximab	EGFR	single	153.1	21	26.8	14	18.3	30	PD
X-3237	CGM097	MDM2	single	356.7	14	93.3	12	6.9	14	PD
X-3237	CKX620	MAPK	single	-18	12	-20.9	12	42.9	61	SD-->PD
X-3237	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	36.4	24	14.1	14	25.8	31	PD
X-3237	HDM201	MDM2	single	78.7	24	21.1	14	16.6	31	PD
X-3237	erlotinib	EGFR	single	69.5	22	8.1	12	25.7	54	PD
X-3237	HSP990	HSP90	single	69.8	22	-19.1	12	26	26	PD
X-3237	INC280	MET	single	282.4	16	88.4	14	10.1	16	PD
X-3237	LCL161 + paclitaxel	"BIRC2,TUBB,Tubulin"	combo	-18.8	25	-3.9	14	43.8	53	SD-->PD
X-3237	LEE011	"CDK4,CDK6,CDK4/6"	single	98.2	21	7.1	14	21.4	37	PD
X-3237	LGH447	PIM	single	283	21	25.8	14	15	24	PD
X-3237	LLM871	FGFR2/4	single	101.1	20	5.4	13	19.9	33	PD
X-3237	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-59.3	14	-36.6	17	49	49	PR-->PD
X-3237	paclitaxel	Tubulin	single	199.6	21	27.9	11	12.8	27	PD
X-3237	untreated	"UNKNOWN,Untreated"	single	241.2	9	105.6	9	5.3	9	PD
X-3237	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	-45.4	10	-34.62	13	48.66571019	61	SD-->PD
X-3267	5FU	chemotherapy	single	-37.1	82	-13.2	89	89	89	SD
X-3267	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	6.7	26	-0.7	12	83.5	89	SD-->PD
X-3267	BKM120 + LJC049	"panPI3K,TNKS"	combo	-7.2	17	-3.6	17	38	38	SD-->PD
X-3267	BYL719	PIK3CA	single	3.4	38	3.2	14	80.2	87	SD-->PD
X-3267	BYL719 + cetuximab	"PIK3CA,EGFR"	combo	-7.9	31	-1.8	13	83	83	SD-->PD
X-3267	BYL719 + cetuximab + encorafenib	"PIK3CA,EGFR,BRAF"	combo	-6.3	14	-5.4	14	50.1	77	SD-->PD
X-3267	BYL719 + encorafenib	"PIK3CA,BRAF"	combo	44.1	20	6	13	43.5	83	PD
X-3267	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-7	45	0.2	14	87	87	SD-->PD
X-3267	BYL719 + binimetinib	"PIK3CA,MAPK"	combo	-52.5	54	-28.2	90	90	90	PR
X-3267	cetuximab	EGFR	single	7.2	12	4.2	12	89	89	SD-->PD
X-3267	cetuximab + encorafenib	"EGFR,BRAF"	combo	14.2	17	7.5	13	44.1	80	SD-->PD
X-3267	CGM097	MDM2	single	65.5	24	14	13	26.9	27	PD
X-3267	CKX620	MAPK	single	-11.2	59	-1.8	17	59	59	SD
X-3267	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	1.6	28	3	14	78.6	87	SD-->PD
X-3267	HDM201	MDM2	single	27.5	20	8.8	13	41	41	SD-->PD
X-3267	LEE011	"CDK4,CDK6,CDK4/6"	single	14.2	12	4.2	12	44.8	71	SD-->PD
X-3267	encorafenib	BRAF	single	-2.6	10	4.7	13	34.2	38	SD-->PD
X-3267	LJC049	TNKS	single	66.3	21	5.2	14	23.5	24	PD
X-3267	LKA136	"NTRK1,NTRK2,NTRK3"	single	21	14	16.7	14	32	35	SD-->PD
X-3267	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-30.1	71	-10.1	89	89	89	SD
X-3267	untreated	"UNKNOWN,Untreated"	single	10.4	11	4	11	76	88	SD-->PD
X-3268	abraxane	Tubulin	single	137.4	21	39.1	11	13.5	28	PD
X-3268	abraxane + gemcitabine	"Tubulin,chemotherapy"	combo	-50.2	105	18.4	12	108	108	SD-->PD
X-3268	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-27.1	10	-7.2	39	115	115	SD-->PD
X-3268	BKM120 + LDE225	"panPI3K,SMO"	combo	44.8	42	40.4	11	22.9	84	PD
X-3268	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-1.1	34	5.9	23	96	96	SD-->PD
X-3268	BYL719	PIK3CA	single	-9	19	-3.1	25	120	120	SD-->PD
X-3268	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-14.2	9	-8.8	12	148	148	SD-->-->PD
X-3268	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	74.7	25	14.5	11	40.9	112	PD
X-3268	HDM201	MDM2	single	138.4	20	40.4	12	13	50	PD
X-3268	figitumumab	IGF1R	single	236.2	18	51.9	12	9.8	18	PD
X-3268	figitumumab + binimetinib	"IGF1R,MAPK"	combo	-5.8	10	2.9	14	24.3	36	SD-->PD
X-3268	gemcitabine-50mpk	chemotherapy	single	32.6	26	33.4	14	26	26	PD
X-3268	INC424	JAK	single	143	22	17.2	11	18	39	PD
X-3268	INC424 + binimetinib	"JAK,MAPK"	combo	-3.1	36	13.4	43	66.7	131	SD-->PD
X-3268	LEE011	"CDK4,CDK6,CDK4/6"	single	-5.4	13	11.8	16	34.8	104	SD-->PD
X-3268	WNT974	PORCN	single	75.5	37	-2.3	13	20.2	65	PD
X-3268	LKA136	"NTRK1,NTRK2,NTRK3"	single	14.7	11	7.3	11	39.2	52	SD-->PD
X-3268	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-54.8	40	-23.1	89	89	89	PR
X-3268	binimetinib-3.5mpk	MAPK	single	-24.8	87	-4.4	14	90	90	SD-->PD
X-3268	trametinib	MAPK	single	-14.2	10	-5.3	13	111	111	SD-->PD
X-3268	untreated	"UNKNOWN,Untreated"	single	126.1	21	41.7	12	12.5	48	PD
X-3298	BGJ398	FGFR	single	137.2	22	32.5	11	16.6	32	PD
X-3298	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	57.2	22	19.6	11	26.8	74	PD
X-3298	BYL719	PIK3CA	single	123.5	25	15.2	11	22	33	PD
X-3298	BYL719 + LEE011	"PIK3CA,CDK4/6"	combo	40.2	28	-7	11	44.9	77	PD
X-3298	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	39.6	25	9.7	15	39.7	60	PD
X-3298	CGM097	MDM2	single	177.9	18	42.1	11	12.3	18	PD
X-3298	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	106.3	28	25.7	11	21.6	46	PD
X-3298	HDM201	MDM2	single	160	22	39	11	15.9	25	PD
X-3298	INC424	JAK	single	155.4	25	52.6	11	11.6	46	PD
X-3298	LEE011	"CDK4,CDK6,CDK4/6"	single	70.4	22	31.9	11	29.2	81	PD
X-3298	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-2.5	15	-0.8	15	61.3	95	SD-->PD
X-3298	LFA102	PRLR 	single	39.9	24	29.6	14	53.1	90	PD
X-3298	LJM716	ERBB3	single	66.3	25	9.1	11	27.7	46	PD
X-3298	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	55	24	25.6	13	34.8	83	PD
X-3298	LKA136	"NTRK1,NTRK2,NTRK3"	single	99.8	25	16.5	11	20.2	81	PD
X-3298	LLM871	FGFR2/4	single	-9.9	9	-6.7	14	71.9	111	SD-->PD
X-3298	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	112.3	21	28.1	11	18	42	PD
X-3298	paclitaxel	Tubulin	single	-95.2	90	-78.5	90	90	90	CR
X-3298	tamoxifen	ESR1	single	234.4	22	42.4	11	15	25	PD
X-3298	trastuzumab	ERBB2	single	53.1	20	5.5	13	31.4	69	PD
X-3298	untreated	"UNKNOWN,Untreated"	single	136.6	24	58.9	13	14.8	52	PD
X-3450	BGJ398	FGFR	single	41.6	22	7.3	13	34.9	56	PD
X-3450	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-57.1	35	-35	42	59	59	PR
X-3450	BYL719	PIK3CA	single	-31.4	42	-16.3	56	91	91	SD-->PD
X-3450	BYL719 + LEE011	"PIK3CA,CDK4/6"	combo	-26.6	60	-17.8	60	60	60	SD
X-3450	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-96.8	66	-76.3	66	66	66	CR
X-3450	CGM097	MDM2	single	82.4	22	21.2	13	25.9	91	PD
X-3450	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-67	59	-31.9	59	59	59	PR
X-3450	HDM201	MDM2	single	85.1	22	32.8	13	29	56	PD
X-3450	INC424	JAK	single	66.6	22	11.7	12	42.7	68	PD
X-3450	LEE011	"CDK4,CDK6,CDK4/6"	single	4.3	76	2.3	14	76	76	SD
X-3450	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-57.3	63	-36.6	67	67	67	PR
X-3450	LFA102	PRLR 	single	39.1	21	18.9	14	21	21	PD
X-3450	LJM716	ERBB3	single	-88.3	61	-58.7	61	61	61	PR
X-3450	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	-57.5	38	-25.9	38	38	38	PR
X-3450	LKA136	"NTRK1,NTRK2,NTRK3"	single	15.1	10	8.8	14	31	31	SD-->PD
X-3450	LLM871	FGFR2/4	single	50.6	21	16.2	14	33.6	55	PD
X-3450	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-3	42	6.3	62	89.7	91	SD-->-->PD
X-3450	paclitaxel	Tubulin	single	78.2	21	30.3	14	29.5	63	PD
X-3450	tamoxifen	ESR1	single	36	21	8.6	11	54.6	74	PD
X-3450	trastuzumab	ERBB2	single	87.6	22	30.1	14	24	24	PD
X-3450	untreated	"UNKNOWN,Untreated"	single	8.1	11	4.5	11	49.3	74	SD-->PD
X-3450	LFW527 + everolimus	"IGF1R,MTOR"	combo	-29.9	13	-18.3	13	13	13	SD
X-3453	LFW527 + everolimus	"IGF1R,MTOR"	combo	-61	52	-42.01388889	123	123	123	PR
X-3468	BGJ398	FGFR	single	191.4	21	34.1	11	11.9	53	PD
X-3468	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-16.3	25	-2.8	94	94	94	SD
X-3468	BYL719	PIK3CA	single	-8.1	32	-2.4	42	71.7	130	SD-->PD
X-3468	BYL719 + LEE011	"PIK3CA,CDK4/6"	combo	-65	38	-32.4	38	38	38	PR
X-3468	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-50.5	24	-39.9	52	147	147	PR-->PD
X-3468	CGM097	MDM2	single	128.2	21	15.2	11	18.9	46	PD
X-3468	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-47.6	32	-31.1	49	116	116	SD-->PD
X-3468	HDM201	MDM2	single	-0.3	14	0.9	14	49.3	74	SD-->PD
X-3468	INC424	JAK	single	42.5	21	6.5	11	54.1	116	PD
X-3468	LEE011	"CDK4,CDK6,CDK4/6"	single	11.2	11	5.4	11	38	73	SD-->PD
X-3468	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-31.3	133	-1.9	137	137	137	SD
X-3468	LFA102	PRLR 	single	88.7	21	13.4	14	23.8	56	PD
X-3468	LJM716	ERBB3	single	-1.1	10	-0.3	14	36	70	SD-->PD
X-3468	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	-5	21	1.9	24	59.5	91	SD-->PD
X-3468	LKA136	"NTRK1,NTRK2,NTRK3"	single	6.6	11	3.1	11	32.1	66	SD-->PD
X-3468	LLM871	FGFR2/4	single	12.8	10	7.7	14	47.6	112	SD-->PD
X-3468	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	59.5	21	15.6	11	42.8	95	PD
X-3468	paclitaxel	Tubulin	single	-34.9	76	-10.4	105	130.4	154	SD-->-->PD
X-3468	tamoxifen	ESR1	single	1.4	11	0.3	11	29.6	53	SD-->PD
X-3468	trastuzumab	ERBB2	single	102.3	21	22.9	14	20.6	56	PD
X-3468	untreated	"UNKNOWN,Untreated"	single	215.9	21	37.6	11	12	39	PD
X-3468	LFW527 + everolimus	"IGF1R,MTOR"	combo	-74.7	84	-48.33783784	126	126	126	PR
X-3483	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-26	10	-16	13	34.3	46	SD-->PD
X-3483	BKM120 + encorafenib	"panPI3K,BRAF,BRAF,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-100	24	-96.7	272	272	272	CR
X-3483	CGM097	MDM2	single	-100	52	-79.1	181	181	181	CR
X-3483	dacarbazine	chemotherapy	single	-100	51	-83.7	119	119	119	CR
X-3483	LDE225	SMO	single	190.6	10	81.4	10	7.1	10	PD
X-3483	LDK378	ALK	single	367.1	13	155	13	5.7	13	PD
X-3483	LEE011	"CDK4,CDK6,CDK4/6"	single	-100	74	-73.3	182	182	182	CR
X-3483	LEE011 + encorafenib	"CDK4/6,BRAF,BRAF,CDK4,CDK6"	combo	-100	21	-96.7	272	272	272	CR
X-3483	WNT974	PORCN	single	387.2	13	140.6	13	6.7	13	PD
X-3483	LGW813	IAP	single	226.7	13	121.2	13	6.4	13	PD
X-3483	encorafenib	BRAF	single	-100	27	-92.5	119	148.9	150	CR-->-->PD
X-3483	encorafenib + binimetinib	"BRAF,MAP2K1,MAP2K2,MAPK"	combo	-100	29	-96.4	272	272	272	CR
X-3483	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-40.9	74	-13.1	94	182	182	SD-->-->PD
X-3483	TAS266	DR5	single	-100	9	-97.3	181	181	181	CR
X-3483	untreated	"UNKNOWN,Untreated"	single	603.1	16	124.8	13	5.5	16	PD
X-3486	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	48.4	12	25	12	12	12	PD
X-3486	BKM120 + encorafenib	"panPI3K,BRAF,BRAF,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	158	23	65.2	12	9.5	23	PD
X-3486	CGM097	MDM2	single	180.4	12	96.9	12	7.8	12	PD
X-3486	dacarbazine	chemotherapy	single	81.9	15	35.5	11	15	15	PD
X-3486	LDE225	SMO	single	175.4	12	69.4	11	8.2	12	PD
X-3486	LDK378	ALK	single	334.8	21	74.7	11	6.9	21	PD
X-3486	LEE011	"CDK4,CDK6,CDK4/6"	single	6.6	38	19.2	43	68	68	SD-->PD
X-3486	LEE011 + encorafenib	"CDK4/6,BRAF,BRAF,CDK4,CDK6"	combo	21.4	34	42.3	39	73.6	86	PD
X-3486	WNT974	PORCN	single	208.6	12	95.1	11	6.1	12	PD
X-3486	LGW813	IAP	single	191.1	21	52.2	12	12.1	21	PD
X-3486	encorafenib	BRAF	single	737.2	16	272.2	13	4	16	PD
X-3486	encorafenib + binimetinib	"BRAF,MAP2K1,MAP2K2,MAPK"	combo	90.5	23	19.1	12	23	23	PD
X-3486	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-4.1	33	4.4	33	55	55	SD-->PD
X-3486	TAS266	DR5	single	313.1	20	73.7	11	7.2	20	PD
X-3486	untreated	"UNKNOWN,Untreated"	single	606.2	22	133	13	5.8	22	PD
X-3503	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	41.5	23	19.2	12	15.8	28	PD
X-3503	BKM120 + encorafenib	"panPI3K,BRAF,BRAF,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-29.9	20	-1.9	32	77.3	96	SD-->PD
X-3503	CGM097	MDM2	single	71	20	8.7	13	22	22	PD
X-3503	dacarbazine	chemotherapy	single	80.1	23	28.3	14	25.7	30	PD
X-3503	LDE225	SMO	single	46.1	24	25	14	26	26	PD
X-3503	LDK378	ALK	single	129.2	20	33.5	13	16.1	25	PD
X-3503	LEE011	"CDK4,CDK6,CDK4/6"	single	43.6	27	25.3	13	32	32	PD
X-3503	LEE011 + encorafenib	"CDK4/6,BRAF,BRAF,CDK4,CDK6"	combo	2.5	14	6.4	14	45.3	53	SD-->PD
X-3503	WNT974	PORCN	single	90	20	25.7	13	22.8	25	PD
X-3503	LGW813	IAP	single	162.5	21	54	14	12.3	21	PD
X-3503	encorafenib	BRAF	single	116	20	22.1	13	15.9	22	PD
X-3503	encorafenib + binimetinib	"BRAF,MAP2K1,MAP2K2,MAPK"	combo	52.7	23	6.5	14	40.3	53	PD
X-3503	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	77.5	20	27.1	11	24.9	25	PD
X-3503	TAS266	DR5	single	148.3	20	27.2	13	15.5	22	PD
X-3503	untreated	"UNKNOWN,Untreated"	single	467.7	21	85.2	14	7.8	25	PD
X-3671	5FU	chemotherapy	single	230	21	66.3	14	9.5	36	PD
X-3671	cetuximab	EGFR	single	-100	63	-86.2	108	108	108	CR
X-3671	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	1.4	13	0.7	13	32.1	69	SD-->PD
X-3671	untreated	"UNKNOWN,Untreated"	single	493	21	118.8	14	7.8	24	PD
X-3676	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	350.1	16	70.5	12	8.2	16	PD
X-3676	BKM120 + encorafenib	"panPI3K,BRAF,BRAF,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-34.3	11	-25.8	16	58.6	60	SD-->PD
X-3676	CGM097	MDM2	single	593.7	9	224.1	9	3	9	PD
X-3676	dacarbazine	chemotherapy	single	359.9	11	172	11	4	11	PD
X-3676	LDE225	SMO	single	393.1	12	166.7	12	4.3	12	PD
X-3676	LDK378	ALK	single	351.8	9	152.5	9	3.4	9	PD
X-3676	LEE011	"CDK4,CDK6,CDK4/6"	single	375.4	9	159.8	9	2.9	9	PD
X-3676	LEE011 + encorafenib	"CDK4/6,BRAF,BRAF,CDK4,CDK6"	combo	28.7	19	19.1	11	28.2	37	SD-->PD
X-3676	WNT974	PORCN	single	406.3	10	184.5	10	4	10	PD
X-3676	LGW813	IAP	single	445.3	12	148.8	12	5.3	12	PD
X-3676	encorafenib	BRAF	single	330.6	21	47.4	12	12.1	21	PD
X-3676	encorafenib + binimetinib	"BRAF,MAP2K1,MAP2K2,MAPK"	combo	-44.9	16	-27.7	16	56.8	60	SD-->PD
X-3676	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	140	21	13.5	12	17.5	29	PD
X-3676	TAS266	DR5	single	389	9	157.2	9	3.6	9	PD
X-3676	untreated	"UNKNOWN,Untreated"	single	342.6	9	140.3	9	3.8	9	PD
X-3684	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	563.5	11	175.375	11	6.774671053	11	PD
X-3697	BGJ398	FGFR	single	2.3	13	-1.4	13	37.5	48	SD-->PD
X-3697	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-28	39	-2.7	68	71	71	SD
X-3697	BYL719	PIK3CA	single	-42.7	25	-31.9	32	39	39	SD-->PD
X-3697	BYL719 + LEE011	"PIK3CA,CDK4/6"	combo	-66.7	31	-26.4	34	34	34	PR
X-3697	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-44.2	17	-23.6	20	41.4	42	SD-->PD
X-3697	CGM097	MDM2	single	64	22	7.8	11	24.4	41	PD
X-3697	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-59.2	24	-42.6	27	34	34	PR
X-3697	HDM201	MDM2	single	125.2	21	49.8	14	16.4	32	PD
X-3697	INC424	JAK	single	12.3	11	4.1	11	35.4	53	SD-->PD
X-3697	LEE011	"CDK4,CDK6,CDK4/6"	single	0.8	52	37	63	83.1	130	PD
X-3697	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-20.3	42	-6.9	61	61	61	SD
X-3697	LFA102	PRLR 	single	90.5	20	9.9	13	22	34	PD
X-3697	LJM716	ERBB3	single	101.2	20	4.5	13	19.9	36	PD
X-3697	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	56.1	24	-7.4	13	29.2	41	PD
X-3697	LKA136	"NTRK1,NTRK2,NTRK3"	single	76.9	22	14.8	11	26.2	34	PD
X-3697	LLM871	FGFR2/4	single	-25	10	-14.8	13	20	20	SD-->PD
X-3697	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	9.7	11	2.2	11	57.9	71	SD-->PD
X-3697	paclitaxel	Tubulin	single	2.9	20	4.6	20	51	51	SD-->PD
X-3697	tamoxifen	ESR1	single	45.7	22	-11	11	34.6	41	PD
X-3697	trastuzumab	ERBB2	single	16.5	13	2.3	13	24.2	34	SD-->PD
X-3697	untreated	"UNKNOWN,Untreated"	single	59.2	20	29.4	13	27	66	PD
X-3746	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	99.2	20	-3.5	11	20.2	25	PD
X-3746	BKM120 + encorafenib	"panPI3K,BRAF,BRAF,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-100	13	-95	160	253	253	CR-->-->PD
X-3746	CGM097	MDM2	single	225	22	41.9	13	11.2	22	PD
X-3746	dacarbazine	chemotherapy	single	105.3	20	16.2	12	18.6	23	PD
X-3746	LDE225	SMO	single	513.8	22	138.6	13	7	22	PD
X-3746	LDK378	ALK	single	425.5	22	80.7	13	9.2	22	PD
X-3746	LEE011	"CDK4,CDK6,CDK4/6"	single	148.4	20	39.7	11	12.3	25	PD
X-3746	LEE011 + encorafenib	"CDK4/6,BRAF,BRAF,CDK4,CDK6"	combo	-100	13	-96.5	201	253	253	CR-->-->PD
X-3746	WNT974	PORCN	single	356.9	22	56.9	13	10.7	22	PD
X-3746	LGW813	IAP	single	634.9	22	189.7	13	7	22	PD
X-3746	encorafenib	BRAF	single	-100	40	-67.9	70	91.8	98	CR-->-->PD
X-3746	encorafenib + binimetinib	"BRAF,MAP2K1,MAP2K2,MAPK"	combo	-100	28	-94.8	253	253	253	CR
X-3746	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-55.8	45	-34.9	63	90.3	98	PR-->-->PD
X-3746	TAS266	DR5	single	203.4	22	23.2	13	13.9	22	PD
X-3746	untreated	"UNKNOWN,Untreated"	single	686.5	22	121.7	13	6.5	22	PD
X-3773	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	125.2	20	21	14	16.6	43	PD
X-3773	BKM120 + encorafenib	"panPI3K,BRAF,BRAF,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	47.2	21	10	12	35.3	44	PD
X-3773	CGM097	MDM2	single	-33.8	9	-26.3	13	40.2	43	SD-->PD
X-3773	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-10.2	128	7	12	180	180	SD-->PD
X-3773	dacarbazine	chemotherapy	single	9.2	10	6.4	14	130	130	SD-->PD
X-3773	LDE225	SMO	single	90.8	20	29.1	13	21.2	36	PD
X-3773	LDK378	ALK	single	14.7	13	16.4	13	13	13	SD
X-3773	LEE011	"CDK4,CDK6,CDK4/6"	single	67.9	21	8.7	14	23.1	43	PD
X-3773	LEE011 + encorafenib	"CDK4/6,BRAF,BRAF,CDK4,CDK6"	combo	62	21	15	12	37.1	44	PD
X-3773	LEE011 + binimetinib	"CDK4,CDK6,MAP2K1,MAP2K2,CDK4/6,MAPK"	combo	5.3	153	13	11	167	167	SD-->PD
X-3773	WNT974	PORCN	single	114.5	22	38.3	13	17.6	42	PD
X-3773	LGW813	IAP	single	66.9	20	0.5	14	27.1	43	PD
X-3773	encorafenib	BRAF	single	-22	13	1.7	13	29	43	SD-->PD
X-3773	encorafenib + binimetinib	"BRAF,MAP2K1,MAP2K2,MAPK"	combo	6.9	13	6.8	13	37	39	SD-->PD
X-3773	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-23.1	14	-8.1	17	23	43	SD-->PD
X-3773	TAS266	DR5	single	-28.2	13	-17	13	24.9	43	SD-->PD
X-3773	untreated	"UNKNOWN,Untreated"	single	92.9	20	18.3	12	21.2	43	PD
X-3782	abraxane	Tubulin	single	-7.7	20	14.4	13	24.3	50	SD-->PD
X-3782	abraxane + gemcitabine	"Tubulin,chemotherapy"	combo	64.7	24	35.2	14	45.3	56	PD
X-3782	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-71.4	113	-24.5	22	116	116	PR-->PD
X-3782	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-0.6	10	-1.8	13	31	31	SD-->PD
X-3782	figitumumab	IGF1R	single	102.9	20	43.1	13	14	34	PD
X-3782	figitumumab + binimetinib	"IGF1R,MAPK"	combo	53.7	25	13.7	11	31.4	46	PD
X-3782	gemcitabine-50mpk	chemotherapy	single	131.8	24	35.5	14	17.4	35	PD
X-3782	INC424	JAK	single	181.8	21	55.8	18	13.6	31	PD
X-3782	LEE011	"CDK4,CDK6,CDK4/6"	single	-5	20	11.2	13	22.8	78	SD-->PD
X-3782	WNT974	PORCN	single	167.9	16	79.1	13	7.1	16	PD
X-3782	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-85.6	35	-11	35	35	35	SD
X-3782	binimetinib-3.5mpk	MAPK	single	-100	77	-53.2	98	98	98	CR
X-3782	trametinib	MAPK	single	-39.7	51	-27.1	51	51	51	SD
X-3782	untreated	"UNKNOWN,Untreated"	single	150.6	20	27.3	14	16.9	37	PD
X-3792	5FU	chemotherapy	single	74.3	21	41.1	14	27	27	PD
X-3792	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	67.8	25	16.1	11	14	27	PD
X-3792	BKM120 + LJC049	"panPI3K,TNKS"	combo	121	16	42.7	13	15	16	PD
X-3792	BYL719	PIK3CA	single	-14.8	11	2.2	11	32	32	SD-->PD
X-3792	BYL719 + cetuximab	"PIK3CA,EGFR"	combo	110.3	24	38.7	14	18	31	PD
X-3792	BYL719 + cetuximab + encorafenib	"PIK3CA,EGFR,BRAF"	combo	138.9	24	25.3	14	18.8	31	PD
X-3792	BYL719 + encorafenib	"PIK3CA,BRAF"	combo	77.6	16	7.3	13	16	16	PD
X-3792	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-28.5	11	-19.3	11	41	41	SD-->PD
X-3792	BYL719 + binimetinib	"PIK3CA,MAPK"	combo	95.8	28	8.4	13	18	28	PD
X-3792	cetuximab	EGFR	single	107.6	14	31	11	13.2	14	PD
X-3792	cetuximab + encorafenib	"EGFR,BRAF"	combo	66.5	22	23.8	11	32.6	39	PD
X-3792	CGM097	MDM2	single	26.4	21	-5.4	11	40	41	SD-->PD
X-3792	CKX620	MAPK	single	61.4	20	6.8	14	27	27	PD
X-3792	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	22.6	16	22.8	16	35	35	SD-->PD
X-3792	HDM201	MDM2	single	72.6	20	54.3	14	21.4	27	PD
X-3792	LEE011	"CDK4,CDK6,CDK4/6"	single	74.4	25	19.8	11	28	28	PD
X-3792	encorafenib	BRAF	single	727.1	21	188.9	11	4	21	PD
X-3792	LJC049	TNKS	single	197.8	21	33.9	14	16.6	27	PD
X-3792	LKA136	"NTRK1,NTRK2,NTRK3"	single	72.2	21	17	14	22.1	27	PD
X-3792	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	195.6	25	53.1	11	9.7	28	PD
X-3792	untreated	"UNKNOWN,Untreated"	single	527.7	21	121.8	14	7.3	28	PD
X-3792	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	52.6	20	6.78	13	26.67170626	37	PD
X-3800	abraxane	Tubulin	single	250.6	21	57.2	11	12.6	21	PD
X-3800	abraxane + gemcitabine	"Tubulin,chemotherapy"	combo	-82.9	97	-38	97	97	97	PR
X-3800	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-2.4	29	17.7	12	49	54	SD
X-3800	BKM120 + LDE225	"panPI3K,SMO"	combo	-79.1	25	-46.6	33	33	33	PR
X-3800	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-100	106	-68.8	106	106	106	CR
X-3800	BYL719	PIK3CA	single	-12.3	25	-0.2	31	62.3	95	SD-->PD
X-3800	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	5	11	5.7	14	43.1	55	SD-->PD
X-3800	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-45.6	17	-28	63	136	136	SD-->-->PD
X-3800	HDM201	MDM2	single	-47	42	-28.7	48	111.9	140	SD-->PD
X-3800	figitumumab	IGF1R	single	149.4	21	16.1	11	15.6	35	PD
X-3800	figitumumab + binimetinib	"IGF1R,MAPK"	combo	57.1	24	60.5	14	8	49	PD
X-3800	gemcitabine-50mpk	chemotherapy	single	-44.9	91	-0.8	94	94	94	SD
X-3800	INC424	JAK	single	67.5	22	17.4	14	32.3	66	PD
X-3800	INC424 + binimetinib	"JAK,MAPK"	combo	-71.9	98	-33	102	102	102	PR
X-3800	LEE011	"CDK4,CDK6,CDK4/6"	single	-67.6	70	-29.5	95	95	95	PR
X-3800	WNT974	PORCN	single	-18.8	9	-3.4	12	65	65	SD-->PD
X-3800	LKA136	"NTRK1,NTRK2,NTRK3"	single	157.7	22	32	11	12.8	32	PD
X-3800	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-66	42	-31.9	42	42	42	PR
X-3800	trametinib	MAPK	single	-47.6	74	-25	91	91	91	SD
X-3800	untreated	"UNKNOWN,Untreated"	single	114	21	30.9	14	13.6	52	PD
X-3816	abraxane	Tubulin	single	66	20	7.3	11	25.1	60	PD
X-3816	abraxane + gemcitabine	"Tubulin,chemotherapy"	combo	-8.4	66	24.2	69	69	69	SD
X-3816	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	115.7	21	15	13	20.4	31	PD
X-3816	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	33.3	46	39.5	11	84	84	PD
X-3816	BYL719	PIK3CA	single	5.9	9	3.4	13	27.8	51	SD-->PD
X-3816	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-16	9	-8.1	13	27.5	48	SD-->PD
X-3816	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-3.5	9	0.5	13	25.8	48	SD-->PD
X-3816	HDM201	MDM2	single	183.3	20	38.4	13	14.3	30	PD
X-3816	figitumumab	IGF1R	single	436.7	22	76.7	12	7	29	PD
X-3816	figitumumab + binimetinib	"IGF1R,MAPK"	combo	61.4	21	2.9	13	31	31	PD
X-3816	gemcitabine-50mpk	chemotherapy	single	47.4	25	18.5	14	54.4	81	PD
X-3816	INC424	JAK	single	106.1	21	17.4	11	20.6	64	PD
X-3816	INC424 + binimetinib	"JAK,MAPK"	combo	3.5	16	2.5	12	82.4	100	SD-->PD
X-3816	LEE011	"CDK4,CDK6,CDK4/6"	single	240.8	22	57.4	12	8.8	43	PD
X-3816	WNT974	PORCN	single	469	27	101.1	12	4.5	30	PD
X-3816	LKA136	"NTRK1,NTRK2,NTRK3"	single	94.8	20	45.3	13	12.5	44	PD
X-3816	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	20.3	25	16.6	11	28	28	SD
X-3816	binimetinib-3.5mpk	MAPK	single	23	21	-6.9	11	39.7	63	SD-->PD
X-3816	trametinib	MAPK	single	-9.3	26	29.1	47	5	47	SD
X-3816	untreated	"UNKNOWN,Untreated"	single	122.2	20	17.4	11	18.7	35	PD
X-3843	BGJ398	FGFR	single	45.7	21	29	16	24.3	27	PD
X-3843	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	119.2	20	47	13	12.6	56	PD
X-3843	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	73.3	20	29.7	13	23	50	PD
X-3843	BYL719	PIK3CA	single	12.5	16	-0.4	16	45	70	SD-->PD
X-3843	BYL719 + LGH447	"PIK3CA,PIM"	combo	-18.9	15	12.1	15	91	91	SD
X-3843	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-2.5	51	14.8	54	54	54	SD
X-3843	cetuximab	EGFR	single	421.1	20	107.3	13	6.8	20	PD
X-3843	CGM097	MDM2	single	244	23	40.3	11	13.2	29	PD
X-3843	CKX620	MAPK	single	194	13	108.4	13	6	13	PD
X-3843	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	8.5	29	18.6	13	82.5	104	SD-->PD
X-3843	HDM201	MDM2	single	149.8	20	59.4	13	14.6	20	PD
X-3843	erlotinib	EGFR	single	322	23	80	11	7.6	29	PD
X-3843	HSP990	HSP90	single	18.3	11	-5.1	11	21.7	74	SD-->PD
X-3843	INC280	MET	single	205.7	20	65.8	13	10.8	20	PD
X-3843	LCL161 + paclitaxel	"BIRC2,TUBB,Tubulin"	combo	-42.9	14	-27.9	14	30.7	41	SD-->PD
X-3843	LEE011	"CDK4,CDK6,CDK4/6"	single	-9.7	30	-3	36	57.2	91	SD-->PD
X-3843	LGH447	PIM	single	243.9	20	71.1	13	9.2	20	PD
X-3843	LLM871	FGFR2/4	single	26.7	11	-2.5	11	23	36	SD-->PD
X-3843	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	94.4	20	23.5	13	26.5	50	PD
X-3843	paclitaxel	Tubulin	single	89.9	27	7.4	11	27.9	54	PD
X-3843	untreated	"UNKNOWN,Untreated"	single	395.5	18	77.1	11	6.9	18	PD
X-3843	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	116.2	21	16.42	15	19.50920245	36	PD
X-3846	abraxane	Tubulin	single	201.2	21	21.5	13	13.3	24	PD
X-3846	abraxane + gemcitabine	"Tubulin,chemotherapy"	combo	-36.6	34	-19.9	34	68	68	SD-->PD
X-3846	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-37.5	14	-18.9	18	39.4	50	SD-->PD
X-3846	BKM120 + LDE225	"panPI3K,SMO"	combo	-48.1	126	-1.9	63	132	132	SD-->-->PD
X-3846	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-44.8	53	-14.2	53	53	53	SD
X-3846	BYL719	PIK3CA	single	6.6	21	4.8	14	37.2	77	SD-->PD
X-3846	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	7.8	20	5.5	12	66.3	97	SD-->PD
X-3846	HDM201	MDM2	single	214.3	21	37.7	14	13.4	31	PD
X-3846	figitumumab	IGF1R	single	259.7	20	58.1	14	15.2	27	PD
X-3846	figitumumab + binimetinib	"IGF1R,MAPK"	combo	52	21	39.6	11	13	39	PD
X-3846	gemcitabine-50mpk	chemotherapy	single	39.6	21	28.1	14	33.4	53	PD
X-3846	INC424	JAK	single	124.8	21	26.6	11	18.1	31	PD
X-3846	INC424 + binimetinib	"JAK,MAPK"	combo	257.1	62	28.1	11	15.8	80	PD
X-3846	WNT974	PORCN	single	39.3	30	11.2	12	32.5	57	PD
X-3846	LKA136	"NTRK1,NTRK2,NTRK3"	single	61.6	21	16.2	14	24.4	32	PD
X-3846	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-57	14	-32.2	26	93.5	96	PR-->PD
X-3846	binimetinib-3.5mpk	MAPK	single	48.9	22	-2	11	15.8	50	PD
X-3846	trametinib	MAPK	single	-55.7	11	-36.5	18	39.6	47	PR-->PD
X-3846	untreated	"UNKNOWN,Untreated"	single	224.9	21	44.7	13	12	37	PD
X-3851	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	73.9	20	15.5	13	22.5	25	PD
X-3851	BKM120 + encorafenib	"panPI3K,BRAF,BRAF,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	215.4	24	-2.3	11	19.5	31	PD
X-3851	CGM097	MDM2	single	269.7	23	39	12	16.8	26	PD
X-3851	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-12.7	16	-0.8	16	30.9	38	SD-->PD
X-3851	dacarbazine	chemotherapy	single	-90.9	80	-54.9	104	140.8	141	PR-->-->PD
X-3851	LDE225	SMO	single	156.3	21	33.7	15	16.3	28	PD
X-3851	LDK378	ALK	single	63.9	21	33.9	15	27.6	28	PD
X-3851	LEE011	"CDK4,CDK6,CDK4/6"	single	29.9	19	23.2	12	26	26	SD
X-3851	LEE011 + encorafenib	"CDK4/6,BRAF,BRAF,CDK4,CDK6"	combo	-65.8	105	-37.3	108	139.5	142	PR-->-->PD
X-3851	LEE011 + binimetinib	"CDK4,CDK6,MAP2K1,MAP2K2,CDK4/6,MAPK"	combo	-24.2	93	10.6	121	142	142	SD-->PD
X-3851	WNT974	PORCN	single	120	21	25.9	15	18.5	28	PD
X-3851	LGW813	IAP	single	477.4	21	103	13	6.3	27	PD
X-3851	encorafenib	BRAF	single	216.1	26	49.7	12	10.8	26	PD
X-3851	encorafenib + binimetinib	"BRAF,MAP2K1,MAP2K2,MAPK"	combo	254.5	25	40.7	11	10	25	PD
X-3851	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-19.1	9	0.5	13	20.9	28	SD-->PD
X-3851	TAS266	DR5	single	159.2	26	47.8	12	10.2	26	PD
X-3851	untreated	"UNKNOWN,Untreated"	single	212.2	23	22.8	12	15.7	26	PD
X-3873	BGJ398	FGFR	single	154.6	21	44.9	14	16.4	42	PD
X-3873	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-45.7	11	-30.1	14	14	14	SD
X-3873	BYL719	PIK3CA	single	66.6	21	-1.5	14	29.7	49	PD
X-3873	BYL719 + LEE011	"PIK3CA,CDK4/6"	combo	-51.1	10	-29.6	10	10	10	PR
X-3873	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-64.7	50	-35.1	50	50	50	PR
X-3873	CGM097	MDM2	single	9.4	11	2.2	11	14	14	SD
X-3873	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-93.7	56	-70	88	88	88	PR
X-3873	HDM201	MDM2	single	138.3	26	33.1	11	19.9	39	PD
X-3873	INC424	JAK	single	0.2	15	-1	15	35	35	SD
X-3873	LEE011	"CDK4,CDK6,CDK4/6"	single	16.3	15	6.3	15	28	28	SD
X-3873	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-85.5	80	-61.1	91	91	91	PR
X-3873	LFA102	PRLR 	single	320.9	14	143.6	14	7	14	PD
X-3873	LJM716	ERBB3	single	-9.3	10	-3.7	14	34	70	SD-->PD
X-3873	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	-6.7	22	-3.9	24	31	31	SD
X-3873	LKA136	"NTRK1,NTRK2,NTRK3"	single	136.9	20	18.6	13	17.2	34	PD
X-3873	LLM871	FGFR2/4	single	26.7	17	3.9	17	36.6	70	SD-->PD
X-3873	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-15.7	24	-1	42	60.6	70	SD-->PD
X-3873	paclitaxel	Tubulin	single	-62.4	49	-33.9	63	70	70	PR
X-3873	tamoxifen	ESR1	single	102.8	21	35.3	14	20.6	49	PD
X-3873	trastuzumab	ERBB2	single	553.3	22	91.2	13	8.4	22	PD
X-3873	untreated	"UNKNOWN,Untreated"	single	9.8	10	6.5	14	136	136	SD-->PD
X-3873	LFW527 + everolimus	"IGF1R,MTOR"	combo	-25.3	80	14.428	87	98	98	SD-->-->PD
X-3880	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	4.1	41	17.5	17	46	46	SD-->PD
X-3880	BKM120 + encorafenib	"panPI3K,BRAF,BRAF,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-5.8	17	6.9	17	43	43	SD-->PD
X-3880	CGM097	MDM2	single	128.3	20	71.3	13	10.5	24	PD
X-3880	dacarbazine	chemotherapy	single	153.4	22	78	12	9.2	22	PD
X-3880	LDE225	SMO	single	28.6	7	7.4	7	7	7	SD
X-3880	LDK378	ALK	single	212.6	21	89.9	14	7.7	21	PD
X-3880	LEE011	"CDK4,CDK6,CDK4/6"	single	44.8	20	23.5	13	24	24	PD
X-3880	LEE011 + encorafenib	"CDK4/6,BRAF,BRAF,CDK4,CDK6"	combo	24.7	17	25.2	17	21	21	SD
X-3880	WNT974	PORCN	single	91.8	21	25.2	14	21	21	PD
X-3880	LGW813	IAP	single	73.2	20	13.2	13	23	24	PD
X-3880	encorafenib	BRAF	single	63.5	20	36.6	13	24	24	PD
X-3880	encorafenib + binimetinib	"BRAF,MAP2K1,MAP2K2,MAPK"	combo	-17.8	28	-8.5	14	87	87	SD-->PD
X-3880	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-84.9	80	-61.2	164	255.7	262	PR-->-->PD
X-3880	TAS266	DR5	single	229	20	124	13	4.5	27	PD
X-3880	untreated	"UNKNOWN,Untreated"	single	556.8	21	128.7	13	5.4	21	PD
X-3898	abraxane	Tubulin	single	146.2	20	20.6	12	14.2	40	PD
X-3898	abraxane + gemcitabine	"Tubulin,chemotherapy"	combo	61.8	23	26.1	14	27	27	PD
X-3898	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-1	18	10.7	11	46.6	48	SD-->PD
X-3898	BKM120 + LDE225	"panPI3K,SMO"	combo	-64.9	113	-24.2	113	113	113	PR
X-3898	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	64.4	34	52.1	13	18.9	93	PD
X-3898	BYL719	PIK3CA	single	6.6	12	4.8	12	18	18	SD
X-3898	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	51.2	21	4.7	14	41	41	PD
X-3898	HDM201	MDM2	single	291.1	26	53.8	13	9.8	26	PD
X-3898	figitumumab	IGF1R	single	19.5	15	8.3	12	30.7	55	SD-->PD
X-3898	figitumumab + binimetinib	"IGF1R,MAPK"	combo	147.4	29	47.8	13	11.6	29	PD
X-3898	gemcitabine-50mpk	chemotherapy	single	23.6	17	14.5	14	58.9	109	SD-->PD
X-3898	INC424	JAK	single	184	24	43.8	13	14.7	45	PD
X-3898	INC424 + binimetinib	"JAK,MAPK"	combo	-15.4	14	-6.9	18	84	84	SD-->PD
X-3898	LEE011	"CDK4,CDK6,CDK4/6"	single	-17.4	53	55	80	8	97	PD
X-3898	WNT974	PORCN	single	224.5	22	32.3	13	19.4	27	PD
X-3898	LKA136	"NTRK1,NTRK2,NTRK3"	single	85.3	21	16.7	14	22.1	38	PD
X-3898	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	146.3	58	90.5	13	7.5	58	PD
X-3898	binimetinib-3.5mpk	MAPK	single	294.6	29	114.9	12	4	33	PD
X-3898	trametinib	MAPK	single	-5.7	39	7.4	11	55.3	61	SD-->PD
X-3898	untreated	"UNKNOWN,Untreated"	single	255.4	22	61.6	13	8.8	27	PD
X-3947	abraxane	Tubulin	single	-58.8	10	-27.5	13	33.9	45	PR-->PD
X-3947	abraxane + gemcitabine	"Tubulin,chemotherapy"	combo	-48.9	79	-1.4	94	94	94	SD
X-3947	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	389.9	22	121.1	12	5.2	26	PD
X-3947	BKM120 + LDE225	"panPI3K,SMO"	combo	162.7	21	31	11	16.9	42	PD
X-3947	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-43.3	42	-28.2	42	42	42	SD
X-3947	BYL719	PIK3CA	single	564.5	20	92	13	6.8	20	PD
X-3947	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	430.9	20	110.2	13	6.5	22	PD
X-3947	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	299.1	20	55.6	13	10.8	37	PD
X-3947	HDM201	MDM2	single	399	20	51.9	13	10.5	20	PD
X-3947	figitumumab	IGF1R	single	527.2	19	134	14	6.2	19	PD
X-3947	figitumumab + binimetinib	"IGF1R,MAPK"	combo	286.6	21	135.5	14	5.7	28	PD
X-3947	gemcitabine-50mpk	chemotherapy	single	-59.5	69	-9.6	82	82	82	SD
X-3947	INC424	JAK	single	97.4	21	8.7	11	21.4	39	PD
X-3947	INC424 + binimetinib	"JAK,MAPK"	combo	4.1	18	2.8	11	84	84	SD-->PD
X-3947	LEE011	"CDK4,CDK6,CDK4/6"	single	219.4	12	88.6	12	8.5	12	PD
X-3947	WNT974	PORCN	single	206.9	7	92.3	7	3.9	7	PD
X-3947	LKA136	"NTRK1,NTRK2,NTRK3"	single	308.7	20	51.2	13	11	25	PD
X-3947	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	28.4	26	32	13	29	163	PD
X-3947	binimetinib-3.5mpk	MAPK	single	546.7	16	120.3	13	4.1	16	PD
X-3947	trametinib	MAPK	single	82.5	32	37.5	11	23.9	41	PD
X-3947	untreated	"UNKNOWN,Untreated"	single	356.2	20	73.9	13	5.9	21	PD
X-3990	abraxane	Tubulin	single	346	21	57.4	11	10.9	21	PD
X-3990	abraxane + gemcitabine	"Tubulin,chemotherapy"	combo	46.4	6	17.9	6	6	6	PD
X-3990	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	254.1	21	76.6	11	6.6	28	PD
X-3990	BKM120 + LDE225	"panPI3K,SMO"	combo	-29.8	49	-7.6	49	49	49	SD
X-3990	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-55.8	94	-27.7	94	94	94	PR
X-3990	BYL719	PIK3CA	single	-13.4	17	-6.7	17	43	62	SD-->PD
X-3990	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	130.5	22	31.5	11	14.6	35	PD
X-3990	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	19.7	11	11.2	11	68.3	97	SD-->PD
X-3990	HDM201	MDM2	single	205.9	21	28.8	11	12.4	35	PD
X-3990	figitumumab	IGF1R	single	307.6	15	122.7	12	4.2	15	PD
X-3990	figitumumab + binimetinib	"IGF1R,MAPK"	combo	247	21	121.9	11	4.5	25	PD
X-3990	gemcitabine-50mpk	chemotherapy	single	-100	50	-55	88	6.7	88	CR
X-3990	INC424	JAK	single	66.7	20	24.1	11	27.9	45	PD
X-3990	INC424 + binimetinib	"JAK,MAPK"	combo	39.3	24	51.3	17	28.6	91	PD
X-3990	LEE011	"CDK4,CDK6,CDK4/6"	single	209.1	22	101.5	12	5	36	PD
X-3990	WNT974	PORCN	single	322.7	23	30.8	13	12	29	PD
X-3990	LKA136	"NTRK1,NTRK2,NTRK3"	single	293.1	21	63.9	14	8.4	26	PD
X-3990	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	4	3	2	3	3	3	SD
X-3990	binimetinib-3.5mpk	MAPK	single	161.9	21	99.1	14	4	28	PD
X-3990	trametinib	MAPK	single	-25.7	25	-7.8	25	92	92	SD-->PD
X-3990	untreated	"UNKNOWN,Untreated"	single	226.3	21	35.1	11	10.7	42	PD
X-4015	abraxane	Tubulin	single	298.4	15	96.3	12	8.3	15	PD
X-4015	abraxane + gemcitabine	"Tubulin,chemotherapy"	combo	-79.7	83	-42.7	97	97	97	PR
X-4015	BKM120 + LDE225	"panPI3K,SMO"	combo	73.3	20	32.8	13	29.8	71	PD
X-4015	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	79.1	27	34.2	13	28.4	71	PD
X-4015	BYL719	PIK3CA	single	12.1	10	5.1	14	31.5	62	SD-->PD
X-4015	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-11	72	13.8	13	97	97	SD-->PD
X-4015	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	111.9	21	49.4	14	15.1	52	PD
X-4015	HDM201	MDM2	single	-11	10	-4.7	14	42	42	SD-->PD
X-4015	figitumumab	IGF1R	single	514.6	22	87	12	5.9	22	PD
X-4015	figitumumab + binimetinib	"IGF1R,MAPK"	combo	95.3	20	46.6	12	20.6	33	PD
X-4015	gemcitabine-50mpk	chemotherapy	single	-57.7	58	-26.2	90	90	90	PR
X-4015	INC424	JAK	single	260.9	21	71.6	14	9.4	35	PD
X-4015	INC424 + binimetinib	"JAK,MAPK"	combo	-14.8	14	-4.2	14	43.2	70	SD-->PD
X-4015	WNT974	PORCN	single	272.7	20	95.3	12	7.5	28	PD
X-4015	LKA136	"NTRK1,NTRK2,NTRK3"	single	314.9	22	53.8	11	10.8	25	PD
X-4015	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-33.2	89	-5.6	43	89	89	SD-->-->PD
X-4015	untreated	"UNKNOWN,Untreated"	single	250.2	22	34.1	11	11.3	24	PD
X-4018	abraxane	Tubulin	single	162	20	10.1	11	14.7	34	PD
X-4018	abraxane + gemcitabine	"Tubulin,chemotherapy"	combo	-26.1	49	-1.6	49	69	69	SD-->PD
X-4018	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	56.2	25	50.8	11	28.9	55	PD
X-4018	BKM120 + LDE225	"panPI3K,SMO"	combo	85	21	13.4	11	21.7	67	PD
X-4018	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-45.5	51	-16.3	65	93	93	SD-->-->PD
X-4018	BYL719	PIK3CA	single	72.9	18	45.6	12	18	18	PD
X-4018	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	16.1	12	9.3	12	18	18	SD
X-4018	HDM201	MDM2	single	79	21	24.8	11	23.1	31	PD
X-4018	figitumumab	IGF1R	single	-21.7	34	14	44	44	44	SD
X-4018	figitumumab + binimetinib	"IGF1R,MAPK"	combo	21.8	25	-34.3	12	25	25	SD
X-4018	gemcitabine-50mpk	chemotherapy	single	19.9	34	18.5	12	42.6	68	SD-->PD
X-4018	INC424 + binimetinib	"JAK,MAPK"	combo	-19.2	14	-13.9	14	62.5	98	SD-->PD
X-4018	LEE011	"CDK4,CDK6,CDK4/6"	single	176.5	20	27.6	13	17.9	20	PD
X-4018	WNT974	PORCN	single	288.3	23	47.1	13	11.6	30	PD
X-4018	LKA136	"NTRK1,NTRK2,NTRK3"	single	234.3	23	37.1	13	13.5	30	PD
X-4018	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-3	16	11.9	16	44	44	SD
X-4018	binimetinib-3.5mpk	MAPK	single	-100	85	-53	98	98	98	CR
X-4018	trametinib	MAPK	single	13.1	15	16.8	15	48.2	51	SD-->PD
X-4018	untreated	"UNKNOWN,Untreated"	single	133.9	24	34.3	11	18.1	48	PD
X-4087	5FU	chemotherapy	single	84.4	20	3.8	11	20	20	PD
X-4087	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	100.1	20	21.8	11	20	20	PD
X-4087	BKM120 + LJC049	"panPI3K,TNKS"	combo	307.2	24	112.9	11	6.3	30	PD
X-4087	BYL719	PIK3CA	single	22.9	3	11.5	3	3	3	SD
X-4087	BYL719 + cetuximab	"PIK3CA,EGFR"	combo	0	12	0	12	31	31	SD-->PD
X-4087	BYL719 + cetuximab + encorafenib	"PIK3CA,EGFR,BRAF"	combo	147.8	20	31	12	16.7	27	PD
X-4087	BYL719 + encorafenib	"PIK3CA,BRAF"	combo	80	21	41.6	15	24	24	PD
X-4087	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	58	20	24.1	11	20	20	PD
X-4087	BYL719 + binimetinib	"PIK3CA,MAPK"	combo	138.4	20	28.4	11	14.8	20	PD
X-4087	cetuximab	EGFR	single	358.9	21	104.6	15	9	21	PD
X-4087	cetuximab + encorafenib	"EGFR,BRAF"	combo	730.3	21	153.1	15	9	21	PD
X-4087	CGM097	MDM2	single	62.2	6	29.5	6	6	6	PD
X-4087	CKX620	MAPK	single	6.1	11	2.7	11	20	20	SD-->PD
X-4087	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	109.4	20	15.4	11	19.5	20	PD
X-4087	HDM201	MDM2	single	82.5	20	12.4	11	20	20	PD
X-4087	LEE011	"CDK4,CDK6,CDK4/6"	single	16.6	20	1.9	11	20	20	SD-->PD
X-4087	encorafenib	BRAF	single	33.6	6	17.8	6	6	6	SD
X-4087	LJC049	TNKS	single	17.2	11	18.1	11	14	14	SD-->PD
X-4087	LKA136	"NTRK1,NTRK2,NTRK3"	single	77.8	6	38.9	6	6	6	PD
X-4087	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-32.4	17	-10	21	27	27	SD
X-4087	untreated	"UNKNOWN,Untreated"	single	58.7	21	18	15	27.4	42	PD
X-4087	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	-23.3	15	5.3	15	29.24429967	38	SD-->PD
X-4145	abraxane	Tubulin	single	302.7	20	73.7	13	9.8	20	PD
X-4145	abraxane + gemcitabine	"Tubulin,chemotherapy"	combo	-82.2	41	-41	48	48	48	PR
X-4145	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	292.4	23	64.8	13	10.5	27	PD
X-4145	BKM120 + LDE225	"panPI3K,SMO"	combo	50.9	23	22.7	13	31.6	71	PD
X-4145	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	13.4	22	21	22	27.4	71	SD-->PD
X-4145	BYL719	PIK3CA	single	101.5	20	15.2	13	19.7	33	PD
X-4145	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	59.6	20	35.3	13	58	58	PD
X-4145	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	97.2	22	36.2	12	23.2	35	PD
X-4145	HDM201	MDM2	single	284.2	20	56.5	13	10.9	37	PD
X-4145	figitumumab	IGF1R	single	186.1	20	35.4	13	12.6	34	PD
X-4145	figitumumab + binimetinib	"IGF1R,MAPK"	combo	46.8	32	7.2	11	53.3	78	PD
X-4145	gemcitabine-50mpk	chemotherapy	single	-71.3	77	-27.6	91	91	91	PR-->PD
X-4145	INC424	JAK	single	127.6	20	44.8	14	16.9	41	PD
X-4145	INC424 + binimetinib	"JAK,MAPK"	combo	111.4	20	56.2	13	9.8	86	PD
X-4145	LEE011	"CDK4,CDK6,CDK4/6"	single	228	20	62.5	13	8.6	34	PD
X-4145	WNT974	PORCN	single	18.1	18	3.3	11	18	18	SD
X-4145	LKA136	"NTRK1,NTRK2,NTRK3"	single	224	20	67.6	13	9.1	28	PD
X-4145	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-44	21	-24.6	34	51	51	SD
X-4145	binimetinib-3.5mpk	MAPK	single	149.2	25	83.3	11	4	27	PD
X-4145	trametinib	MAPK	single	191.1	22	98.9	12	4	39	PD
X-4145	untreated	"UNKNOWN,Untreated"	single	344	21	106.4	14	6	25	PD
X-4157	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	60.5	20	9.5	11	28	28	PD
X-4157	BKM120 + encorafenib	"panPI3K,BRAF,BRAF,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	12.8	9	9.8	14	28	28	SD-->PD
X-4157	CGM097	MDM2	single	90.2	20	35.9	14	20.5	28	PD
X-4157	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	112.1	20	35.3	11	13	28	PD
X-4157	dacarbazine	chemotherapy	single	58	20	16	14	29	29	PD
X-4157	LDE225	SMO	single	10	9	8.6	12	13	13	SD
X-4157	LDK378	ALK	single	65.4	25	22.1	12	28	28	PD
X-4157	LEE011	"CDK4,CDK6,CDK4/6"	single	71.7	22	14	13	26.4	28	PD
X-4157	LEE011 + encorafenib	"CDK4/6,BRAF,BRAF,CDK4,CDK6"	combo	66.8	22	18.3	11	25.8	28	PD
X-4157	WNT974	PORCN	single	131.5	21	20.1	14	19	28	PD
X-4157	LGW813	IAP	single	-23.5	11	-17	11	67.5	105	SD-->PD
X-4157	encorafenib	BRAF	single	106.2	20	18.4	13	19.5	28	PD
X-4157	encorafenib + binimetinib	"BRAF,MAP2K1,MAP2K2,MAPK"	combo	-33.5	16	-8.1	25	66.6	87	SD-->PD
X-4157	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-14.7	60	13.6	13	88.8	108	SD-->PD
X-4157	TAS266	DR5	single	143.4	20	24.7	14	16.5	28	PD
X-4157	untreated	"UNKNOWN,Untreated"	single	239.7	20	52.9	14	11.2	28	PD
X-4215	abraxane	Tubulin	single	87.8	25	19.3	11	33.9	54	PD
X-4215	abraxane + gemcitabine	"Tubulin,chemotherapy"	combo	-81.9	48	-32.5	79	79	79	PR-->-->PD
X-4215	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	77.8	22	40.6	12	22	22	PD
X-4215	BKM120 + LDE225	"panPI3K,SMO"	combo	147.2	16	117.3	13	3.5	16	PD
X-4215	BYL719	PIK3CA	single	71.1	21	2.8	11	26.6	35	PD
X-4215	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-97.8	97	-66	97	97	97	CR
X-4215	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	50.4	21	21.3	11	33.2	56	PD
X-4215	HDM201	MDM2	single	100.8	20	40.6	13	19.8	31	PD
X-4215	figitumumab	IGF1R	single	223.1	21	57.3	11	8.9	21	PD
X-4215	figitumumab + binimetinib	"IGF1R,MAPK"	combo	27.7	22	12.8	15	42.7	51	SD-->PD
X-4215	gemcitabine-50mpk	chemotherapy	single	-77.2	39	-33.7	56	100.8	109	PR-->PD
X-4215	INC424	JAK	single	93.1	20	21.5	13	20	20	PD
X-4215	INC424 + binimetinib	"JAK,MAPK"	combo	4.6	90	28.1	12	131	131	SD
X-4215	LEE011	"CDK4,CDK6,CDK4/6"	single	1.3	53	57.5	11	10.3	91	PD
X-4215	WNT974	PORCN	single	116.8	20	73.4	12	9.3	28	PD
X-4215	LKA136	"NTRK1,NTRK2,NTRK3"	single	327.1	22	48.6	11	9.5	25	PD
X-4215	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	0.6	19	22.6	22	22	22	SD
X-4215	binimetinib-3.5mpk	MAPK	single	158.9	22	111.7	12	5.2	27	PD
X-4215	trametinib	MAPK	single	62.9	28	11.9	11	32	40	PD
X-4215	untreated	"UNKNOWN,Untreated"	single	167.2	21	61.1	12	7.6	36	PD
X-4226	abraxane	Tubulin	single	278.2	20	75.2	14	6.6	27	PD
X-4226	abraxane + gemcitabine	"Tubulin,chemotherapy"	combo	48.4	21	17.7	14	27.7	87	PD
X-4226	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-21.6	16	10.3	16	36.3	44	SD-->PD
X-4226	BKM120 + LDE225	"panPI3K,SMO"	combo	-30.7	13	-17.6	18	81	81	SD-->PD
X-4226	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-17.5	34	-2	40	71.3	122	SD-->PD
X-4226	BYL719	PIK3CA	single	-1	14	-1.1	14	51.3	91	SD-->PD
X-4226	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	43.7	29	15	14	43.5	63	PD
X-4226	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	65	22	13.1	14	31.7	73	PD
X-4226	HDM201	MDM2	single	260.5	20	60.3	12	7.7	33	PD
X-4226	figitumumab	IGF1R	single	58.7	26	-2	12	18.9	36	PD
X-4226	figitumumab + binimetinib	"IGF1R,MAPK"	combo	141.1	21	87.9	11	5.8	28	PD
X-4226	gemcitabine-50mpk	chemotherapy	single	44.5	17	30.8	14	17	17	PD
X-4226	INC424	JAK	single	83.3	20	19.6	12	26	71	PD
X-4226	INC424 + binimetinib	"JAK,MAPK"	combo	-17.6	20	2.6	20	63.7	99	SD-->PD
X-4226	LEE011	"CDK4,CDK6,CDK4/6"	single	176.6	22	61.7	12	12.4	29	PD
X-4226	WNT974	PORCN	single	273.3	21	55.1	13	10.8	22	PD
X-4226	LKA136	"NTRK1,NTRK2,NTRK3"	single	59.4	20	30.8	13	25.2	36	PD
X-4226	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-30.3	28	-5.9	35	35	35	SD
X-4226	binimetinib-3.5mpk	MAPK	single	52	21	37.3	13	27.7	34	PD
X-4226	trametinib	MAPK	single	-7.4	11	-3.7	11	29.8	48	SD-->PD
X-4226	untreated	"UNKNOWN,Untreated"	single	83.7	24	28.5	13	19	40	PD
X-4316	abraxane	Tubulin	single	122.2	22	35.1	12	16.6	54	PD
X-4316	abraxane + gemcitabine	"Tubulin,chemotherapy"	combo	-100	84	-63.2	87	87	87	CR
X-4316	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	93.4	21	20	13	16.5	28	PD
X-4316	BKM120 + LDE225	"panPI3K,SMO"	combo	-20.2	14	-9.9	14	53	53	SD-->PD
X-4316	BYL719	PIK3CA	single	72.5	22	6.4	14	29.7	115	PD
X-4316	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	1.2	13	0.3	13	41.2	51	SD-->PD
X-4316	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	11.6	9	4.8	13	21.4	37	SD-->PD
X-4316	HDM201	MDM2	single	132.6	20	29.4	13	16.1	30	PD
X-4316	figitumumab	IGF1R	single	-2.1	19	34.6	19	29.6	68	PD
X-4316	figitumumab + binimetinib	"IGF1R,MAPK"	combo	276	20	133.5	12	3.2	33	PD
X-4316	gemcitabine-50mpk	chemotherapy	single	-80	77	-41.1	77	77	77	PR
X-4316	INC424	JAK	single	44.4	22	8.3	14	57.4	115	PD
X-4316	LEE011	"CDK4,CDK6,CDK4/6"	single	3	21	1.9	11	62.7	77	SD-->PD
X-4316	WNT974	PORCN	single	26.8	16	19.8	13	27.6	51	SD-->PD
X-4316	LKA136	"NTRK1,NTRK2,NTRK3"	single	59.2	22	9.6	15	31.1	45	PD
X-4316	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-45.2	109	-26.9	109	122	122	SD-->-->PD
X-4316	binimetinib-3.5mpk	MAPK	single	29.2	18	10.1	13	20.7	39	SD-->PD
X-4316	trametinib	MAPK	single	-32.1	19	-12.5	40	91	91	SD-->PD
X-4316	untreated	"UNKNOWN,Untreated"	single	132.8	20	12.8	11	15.2	44	PD
X-4339	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-26.4	16	-10.2	19	44	44	SD-->PD
X-4339	BKM120 + encorafenib	"panPI3K,BRAF,BRAF,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-0.3	14	3.4	14	40	40	SD
X-4339	CGM097	MDM2	single	50	22	11.5	11	64.8	66	PD
X-4339	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	9.6	22	7.6	12	85	85	SD-->PD
X-4339	dacarbazine	chemotherapy	single	9.7	15	13.1	15	15	15	SD
X-4339	LDE225	SMO	single	13.4	19	14.1	20	22	22	SD
X-4339	LDK378	ALK	single	16.3	19	8.2	11	44	44	SD-->PD
X-4339	LEE011	"CDK4,CDK6,CDK4/6"	single	-72.7	149	-37.2	226	240	240	PR-->-->PD
X-4339	LEE011 + encorafenib	"CDK4/6,BRAF,BRAF,CDK4,CDK6"	combo	-48.3	120	-14.8	170	170	170	SD
X-4339	LEE011 + binimetinib	"CDK4,CDK6,MAP2K1,MAP2K2,CDK4/6,MAPK"	combo	-86.8	103	-66.2	177	177	177	PR
X-4339	WNT974	PORCN	single	15.9	11	9.2	11	26	26	SD-->PD
X-4339	LGW813	IAP	single	13.3	11	9.8	11	49.9	51	SD-->PD
X-4339	encorafenib	BRAF	single	89.7	24	30.5	14	16.5	46	PD
X-4339	encorafenib + binimetinib	"BRAF,MAP2K1,MAP2K2,MAPK"	combo	81.3	26	17.1	11	31.7	47	PD
X-4339	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-5.3	14	0.1	14	78	85	SD-->PD
X-4339	TAS266	DR5	single	14.2	13	10.9	13	38	47	SD-->PD
X-4339	untreated	"UNKNOWN,Untreated"	single	89.3	20	39.5	16	20.8	45	PD
X-4347	BGJ398	FGFR	single	55.9	21	7	14	31.1	60	PD
X-4347	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-22	11	-11.7	34	67	67	SD-->-->PD
X-4347	BYL719	PIK3CA	single	63.1	34	8.9	13	46	98	PD
X-4347	BYL719 + LEE011	"PIK3CA,CDK4/6"	combo	-73.3	45	-42.6	48	48	48	PR
X-4347	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-14.6	11	-11.9	11	63.1	88	SD-->PD
X-4347	CGM097	MDM2	single	79.3	22	2.2	11	25.6	67	PD
X-4347	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	12.4	11	-1.9	11	77.4	91	SD-->PD
X-4347	HDM201	MDM2	single	33.7	39	0.7	11	56	56	SD-->PD
X-4347	INC424	JAK	single	101.6	21	23.1	11	20.8	28	PD
X-4347	LEE011	"CDK4,CDK6,CDK4/6"	single	-7.9	52	11.2	91	134.1	143	SD-->-->PD
X-4347	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-83.6	87	-50.1	87	87	87	PR
X-4347	LFA102	PRLR 	single	162.6	20	30.1	13	17.2	48	PD
X-4347	LJM716	ERBB3	single	119.9	21	43.5	16	18.5	49	PD
X-4347	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	124.6	20	18.3	13	19	48	PD
X-4347	LKA136	"NTRK1,NTRK2,NTRK3"	single	127.1	21	27.9	11	16.1	28	PD
X-4347	LLM871	FGFR2/4	single	72.1	24	25.4	13	25.8	41	PD
X-4347	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-58.8	56	-31.7	56	56	56	PR
X-4347	paclitaxel	Tubulin	single	78.5	24	31.5	13	32.2	62	PD
X-4347	tamoxifen	ESR1	single	93.9	32	39.9	16	23.1	49	PD
X-4347	trastuzumab	ERBB2	single	128.6	20	45.7	13	18.8	62	PD
X-4347	untreated	"UNKNOWN,Untreated"	single	165.8	17	54.4	13	11.1	17	PD
X-4347	LFW527 + everolimus	"IGF1R,MTOR"	combo	-7.1	21	0.214285714	21	78.56962025	98	SD-->PD
X-4377	abraxane	Tubulin	single	257.8	9	114.5	9	4	9	PD
X-4377	abraxane + gemcitabine	"Tubulin,chemotherapy"	combo	43.5	23	12.8	14	37	37	PD
X-4377	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	193.4	26	20.6	12	16.4	29	PD
X-4377	BKM120 + LDE225	"panPI3K,SMO"	combo	-46.3	29	-21.5	29	29	29	SD
X-4377	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-13.6	17	3.3	17	35	74	SD-->PD
X-4377	BYL719	PIK3CA	single	159	22	40.6	11	12.1	28	PD
X-4377	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	65.6	20	22.2	14	24.8	41	PD
X-4377	HDM201	MDM2	single	260.9	20	89.1	14	6	27	PD
X-4377	figitumumab	IGF1R	single	321.7	16	91.9	13	7	16	PD
X-4377	figitumumab + binimetinib	"IGF1R,MAPK"	combo	487.8	21	174.4	14	3.8	21	PD
X-4377	gemcitabine-50mpk	chemotherapy	single	-21.2	41	11	63	72.8	73	SD-->PD
X-4377	INC424	JAK	single	291	20	94.8	14	6.2	20	PD
X-4377	INC424 + binimetinib	"JAK,MAPK"	combo	163.5	22	29.4	11	16.8	36	PD
X-4377	LEE011	"CDK4,CDK6,CDK4/6"	single	129.2	21	20.4	11	17.1	42	PD
X-4377	WNT974	PORCN	single	6.9	16	23.2	16	23.9	63	SD
X-4377	LKA136	"NTRK1,NTRK2,NTRK3"	single	-100	19	-85.3	89	89	89	CR
X-4377	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-29.7	35	-3.2	11	35	35	SD-->PD
X-4377	binimetinib-3.5mpk	MAPK	single	300.3	20	73.8	13	10	28	PD
X-4377	trametinib	MAPK	single	-12.8	25	-15	12	46.3	52	SD-->PD
X-4378	abraxane	Tubulin	single	180.1	21	44.2	13	13	24	PD
X-4378	abraxane + gemcitabine	"Tubulin,chemotherapy"	combo	29.1	20	13.3	17	69	69	SD
X-4378	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	102.3	28	21.3	11	16	41	PD
X-4378	BKM120 + LDE225	"panPI3K,SMO"	combo	-66.3	39	-46.9	49	84	84	PR-->PD
X-4378	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-15.6	39	-5.6	21	83.7	84	SD-->PD
X-4378	BYL719	PIK3CA	single	-45.2	32	-23.9	64	119	119	SD
X-4378	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	61.7	32	11.4	11	45	45	PD
X-4378	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-14.3	34	3.7	13	44.4	77	SD-->PD
X-4378	HDM201	MDM2	single	70	24	16.2	14	35	35	PD
X-4378	figitumumab	IGF1R	single	128.9	20	27	14	17.8	27	PD
X-4378	figitumumab + binimetinib	"IGF1R,MAPK"	combo	10.6	29	24.7	13	29	29	SD-->PD
X-4378	gemcitabine-50mpk	chemotherapy	single	-28.7	73	-11.1	105	112	112	SD
X-4378	INC424	JAK	single	115	18	44.5	12	14	18	PD
X-4378	INC424 + binimetinib	"JAK,MAPK"	combo	20.3	11	2.2	11	74.3	84	SD-->PD
X-4378	LEE011	"CDK4,CDK6,CDK4/6"	single	106.5	21	51.1	13	13.6	44	PD
X-4378	WNT974	PORCN	single	151.9	28	58.7	12	9.5	41	PD
X-4378	LKA136	"NTRK1,NTRK2,NTRK3"	single	207.8	21	64.5	13	8.9	27	PD
X-4378	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-22.4	28	-12.8	11	49	49	SD-->PD
X-4378	binimetinib-3.5mpk	MAPK	single	184.5	20	47.2	12	13.1	23	PD
X-4378	trametinib	MAPK	single	66.1	21	38.1	14	23.2	41	PD
X-4378	untreated	"UNKNOWN,Untreated"	single	87.3	21	25.3	12	26.4	63	PD
X-4426	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	107.9	20	47.3	11	12.7	22	PD
X-4426	BKM120 + encorafenib	"panPI3K,BRAF,BRAF,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	10.3	34	52	12	12	34	PD
X-4426	CGM097	MDM2	single	231.4	20	56.4	13	11.5	20	PD
X-4426	dacarbazine	chemotherapy	single	306.7	21	72.1	15	9.4	21	PD
X-4426	LDE225	SMO	single	302.1	20	62.5	11	9	20	PD
X-4426	LDK378	ALK	single	222.5	20	28.5	11	14.2	20	PD
X-4426	LEE011	"CDK4,CDK6,CDK4/6"	single	31.3	23	45.9	23	23	23	PD
X-4426	LEE011 + encorafenib	"CDK4/6,BRAF,BRAF,CDK4,CDK6"	combo	-50.6	40	-4.2	56	71.6	88	SD-->PD
X-4426	WNT974	PORCN	single	364.4	20	84.7	11	8.1	20	PD
X-4426	LGW813	IAP	single	229.4	20	53.6	11	10	26	PD
X-4426	encorafenib	BRAF	single	369.1	20	108.1	13	7.5	20	PD
X-4426	encorafenib + binimetinib	"BRAF,MAP2K1,MAP2K2,MAPK"	combo	614.7	19	122.6	13	5.8	19	PD
X-4426	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	107.5	20	44.9	14	19.4	29	PD
X-4426	TAS266	DR5	single	-53.2	10	-32.2	16	32.3	41	PR-->PD
X-4426	untreated	"UNKNOWN,Untreated"	single	757.9	18	183	12	3.7	18	PD
X-4439	abraxane	Tubulin	single	125.8	20	-8	11	16.1	48	PD
X-4439	abraxane + gemcitabine	"Tubulin,chemotherapy"	combo	-61.4	45	-27.5	48	48	48	PR
X-4439	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-38	21	-14.7	51	51	51	SD
X-4439	BKM120 + LDE225	"panPI3K,SMO"	combo	-50.7	40	-28.4	43	43	43	PR
X-4439	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-57.8	67	-24.3	94	94	94	PR-->PD
X-4439	BYL719	PIK3CA	single	-28.6	17	-16.7	28	83	83	SD
X-4439	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-41.4	49	-32	58	76	76	SD
X-4439	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-24.3	38	-15.5	52	83	83	SD
X-4439	HDM201	MDM2	single	42.2	21	7.5	11	28.8	31	PD
X-4439	figitumumab	IGF1R	single	79.2	20	43.8	13	21.8	33	PD
X-4439	figitumumab + binimetinib	"IGF1R,MAPK"	combo	98.4	22	25.7	11	16.9	36	PD
X-4439	gemcitabine-50mpk	chemotherapy	single	22	66	35.8	15	21	94	PD
X-4439	INC424	JAK	single	63.1	21	12.9	11	32.2	45	PD
X-4439	INC424 + binimetinib	"JAK,MAPK"	combo	-17.5	14	-9.8	14	84	84	SD-->PD
X-4439	LEE011	"CDK4,CDK6,CDK4/6"	single	60.7	20	19.8	13	22.7	43	PD
X-4439	WNT974	PORCN	single	149.2	24	27.4	12	20.1	28	PD
X-4439	LKA136	"NTRK1,NTRK2,NTRK3"	single	113.7	21	31.1	15	19.8	32	PD
X-4439	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	19.6	35	25.9	11	26.5	77	SD
X-4439	binimetinib-3.5mpk	MAPK	single	25.3	25	-11.2	11	30.2	36	SD-->PD
X-4439	trametinib	MAPK	single	-33.4	45	0.7	24	51	51	SD-->PD
X-4439	untreated	"UNKNOWN,Untreated"	single	120.4	23	31.7	13	17.7	51	PD
X-4455	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	419.9	12	132	12	8.4	12	PD
X-4455	BKM120 + encorafenib	"panPI3K,BRAF,BRAF,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	485.4	21	79.5	12	8.1	21	PD
X-4455	CGM097	MDM2	single	164.6	20	34.1	12	11.9	23	PD
X-4455	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	169.6	21	36.9	15	12.5	21	PD
X-4455	dacarbazine	chemotherapy	single	150.8	20	38.6	13	17.2	21	PD
X-4455	LDE225	SMO	single	102.8	21	3.3	12	17.4	21	PD
X-4455	LDK378	ALK	single	447.6	18	104.1	12	6.4	18	PD
X-4455	LEE011	"CDK4,CDK6,CDK4/6"	single	-1.8	17	16.8	17	23	23	SD-->PD
X-4455	LEE011 + encorafenib	"CDK4/6,BRAF,BRAF,CDK4,CDK6"	combo	-4.9	9	-5.3	12	84.1	88	SD-->PD
X-4455	WNT974	PORCN	single	328.6	21	49.8	12	10.1	21	PD
X-4455	LGW813	IAP	single	336.4	21	43.1	12	11.1	21	PD
X-4455	encorafenib	BRAF	single	259.9	20	51.5	12	10.5	23	PD
X-4455	encorafenib + binimetinib	"BRAF,MAP2K1,MAP2K2,MAPK"	combo	479.5	20	88	13	7.5	21	PD
X-4455	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	221.1	20	65.6	12	8.1	23	PD
X-4455	TAS266	DR5	single	98.7	20	44.7	12	7.9	23	PD
X-4455	untreated	"UNKNOWN,Untreated"	single	740.4	21	101.4	11	5.4	21	PD
X-4530	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	207.4	22	8.6	11	14.8	22	PD
X-4530	BKM120 + encorafenib	"panPI3K,BRAF,BRAF,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-19.5	13	-14.7	13	59.5	72	SD-->PD
X-4530	CGM097	MDM2	single	300.3	22	30.6	11	14.5	22	PD
X-4530	LDE225	SMO	single	85.3	21	9.1	15	22.6	29	PD
X-4530	LDK378	ALK	single	238.7	21	44.5	15	13	21	PD
X-4530	LEE011	"CDK4,CDK6,CDK4/6"	single	270.7	20	43	12	11.5	20	PD
X-4530	LEE011 + encorafenib	"CDK4/6,BRAF,BRAF,CDK4,CDK6"	combo	-100	36	-81	73	99.3	119	CR-->-->PD
X-4530	WNT974	PORCN	single	925.6	21	186.6	15	6.5	21	PD
X-4530	LGW813	IAP	single	243.9	16	68.2	11	7.4	16	PD
X-4530	encorafenib	BRAF	single	199.2	22	49.1	11	12.7	22	PD
X-4530	encorafenib + binimetinib	"BRAF,MAP2K1,MAP2K2,MAPK"	combo	-82.1	24	-52.7	34	48.5	65	PR-->PD
X-4530	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-32.5	15	-9.7	20	40	40	SD-->PD
X-4530	TAS266	DR5	single	499	18	93.5	11	7.1	18	PD
X-4530	untreated	"UNKNOWN,Untreated"	single	233.7	22	41.3	11	12.4	33	PD
X-4538	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	12.4	19	2	11	36.3	47	SD-->PD
X-4538	BKM120 + encorafenib	"panPI3K,BRAF,BRAF,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-65	72	-49.2	102	158.8	182	PR-->-->PD
X-4538	CGM097	MDM2	single	60.9	25	39.6	13	27.6	38	PD
X-4538	dacarbazine	chemotherapy	single	-12.6	15	-9.6	15	32.7	43	SD-->PD
X-4538	LDE225	SMO	single	273.3	21	28.4	15	14.1	21	PD
X-4538	LDK378	ALK	single	352.1	21	76.5	15	10.9	21	PD
X-4538	LEE011	"CDK4,CDK6,CDK4/6"	single	89.1	35	47.3	14	16.2	35	PD
X-4538	LEE011 + encorafenib	"CDK4/6,BRAF,BRAF,CDK4,CDK6"	combo	-68.2	72	-52	119	182	182	PR-->-->PD
X-4538	WNT974	PORCN	single	317.9	21	77.8	15	10.1	21	PD
X-4538	LGW813	IAP	single	335.5	22	57.8	11	9	25	PD
X-4538	encorafenib	BRAF	single	-10.4	10	-7.8	14	39	39	SD-->PD
X-4538	encorafenib + binimetinib	"BRAF,MAP2K1,MAP2K2,MAPK"	combo	-89.7	77	-72.2	119	182	182	PR-->-->PD
X-4538	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	100.1	22	38.7	11	22	32	PD
X-4538	TAS266	DR5	single	420	20	84.9	13	8.1	20	PD
X-4538	untreated	"UNKNOWN,Untreated"	single	627.8	20	111	13	6.2	25	PD
X-4567	BGJ398	FGFR	single	82.9	25	17.6	11	26.4	42	PD
X-4567	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-100	39	-84.8	84	84	84	CR
X-4567	BYL719	PIK3CA	single	-100	56	-85.2	95	95	95	CR
X-4567	BYL719 + LEE011	"PIK3CA,CDK4/6"	combo	-100	74	-84.8	88	88	88	CR
X-4567	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-97.2	85	-85.4	95	95	95	CR
X-4567	CGM097	MDM2	single	62.3	24	-4.5	11	16.8	59	PD
X-4567	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-99.6	90	-79.3	94	94	94	CR
X-4567	HDM201	MDM2	single	-4.7	11	-7.1	11	50.4	80	SD-->PD
X-4567	INC424	JAK	single	-31	25	-5.6	42	64.6	91	SD-->PD
X-4567	LEE011	"CDK4,CDK6,CDK4/6"	single	13.5	74	37	11	39.7	109	PD
X-4567	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-97.1	94	-73.3	104	104	104	CR
X-4567	LFA102	PRLR 	single	79	20	12.6	13	25	41	PD
X-4567	LJM716	ERBB3	single	-21.3	69	-15.2	13	104	104	SD-->-->PD
X-4567	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	-100	10	-91.8	90	90	90	CR
X-4567	LKA136	"NTRK1,NTRK2,NTRK3"	single	88.5	20	19.6	13	21.4	41	PD
X-4567	LLM871	FGFR2/4	single	-100	38	-80.9	69	69	69	CR
X-4567	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-80.3	97	-43.5	97	97	97	PR
X-4567	paclitaxel	Tubulin	single	-100	55	-75.7	97	97	97	CR
X-4567	tamoxifen	ESR1	single	181.2	25	47.9	11	10.2	32	PD
X-4567	trastuzumab	ERBB2	single	57.9	24	28.4	14	31.9	76	PD
X-4567	untreated	"UNKNOWN,Untreated"	single	325.6	20	94.6	14	7.8	27	PD
X-4567	LFW527 + everolimus	"IGF1R,MTOR"	combo	-68.1	46	-44.90588235	56	56	56	PR
X-4644	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	126.9	20	12.7	11	19	24	PD
X-4644	BKM120 + encorafenib	"panPI3K,BRAF,BRAF,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-100	21	-94.6	223	247	247	CR-->-->PD
X-4644	CGM097	MDM2	single	460.4	20	122.2	13	5.7	20	PD
X-4644	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	218.4	21	41.6	11	11.4	21	PD
X-4644	dacarbazine	chemotherapy	single	238	21	56.9	11	8.7	21	PD
X-4644	LDE225	SMO	single	256.7	20	82.1	13	7.9	20	PD
X-4644	LDK378	ALK	single	476.8	20	88.8	13	7.9	20	PD
X-4644	LEE011	"CDK4,CDK6,CDK4/6"	single	338.4	20	77.2	13	8.5	20	PD
X-4644	LEE011 + encorafenib	"CDK4/6,BRAF,BRAF,CDK4,CDK6"	combo	-100	18	-95	182	235.5	244	CR-->-->PD
X-4644	WNT974	PORCN	single	631.5	21	81.8	14	10.5	21	PD
X-4644	LGW813	IAP	single	637.5	21	128.4	14	6.4	21	PD
X-4644	encorafenib	BRAF	single	-68	20	-52.6	30	84	98	PR-->PD
X-4644	encorafenib + binimetinib	"BRAF,MAP2K1,MAP2K2,MAPK"	combo	-100	20	-95.4	227	237	237	CR
X-4644	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-46	24	-29.7	27	76.4	85	SD-->PD
X-4644	TAS266	DR5	single	571.1	20	99.3	13	8.1	20	PD
X-4644	untreated	"UNKNOWN,Untreated"	single	616	20	166.8	13	5.1	20	PD
X-4649	abraxane	Tubulin	single	130.6	20	33.1	11	15.6	41	PD
X-4649	abraxane + gemcitabine	"Tubulin,chemotherapy"	combo	-26.3	42	-2.2	48	79	79	SD-->PD
X-4649	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	29	16	19.3	13	57	57	SD-->PD
X-4649	BKM120 + LDE225	"panPI3K,SMO"	combo	-6	67	31.8	11	13.2	94	PD
X-4649	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-26.7	77	-10.6	80	94	94	SD-->-->PD
X-4649	BYL719	PIK3CA	single	0.3	22	5	36	46	46	SD
X-4649	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-20	14	-11.6	21	62	62	SD-->PD
X-4649	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-7.7	35	8.8	14	41	41	SD
X-4649	HDM201	MDM2	single	10.4	10	6.7	14	59.5	62	SD-->PD
X-4649	figitumumab	IGF1R	single	165.6	20	29.8	13	14.2	34	PD
X-4649	figitumumab + binimetinib	"IGF1R,MAPK"	combo	20.2	17	23.2	17	17	17	SD
X-4649	gemcitabine-50mpk	chemotherapy	single	-33.7	15	-5.7	15	15	15	SD
X-4649	INC424	JAK	single	134.1	21	46.8	14	15.3	56	PD
X-4649	INC424 + binimetinib	"JAK,MAPK"	combo	83.8	23	40.2	13	11.3	93	PD
X-4649	LEE011	"CDK4,CDK6,CDK4/6"	single	120	13	52.4	13	11	13	PD
X-4649	WNT974	PORCN	single	333.9	24	65.5	12	9	28	PD
X-4649	LKA136	"NTRK1,NTRK2,NTRK3"	single	40.5	21	18.6	14	30.5	46	PD
X-4649	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	9	35	13.6	11	77	77	SD-->PD
X-4649	binimetinib-3.5mpk	MAPK	single	160	20	68.6	12	9.8	23	PD
X-4649	trametinib	MAPK	single	-24.5	16	-7.9	27	57	57	SD-->PD
X-4649	untreated	"UNKNOWN,Untreated"	single	74.7	22	23.4	11	24.4	60	PD
X-4668	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	227.3	20	43	14	14	20	PD
X-4668	BKM120 + encorafenib	"panPI3K,BRAF,BRAF,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-26.5	14	-20.1	14	44	44	SD-->PD
X-4668	CGM097	MDM2	single	222	20	62.4	14	9.4	20	PD
X-4668	dacarbazine	chemotherapy	single	217.1	22	67.1	11	8.6	28	PD
X-4668	LDE225	SMO	single	211.3	11	107.7	11	6.1	11	PD
X-4668	LDK378	ALK	single	514.8	18	97	12	7	18	PD
X-4668	LEE011	"CDK4,CDK6,CDK4/6"	single	5.3	10	12.5	14	14	14	SD
X-4668	LEE011 + encorafenib	"CDK4/6,BRAF,BRAF,CDK4,CDK6"	combo	-39.4	22	-32.2	25	96.4	108	SD-->-->PD
X-4668	WNT974	PORCN	single	221.6	14	59.7	11	9.4	14	PD
X-4668	LGW813	IAP	single	392.3	20	81.9	14	8.8	20	PD
X-4668	encorafenib	BRAF	single	57.9	20	-7.9	14	27.6	37	PD
X-4668	encorafenib + binimetinib	"BRAF,MAP2K1,MAP2K2,MAPK"	combo	-30.7	16	-19.4	35	101.2	105	SD-->PD
X-4668	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	85.9	20	19.5	14	21.1	37	PD
X-4668	TAS266	DR5	single	-100	48	-90.2	251	251	251	CR
X-4668	untreated	"UNKNOWN,Untreated"	single	513.8	20	132.2	14	7.3	20	PD
X-4676	abraxane	Tubulin	single	338.9	15	106.3	12	7.7	15	PD
X-4676	abraxane + gemcitabine	"Tubulin,chemotherapy"	combo	-68.4	48	-17.5	48	48	48	SD
X-4676	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	16.1	41	7.3	11	41	41	SD-->PD
X-4676	BKM120 + LDE225	"panPI3K,SMO"	combo	-51.5	48	-38.7	48	93	93	PR-->PD
X-4676	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-100	93	-46.4	96	96	96	CR
X-4676	BYL719	PIK3CA	single	237.3	21	77.1	11	8.2	36	PD
X-4676	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	79.3	20	17.2	11	38	38	PD
X-4676	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	85.6	21	12.5	11	21.6	42	PD
X-4676	HDM201	MDM2	single	105.7	21	1.8	11	18	28	PD
X-4676	figitumumab	IGF1R	single	127.7	22	19.7	12	19.8	36	PD
X-4676	figitumumab + binimetinib	"IGF1R,MAPK"	combo	108.6	17	57.2	11	14.2	17	PD
X-4676	gemcitabine-50mpk	chemotherapy	single	-79.7	97	-37	97	97	97	PR
X-4676	INC424	JAK	single	265.8	21	62.8	11	9.9	21	PD
X-4676	INC424 + binimetinib	"JAK,MAPK"	combo	-28.3	25	-10.4	59	84	84	SD-->PD
X-4676	LEE011	"CDK4,CDK6,CDK4/6"	single	304.4	15	95.6	12	7	15	PD
X-4676	WNT974	PORCN	single	167.3	20	69.9	13	7.6	26	PD
X-4676	LKA136	"NTRK1,NTRK2,NTRK3"	single	111	20	12.6	12	18.6	34	PD
X-4676	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-100	83	-38.2	96	96	96	PR
X-4676	binimetinib-3.5mpk	MAPK	single	219.4	19	57.3	12	9.8	19	PD
X-4676	trametinib	MAPK	single	-31.2	72	-10.5	27	91	91	SD
X-4676	untreated	"UNKNOWN,Untreated"	single	267	20	70.8	13	6.9	29	PD
X-4819	BGJ398	FGFR	single	207.8	5	113.8	5	3	5	PD
X-4819	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	475.2	11	204.8	11	4.7	11	PD
X-4819	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	256.4	5	133.9	5	3	5	PD
X-4819	BYL719	PIK3CA	single	398.7	11	173	11	4.1	11	PD
X-4819	BYL719 + LGH447	"PIK3CA,PIM"	combo	224.5	5	131.2	5	3	5	PD
X-4819	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	435.4	5	233.5	5	3	5	PD
X-4819	cetuximab	EGFR	single	192.2	5	106	5	3	5	PD
X-4819	CGM097	MDM2	single	290.6	5	162.7	5	3	5	PD
X-4819	CKX620	MAPK	single	-58.1	17	-14.4	17	29.5	46	SD-->PD
X-4819	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	442.8	20	90.1	13	5.9	20	PD
X-4819	HDM201	MDM2	single	388.8	5	189.1	5	3	5	PD
X-4819	erlotinib	EGFR	single	553.9	5	297.2	5	3	5	PD
X-4819	HSP990	HSP90	single	253.8	5	131.1	5	3	5	PD
X-4819	INC280	MET	single	601	11	227	11	4	11	PD
X-4819	LCL161 + paclitaxel	"BIRC2,TUBB,Tubulin"	combo	492.2	11	161.1	11	6.7	11	PD
X-4819	LEE011	"CDK4,CDK6,CDK4/6"	single	316	5	187.9	5	3	5	PD
X-4819	LGH447	PIM	single	364.4	11	196.9	11	3.4	11	PD
X-4819	LLM871	FGFR2/4	single	344.2	10	182	10	3	10	PD
X-4819	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-8.8	13	17.9	13	20.9	27	SD-->PD
X-4819	paclitaxel	Tubulin	single	724	11	379.8	11	3	11	PD
X-4819	untreated	"UNKNOWN,Untreated"	single	253.4	5	123.8	5	3	5	PD
X-4819	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	556.6	20	100.5	13	5.529411765	21	PD
X-4824	BGJ398	FGFR	single	165.4	22	27.8	11	13.5	34	PD
X-4824	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-27	68	-5.4	88	88	88	SD
X-4824	BYL719	PIK3CA	single	5.8	11	1.4	11	39	39	SD-->PD
X-4824	BYL719 + LEE011	"PIK3CA,CDK4/6"	combo	-63.3	50	-12.7	50	50	50	SD
X-4824	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	10.9	15	10.2	11	43	43	SD-->PD
X-4824	CGM097	MDM2	single	143.1	22	25.9	11	14.5	34	PD
X-4824	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-54.4	40	-30.4	43	43	43	PR
X-4824	HDM201	MDM2	single	138	20	21.8	13	17.9	40	PD
X-4824	INC424	JAK	single	75.7	23	41.5	12	33	33	PD
X-4824	LEE011	"CDK4,CDK6,CDK4/6"	single	85	22	17.4	11	33.3	34	PD
X-4824	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-84	94	-46.5	94	94	94	PR
X-4824	LFA102	PRLR 	single	69.9	21	18.8	11	28.9	35	PD
X-4824	LJM716	ERBB3	single	50.7	23	10.7	12	35.4	37	PD
X-4824	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	-28.8	75	-13.3	92	92	92	SD
X-4824	LKA136	"NTRK1,NTRK2,NTRK3"	single	152	23	31.4	12	18.2	33	PD
X-4824	LLM871	FGFR2/4	single	60	21	27.9	11	35	35	PD
X-4824	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	1.9	38	10	13	45	45	SD
X-4824	paclitaxel	Tubulin	single	124.3	21	35.9	11	18	35	PD
X-4824	tamoxifen	ESR1	single	171.7	20	39.5	17	14.6	34	PD
X-4824	trastuzumab	ERBB2	single	137.1	21	28.8	11	16.9	21	PD
X-4824	untreated	"UNKNOWN,Untreated"	single	199	21	39.3	11	12.9	34	PD
X-4832	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	319.1	14	121.5	14	6	14	PD
X-4832	BKM120 + encorafenib	"panPI3K,BRAF,BRAF,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	111.1	14	63.3	11	9.3	14	PD
X-4832	CGM097	MDM2	single	-20.5	14	2.3	14	14	14	SD
X-4832	dacarbazine	chemotherapy	single	-0.5	4	-0.3	4	4	4	SD
X-4832	LDE225	SMO	single	289.3	7	133.3	7	4	7	PD
X-4832	LDK378	ALK	single	128.6	6	60	6	4.9	6	PD
X-4832	LEE011	"CDK4,CDK6,CDK4/6"	single	164.5	9	99.7	9	6	9	PD
X-4832	LEE011 + encorafenib	"CDK4/6,BRAF,BRAF,CDK4,CDK6"	combo	50.8	22	50.2	11	22	22	PD
X-4832	WNT974	PORCN	single	223.3	14	91.7	11	6.5	14	PD
X-4832	LGW813	IAP	single	201.2	19	78.9	12	8.3	19	PD
X-4832	encorafenib	BRAF	single	643.4	14	323.9	14	6	14	PD
X-4832	encorafenib + binimetinib	"BRAF,MAP2K1,MAP2K2,MAPK"	combo	212.5	22	59.4	11	9.5	22	PD
X-4832	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	288.6	21	69.5	14	10.9	21	PD
X-4832	TAS266	DR5	single	488.7	21	81.9	14	10.1	21	PD
X-4832	untreated	"UNKNOWN,Untreated"	single	498.4	14	289.5	14	6	14	PD
X-4849	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	168.3	20	67.1	13	7.9	20	PD
X-4849	BKM120 + encorafenib	"panPI3K,BRAF,BRAF,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-78.4	217	-48.2	237	237	237	PR
X-4849	CGM097	MDM2	single	44.3	21	8.3	11	24	24	PD
X-4849	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	156.7	20	28.3	12	12.5	27	PD
X-4849	dacarbazine	chemotherapy	single	222.9	21	41.7	11	10.9	25	PD
X-4849	LDE225	SMO	single	32.4	9	16.8	9	9	9	SD
X-4849	LDK378	ALK	single	347.6	21	83.9	14	6.6	24	PD
X-4849	LEE011	"CDK4,CDK6,CDK4/6"	single	72.7	24	38.3	13	24	24	PD
X-4849	LEE011 + encorafenib	"CDK4/6,BRAF,BRAF,CDK4,CDK6"	combo	-29	11	-18	11	77	77	SD-->-->PD
X-4849	LEE011 + binimetinib	"CDK4,CDK6,MAP2K1,MAP2K2,CDK4/6,MAPK"	combo	-41.3	13	-27.7	20	63.9	65	SD-->PD
X-4849	WNT974	PORCN	single	430.7	15	148.8	14	5.8	15	PD
X-4849	LGW813	IAP	single	193.5	13	84.5	13	9.4	13	PD
X-4849	encorafenib	BRAF	single	268.1	20	43.7	11	10.9	24	PD
X-4849	encorafenib + binimetinib	"BRAF,MAP2K1,MAP2K2,MAPK"	combo	-8.4	28	4.9	47	77	77	SD-->PD
X-4849	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	53.5	20	29.4	13	24	24	PD
X-4849	TAS266	DR5	single	494.8	21	135	11	3.7	24	PD
X-4849	untreated	"UNKNOWN,Untreated"	single	359.7	21	134.1	11	3	24	PD
X-4888	BGJ398	FGFR	single	-15.4	11	-8.8	14	84	84	SD-->PD
X-4888	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	60.1	28	24.5	11	42	77	PD
X-4888	BYL719	PIK3CA	single	-11.1	32	8.3	60	84	84	SD-->-->PD
X-4888	BYL719 + LEE011	"PIK3CA,CDK4/6"	combo	-54.3	95	-24.4	102	102	102	PR
X-4888	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	6.2	17	14	17	44.7	80	SD-->PD
X-4888	CGM097	MDM2	single	88.5	21	36.5	11	21.6	70	PD
X-4888	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-4.6	11	-5.1	11	85.3	112	SD-->PD
X-4888	HDM201	MDM2	single	40.2	21	17	11	45.1	84	PD
X-4888	INC424	JAK	single	67.3	21	19.2	14	27.3	59	PD
X-4888	LEE011	"CDK4,CDK6,CDK4/6"	single	-1.3	52	18.7	52	94	94	SD-->PD
X-4888	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-30	87	-8.2	115	115	115	SD
X-4888	LFA102	PRLR 	single	-11	10	-5.8	13	31.3	48	SD-->PD
X-4888	LJM716	ERBB3	single	136.8	21	52.7	11	10.8	35	PD
X-4888	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	107.4	20	19.1	13	19.2	90	PD
X-4888	LKA136	"NTRK1,NTRK2,NTRK3"	single	122.4	25	49.8	11	16.5	53	PD
X-4888	LLM871	FGFR2/4	single	22	20	21.4	13	38.1	69	SD
X-4888	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	36.9	21	13.2	11	39.7	98	PD
X-4888	paclitaxel	Tubulin	single	-59.2	101	-17.7	55	104	104	SD-->-->PD
X-4888	tamoxifen	ESR1	single	173	21	51.8	11	10.5	42	PD
X-4888	trastuzumab	ERBB2	single	154.7	20	50.3	13	17.1	48	PD
X-4888	untreated	"UNKNOWN,Untreated"	single	93.4	21	31.3	11	22	56	PD
X-4888	LFW527 + everolimus	"IGF1R,MTOR"	combo	-14.6	10	-5.2	14	52.77536232	66	SD-->PD
X-4927	abraxane	Tubulin	single	386.3	17	91.4	11	5.2	17	PD
X-4927	abraxane + gemcitabine	"Tubulin,chemotherapy"	combo	-65.6	38	-30.4	48	48	48	PR
X-4927	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	616.7	21	161.1	13	5.1	21	PD
X-4927	BKM120 + LDE225	"panPI3K,SMO"	combo	19.7	18	13.5	11	35.6	55	SD-->PD
X-4927	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-68.1	49	-30.6	81	81	81	PR
X-4927	BYL719	PIK3CA	single	319.4	18	85.7	11	6.4	18	PD
X-4927	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-41.8	9	-13.4	14	25.4	52	SD-->PD
X-4927	HDM201	MDM2	single	179.5	20	97.9	14	9.9	32	PD
X-4927	figitumumab	IGF1R	single	209	17	61.8	11	7	17	PD
X-4927	figitumumab + binimetinib	"IGF1R,MAPK"	combo	701.4	20	57.8	12	7.8	20	PD
X-4927	gemcitabine-50mpk	chemotherapy	single	-70.5	19	-39.1	25	41.3	60	PR-->PD
X-4927	INC424	JAK	single	196.3	24	48.5	16	12.5	28	PD
X-4927	INC424 + binimetinib	"JAK,MAPK"	combo	187.2	21	16.7	11	18.1	62	PD
X-4927	LEE011	"CDK4,CDK6,CDK4/6"	single	50.1	36	34	13	24	50	PD
X-4927	WNT974	PORCN	single	286.1	16	98.6	13	6.9	16	PD
X-4927	LKA136	"NTRK1,NTRK2,NTRK3"	single	346.1	19	59.9	11	8.8	19	PD
X-4927	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-48.5	84	-26	94	94	94	SD
X-4927	binimetinib-3.5mpk	MAPK	single	477.4	20	120.8	12	6.3	23	PD
X-4927	trametinib	MAPK	single	331.4	18	195.4	13	5.1	18	PD
X-4927	untreated	"UNKNOWN,Untreated"	single	501.8	19	128.4	11	5.3	19	PD
X-4949	BGJ398	FGFR	single	57.9	21	39.2	13	24	41	PD
X-4949	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-47	18	-21.2	26	26	26	SD
X-4949	BYL719	PIK3CA	single	-11.5	10	-7	13	38.4	41	SD-->PD
X-4949	BYL719 + LEE011	"PIK3CA,CDK4/6"	combo	-29.6	11	-16.6	11	24.7	32	SD-->PD
X-4949	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	59.6	22	-10	12	39.2	46	PD
X-4949	CGM097	MDM2	single	223.7	21	76	13	8.7	27	PD
X-4949	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	196.5	21	63.4	13	12	41	PD
X-4949	HDM201	MDM2	single	122.7	21	100.8	13	8	27	PD
X-4949	INC424	JAK	single	322.6	22	35.9	12	12.5	32	PD
X-4949	LEE011	"CDK4,CDK6,CDK4/6"	single	101.7	20	16.3	14	19.5	27	PD
X-4949	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	7.2	15	6.2	11	26.9	32	SD-->PD
X-4949	LFA102	PRLR 	single	227.2	21	82.7	13	10.4	27	PD
X-4949	LJM716	ERBB3	single	134.1	20	26.5	14	18	34	PD
X-4949	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	139	20	17.4	14	18.6	34	PD
X-4949	LKA136	"NTRK1,NTRK2,NTRK3"	single	456.7	22	78.9	12	6	26	PD
X-4949	LLM871	FGFR2/4	single	152.6	21	19.5	13	14.9	27	PD
X-4949	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	172.7	22	30.1	12	13.4	46	PD
X-4949	paclitaxel	Tubulin	single	133.7	21	44.3	13	18.7	41	PD
X-4949	tamoxifen	ESR1	single	439	20	110.7	14	6.2	22	PD
X-4949	trastuzumab	ERBB2	single	95	24	36.1	14	18.3	34	PD
X-4949	untreated	"UNKNOWN,Untreated"	single	615.5	20	154.8	14	4.6	20	PD
X-5189	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	0.6	13	-0.2	13	18	18	SD
X-5189	BKM120 + encorafenib	"panPI3K,BRAF,BRAF,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	74.6	21	12.7	14	21	21	PD
X-5189	CGM097	MDM2	single	75.3	21	10.4	11	24.3	35	PD
X-5189	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	74.4	23	31.2	13	24	24	PD
X-5189	dacarbazine	chemotherapy	single	19.3	10	16.6	13	13	13	SD
X-5189	LDE225	SMO	single	5.3	13	10.1	13	18	18	SD
X-5189	LDK378	ALK	single	156.2	21	23.7	13	16	21	PD
X-5189	LEE011	"CDK4,CDK6,CDK4/6"	single	14.4	11	2.8	11	35	35	SD-->PD
X-5189	LEE011 + encorafenib	"CDK4/6,BRAF,BRAF,CDK4,CDK6"	combo	141.8	21	54.7	14	11.4	21	PD
X-5189	LEE011 + binimetinib	"CDK4,CDK6,MAP2K1,MAP2K2,CDK4/6,MAPK"	combo	-90.7	35	-63.1	41	41	41	PR
X-5189	WNT974	PORCN	single	695.5	18	203.4	13	4	18	PD
X-5189	LGW813	IAP	single	22.3	18	1.3	13	32	32	SD-->PD
X-5189	encorafenib	BRAF	single	486.6	21	162.1	11	3	21	PD
X-5189	encorafenib + binimetinib	"BRAF,MAP2K1,MAP2K2,MAPK"	combo	-56.8	21	-34.5	27	58	58	PR-->PD
X-5189	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-70.6	16	-34.5	28	64	64	PR-->PD
X-5189	TAS266	DR5	single	-86.5	11	-72.4	42	92	92	PR-->PD
X-5189	untreated	"UNKNOWN,Untreated"	single	495.8	21	132.4	11	4	21	PD
X-5205	abraxane + gemcitabine	"Tubulin,chemotherapy"	combo	-82.6	48	-65.2	58	58	58	PR
X-5205	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	118.8	25	26	11	15.6	34	PD
X-5205	BKM120 + LDE225	"panPI3K,SMO"	combo	-77.3	36	-43.8	55	86	86	PR-->PD
X-5205	BKM120 + binimetinib	"panPI3K,MAPK,MAP2K1,MAP2K2,PIK3CA,PIK3CB,PIK3CG,PIK3CD"	combo	-43.6	35	-25.5	49	84	84	SD-->-->PD
X-5205	BYL719	PIK3CA	single	-0.5	11	-2.9	11	45	45	SD-->PD
X-5205	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	48.9	21	7.8	11	32.4	45	PD
X-5205	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	44.1	24	20.2	11	35.6	45	PD
X-5205	HDM201	MDM2	single	-95.6	24	-68.2	24	24	24	CR
X-5205	figitumumab	IGF1R	single	38.2	37	-4.3	12	40.8	83	PD
X-5205	gemcitabine-50mpk	chemotherapy	single	-100	83	-76.7	112	112	112	CR
X-5205	INC424 + binimetinib	"JAK,MAPK"	combo	59.6	25	12.8	11	32.8	62	PD
X-5205	WNT974	PORCN	single	60.8	27	13.4	13	34.4	62	PD
X-5205	LKA136	"NTRK1,NTRK2,NTRK3"	single	12.2	10	3.1	14	35.7	38	SD-->PD
X-5205	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-9.2	9	3.7	16	34	34	SD-->PD
X-5205	binimetinib-3.5mpk	MAPK	single	-100	33	-48.2	46	46	46	CR
X-5205	trametinib	MAPK	single	166.7	14	45.5	11	11.8	14	PD
X-5205	untreated	"UNKNOWN,Untreated"	single	268.6	20	75.7	13	7.5	30	PD
X-5238	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	89.7	22	27.3	14	30.27027027	45	PD
X-5249	BGJ398	FGFR	single	-100	63	-84.7	91	91	91	CR
X-5249	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-34.1	11	-18.2	11	40	40	SD-->PD
X-5249	BYL719	PIK3CA	single	296.9	20	77.4	14	8.4	28	PD
X-5249	BYL719 + LEE011	"PIK3CA,CDK4/6"	combo	-37.7	27	-13.7	31	31	31	SD
X-5249	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	152.2	22	52.2	12	9.5	32	PD
X-5249	CGM097	MDM2	single	177.7	21	83.1	13	8.4	27	PD
X-5249	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	78.4	25	29.6	15	27.8	32	PD
X-5249	HDM201	MDM2	single	199.4	20	37.9	14	12.1	28	PD
X-5249	INC424	JAK	single	380.1	26	89.5	12	4.3	32	PD
X-5249	LEE011	"CDK4,CDK6,CDK4/6"	single	-72.7	17	-38.4	27	51.4	56	PR-->PD
X-5249	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-22.2	31	0.2	35	63	63	SD-->PD
X-5249	LFA102	PRLR 	single	221.8	28	81	14	7.5	34	PD
X-5249	LJM716	ERBB3	single	-81.2	91	-8.2	91	13.5	91	SD
X-5249	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	343.3	20	93.8	14	3	20	PD
X-5249	LKA136	"NTRK1,NTRK2,NTRK3"	single	136.6	22	47	12	12.7	32	PD
X-5249	LLM871	FGFR2/4	single	244.2	21	42.8	13	11.6	27	PD
X-5249	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	24.3	22	11.5	12	34.4	39	SD-->PD
X-5249	paclitaxel	Tubulin	single	17.1	27	2.7	13	48	48	SD-->PD
X-5249	tamoxifen	ESR1	single	168.7	20	42.6	14	13.3	34	PD
X-5249	trastuzumab	ERBB2	single	162.9	20	45.8	14	11.8	34	PD
X-5249	untreated	"UNKNOWN,Untreated"	single	116.8	20	60.5	14	9.3	63	PD
X-5249	LFW527 + everolimus	"IGF1R,MTOR"	combo	-11.6	10	-4.1	14	47.8	73	SD-->PD
X-5254	5FU	chemotherapy	single	-25.4	9	-19.2	14	35	35	SD-->PD
X-5254	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	79.8	21	4.3	14	22.9	23	PD
X-5254	BKM120 + LJC049	"panPI3K,TNKS"	combo	150.5	22	42.4	12	12.6	25	PD
X-5254	BYL719	PIK3CA	single	50.8	21	7.8	14	26	26	PD
X-5254	BYL719 + cetuximab	"PIK3CA,EGFR"	combo	104.8	21	43.7	15	20.4	28	PD
X-5254	BYL719 + cetuximab + encorafenib	"PIK3CA,EGFR,BRAF"	combo	69.3	21	14.2	15	23.8	28	PD
X-5254	BYL719 + encorafenib	"PIK3CA,BRAF"	combo	154.1	21	39.9	13	11.5	21	PD
X-5254	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-28.3	14	-25.4	21	47	47	SD-->PD
X-5254	BYL719 + binimetinib	"PIK3CA,MAPK"	combo	71.6	21	33	12	26.3	27	PD
X-5254	cetuximab	EGFR	single	146.7	20	3	13	17.4	31	PD
X-5254	cetuximab + encorafenib	"EGFR,BRAF"	combo	83.9	21	40.7	13	25.2	55	PD
X-5254	CGM097	MDM2	single	398.6	20	56.1	11	9.8	20	PD
X-5254	CKX620	MAPK	single	36.1	20	20.9	11	27	27	PD
X-5254	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-39.3	11	-23.8	11	35	35	SD-->PD
X-5254	HDM201	MDM2	single	104.6	21	14	14	16.8	23	PD
X-5254	LEE011	"CDK4,CDK6,CDK4/6"	single	139.8	21	21.5	14	16.5	23	PD
X-5254	encorafenib	BRAF	single	502.4	21	77.3	12	8.5	21	PD
X-5254	LJC049	TNKS	single	296.7	20	37.3	11	11.1	20	PD
X-5254	LKA136	"NTRK1,NTRK2,NTRK3"	single	132.3	21	30	12	11.2	26	PD
X-5254	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	69.8	21	25.7	13	22.4	34	PD
X-5254	untreated	"UNKNOWN,Untreated"	single	247.9	21	40.8	11	12.1	28	PD
X-5254	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	95.3	22	24.45	12	22.78896882	61	PD
X-5267	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	-32.9	10	-25.15	17	48	48	SD-->PD
X-5355	BGJ398	FGFR	single	279	21	65.5	11	8.3	21	PD
X-5355	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-64.9	63	-48.5	88	91	91	PR
X-5355	BYL719	PIK3CA	single	8.5	21	9	11	58.6	70	SD-->PD
X-5355	BYL719 + LEE011	"PIK3CA,CDK4/6"	combo	-50.4	28	-32.4	52	52	52	PR
X-5355	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-21	10	-14.1	24	59	59	SD-->PD
X-5355	CGM097	MDM2	single	339.2	21	79.1	11	8.1	21	PD
X-5355	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-17.9	11	-13.7	11	95	95	SD-->PD
X-5355	HDM201	MDM2	single	258.9	21	66.1	11	8.1	28	PD
X-5355	INC424	JAK	single	49	24	25.3	13	77.9	90	PD
X-5355	LEE011	"CDK4,CDK6,CDK4/6"	single	-4.6	10	4.3	13	42.8	97	SD-->PD
X-5355	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-72.1	101	-56.3	104	104	104	PR
X-5355	LFA102	PRLR 	single	198.3	20	57.4	13	11.2	34	PD
X-5355	LJM716	ERBB3	single	164.1	22	19.6	11	19	39	PD
X-5355	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	277.4	20	95.3	13	7.5	20	PD
X-5355	LKA136	"NTRK1,NTRK2,NTRK3"	single	92.8	21	34.8	14	21.4	49	PD
X-5355	LLM871	FGFR2/4	single	19.6	20	27.3	20	26.2	41	SD
X-5355	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-63.1	18	-45.8	25	121.6	140	PR-->PD
X-5355	paclitaxel	Tubulin	single	-71.7	45	-45.7	62	85.1	97	PR-->PD
X-5355	tamoxifen	ESR1	single	273	21	48.6	11	10.5	21	PD
X-5355	trastuzumab	ERBB2	single	202.4	20	60.2	13	9.2	27	PD
X-5355	untreated	"UNKNOWN,Untreated"	single	118.3	21	32.4	11	14.7	56	PD
X-5355	LFW527 + everolimus	"IGF1R,MTOR"	combo	-62	72	-45.725	79	149	149	PR-->-->PD
X-5405	5FU	chemotherapy	single	86	20	7.1	13	22.4	34	PD
X-5405	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	55.3	21	-0.3	11	26.5	49	PD
X-5405	BKM120 + LJC049	"panPI3K,TNKS"	combo	8.5	10	5.6	14	17	17	SD-->PD
X-5405	BYL719	PIK3CA	single	293	22	53.1	12	10.1	26	PD
X-5405	BYL719 + cetuximab	"PIK3CA,EGFR"	combo	-4.3	11	-1.6	11	39.2	53	SD-->PD
X-5405	BYL719 + cetuximab + encorafenib	"PIK3CA,EGFR,BRAF"	combo	225.2	20	61.6	13	10.6	28	PD
X-5405	BYL719 + encorafenib	"PIK3CA,BRAF"	combo	222.7	26	29.6	12	13.5	36	PD
X-5405	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-21.5	26	-13.5	12	89	89	SD-->PD
X-5405	BYL719 + binimetinib	"PIK3CA,MAPK"	combo	-47.3	50	-17.5	15	50	50	SD-->PD
X-5405	cetuximab	EGFR	single	88.7	22	32.6	11	18.4	28	PD
X-5405	cetuximab + encorafenib	"EGFR,BRAF"	combo	537.3	21	82.9	11	7.8	21	PD
X-5405	CGM097	MDM2	single	88.1	21	28.4	14	22.5	24	PD
X-5405	CKX620	MAPK	single	61.8	31	23.3	14	31	31	PD
X-5405	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	92.1	24	14.3	14	28.2	73	PD
X-5405	HDM201	MDM2	single	50.5	25	1.4	11	35	35	PD
X-5405	LEE011	"CDK4,CDK6,CDK4/6"	single	-0.9	9	-2.4	13	35.9	69	SD-->PD
X-5405	encorafenib	BRAF	single	258	22	17.2	12	16.2	29	PD
X-5405	LJC049	TNKS	single	530.2	22	95.9	12	6.7	22	PD
X-5405	LKA136	"NTRK1,NTRK2,NTRK3"	single	64.7	22	5.3	12	26.7	43	PD
X-5405	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-38.9	13	-20.4	13	48	48	SD-->PD
X-5405	untreated	"UNKNOWN,Untreated"	single	280.2	21	63.1	14	9	28	PD
X-5421	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	262.4	18	101.52	11	3.860927152	18	PD
X-5438	5FU	chemotherapy	single	109.8	27	41.7	15	17.4	50	PD
X-5438	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-12.7	10	-5.1	15	69.2	81	SD-->PD
X-5438	BKM120 + LJC049	"panPI3K,TNKS"	combo	191	27	53	13	14.9	47	PD
X-5438	BYL719	PIK3CA	single	0.6	10	-8.2	15	32	57	SD-->PD
X-5438	BYL719 + cetuximab	"PIK3CA,EGFR"	combo	24.1	18	2.5	13	55.5	92	SD-->PD
X-5438	BYL719 + cetuximab + encorafenib	"PIK3CA,EGFR,BRAF"	combo	23	66	20.1	12	74	74	SD
X-5438	BYL719 + encorafenib	"PIK3CA,BRAF"	combo	-40.7	74	-23.3	42	92	92	SD
X-5438	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	40	74	32.4	12	74	74	PD
X-5438	BYL719 + binimetinib	"PIK3CA,MAPK"	combo	-21.9	26	-9.5	31	105	105	SD-->PD
X-5438	cetuximab	EGFR	single	-16.1	12	-13.3	12	60.8	75	SD-->PD
X-5438	cetuximab + encorafenib	"EGFR,BRAF"	combo	-26.5	15	-11.7	18	92	92	SD-->PD
X-5438	CGM097	MDM2	single	-9.3	13	-5.3	13	105	105	SD-->PD
X-5438	CKX620	MAPK	single	-0.7	16	-2.4	13	64.1	77	SD-->PD
X-5438	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-0.4	10	7.3	15	53.9	59	SD-->PD
X-5438	HDM201	MDM2	single	78	20	29.5	15	24.4	84	PD
X-5438	LEE011	"CDK4,CDK6,CDK4/6"	single	15.2	10	7.7	15	50.9	81	SD-->PD
X-5438	encorafenib	BRAF	single	184.8	22	51	12	10.7	58	PD
X-5438	LJC049	TNKS	single	184.9	22	54.5	11	6.8	44	PD
X-5438	LKA136	"NTRK1,NTRK2,NTRK3"	single	-7.4	10	1.9	15	41.9	85	SD-->PD
X-5438	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-16.5	18	-4.3	37	106	106	SD-->PD
X-5438	untreated	"UNKNOWN,Untreated"	single	1.7	15	-1.7	13	92	92	SD-->PD
X-5438	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	100.5	32	11.5	12	11.51981195	32	PD
X-5446	5FU	chemotherapy	single	-2.4	14	3.1	14	23.3	42	SD-->PD
X-5446	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	160.6	21	40	11	12.7	25	PD
X-5446	BKM120 + LJC049	"panPI3K,TNKS"	combo	119.8	20	31.1	13	17.8	31	PD
X-5446	BYL719	PIK3CA	single	50.4	21	17.7	11	30.9	46	PD
X-5446	BYL719 + cetuximab	"PIK3CA,EGFR"	combo	11.8	11	12.1	11	68.6	84	SD-->PD
X-5446	BYL719 + cetuximab + encorafenib	"PIK3CA,EGFR,BRAF"	combo	223.2	27	54.9	14	13.2	35	PD
X-5446	BYL719 + encorafenib	"PIK3CA,BRAF"	combo	95.8	25	12.4	13	18.8	31	PD
X-5446	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	154.1	30	74.7	14	9.2	35	PD
X-5446	BYL719 + binimetinib	"PIK3CA,MAPK"	combo	-38.7	11	-14.4	24	84	84	SD-->PD
X-5446	cetuximab	EGFR	single	149.6	21	43.6	14	14.9	42	PD
X-5446	cetuximab + encorafenib	"EGFR,BRAF"	combo	157.7	23	91.9	14	7.4	35	PD
X-5446	CGM097	MDM2	single	375.3	21	91.4	11	8	25	PD
X-5446	CKX620	MAPK	single	76.2	25	24	11	28.8	52	PD
X-5446	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	40.7	21	16.7	11	35	35	PD
X-5446	HDM201	MDM2	single	62.9	25	14.7	11	29.9	46	PD
X-5446	LEE011	"CDK4,CDK6,CDK4/6"	single	74.3	20	29.4	13	15.4	27	PD
X-5446	encorafenib	BRAF	single	328.8	25	85.2	11	6.9	25	PD
X-5446	LJC049	TNKS	single	284.2	21	58.9	11	9.8	25	PD
X-5446	LKA136	"NTRK1,NTRK2,NTRK3"	single	383	21	85.9	11	6.8	25	PD
X-5446	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	314.1	20	78.8	13	6.8	27	PD
X-5446	untreated	"UNKNOWN,Untreated"	single	163.1	20	45.1	13	12.4	63	PD
X-5446	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	4.3	10	1.5	15	26.26697892	56	SD-->PD
X-5494	5FU	chemotherapy	single	11.4	9	8.8	13	51.5	55	SD-->PD
X-5494	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-47.2	24	-11.3	89	89	89	SD
X-5494	BKM120 + LJC049	"panPI3K,TNKS"	combo	-44.9	74	-21.9	86	86	86	SD
X-5494	BYL719	PIK3CA	single	110.1	21	35	13	20.1	25	PD
X-5494	BYL719 + cetuximab + encorafenib	"PIK3CA,EGFR,BRAF"	combo	-91.3	84	-68.8	88	88	88	PR
X-5494	BYL719 + encorafenib	"PIK3CA,BRAF"	combo	-24.1	9	-15.7	26	51.5	54	SD-->PD
X-5494	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-80.7	34	-62.8	49	53	53	PR
X-5494	BYL719 + binimetinib	"PIK3CA,MAPK"	combo	-77	42	-59.2	81	81	81	PR
X-5494	cetuximab + encorafenib	"EGFR,BRAF"	combo	-100	53	-75.6	90	90	90	CR
X-5494	CGM097	MDM2	single	136.7	24	54.9	11	9.9	36	PD
X-5494	CKX620	MAPK	single	79.9	32	79	11	6.2	36	PD
X-5494	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	33.9	21	-30.9	13	25	25	SD-->PD
X-5494	HDM201	MDM2	single	119	32	68.8	11	7.7	36	PD
X-5494	LEE011	"CDK4,CDK6,CDK4/6"	single	20.9	15	23.1	15	36	36	SD
X-5494	encorafenib	BRAF	single	54.4	29	27.5	11	30.9	36	PD
X-5494	LJC049	TNKS	single	-85.5	25	-61.4	29	54.1	57	PR-->PD
X-5494	LKA136	"NTRK1,NTRK2,NTRK3"	single	123.6	21	16.1	13	19.9	25	PD
X-5494	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-40.4	15	-20.9	29	57	57	SD-->PD
X-5494	untreated	"UNKNOWN,Untreated"	single	116.9	20	45.4	11	10.8	36	PD
X-5495	5FU	chemotherapy	single	41.9	20	15	12	49	55	PD
X-5495	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-4.5	21	3.2	21	88	88	SD-->PD
X-5495	BKM120 + LJC049	"panPI3K,TNKS"	combo	-4.9	13	13	16	16	16	SD
X-5495	BYL719	PIK3CA	single	28.4	27	2.9	11	46	46	SD-->PD
X-5495	BYL719 + cetuximab	"PIK3CA,EGFR"	combo	26.1	49	24.4	17	83.4	125	SD
X-5495	BYL719 + cetuximab + encorafenib	"PIK3CA,EGFR,BRAF"	combo	259.5	17	84.9	17	10	17	PD
X-5495	BYL719 + encorafenib	"PIK3CA,BRAF"	combo	87.1	35	45.5	13	15.6	45	PD
X-5495	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-15.9	14	-12.1	17	31	31	SD-->PD
X-5495	BYL719 + binimetinib	"PIK3CA,MAPK"	combo	-83.5	29	-45.3	39	39	39	PR
X-5495	cetuximab	EGFR	single	14.8	21	36.1	32	32	32	PD
X-5495	cetuximab + encorafenib	"EGFR,BRAF"	combo	226.7	17	95.8	17	8.4	17	PD
X-5495	CGM097	MDM2	single	55.1	20	29.2	14	29.1	32	PD
X-5495	CKX620	MAPK	single	-20.7	10	-5.1	10	10	10	SD
X-5495	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-30.5	38	-20	70	90	90	SD-->-->PD
X-5495	HDM201	MDM2	single	97.3	21	33.2	15	21.3	28	PD
X-5495	LEE011	"CDK4,CDK6,CDK4/6"	single	113.3	20	37.2	12	13.3	33	PD
X-5495	encorafenib	BRAF	single	132	20	11.6	11	16.8	32	PD
X-5495	LJC049	TNKS	single	499.4	20	49.6	11	8.1	24	PD
X-5495	LKA136	"NTRK1,NTRK2,NTRK3"	single	119.9	24	10.6	11	15.8	32	PD
X-5495	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-36.9	15	-18.3	15	45.9	50	SD-->PD
X-5495	untreated	"UNKNOWN,Untreated"	single	194.6	23	72.8	11	8.9	29	PD
X-5495	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	-38.2	13	-20.0875	23	34	34	SD
X-5502	BGJ398	FGFR	single	95.4	21	37.6	14	24	24	PD
X-5502	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-14.6	63	7	107	135.4	153	SD-->-->PD
X-5502	BYL719	PIK3CA	single	-9.2	49	-0.6	94	150	150	SD-->-->PD
X-5502	BYL719 + LEE011	"PIK3CA,CDK4/6"	combo	-46	23	-21	27	27	27	SD
X-5502	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-9.4	12	-4.6	14	44.5	67	SD-->PD
X-5502	CGM097	MDM2	single	137	21	19.1	14	16.9	28	PD
X-5502	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	-6.5	10	-1.7	14	128.4	153	SD-->PD
X-5502	HDM201	MDM2	single	78.5	20	21.4	14	26	49	PD
X-5502	INC424	JAK	single	10.2	10	7	14	45.3	56	SD-->PD
X-5502	LEE011	"CDK4,CDK6,CDK4/6"	single	13	21	9.8	11	55.7	74	SD-->PD
X-5502	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-63.9	45	-27.8	45	45	45	PR
X-5502	LFA102	PRLR 	single	81.8	20	19.5	14	22.9	42	PD
X-5502	LJM716	ERBB3	single	71	21	4.3	11	27.7	39	PD
X-5502	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	76.4	20	19.7	14	25.3	49	PD
X-5502	LKA136	"NTRK1,NTRK2,NTRK3"	single	58.3	21	6.3	14	27.4	48	PD
X-5502	LLM871	FGFR2/4	single	55.1	21	17.2	14	33.1	55	PD
X-5502	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	-3.7	12	-2.6	12	67	67	SD-->PD
X-5502	paclitaxel	Tubulin	single	-28.1	41	5.3	41	41	41	SD
X-5502	tamoxifen	ESR1	single	97.2	21	14.5	12	21.4	67	PD
X-5502	trastuzumab	ERBB2	single	63.7	21	15	14	25.3	56	PD
X-5502	untreated	"UNKNOWN,Untreated"	single	4.6	11	2.5	11	48.7	88	SD-->PD
X-5502	LFW527 + everolimus	"IGF1R,MTOR"	combo	-17.3	13	-9.64	13	80.70442287	97	SD-->PD
X-5536	LFW527 + binimetinib	"IGF1R,MAP2K1,MAP2K2"	combo	51.5	22	6	11	34.85714286	39	PD
X-5541	LFW527 + everolimus	"IGF1R,MTOR"	combo	-54.5	27	-38.29333333	48	69	69	PR-->PD
X-5578	5FU	chemotherapy	single	249.5	20	43.5	15	13.2	33	PD
X-5578	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	12.9	21	1	14	41.5	43	SD-->PD
X-5578	BKM120 + LJC049	"panPI3K,TNKS"	combo	-47.4	28	-5.6	28	28	28	SD
X-5578	BYL719	PIK3CA	single	140.7	26	15.8	11	21.9	80	PD
X-5578	BYL719 + cetuximab	"PIK3CA,EGFR"	combo	-25.3	33	38.7	62	8.1	71	PD
X-5578	BYL719 + cetuximab + encorafenib	"PIK3CA,EGFR,BRAF"	combo	147.6	33	58.4	15	11.9	81	PD
X-5578	BYL719 + encorafenib	"PIK3CA,BRAF"	combo	-44.1	19	-27.7	28	58	58	SD-->PD
X-5578	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	-41.8	67	-8.9	72	100.2	105	SD-->PD
X-5578	BYL719 + binimetinib	"PIK3CA,MAPK"	combo	-29	9	-13.8	14	80	80	SD-->PD
X-5578	cetuximab	EGFR	single	52.9	21	18.4	14	23.7	33	PD
X-5578	cetuximab + encorafenib	"EGFR,BRAF"	combo	-13.8	18	-3.5	32	55	55	SD-->PD
X-5578	CGM097	MDM2	single	216.5	21	61.3	14	12.6	43	PD
X-5578	CKX620	MAPK	single	70	21	28.8	14	30.2	43	PD
X-5578	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	0.2	26	2.1	11	80	80	SD-->PD
X-5578	HDM201	MDM2	single	196.4	21	74.8	14	11.1	43	PD
X-5578	LEE011	"CDK4,CDK6,CDK4/6"	single	82	21	10.9	14	36	43	PD
X-5578	encorafenib	BRAF	single	16.7	13	14.4	13	24.7	42	SD-->PD
X-5578	LJC049	TNKS	single	162.8	26	39.7	11	10.9	48	PD
X-5578	LKA136	"NTRK1,NTRK2,NTRK3"	single	149.2	26	21.5	11	19.3	48	PD
X-5578	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	181.6	21	57.6	14	11.5	33	PD
X-5578	untreated	"UNKNOWN,Untreated"	single	283.4	21	57.3	14	9.9	33	PD
X-5975	BGJ398	FGFR	single	108.2	20	18.3	13	19.2	39	PD
X-5975	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	69	20	22.5	11	24.9	37	PD
X-5975	BYL719	PIK3CA	single	64.7	20	3.6	11	23.3	37	PD
X-5975	BYL719 + LEE011	"PIK3CA,CDK4/6"	combo	-93.3	54	-44.1	58	58	58	PR
X-5975	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	63.9	21	13.2	11	26.3	39	PD
X-5975	CGM097	MDM2	single	271	19	39.3	11	11	19	PD
X-5975	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	112.7	23	37.5	13	18.1	35	PD
X-5975	HDM201	MDM2	single	66.4	23	6.6	13	33.3	35	PD
X-5975	INC424	JAK	single	113.3	23	8.4	12	19.9	28	PD
X-5975	LEE011	"CDK4,CDK6,CDK4/6"	single	-100	90	-22.8	94	17.9	94	PR
X-5975	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	-100	78	-51.2	91	91	91	CR
X-5975	LFA102	PRLR 	single	8.4	105	16.2	15	105	105	SD-->PD
X-5975	LJM716	ERBB3	single	135.3	21	19.7	15	18.5	21	PD
X-5975	LKA136	"NTRK1,NTRK2,NTRK3"	single	199.7	23	26.6	12	16.1	28	PD
X-5975	LLM871	FGFR2/4	single	-95	66	-40.7	66	66	66	PR
X-5975	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	2.5	23	13.3	33	33	33	SD
X-5975	paclitaxel	Tubulin	single	-100	89	-50.9	89	89	89	CR
X-5975	tamoxifen	ESR1	single	148.8	23	29.2	12	17.1	33	PD
X-5975	untreated	"UNKNOWN,Untreated"	single	264.8	20	99.2	13	5	27	PD
X-6047	BGJ398	FGFR	single	104.7	21	18.7	14	20.7	49	PD
X-6047	BKM120	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	173.8	21	15.3	11	14.8	28	PD
X-6047	BYL719	PIK3CA	single	311.6	19	93.3	11	5.7	19	PD
X-6047	BYL719 + LEE011	"PIK3CA,CDK4/6"	combo	90.6	21	28.1	11	21.3	28	PD
X-6047	BYL719 + LJM716	"PIK3CA,ERBB3,ERBB3,PIK3CA"	combo	76.1	21	-1.6	12	22	31	PD
X-6047	CGM097	MDM2	single	453.9	14	145.4	11	4	14	PD
X-6047	CLR457	"PIK3CA,PIK3CB,PIK3CG,PIK3CD,panPI3K"	single	115.2	21	24.3	11	17.7	38	PD
X-6047	HDM201	MDM2	single	304.1	14	130.8	11	4	14	PD
X-6047	INC424	JAK	single	74.2	21	11.4	14	23.4	33	PD
X-6047	LEE011	"CDK4,CDK6,CDK4/6"	single	347	19	92.1	11	7.1	19	PD
X-6047	LEE011 + everolimus	"CDK4,CDK6,MTOR,CDK4/6"	combo	12.9	19	6.8	11	24.7	38	SD-->PD
X-6047	LFA102	PRLR 	single	562.6	17	115.1	11	4.7	17	PD
X-6047	LJM716	ERBB3	single	383.4	21	85.6	11	6.8	21	PD
X-6047	LJM716 + trastuzumab	"ERBB3,ERBB2"	combo	339.1	14	86.6	11	7.1	14	PD
X-6047	LKA136	"NTRK1,NTRK2,NTRK3"	single	249.5	21	36	14	12.8	28	PD
X-6047	LLM871	FGFR2/4	single	82.1	23	3.8	13	25.2	35	PD
X-6047	binimetinib	"MAP2K1,MAP2K2,MAPK"	single	531.2	14	185.6	11	4	14	PD
X-6047	paclitaxel	Tubulin	single	125.1	21	6	12	18.3	31	PD
X-6047	tamoxifen	ESR1	single	158.7	21	31.7	12	15.3	31	PD
X-6047	trastuzumab	ERBB2	single	402.2	21	55.8	11	8.8	21	PD
X-6047	untreated	"UNKNOWN,Untreated"	single	405.4	14	126.3	11	4.7	14	PD
